Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:PCB138
go back to main search page
Accession:CHEBI:165219 term browser browse the term
Synonyms:exact_synonym: 1,2,3-trichloro-4-(2,4,5-trichlorophenyl)benzene
 related_synonym: Formula=C12H4Cl6;   InChI=1S/C12H4Cl6/c13-7-2-1-5(11(17)12(7)18)6-3-9(15)10(16)4-8(6)14/h1-4H;   InChIKey=RPUMZMSNLZHIGZ-UHFFFAOYSA-N;   SMILES=ClC1=C(C=2C(Cl)=CC(Cl)=C(Cl)C2)C=CC(Cl)=C1Cl
 xref: CAS:35065-28-2;   Chemspider:33984
 xref_mesh: MESH:C029790



show annotations for term's descendants           Sort by:
PCB138 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCA13 ATP binding cassette subfamily A member 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ABCA13 mRNA CTD PMID:25510870 NCBI chr 7:48,171,458...48,647,497
Ensembl chr 7:48,171,458...48,647,497
JBrowse link
G ABCB1 ATP binding cassette subfamily B member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ABCB1A mRNA CTD PMID:25510870 NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
JBrowse link
G ABCB11 ATP binding cassette subfamily B member 11 affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of ABCB11 mRNA CTD PMID:21703328 NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ABCC2 mRNA CTD PMID:25510870 NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
JBrowse link
G ABCC3 ATP binding cassette subfamily C member 3 multiple interactions ISO [2,5,2',5'-tetrachlorobiphenyl co-treated with 2,2',3,5',6-pentachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3,3',4',6-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of ABCC3 mRNA CTD PMID:29142165 NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
JBrowse link
G ABCG5 ATP binding cassette subfamily G member 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ABCG5 mRNA CTD PMID:25510870 NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
JBrowse link
G ABHD1 abhydrolase domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ABHD1 mRNA CTD PMID:25510870 NCBI chr 2:27,123,815...27,130,812
Ensembl chr 2:27,123,789...27,130,812
JBrowse link
G ABLIM1 actin binding LIM protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ABLIM1 mRNA CTD PMID:25510870 NCBI chr10:114,431,110...114,801,373
Ensembl chr10:114,431,112...114,768,061
JBrowse link
G ABR ABR activator of RhoGEF and GTPase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ABR mRNA CTD PMID:25510870 NCBI chr17:1,003,519...1,229,722
Ensembl chr17:1,003,519...1,229,738
JBrowse link
G ACACB acetyl-CoA carboxylase beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ACACB mRNA CTD PMID:25510870 NCBI chr12:109,111,189...109,268,226
Ensembl chr12:109,116,587...109,268,226
JBrowse link
G ACADSB acyl-CoA dehydrogenase short/branched chain decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ACADSB mRNA CTD PMID:23829299 NCBI chr10:123,009,006...123,058,290
Ensembl chr10:123,008,979...123,058,290
JBrowse link
G ACBD5 acyl-CoA binding domain containing 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ACBD5 mRNA CTD PMID:23829299 NCBI chr10:27,182,838...27,242,111
Ensembl chr10:27,168,135...27,243,046
JBrowse link
G ACER1 alkaline ceramidase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ACER1 mRNA CTD PMID:25510870 NCBI chr19:6,306,142...6,360,368
Ensembl chr19:6,306,142...6,333,612
JBrowse link
G ACHE acetylcholinesterase (Yt blood group) decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ACHE mRNA CTD PMID:23829299 NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
JBrowse link
G ACIN1 apoptotic chromatin condensation inducer 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ACIN1 mRNA CTD PMID:23829299 NCBI chr14:23,058,564...23,095,614
Ensembl chr14:23,058,564...23,095,614
JBrowse link
G ACLY ATP citrate lyase decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ACLY protein CTD PMID:21673325 NCBI chr17:41,866,917...41,930,545
Ensembl chr17:41,866,917...41,930,542
JBrowse link
G ACOT4 acyl-CoA thioesterase 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ACOT4 mRNA CTD PMID:25510870 NCBI chr14:73,591,873...73,595,766
Ensembl chr14:73,591,873...73,595,766
JBrowse link
G ACOX3 acyl-CoA oxidase 3, pristanoyl multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ACOX3 mRNA CTD PMID:25510870 NCBI chr 4:8,355,305...8,440,723
Ensembl chr 4:8,366,282...8,440,723
JBrowse link
G ACP7 acid phosphatase 7, tartrate resistant (putative) multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ACP7 mRNA CTD PMID:25510870 NCBI chr19:39,083,788...39,111,493
Ensembl chr19:39,083,913...39,111,493
JBrowse link
G ACRBP acrosin binding protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ACRBP mRNA CTD PMID:25510870 NCBI chr12:6,638,075...6,647,432
Ensembl chr12:6,638,075...6,647,433
JBrowse link
G ACSL6 acyl-CoA synthetase long chain family member 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ACSL6 mRNA CTD PMID:25510870 NCBI chr 5:131,949,973...132,012,213
Ensembl chr 5:131,949,973...132,012,243
JBrowse link
G ACSS3 acyl-CoA synthetase short chain family member 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ACSS3 mRNA CTD PMID:25510870 NCBI chr12:81,077,871...81,261,210
Ensembl chr12:80,936,414...81,261,210
JBrowse link
G ACTBL2 actin beta like 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ACTBL2 mRNA CTD PMID:25510870 NCBI chr 5:57,480,018...57,482,811
Ensembl chr 5:57,480,018...57,482,811
JBrowse link
G ACTC1 actin alpha cardiac muscle 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ACTC1 mRNA CTD PMID:25510870 NCBI chr15:34,790,230...34,795,549
Ensembl chr15:34,790,107...34,795,589
JBrowse link
G ACTR3B actin related protein 3B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ACTR3B mRNA CTD PMID:25510870 NCBI chr 7:152,759,752...152,855,378
Ensembl chr 7:152,759,749...152,855,378
JBrowse link
G ACVR2B activin A receptor type 2B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ACVR2B mRNA CTD PMID:25510870 NCBI chr 3:38,453,890...38,493,142
Ensembl chr 3:38,453,890...38,493,142
JBrowse link
G ADAM12 ADAM metallopeptidase domain 12 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADAM12 mRNA CTD PMID:25510870 NCBI chr10:126,012,391...126,388,477
Ensembl chr10:126,012,381...126,388,477
JBrowse link
G ADAM22 ADAM metallopeptidase domain 22 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADAM22 mRNA CTD PMID:25510870 NCBI chr 7:87,934,251...88,202,889
Ensembl chr 7:87,934,143...88,202,889
JBrowse link
G ADAM32 ADAM metallopeptidase domain 32 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADAM32 mRNA CTD PMID:25510870 NCBI chr 8:39,107,529...39,284,917
Ensembl chr 8:39,106,990...39,284,917
JBrowse link
G ADAM8 ADAM metallopeptidase domain 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ADAM8 mRNA CTD PMID:25510870 NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
JBrowse link
G ADAMTS7 ADAM metallopeptidase with thrombospondin type 1 motif 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ADAMTS7 mRNA CTD PMID:25510870 NCBI chr15:78,759,206...78,811,464
Ensembl chr15:78,759,206...78,811,464
JBrowse link
G ADAT2 adenosine deaminase tRNA specific 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADAT2 mRNA CTD PMID:25510870 NCBI chr 6:143,422,832...143,450,695
Ensembl chr 6:143,422,832...143,450,695
JBrowse link
G ADCY10 adenylate cyclase 10 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADCY10 mRNA CTD PMID:25510870 NCBI chr 1:167,809,386...167,914,134
Ensembl chr 1:167,809,386...167,914,215
JBrowse link
G ADGRF5 adhesion G protein-coupled receptor F5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ADGRF5 mRNA CTD PMID:25510870 NCBI chr 6:46,852,522...46,954,939
Ensembl chr 6:46,852,522...46,954,943
JBrowse link
G ADGRG3 adhesion G protein-coupled receptor G3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADGRG3 mRNA CTD PMID:25510870 NCBI chr16:57,665,629...57,689,378
Ensembl chr16:57,668,277...57,689,378
JBrowse link
G ADGRL4 adhesion G protein-coupled receptor L4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ADGRL4 mRNA CTD PMID:25510870 NCBI chr 1:78,889,764...79,006,730
Ensembl chr 1:78,889,764...79,282,124
JBrowse link
G ADHFE1 alcohol dehydrogenase iron containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADHFE1 mRNA CTD PMID:25510870 NCBI chr 8:66,432,504...66,468,907
Ensembl chr 8:66,432,492...66,468,907
JBrowse link
G ADIPOQ adiponectin, C1Q and collagen domain containing multiple interactions
affects expression
ISO
EXP
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ADIPOQ mRNA
2,2',3',4,4',5-hexachlorobiphenyl affects the expression of ADIPOQ mRNA
CTD PMID:21703328 PMID:25510870 NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
JBrowse link
G ADM2 adrenomedullin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADM2 mRNA CTD PMID:25510870 NCBI chr22:50,481,543...50,486,437
Ensembl chr22:50,481,543...50,486,440
JBrowse link
G ADRM1 ADRM1 26S proteasome ubiquitin receptor decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ADRM1 mRNA CTD PMID:23829299 NCBI chr20:62,302,896...62,308,862
Ensembl chr20:62,302,093...62,308,862
JBrowse link
G AFAP1 actin filament associated protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AFAP1 mRNA CTD PMID:25510870 NCBI chr 4:7,758,713...7,939,861
Ensembl chr 4:7,758,714...7,939,926
JBrowse link
G AGAP2 ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AGAP2 mRNA CTD PMID:25510870 NCBI chr12:57,723,761...57,742,161
Ensembl chr12:57,723,761...57,742,157
JBrowse link
G AGBL2 AGBL carboxypeptidase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AGBL2 mRNA CTD PMID:25510870 NCBI chr11:47,659,591...47,715,369
Ensembl chr11:47,659,591...47,715,389
JBrowse link
G AGO4 argonaute RISC component 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AGO4 mRNA CTD PMID:25510870 NCBI chr 1:35,807,636...35,857,890
Ensembl chr 1:35,808,016...35,857,890
JBrowse link
G AGTR1 angiotensin II receptor type 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AGTR1A mRNA CTD PMID:25510870 NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
JBrowse link
G AGXT2 alanine--glyoxylate aminotransferase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AGXT2 mRNA CTD PMID:25510870 NCBI chr 5:34,998,102...35,047,949
Ensembl chr 5:34,998,101...35,048,135
JBrowse link
G AHCY adenosylhomocysteinase increases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of AHCY protein
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AHCY mRNA
CTD PMID:21673325 PMID:25510870 NCBI chr20:34,231,981...34,311,836
Ensembl chr20:34,280,268...34,311,802
JBrowse link
G AHR aryl hydrocarbon receptor multiple interactions ISO 2,2',3',4,4',5-hexachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]; [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] promotes the reaction [AHR protein results in increased expression of CYP1A2 mRNA]; [AHR protein co-treated with CYP1A2 protein] affects the susceptibility to [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] CTD PMID:20961953 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
G AIPL1 aryl hydrocarbon receptor interacting protein like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AIPL1 mRNA CTD PMID:25510870 NCBI chr17:6,423,738...6,435,121
Ensembl chr17:6,393,693...6,435,199
JBrowse link
G AJAP1 adherens junctions associated protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AJAP1 mRNA CTD PMID:25510870 NCBI chr 1:4,654,609...4,792,534
Ensembl chr 1:4,654,609...4,792,534
JBrowse link
G AK1 adenylate kinase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AK1 mRNA CTD PMID:25510870 NCBI chr 9:127,866,480...127,879,621
Ensembl chr 9:127,866,486...127,877,675
JBrowse link
G AK5 adenylate kinase 5 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of AK5 mRNA CTD PMID:23829299 NCBI chr 1:77,282,019...77,559,966
Ensembl chr 1:77,282,019...77,559,966
JBrowse link
G AKAP10 A-kinase anchoring protein 10 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AKAP10 mRNA CTD PMID:25510870 NCBI chr17:19,904,302...19,977,828
Ensembl chr17:19,904,302...19,978,343
JBrowse link
G AKAP9 A-kinase anchoring protein 9 multiple interactions
increases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AKAP9 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of AKAP9 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 7:91,940,862...92,110,673
Ensembl chr 7:91,940,840...92,110,673
JBrowse link
G AKR1B15 aldo-keto reductase family 1 member B15 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AKR1B7 mRNA CTD PMID:25510870 NCBI chr 7:134,549,110...134,579,869
Ensembl chr 7:134,549,110...134,579,875
JBrowse link
G AKR1C1 aldo-keto reductase family 1 member C1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AKR1C20 mRNA CTD PMID:25510870 NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283
JBrowse link
G AKT2 AKT serine/threonine kinase 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of AKT2 mRNA CTD PMID:23829299 NCBI chr19:40,230,317...40,285,345
Ensembl chr19:40,230,317...40,285,536
JBrowse link
G AKT3 AKT serine/threonine kinase 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AKT3 mRNA CTD PMID:25510870 NCBI chr 1:243,488,233...243,851,079
Ensembl chr 1:243,488,233...243,851,079
JBrowse link
G AKTIP AKT interacting protein increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of AKTIP mRNA CTD PMID:23829299 NCBI chr16:53,491,040...53,504,412
Ensembl chr16:53,491,040...53,504,411
JBrowse link
G ALDH18A1 aldehyde dehydrogenase 18 family member A1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ALDH18A1 mRNA CTD PMID:25510870 NCBI chr10:95,605,941...95,656,711
Ensembl chr10:95,605,941...95,656,711
JBrowse link
G ALDH6A1 aldehyde dehydrogenase 6 family member A1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ALDH6A1 mRNA CTD PMID:23829299 NCBI chr14:74,056,847...74,084,453
Ensembl chr14:74,056,847...74,084,492
JBrowse link
G ALDOC aldolase, fructose-bisphosphate C decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ALDOC mRNA CTD PMID:23829299 NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948
JBrowse link
G ALG13 ALG13 UDP-N-acetylglucosaminyltransferase subunit multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ALG13 mRNA CTD PMID:25510870 NCBI chr  X:111,681,170...111,760,649
Ensembl chr  X:111,665,811...111,760,649
JBrowse link
G ALKBH8 alkB homolog 8, tRNA methyltransferase increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ALKBH8 mRNA CTD PMID:23829299 NCBI chr11:107,502,727...107,565,735
Ensembl chr11:107,502,727...107,565,742
JBrowse link
G ALS2 alsin Rho guanine nucleotide exchange factor ALS2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ALS2 mRNA CTD PMID:25510870 NCBI chr 2:201,700,267...201,780,933
Ensembl chr 2:201,700,267...201,782,112
JBrowse link
G AMBN ameloblastin increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of AMBN mRNA CTD PMID:23829299 NCBI chr 4:70,592,256...70,607,288
Ensembl chr 4:70,592,256...70,607,288
JBrowse link
G AMER3 APC membrane recruitment protein 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AMER3 mRNA CTD PMID:25510870 NCBI chr 2:130,755,540...130,768,134
Ensembl chr 2:130,755,540...130,768,134
JBrowse link
G AMH anti-Mullerian hormone multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AMH mRNA CTD PMID:25510870 NCBI chr19:2,249,323...2,252,073
Ensembl chr19:2,249,309...2,252,073
JBrowse link
G AMPH amphiphysin decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of AMPH protein CTD PMID:21673325 NCBI chr 7:38,383,704...38,631,373
Ensembl chr 7:38,383,704...38,631,420
JBrowse link
G ANGPTL3 angiopoietin like 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ANGPTL3 mRNA CTD PMID:25510870 NCBI chr 1:62,597,520...62,606,313
Ensembl chr 1:62,597,520...62,606,313
JBrowse link
G ANK1 ankyrin 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ANK1 mRNA CTD PMID:25510870 NCBI chr 8:41,653,225...41,896,741
Ensembl chr 8:41,653,220...41,896,741
JBrowse link
G ANK3 ankyrin 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ANK3 mRNA CTD PMID:23829299 NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490
JBrowse link
G ANKLE1 ankyrin repeat and LEM domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ANKLE1 mRNA CTD PMID:25510870 NCBI chr19:17,281,901...17,287,646
Ensembl chr19:17,281,645...17,287,646
JBrowse link
G ANKRD12 ankyrin repeat domain 12 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ANKRD12 mRNA CTD PMID:25510870 NCBI chr18:9,136,781...9,285,985
Ensembl chr18:9,136,228...9,285,985
JBrowse link
G ANKRD22 ankyrin repeat domain 22 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ANKRD22 mRNA CTD PMID:25510870 NCBI chr10:88,819,896...88,851,844
Ensembl chr10:88,819,896...88,851,844
JBrowse link
G ANKRD34A ankyrin repeat domain 34A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ANKRD34A mRNA CTD PMID:25510870 NCBI chr 1:145,959,441...145,964,575
Ensembl chr 1:145,959,441...145,964,575
JBrowse link
G ANKRD34B ankyrin repeat domain 34B increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ANKRD34B mRNA CTD PMID:23829299 NCBI chr 5:80,556,755...80,570,280
Ensembl chr 5:80,556,755...80,570,280
JBrowse link
G ANKRD40 ankyrin repeat domain 40 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ANKRD40 mRNA CTD PMID:25510870 NCBI chr17:50,693,198...50,707,914
Ensembl chr17:50,693,198...50,707,914
JBrowse link
G ANKS1B ankyrin repeat and sterile alpha motif domain containing 1B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ANKS1B mRNA CTD PMID:25510870 NCBI chr12:98,734,786...99,984,936
Ensembl chr12:98,726,457...99,984,936
JBrowse link
G ANO10 anoctamin 10 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ANO10 mRNA CTD PMID:25510870 NCBI chr 3:43,365,848...43,691,594
Ensembl chr 3:43,354,859...43,691,594
JBrowse link
G ANO3 anoctamin 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ANO3 mRNA CTD PMID:25510870 NCBI chr11:26,188,808...26,663,289
Ensembl chr11:26,188,842...26,663,289
JBrowse link
G ANP32A acidic nuclear phosphoprotein 32 family member A increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ANP32A protein CTD PMID:21673325 NCBI chr15:68,778,535...68,820,895
Ensembl chr15:68,778,535...68,820,897
JBrowse link
G ANTXR2 ANTXR cell adhesion molecule 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ANTXR2 mRNA CTD PMID:25510870 NCBI chr 4:79,901,146...80,073,472
Ensembl chr 4:79,901,146...80,125,454
JBrowse link
G ANXA3 annexin A3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ANXA3 protein CTD PMID:21673325 NCBI chr 4:78,551,770...78,610,447
Ensembl chr 4:78,551,747...78,610,451
JBrowse link
G ANXA7 annexin A7 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ANXA7 mRNA CTD PMID:23829299 NCBI chr10:73,375,101...73,414,058
Ensembl chr10:73,375,101...73,414,076
JBrowse link
G AP4E1 adaptor related protein complex 4 subunit epsilon 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AP4E1 mRNA CTD PMID:25510870 NCBI chr15:50,907,492...51,005,895
Ensembl chr15:50,908,672...51,005,895
JBrowse link
G APC2 APC regulator of WNT signaling pathway 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of APC2 mRNA CTD PMID:23829299 NCBI chr19:1,446,230...1,473,244
Ensembl chr19:1,446,302...1,473,244
JBrowse link
G APOA1 apolipoprotein A1 affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of APOA1 mRNA CTD PMID:21703328 NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
JBrowse link
G APOBR apolipoprotein B receptor increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of APOBR mRNA CTD PMID:23829299 NCBI chr16:28,494,643...28,498,964
Ensembl chr16:28,494,643...28,498,964
JBrowse link
G APOD apolipoprotein D multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of APOD mRNA CTD PMID:25510870 NCBI chr 3:195,568,705...195,583,940
Ensembl chr 3:195,568,705...195,584,033
JBrowse link
G APOL2 apolipoprotein L2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of APOL8 mRNA CTD PMID:25510870 NCBI chr22:36,226,209...36,239,954
Ensembl chr22:36,226,209...36,239,954
JBrowse link
G APOOL apolipoprotein O like decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of APOOL mRNA CTD PMID:23829299 NCBI chr  X:85,003,877...85,093,315
Ensembl chr  X:85,003,877...85,093,315
JBrowse link
G APP amyloid beta precursor protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with APP protein modified form] results in decreased expression of DLG4 protein; [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with APP protein modified form] results in decreased expression of SYP protein CTD PMID:26480858 NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
JBrowse link
G AQP1 aquaporin 1 (Colton blood group) multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AQP1 mRNA CTD PMID:25510870 NCBI chr 7:30,911,853...30,925,516
Ensembl chr 7:30,911,853...30,925,517
JBrowse link
G AQP3 aquaporin 3 (Gill blood group) decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of AQP3 mRNA CTD PMID:23829299 NCBI chr 9:33,441,160...33,447,593
Ensembl chr 9:33,441,156...33,447,596
JBrowse link
G AR androgen receptor multiple interactions
decreases expression
EXP
ISO
2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [Metribolone results in increased activity of AR protein]
2,2',3',4,4',5-hexachlorobiphenyl analog inhibits the reaction [Dihydrotestosterone binds to AR protein]; [2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AR mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of AR protein
CTD PMID:11906248 PMID:18324785 PMID:21190954 PMID:21357386 PMID:21673325 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619
JBrowse link
G ARFGAP1 ADP ribosylation factor GTPase activating protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ARFGAP1 mRNA CTD PMID:25510870 NCBI chr20:63,272,813...63,289,790
Ensembl chr20:63,272,785...63,289,790
JBrowse link
G ARHGAP11A Rho GTPase activating protein 11A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ARHGAP11A mRNA CTD PMID:25510870 NCBI chr15:32,615,144...32,639,941
Ensembl chr15:32,615,144...32,639,941
JBrowse link
G ARHGAP20 Rho GTPase activating protein 20 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ARHGAP20 mRNA CTD PMID:23829299 NCBI chr11:110,577,043...110,713,189
Ensembl chr11:110,577,042...110,713,189
JBrowse link
G ARHGAP26 Rho GTPase activating protein 26 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ARHGAP26 mRNA CTD PMID:25510870 NCBI chr 5:142,770,377...143,229,011
Ensembl chr 5:142,770,377...143,229,011
JBrowse link
G ARHGEF10 Rho guanine nucleotide exchange factor 10 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ARHGEF10 mRNA CTD PMID:23829299 NCBI chr 8:1,823,300...1,958,641
Ensembl chr 8:1,823,926...1,958,641
JBrowse link
G ARHGEF15 Rho guanine nucleotide exchange factor 15 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ARHGEF15 mRNA CTD PMID:25510870 NCBI chr17:8,310,241...8,322,511
Ensembl chr17:8,310,241...8,322,514
JBrowse link
G ARHGEF33 Rho guanine nucleotide exchange factor 33 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ARHGEF33 mRNA CTD PMID:25510870 NCBI chr 2:38,889,875...38,975,454
Ensembl chr 2:38,889,875...38,975,454
JBrowse link
G ARHGEF37 Rho guanine nucleotide exchange factor 37 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ARHGEF37 mRNA CTD PMID:25510870 NCBI chr 5:149,551,625...149,634,968
Ensembl chr 5:149,551,947...149,634,968
JBrowse link
G ARHGEF38 Rho guanine nucleotide exchange factor 38 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ARHGEF38 mRNA CTD PMID:25510870 NCBI chr 4:105,552,620...105,682,566
Ensembl chr 4:105,552,620...105,708,093
JBrowse link
G ARHGEF39 Rho guanine nucleotide exchange factor 39 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ARHGEF39 mRNA CTD PMID:25510870 NCBI chr 9:35,659,343...35,665,195
Ensembl chr 9:35,658,875...35,675,866
JBrowse link
G ARHGEF4 Rho guanine nucleotide exchange factor 4 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ARHGEF4 mRNA CTD PMID:23829299 NCBI chr 2:130,836,914...131,047,253
Ensembl chr 2:130,836,914...131,047,263
JBrowse link
G ARHGEF5 Rho guanine nucleotide exchange factor 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ARHGEF5 mRNA CTD PMID:23829299 NCBI chr 7:144,355,402...144,380,632
Ensembl chr 7:144,355,288...144,380,632
JBrowse link
G ARHGEF7 Rho guanine nucleotide exchange factor 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ARHGEF7 mRNA CTD PMID:25510870 NCBI chr13:111,114,619...111,305,734
Ensembl chr13:111,114,559...111,305,737
JBrowse link
G ARID1A AT-rich interaction domain 1A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ARID1A mRNA CTD PMID:25510870 NCBI chr 1:26,696,015...26,782,104
Ensembl chr 1:26,693,236...26,782,104
JBrowse link
G ARIH2 ariadne RBR E3 ubiquitin protein ligase 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ARIH2 mRNA CTD PMID:23829299 NCBI chr 3:48,918,842...48,986,382
Ensembl chr 3:48,918,821...48,986,382
JBrowse link
G ARK2C arkadia (RNF111) C-terminal like ring finger ubiquitin ligase 2C multiple interactions
decreases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ARK2C mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ARK2C mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr18:46,334,018...46,463,140
Ensembl chr18:46,326,809...46,463,140
JBrowse link
G ARL16 ADP ribosylation factor like GTPase 16 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ARL16 mRNA CTD PMID:25510870 NCBI chr17:81,681,165...81,683,797
Ensembl chr17:81,681,187...81,683,797
JBrowse link
G ARPC2 actin related protein 2/3 complex subunit 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ARPC2 protein CTD PMID:21673325 NCBI chr 2:218,217,189...218,254,348
Ensembl chr 2:218,217,141...218,254,356
JBrowse link
G ARSJ arylsulfatase family member J multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ARSJ mRNA CTD PMID:25510870 NCBI chr 4:113,900,284...113,979,647
Ensembl chr 4:113,900,284...113,979,727
JBrowse link
G ART4 ADP-ribosyltransferase 4 (inactive) (Dombrock blood group) multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ART4 mRNA CTD PMID:25510870 NCBI chr12:14,825,569...14,843,526
Ensembl chr12:14,825,569...14,843,526
JBrowse link
G ARVCF ARVCF delta catenin family member multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ARVCF mRNA CTD PMID:25510870 NCBI chr22:19,965,134...20,016,823
Ensembl chr22:19,969,896...20,016,823
JBrowse link
G ASB16 ankyrin repeat and SOCS box containing 16 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ASB16 mRNA CTD PMID:25510870 NCBI chr17:44,170,704...44,179,084
Ensembl chr17:44,170,447...44,179,084
JBrowse link
G ASCC1 activating signal cointegrator 1 complex subunit 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ASCC1 mRNA CTD PMID:23829299 NCBI chr10:72,096,032...72,217,134
Ensembl chr10:72,096,032...72,217,134
JBrowse link
G ASF1B anti-silencing function 1B histone chaperone multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASF1B mRNA CTD PMID:25510870 NCBI chr19:14,119,512...14,136,589
Ensembl chr19:14,119,512...14,136,613
JBrowse link
G ASGR1 asialoglycoprotein receptor 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ASGR1 mRNA CTD PMID:23829299 NCBI chr17:7,173,431...7,179,370
Ensembl chr17:7,173,431...7,179,564
JBrowse link
G ASIC2 acid sensing ion channel subunit 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ASIC2 mRNA CTD PMID:25510870 NCBI chr17:33,013,087...34,156,768
Ensembl chr17:33,013,087...34,174,964
JBrowse link
G ASIC4 acid sensing ion channel subunit family member 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ASIC4 mRNA CTD PMID:25510870 NCBI chr 2:219,507,093...219,538,772
Ensembl chr 2:219,514,170...219,538,772
JBrowse link
G ASPA aspartoacylase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ASPA mRNA CTD PMID:25510870 NCBI chr17:3,474,110...3,503,405
Ensembl chr17:3,472,374...3,503,405
JBrowse link
G ASPH aspartate beta-hydroxylase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ASPH mRNA CTD PMID:25510870 NCBI chr 8:61,500,556...61,714,592
Ensembl chr 8:61,500,556...61,714,640
JBrowse link
G ASPM assembly factor for spindle microtubules multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASPM mRNA CTD PMID:25510870 NCBI chr 1:197,084,127...197,146,669
Ensembl chr 1:197,084,121...197,146,694
JBrowse link
G ASXL3 ASXL transcriptional regulator 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASXL3 mRNA CTD PMID:25510870 NCBI chr18:33,578,219...33,751,195
Ensembl chr18:33,578,219...33,751,195
JBrowse link
G ATAD2B ATPase family AAA domain containing 2B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATAD2B mRNA CTD PMID:25510870 NCBI chr 2:23,677,969...23,927,123
Ensembl chr 2:23,748,664...23,927,123
JBrowse link
G ATAD5 ATPase family AAA domain containing 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATAD5 mRNA CTD PMID:25510870 NCBI chr17:30,831,966...30,895,869
Ensembl chr17:30,831,966...30,895,869
JBrowse link
G ATE1 arginyltransferase 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ATE1 mRNA CTD PMID:23829299 NCBI chr10:121,740,424...121,928,463
Ensembl chr10:121,709,393...121,928,801
JBrowse link
G ATM ATM serine/threonine kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATM mRNA; [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATM protein CTD PMID:25510870 NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,804...108,369,102
JBrowse link
G ATOH1 atonal bHLH transcription factor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATOH1 mRNA CTD PMID:25510870 NCBI chr 4:93,828,753...93,830,964
Ensembl chr 4:93,828,753...93,830,964
JBrowse link
G ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ATP1A1 protein CTD PMID:21673325 NCBI chr 1:116,373,244...116,404,774
Ensembl chr 1:116,372,668...116,410,261
JBrowse link
G ATP1A2 ATPase Na+/K+ transporting subunit alpha 2 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ATP1A2 protein CTD PMID:21673325 NCBI chr 1:160,115,759...160,143,591
Ensembl chr 1:160,115,759...160,143,591
JBrowse link
G ATP1A3 ATPase Na+/K+ transporting subunit alpha 3 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ATP1A3 protein CTD PMID:21673325 NCBI chr19:41,966,582...41,994,230
Ensembl chr19:41,966,582...41,997,497
JBrowse link
G ATP1B1 ATPase Na+/K+ transporting subunit beta 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ATP1B1 protein CTD PMID:21673325 NCBI chr 1:169,106,690...169,132,719
Ensembl chr 1:169,105,697...169,310,992
JBrowse link
G ATP2A2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ATP2A2 protein CTD PMID:21673325 NCBI chr12:110,280,616...110,351,093
Ensembl chr12:110,280,756...110,351,093
JBrowse link
G ATP2B1 ATPase plasma membrane Ca2+ transporting 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ATP2B1 mRNA; 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ATP2B1 protein CTD PMID:21673325 PMID:23829299 NCBI chr12:89,588,049...89,709,366
Ensembl chr12:89,588,049...89,709,366
JBrowse link
G ATP2B2 ATPase plasma membrane Ca2+ transporting 2 increases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ATP2B2 protein
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP2B2 mRNA
CTD PMID:21673325 PMID:25510870 NCBI chr 3:10,324,023...10,708,007
Ensembl chr 3:10,324,023...10,708,007
JBrowse link
G ATP2B3 ATPase plasma membrane Ca2+ transporting 3 increases expression
decreases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ATP2B3 protein
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ATP2B3 mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP2B3 mRNA
CTD PMID:21673325 PMID:23829299 PMID:25510870 NCBI chr  X:153,517,642...153,582,929
Ensembl chr  X:153,517,642...153,582,939
JBrowse link
G ATP2B4 ATPase plasma membrane Ca2+ transporting 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP2B4 mRNA CTD PMID:25510870 NCBI chr 1:203,626,832...203,744,081
Ensembl chr 1:203,626,832...203,744,081
JBrowse link
G ATP5F1A ATP synthase F1 subunit alpha increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ATP5F1A protein CTD PMID:21673325 NCBI chr18:46,080,248...46,104,227
Ensembl chr18:46,080,248...46,104,334
JBrowse link
G ATP5F1E ATP synthase F1 subunit epsilon multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP5F1E mRNA CTD PMID:25510870 NCBI chr20:59,025,475...59,032,335
Ensembl chr20:59,025,475...59,032,345
JBrowse link
G ATP5MC1 ATP synthase membrane subunit c locus 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP5MC1 mRNA CTD PMID:25510870 NCBI chr17:48,892,787...48,895,871
Ensembl chr17:48,892,765...48,895,871
JBrowse link
G ATP5MF ATP synthase membrane subunit f multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP5MF mRNA CTD PMID:25510870 NCBI chr 7:99,458,195...99,466,167
Ensembl chr 7:99,448,475...99,466,186
JBrowse link
G ATP5MG ATP synthase membrane subunit g multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP5MG mRNA CTD PMID:25510870 NCBI chr11:118,401,606...118,409,847
Ensembl chr11:118,401,346...118,433,278
JBrowse link
G ATP5MK ATP synthase membrane subunit k multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP5MK mRNA CTD PMID:25510870 NCBI chr10:103,389,050...103,396,475
Ensembl chr10:103,389,041...103,396,492
JBrowse link
G ATP5PD ATP synthase peripheral stalk subunit d decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ATP5PD mRNA; 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ATP5PD protein CTD PMID:21673325 PMID:23829299 NCBI chr17:75,038,863...75,046,969
Ensembl chr17:75,038,863...75,046,985
JBrowse link
G ATP6AP1L ATPase H+ transporting accessory protein 1 like (pseudogene) multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP6AP1L mRNA CTD PMID:25510870 NCBI chr 5:82,278,650...82,318,806
Ensembl chr 5:82,295,449...82,318,300
JBrowse link
G ATP6V1G2 ATPase H+ transporting V1 subunit G2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ATP6V1G2 mRNA CTD PMID:23829299 NCBI chr 6:31,544,444...31,546,742
Ensembl chr 6:31,544,444...31,548,427
JBrowse link
G ATP6V1G3 ATPase H+ transporting V1 subunit G3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP6V1G3 mRNA CTD PMID:25510870 NCBI chr 1:198,523,222...198,540,945
Ensembl chr 1:198,523,222...198,540,945
JBrowse link
G ATR ATR serine/threonine kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATR mRNA CTD PMID:25510870 NCBI chr 3:142,449,235...142,578,733
Ensembl chr 3:142,449,007...142,578,733
JBrowse link
G ATXN7L2 ataxin 7 like 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATXN7L2 mRNA CTD PMID:25510870 NCBI chr 1:109,483,905...109,492,804
Ensembl chr 1:109,483,479...109,492,804
JBrowse link
G AUH AU RNA binding methylglutaconyl-CoA hydratase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AUH mRNA CTD PMID:25510870 NCBI chr 9:91,213,823...91,361,918
Ensembl chr 9:91,213,815...91,361,918
JBrowse link
G AURKA aurora kinase A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AURKA mRNA CTD PMID:25510870 NCBI chr20:56,369,390...56,392,215
Ensembl chr20:56,369,389...56,392,337
JBrowse link
G AURKB aurora kinase B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AURKB mRNA CTD PMID:25510870 NCBI chr17:8,204,731...8,210,575
Ensembl chr17:8,204,733...8,210,600
JBrowse link
G AVPI1 arginine vasopressin induced 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AVPI1 mRNA CTD PMID:25510870 NCBI chr10:97,677,424...97,687,241
Ensembl chr10:97,677,424...97,687,241
JBrowse link
G AZGP1 alpha-2-glycoprotein 1, zinc-binding multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AZGP1 mRNA CTD PMID:25510870 NCBI chr 7:99,966,730...99,976,031
Ensembl chr 7:99,966,720...99,976,042
JBrowse link
G B3GAT1 beta-1,3-glucuronyltransferase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of B3GAT1 mRNA CTD PMID:25510870 NCBI chr11:134,378,504...134,412,242
Ensembl chr11:134,378,504...134,412,242
JBrowse link
G B3GAT2 beta-1,3-glucuronyltransferase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of B3GAT2 mRNA CTD PMID:25510870 NCBI chr 6:70,856,679...70,957,060
Ensembl chr 6:70,856,679...70,957,060
JBrowse link
G B4GALNT4 beta-1,4-N-acetyl-galactosaminyltransferase 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of B4GALNT4 mRNA CTD PMID:25510870 NCBI chr11:369,499...382,117
Ensembl chr11:369,499...382,117
JBrowse link
G BABAM2 BRISC and BRCA1 A complex member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BABAM2 mRNA CTD PMID:25510870 NCBI chr 2:27,888,709...28,338,901
Ensembl chr 2:27,889,941...28,338,901
JBrowse link
G BARD1 BRCA1 associated RING domain 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BARD1 mRNA CTD PMID:25510870 NCBI chr 2:214,725,646...214,809,683
Ensembl chr 2:214,725,646...214,809,683
JBrowse link
G BARHL1 BarH like homeobox 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BARHL1 mRNA CTD PMID:25510870 NCBI chr 9:132,582,606...132,590,252
Ensembl chr 9:132,582,606...132,590,252
JBrowse link
G BARX2 BARX homeobox 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BARX2 mRNA CTD PMID:25510870 NCBI chr11:129,375,233...129,452,279
Ensembl chr11:129,375,848...129,452,279
JBrowse link
G BAZ1A bromodomain adjacent to zinc finger domain 1A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BAZ1A mRNA CTD PMID:25510870 NCBI chr14:34,752,731...34,875,360
Ensembl chr14:34,752,731...34,875,647
JBrowse link
G BAZ2B bromodomain adjacent to zinc finger domain 2B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BAZ2B mRNA CTD PMID:25510870 NCBI chr 2:159,315,312...159,712,442
Ensembl chr 2:159,318,979...159,616,569
JBrowse link
G BBS7 Bardet-Biedl syndrome 7 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of BBS7 mRNA CTD PMID:23829299 NCBI chr 4:121,824,329...121,870,474
Ensembl chr 4:121,824,329...121,870,487
JBrowse link
G BBX BBX high mobility group box domain containing multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BBX mRNA CTD PMID:25510870 NCBI chr 3:107,522,962...107,811,339
Ensembl chr 3:107,522,936...107,811,339
JBrowse link
G BCL2L1 BCL2 like 1 multiple interactions
increases expression
ISO 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of BCL2L1 protein]; 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [TNF protein results in decreased expression of BCL2L1 protein]
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of BCL2L1 protein
CTD PMID:29704545 NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
JBrowse link
G BCL2L14 BCL2 like 14 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BCL2L14 mRNA CTD PMID:25510870 NCBI chr12:12,049,861...12,099,695
Ensembl chr12:12,049,844...12,211,084
JBrowse link
G BEND4 BEN domain containing 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BEND4 mRNA CTD PMID:25510870 NCBI chr 4:42,110,853...42,152,655
Ensembl chr 4:42,110,853...42,152,878
JBrowse link
G BEND7 BEN domain containing 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BEND7 mRNA CTD PMID:25510870 NCBI chr10:13,438,481...13,529,634
Ensembl chr10:13,438,484...13,529,014
JBrowse link
G BIN1 bridging integrator 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of BIN1 protein CTD PMID:21673325 NCBI chr 2:127,048,023...127,107,154
Ensembl chr 2:127,048,027...127,107,288
JBrowse link
G BIRC3 baculoviral IAP repeat containing 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BIRC3 mRNA CTD PMID:25510870 NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 multiple interactions ISO 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of BIRC5 protein]; 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [TNF protein results in decreased expression of BIRC5 protein]; [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BIRC5 mRNA CTD PMID:25510870 PMID:29704545 NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
JBrowse link
G BLTP3A bridge-like lipid transfer protein family member 3A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BLTP3A mRNA CTD PMID:25510870 NCBI chr 6:34,792,083...34,877,514
Ensembl chr 6:34,792,083...34,877,514
JBrowse link
G BLZF1 basic leucine zipper nuclear factor 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of BLZF1 mRNA CTD PMID:23829299 NCBI chr 1:169,368,195...169,396,575
Ensembl chr 1:169,367,970...169,396,540
JBrowse link
G BMAL2 basic helix-loop-helix ARNT like 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BMAL2 mRNA CTD PMID:25510870 NCBI chr12:27,332,836...27,425,286
Ensembl chr12:27,332,836...27,425,289
JBrowse link
G BMP1 bone morphogenetic protein 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of BMP1 mRNA CTD PMID:23829299 NCBI chr 8:22,165,372...22,212,326
Ensembl chr 8:22,165,140...22,212,326
JBrowse link
G BMS1 BMS1 ribosome biogenesis factor increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of BMS1 mRNA CTD PMID:23829299 NCBI chr10:42,782,795...42,834,937
Ensembl chr10:42,782,795...42,834,937
JBrowse link
G BNIP2 BCL2 interacting protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BNIP2 mRNA CTD PMID:25510870 NCBI chr15:59,659,146...59,689,320
Ensembl chr15:59,659,146...59,689,339
JBrowse link
G BORA BORA aurora kinase A activator multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BORA mRNA CTD PMID:25510870 NCBI chr13:72,727,923...72,756,196
Ensembl chr13:72,727,749...72,756,198
JBrowse link
G BORCS8 BLOC-1 related complex subunit 8 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of BORCS8 mRNA CTD PMID:23829299 NCBI chr19:19,176,906...19,192,152
Ensembl chr19:19,176,903...19,192,591
JBrowse link
G BPIFB6 BPI fold containing family B member 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BPIFB6 mRNA CTD PMID:25510870 NCBI chr20:33,031,648...33,044,108
Ensembl chr20:33,031,648...33,044,047
JBrowse link
G BRCA1 BRCA1 DNA repair associated multiple interactions EXP 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] CTD PMID:12473173 NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
JBrowse link
G BRCA2 BRCA2 DNA repair associated multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BRCA2 mRNA; [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BRCA2 protein CTD PMID:25510870 NCBI chr13:32,315,508...32,400,268
Ensembl chr13:32,315,086...32,400,268
JBrowse link
G BRD8 bromodomain containing 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BRD8 mRNA CTD PMID:25510870 NCBI chr 5:138,139,770...138,178,630
Ensembl chr 5:138,139,770...138,178,953
JBrowse link
G BRICD5 BRICHOS domain containing 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BRICD5 mRNA CTD PMID:25510870 NCBI chr16:2,209,253...2,210,863
Ensembl chr16:2,209,253...2,210,905
JBrowse link
G BRINP3 BMP/retinoic acid inducible neural specific 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BRINP3 mRNA CTD PMID:25510870 NCBI chr 1:190,097,658...190,477,864
Ensembl chr 1:190,097,658...190,478,404
JBrowse link
G BRIP1 BRCA1 interacting helicase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BRIP1 mRNA CTD PMID:25510870 NCBI chr17:61,679,139...61,863,528
Ensembl chr17:61,679,139...61,863,559
JBrowse link
G BRWD3 bromodomain and WD repeat domain containing 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BRWD3 mRNA CTD PMID:25510870 NCBI chr  X:80,669,503...80,809,877
Ensembl chr  X:80,669,503...80,809,877
JBrowse link
G BTG1 BTG anti-proliferation factor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BTG1 mRNA CTD PMID:25510870 NCBI chr12:92,140,278...92,145,846
Ensembl chr12:92,140,278...92,145,846
JBrowse link
G BUB1 BUB1 mitotic checkpoint serine/threonine kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BUB1 mRNA CTD PMID:25510870 NCBI chr 2:110,637,528...110,678,063
Ensembl chr 2:110,637,528...110,678,063
JBrowse link
G BUB1B BUB1 mitotic checkpoint serine/threonine kinase B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BUB1B mRNA CTD PMID:25510870 NCBI chr15:40,161,069...40,221,123
Ensembl chr15:40,161,023...40,221,123
JBrowse link
G BVES blood vessel epicardial substance multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BVES mRNA CTD PMID:25510870 NCBI chr 6:105,096,822...105,137,157
Ensembl chr 6:105,096,822...105,137,157
JBrowse link
G C1QTNF4 C1q and TNF related 4 decreases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of C1QTNF4 mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of C1QTNF4 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr11:47,589,667...47,595,304
Ensembl chr11:47,589,667...47,594,411
JBrowse link
G C3 complement C3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of C3 protein CTD PMID:21673325 NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
JBrowse link
G C5AR2 complement C5a receptor 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of C5AR2 mRNA CTD PMID:23829299 NCBI chr19:47,332,175...47,347,329
Ensembl chr19:47,332,175...47,347,329
JBrowse link
G C7 complement C7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of C7 mRNA CTD PMID:25510870 NCBI chr 5:40,909,497...40,984,643
Ensembl chr 5:40,909,492...41,020,216
JBrowse link
G C8B complement C8 beta chain multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of C8B mRNA CTD PMID:25510870 NCBI chr 1:56,929,207...56,966,015
Ensembl chr 1:56,929,207...56,974,383
JBrowse link
G CA12 carbonic anhydrase 12 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAR12 mRNA CTD PMID:25510870 NCBI chr15:63,321,378...63,381,846
Ensembl chr15:63,321,378...63,381,846
JBrowse link
G CA7 carbonic anhydrase 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAR7 mRNA CTD PMID:25510870 NCBI chr16:66,844,414...66,854,147
Ensembl chr16:66,844,414...66,854,153
JBrowse link
G CA8 carbonic anhydrase 8 multiple interactions
increases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAR8 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CAR8 protein
CTD PMID:21673325 PMID:25510870 NCBI chr 8:60,185,412...60,281,400
Ensembl chr 8:60,185,412...60,281,400
JBrowse link
G CACNA1F calcium voltage-gated channel subunit alpha1 F multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CACNA1F mRNA CTD PMID:25510870 NCBI chr  X:49,205,063...49,233,340
Ensembl chr  X:49,205,063...49,233,371
JBrowse link
G CACNG7 calcium voltage-gated channel auxiliary subunit gamma 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CACNG7 mRNA CTD PMID:25510870 NCBI chr19:53,909,278...53,943,950
Ensembl chr19:53,909,278...53,943,950
JBrowse link
G CALB1 calbindin 1 multiple interactions
increases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CALB1 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CALB1 protein
CTD PMID:21673325 PMID:25510870 NCBI chr 8:90,058,608...90,082,879
Ensembl chr 8:90,058,608...90,095,475
JBrowse link
G CALB2 calbindin 2 multiple interactions
increases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CALB2 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CALB2 protein
CTD PMID:21673325 PMID:25510870 NCBI chr16:71,358,723...71,390,433
Ensembl chr16:71,358,713...71,390,436
JBrowse link
G CALM3 calmodulin 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CALM3 mRNA CTD PMID:25510870 NCBI chr19:46,601,074...46,610,782
Ensembl chr19:46,601,074...46,610,782
JBrowse link
G CALU calumenin increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CALU mRNA CTD PMID:23829299 NCBI chr 7:128,739,359...128,773,400
Ensembl chr 7:128,739,292...128,773,400
JBrowse link
G CALY calcyon neuron specific vesicular protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CALY mRNA CTD PMID:25510870 NCBI chr10:133,324,072...133,336,896
Ensembl chr10:133,324,072...133,336,935
JBrowse link
G CAMK2A calcium/calmodulin dependent protein kinase II alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAMK2A mRNA CTD PMID:25510870 NCBI chr 5:150,219,491...150,290,130
Ensembl chr 5:150,219,491...150,290,093
JBrowse link
G CAMK2B calcium/calmodulin dependent protein kinase II beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAMK2B mRNA CTD PMID:25510870 NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,210,019...44,334,577
JBrowse link
G CAMK2N1 calcium/calmodulin dependent protein kinase II inhibitor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAMK2N1 mRNA CTD PMID:25510870 NCBI chr 1:20,482,391...20,486,210
Ensembl chr 1:20,482,391...20,486,210
JBrowse link
G CAMK4 calcium/calmodulin dependent protein kinase IV multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAMK4 mRNA CTD PMID:25510870 NCBI chr 5:111,223,583...111,494,886
Ensembl chr 5:111,223,653...111,494,886
JBrowse link
G CAMKK2 calcium/calmodulin dependent protein kinase kinase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAMKK2 mRNA CTD PMID:25510870 NCBI chr12:121,237,692...121,297,819
Ensembl chr12:121,237,675...121,298,308
JBrowse link
G CAP2 cyclase associated actin cytoskeleton regulatory protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAP2 mRNA CTD PMID:25510870 NCBI chr 6:17,393,595...17,557,780
Ensembl chr 6:17,393,595...17,557,780
JBrowse link
G CAPRIN1 cell cycle associated protein 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CAPRIN1 mRNA CTD PMID:23829299 NCBI chr11:34,051,731...34,102,610
Ensembl chr11:34,051,731...34,102,610
JBrowse link
G CAPZA1 capping actin protein of muscle Z-line subunit alpha 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CAPZA1 mRNA CTD PMID:25510870 NCBI chr 1:112,619,832...112,671,616
Ensembl chr 1:112,619,805...112,671,616
JBrowse link
G CARTPT CART prepropeptide multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CARTPT mRNA CTD PMID:25510870 NCBI chr 5:71,719,275...71,721,045
Ensembl chr 5:71,719,275...71,721,048
JBrowse link
G CASP3 caspase 3 multiple interactions ISO 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [TNF protein results in increased cleavage of CASP3 protein] CTD PMID:29704545 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G CASZ1 castor zinc finger 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CASZ1 mRNA CTD PMID:25510870 NCBI chr 1:10,636,604...10,796,646
Ensembl chr 1:10,636,604...10,796,650
JBrowse link
G CATSPERD cation channel sperm associated auxiliary subunit delta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CATSPERD mRNA CTD PMID:25510870 NCBI chr19:5,720,637...5,778,734
Ensembl chr19:5,720,637...5,778,734
JBrowse link
G CATSPERG cation channel sperm associated auxiliary subunit gamma multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CATSPERG1 mRNA CTD PMID:25510870 NCBI chr19:38,335,830...38,370,943
Ensembl chr19:38,335,775...38,370,943
JBrowse link
G CBFA2T3 CBFA2/RUNX1 partner transcriptional co-repressor 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CBFA2T3 mRNA CTD PMID:23829299 NCBI chr16:88,874,858...88,977,207
Ensembl chr16:88,874,858...88,977,207
JBrowse link
G CBLC Cbl proto-oncogene C decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CBLC mRNA CTD PMID:23829299 NCBI chr19:44,777,869...44,800,652
Ensembl chr19:44,777,869...44,800,652
JBrowse link
G CBLN4 cerebellin 4 precursor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CBLN4 mRNA CTD PMID:25510870 NCBI chr20:55,997,357...56,005,519
Ensembl chr20:55,997,357...56,005,519
JBrowse link
G CBX2 chromobox 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CBX2 mRNA CTD PMID:25510870 NCBI chr17:79,777,311...79,787,983
Ensembl chr17:79,778,148...79,787,983
JBrowse link
G CBX7 chromobox 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CBX7 mRNA CTD PMID:25510870 NCBI chr22:39,130,772...39,152,680
Ensembl chr22:39,120,167...39,152,680
JBrowse link
G CCDC106 coiled-coil domain containing 106 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CCDC106 mRNA CTD PMID:23829299 NCBI chr19:55,647,400...55,653,161
Ensembl chr19:55,641,062...55,653,161
JBrowse link
G CCDC116 coiled-coil domain containing 116 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCDC116 mRNA CTD PMID:25510870 NCBI chr22:21,632,760...21,637,329
Ensembl chr22:21,632,716...21,637,329
JBrowse link
G CCDC148 coiled-coil domain containing 148 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CCDC148 mRNA CTD PMID:25510870 NCBI chr 2:158,171,073...158,456,753
Ensembl chr 2:158,171,073...158,456,753
JBrowse link
G CCDC175 coiled-coil domain containing 175 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CCDC175 mRNA CTD PMID:25510870 NCBI chr14:59,505,067...59,576,812
Ensembl chr14:59,504,539...59,576,812
JBrowse link
G CCDC60 coiled-coil domain containing 60 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CCDC60 mRNA CTD PMID:25510870 NCBI chr12:119,334,729...119,541,040
Ensembl chr12:119,334,712...119,541,040
JBrowse link
G CCDC70 coiled-coil domain containing 70 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CCDC70 mRNA CTD PMID:25510870 NCBI chr13:51,861,969...51,866,232
Ensembl chr13:51,861,969...51,866,232
JBrowse link
G CCDC74A coiled-coil domain containing 74A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CCDC74A mRNA CTD PMID:25510870 NCBI chr 2:131,522,592...131,533,666
Ensembl chr 2:131,527,675...131,533,666
JBrowse link
G CCDC8 coiled-coil domain containing 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCDC8 mRNA CTD PMID:25510870 NCBI chr19:46,410,329...46,413,564
Ensembl chr19:46,410,329...46,413,564
JBrowse link
G CCDC83 coiled-coil domain containing 83 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CCDC83 mRNA CTD PMID:25510870 NCBI chr11:85,855,066...85,920,013
Ensembl chr11:85,855,101...85,920,021
JBrowse link
G CCDC85B coiled-coil domain containing 85B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CCDC85B mRNA CTD PMID:25510870 NCBI chr11:65,890,673...65,891,635
Ensembl chr11:65,890,673...65,891,635
JBrowse link
G CCDC85C coiled-coil domain containing 85C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CCDC85C mRNA CTD PMID:25510870 NCBI chr14:99,500,190...99,604,207
Ensembl chr14:99,500,190...99,604,207
JBrowse link
G CCDC92 coiled-coil domain containing 92 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CCDC92 mRNA CTD PMID:23829299 NCBI chr12:123,935,626...123,972,831
Ensembl chr12:123,918,660...123,972,831
JBrowse link
G CCK cholecystokinin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CCK mRNA CTD PMID:25510870 NCBI chr 3:42,257,826...42,266,185
Ensembl chr 3:42,257,825...42,266,185
JBrowse link
G CCL1 C-C motif chemokine ligand 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCL1 mRNA CTD PMID:25510870 NCBI chr17:34,360,328...34,363,233
Ensembl chr17:34,360,328...34,363,233
JBrowse link
G CCL19 C-C motif chemokine ligand 19 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CCL19 mRNA CTD PMID:23829299 NCBI chr 9:34,689,570...34,691,276
Ensembl chr 9:34,689,570...34,691,276
JBrowse link
G CCL2 C-C motif chemokine ligand 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCL2 mRNA CTD PMID:25510870 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
JBrowse link
G CCL21 C-C motif chemokine ligand 21 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CCL21 mRNA CTD PMID:23829299 NCBI chr 9:34,709,005...34,710,136
Ensembl chr 9:34,709,005...34,710,136
JBrowse link
G CCL28 C-C motif chemokine ligand 28 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCL28 mRNA CTD PMID:25510870 NCBI chr 5:43,356,975...43,412,391
Ensembl chr 5:43,376,645...43,412,391
JBrowse link
G CCL3 C-C motif chemokine ligand 3 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CCL3 mRNA CTD PMID:23829299 NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
JBrowse link
G CCL5 C-C motif chemokine ligand 5 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CCL5 mRNA CTD PMID:23829299 NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
JBrowse link
G CCNA1 cyclin A1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCNA1 mRNA CTD PMID:25510870 NCBI chr13:36,431,517...36,442,870
Ensembl chr13:36,431,520...36,442,870
JBrowse link
G CCNA2 cyclin A2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCNA2 mRNA CTD PMID:25510870 NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
JBrowse link
G CCNB1 cyclin B1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCNB1 mRNA CTD PMID:25510870 NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
JBrowse link
G CCNB2 cyclin B2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCNB2 mRNA CTD PMID:25510870 NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
JBrowse link
G CCND2 cyclin D2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCND2 mRNA CTD PMID:25510870 NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353
JBrowse link
G CCNE1 cyclin E1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCNE1 mRNA CTD PMID:25510870 NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
JBrowse link
G CCNF cyclin F multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCNF mRNA CTD PMID:25510870 NCBI chr16:2,429,447...2,458,854
Ensembl chr16:2,429,394...2,458,854
JBrowse link
G CCR2 C-C motif chemokine receptor 2 affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of CCR2 mRNA CTD PMID:21703328 NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
JBrowse link
G CCT5 chaperonin containing TCP1 subunit 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CCT5 protein CTD PMID:21673325 NCBI chr 5:10,249,921...10,266,412
Ensembl chr 5:10,249,929...10,266,389
JBrowse link
G CD1D CD1d molecule multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CD1D1 mRNA CTD PMID:25510870 NCBI chr 1:158,178,030...158,186,427
Ensembl chr 1:158,178,030...158,186,427
JBrowse link
G CD276 CD276 molecule multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CD276 mRNA CTD PMID:25510870 NCBI chr15:73,683,944...73,714,514
Ensembl chr15:73,683,966...73,714,514
JBrowse link
G CD300LD CD300 molecule like family member d multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CD300LD mRNA CTD PMID:25510870 NCBI chr17:74,578,643...74,592,283
Ensembl chr17:74,579,365...74,592,283
JBrowse link
G CD320 CD320 molecule multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CD320 mRNA CTD PMID:25510870 NCBI chr19:8,302,127...8,308,358
Ensembl chr19:8,302,127...8,308,358
JBrowse link
G CD38 CD38 molecule increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CD38 mRNA CTD PMID:23829299 NCBI chr 4:15,778,328...15,853,232
Ensembl chr 4:15,778,275...15,853,232
JBrowse link
G CD6 CD6 molecule multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CD6 mRNA CTD PMID:25510870 NCBI chr11:60,971,680...61,020,377
Ensembl chr11:60,971,680...61,020,377
JBrowse link
G CD70 CD70 molecule multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CD70 mRNA CTD PMID:25510870 NCBI chr19:6,581,648...6,591,150
Ensembl chr19:6,583,183...6,604,103
JBrowse link
G CD80 CD80 molecule multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CD80 mRNA CTD PMID:25510870 NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
JBrowse link
G CD8A CD8 subunit alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CD8A mRNA CTD PMID:25510870 NCBI chr 2:86,784,605...86,808,396
Ensembl chr 2:86,784,610...86,808,396
JBrowse link
G CD93 CD93 molecule multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CD93 mRNA CTD PMID:25510870 NCBI chr20:23,079,360...23,086,324
Ensembl chr20:23,079,360...23,086,324
JBrowse link
G CD96 CD96 molecule multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CD96 mRNA CTD PMID:25510870 NCBI chr 3:111,542,197...111,665,996
Ensembl chr 3:111,292,719...111,665,750
JBrowse link
G CDC20 cell division cycle 20 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDC20 mRNA CTD PMID:25510870 NCBI chr 1:43,358,981...43,363,203
Ensembl chr 1:43,358,981...43,363,203
JBrowse link
G CDC25B cell division cycle 25B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDC25B mRNA CTD PMID:25510870 NCBI chr20:3,786,951...3,806,115
Ensembl chr20:3,786,772...3,806,121
JBrowse link
G CDC25C cell division cycle 25C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDC25C mRNA CTD PMID:25510870 NCBI chr 5:138,285,265...138,338,355
Ensembl chr 5:138,285,269...138,338,355
JBrowse link
G CDC42BPA CDC42 binding protein kinase alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDC42BPA mRNA CTD PMID:25510870 NCBI chr 1:226,989,858...227,318,492
Ensembl chr 1:226,989,865...227,318,492
JBrowse link
G CDC6 cell division cycle 6 decreases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CDC6 mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDC6 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr17:40,287,879...40,304,657
Ensembl chr17:40,287,879...40,304,657
JBrowse link
G CDCA2 cell division cycle associated 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDCA2 mRNA CTD PMID:25510870 NCBI chr 8:25,458,931...25,507,917
Ensembl chr 8:25,459,199...25,507,911
JBrowse link
G CDCA3 cell division cycle associated 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDCA3 mRNA CTD PMID:25510870 NCBI chr12:6,844,798...6,851,286
Ensembl chr12:6,844,793...6,851,292
JBrowse link
G CDCA5 cell division cycle associated 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDCA5 mRNA CTD PMID:25510870 NCBI chr11:65,061,093...65,084,040
Ensembl chr11:65,066,300...65,084,164
JBrowse link
G CDCA7L cell division cycle associated 7 like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDCA7L mRNA CTD PMID:25510870 NCBI chr 7:21,900,899...21,945,899
Ensembl chr 7:21,900,899...21,945,903
JBrowse link
G CDCA8 cell division cycle associated 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDCA8 mRNA CTD PMID:25510870 NCBI chr 1:37,692,516...37,709,719
Ensembl chr 1:37,692,481...37,709,719
JBrowse link
G CDH18 cadherin 18 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH18 mRNA CTD PMID:25510870 NCBI chr 5:19,471,296...20,575,713
Ensembl chr 5:19,471,296...20,575,873
JBrowse link
G CDH22 cadherin 22 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH22 mRNA CTD PMID:25510870 NCBI chr20:46,173,739...46,308,498
Ensembl chr20:46,173,739...46,308,498
JBrowse link
G CDH23 cadherin related 23 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH23 mRNA CTD PMID:25510870 NCBI chr10:71,396,920...71,815,947
Ensembl chr10:71,396,920...71,815,947
JBrowse link
G CDH5 cadherin 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDH5 mRNA CTD PMID:25510870 NCBI chr16:66,366,691...66,404,784
Ensembl chr16:66,366,690...66,404,784
JBrowse link
G CDH7 cadherin 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH7 mRNA CTD PMID:25510870 NCBI chr18:65,750,252...65,890,337
Ensembl chr18:65,750,252...65,890,337
JBrowse link
G CDH8 cadherin 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH8 mRNA CTD PMID:25510870 NCBI chr16:61,647,250...62,036,438
Ensembl chr16:61,647,242...62,037,035
JBrowse link
G CDK1 cyclin dependent kinase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDK1 mRNA CTD PMID:25510870 NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
JBrowse link
G CDK2 cyclin dependent kinase 2 multiple interactions
affects expression
ISO
EXP
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDK2 mRNA
2,2',3',4,4',5-hexachlorobiphenyl affects the expression of CDK2 mRNA
CTD PMID:21703328 PMID:25510870 NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
JBrowse link
G CDK6 cyclin dependent kinase 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDK6 mRNA CTD PMID:25510870 NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
JBrowse link
G CDON cell adhesion associated, oncogene regulated multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDON mRNA CTD PMID:25510870 NCBI chr11:125,956,821...126,063,352
Ensembl chr11:125,955,796...126,063,335
JBrowse link
G CDT1 chromatin licensing and DNA replication factor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CDT1 mRNA CTD PMID:25510870 NCBI chr16:88,803,789...88,809,258
Ensembl chr16:88,803,789...88,809,258
JBrowse link
G CECR2 CECR2 histone acetyl-lysine reader multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CECR2 mRNA CTD PMID:25510870 NCBI chr22:17,359,949...17,558,151
Ensembl chr22:17,359,949...17,558,151
JBrowse link
G CELA1 chymotrypsin like elastase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CELA1 mRNA CTD PMID:25510870 NCBI chr12:51,328,442...51,346,679
Ensembl chr12:51,328,442...51,346,679
JBrowse link
G CELF1 CUGBP Elav-like family member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CELF1 mRNA CTD PMID:25510870 NCBI chr11:47,465,937...47,565,539
Ensembl chr11:47,465,933...47,565,569
JBrowse link
G CELSR2 cadherin EGF LAG seven-pass G-type receptor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CELSR2 mRNA CTD PMID:25510870 NCBI chr 1:109,249,539...109,275,751
Ensembl chr 1:109,249,539...109,275,751
JBrowse link
G CELSR3 cadherin EGF LAG seven-pass G-type receptor 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CELSR3 mRNA CTD PMID:25510870 NCBI chr 3:48,636,463...48,662,886
Ensembl chr 3:48,636,463...48,662,886
JBrowse link
G CEMIP cell migration inducing hyaluronidase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEMIP mRNA CTD PMID:25510870 NCBI chr15:80,779,370...80,951,771
Ensembl chr15:80,779,343...80,951,776
JBrowse link
G CENPE centromere protein E multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPE mRNA CTD PMID:25510870 NCBI chr 4:103,105,811...103,198,343
Ensembl chr 4:103,105,349...103,198,445
JBrowse link
G CENPF centromere protein F decreases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CENPF mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPF mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 1:214,603,195...214,664,571
Ensembl chr 1:214,603,185...214,664,574
JBrowse link
G CENPH centromere protein H multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPH mRNA CTD PMID:25510870 NCBI chr 5:69,189,583...69,210,357
Ensembl chr 5:69,189,574...69,210,357
JBrowse link
G CENPI centromere protein I multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPI mRNA CTD PMID:25510870 NCBI chr  X:101,098,204...101,181,859
Ensembl chr  X:101,098,188...101,166,126
JBrowse link
G CENPJ centromere protein J multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPJ mRNA CTD PMID:25510870 NCBI chr13:24,882,279...24,934,000
Ensembl chr13:24,882,279...24,922,889
JBrowse link
G CENPK centromere protein K multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPK mRNA CTD PMID:25510870 NCBI chr 5:65,495,624...65,563,168
Ensembl chr 5:65,517,766...65,563,168
JBrowse link
G CENPM centromere protein M multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPM mRNA CTD PMID:25510870 NCBI chr22:41,927,196...41,947,152
Ensembl chr22:41,938,737...41,947,152
JBrowse link
G CENPN centromere protein N multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPN mRNA CTD PMID:25510870 NCBI chr16:81,007,214...81,033,107
Ensembl chr16:81,006,552...81,033,114
JBrowse link
G CENPP centromere protein P multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPP mRNA CTD PMID:25510870 NCBI chr 9:92,325,468...92,620,529
Ensembl chr 9:92,325,953...92,620,529
JBrowse link
G CENPS centromere protein S multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CENPS mRNA CTD PMID:25510870 NCBI chr 1:10,430,433...10,442,808
Ensembl chr 1:10,430,433...10,442,808
JBrowse link
G CENPT centromere protein T decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CENPT mRNA CTD PMID:23829299 NCBI chr16:67,828,157...67,847,693
Ensembl chr16:67,828,157...67,847,811
JBrowse link
G CENPU centromere protein U multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPU mRNA CTD PMID:25510870 NCBI chr 4:184,694,085...184,734,096
Ensembl chr 4:184,694,085...184,734,130
JBrowse link
G CEP164 centrosomal protein 164 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEP164 mRNA CTD PMID:25510870 NCBI chr11:117,321,778...117,413,266
Ensembl chr11:117,314,557...117,413,266
JBrowse link
G CEP295 centrosomal protein 295 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CEP295 mRNA CTD PMID:25510870 NCBI chr11:93,661,682...93,730,358
Ensembl chr11:93,661,682...93,730,358
JBrowse link
G CEP55 centrosomal protein 55 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEP55 mRNA CTD PMID:25510870 NCBI chr10:93,496,612...93,529,092
Ensembl chr10:93,496,612...93,529,092
JBrowse link
G CERS3 ceramide synthase 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CERS3 mRNA CTD PMID:25510870 NCBI chr15:100,400,395...100,544,683
Ensembl chr15:100,400,395...100,544,995
JBrowse link
G CFL1 cofilin 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CFL1 protein CTD PMID:21673325 NCBI chr11:65,854,673...65,858,180
Ensembl chr11:65,823,022...65,862,026
JBrowse link
G CHAC2 ChaC glutathione specific gamma-glutamylcyclotransferase 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CHAC2 mRNA CTD PMID:23829299 NCBI chr 2:53,767,783...53,775,196
Ensembl chr 2:53,767,804...53,775,196
JBrowse link
G CHAF1A chromatin assembly factor 1 subunit A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CHAF1A mRNA CTD PMID:25510870 NCBI chr19:4,402,640...4,450,830
Ensembl chr19:4,402,640...4,445,018
JBrowse link
G CHAF1B chromatin assembly factor 1 subunit B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CHAF1B mRNA CTD PMID:25510870 NCBI chr21:36,385,392...36,419,015
Ensembl chr21:36,385,392...36,419,015
JBrowse link
G CHCT1 CHD1 helical C-terminal domain containing 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CHCT1 mRNA CTD PMID:23829299 NCBI chr17:60,421,214...60,431,426
Ensembl chr17:60,392,429...60,431,426
JBrowse link
G CHMP4C charged multivesicular body protein 4C decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CHMP4C mRNA CTD PMID:23829299 NCBI chr 8:81,732,448...81,759,515
Ensembl chr 8:81,732,448...81,759,515
JBrowse link
G CHN1 chimerin 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CHN1 mRNA CTD PMID:23829299 NCBI chr 2:174,798,809...175,005,381
Ensembl chr 2:174,798,809...175,005,381
JBrowse link
G CHN2 chimerin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHN2 mRNA CTD PMID:25510870 NCBI chr 7:29,146,591...29,514,328
Ensembl chr 7:29,146,547...29,514,328
JBrowse link
G CHRM1 cholinergic receptor muscarinic 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CHRM1 mRNA CTD PMID:25510870 NCBI chr11:62,908,679...62,921,878
Ensembl chr11:62,908,679...62,921,807
JBrowse link
G CHRNA10 cholinergic receptor nicotinic alpha 10 subunit multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHRNA10 mRNA CTD PMID:25510870 NCBI chr11:3,665,587...3,671,384
Ensembl chr11:3,665,587...3,671,384
JBrowse link
G CHRNA3 cholinergic receptor nicotinic alpha 3 subunit multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CHRNA3 mRNA CTD PMID:25510870 NCBI chr15:78,593,052...78,620,996
Ensembl chr15:78,593,052...78,621,295
JBrowse link
G CHRNA7 cholinergic receptor nicotinic alpha 7 subunit increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CHRNA7 mRNA CTD PMID:23829299 NCBI chr15:32,030,483...32,173,018
Ensembl chr15:31,923,438...32,173,018
JBrowse link
G CHST15 carbohydrate sulfotransferase 15 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CHST15 mRNA CTD PMID:25510870 NCBI chr10:124,007,668...124,093,598
Ensembl chr10:124,007,668...124,093,598
JBrowse link
G CHURC1 churchill domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHURC1 mRNA CTD PMID:25510870 NCBI chr14:64,914,455...64,935,368
Ensembl chr14:64,914,361...64,944,591
JBrowse link
G CIB2 calcium and integrin binding family member 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CIB2 mRNA CTD PMID:23829299 NCBI chr15:78,104,606...78,131,535
Ensembl chr15:78,104,606...78,131,535
JBrowse link
G CIBAR1 CBY1 interacting BAR domain containing 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CIBAR1 mRNA CTD PMID:23829299 NCBI chr 8:93,700,550...93,731,527
Ensembl chr 8:93,698,561...93,731,527
JBrowse link
G CIDEC cell death inducing DFFA like effector c increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CIDEC protein CTD PMID:29704545 NCBI chr 3:9,866,710...9,880,253
Ensembl chr 3:9,866,711...9,880,255
JBrowse link
G CILP cartilage intermediate layer protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CILP mRNA CTD PMID:25510870 NCBI chr15:65,194,760...65,211,473
Ensembl chr15:65,194,760...65,211,473
JBrowse link
G CIMAP1D CIMAP1 family member D increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CIMAP1D mRNA CTD PMID:23829299 NCBI chr19:463,361...491,624
Ensembl chr19:463,346...474,983
JBrowse link
G CIROP ciliated left-right organizer metallopeptidase decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CIROP mRNA CTD PMID:23829299 NCBI chr14:23,099,062...23,104,989
Ensembl chr14:23,099,062...23,104,989
JBrowse link
G CISH cytokine inducible SH2 containing protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CISH mRNA CTD PMID:25510870 NCBI chr 3:50,606,489...50,611,774
Ensembl chr 3:50,606,489...50,611,774
JBrowse link
G CKAP2 cytoskeleton associated protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CKAP2 mRNA CTD PMID:25510870 NCBI chr13:52,455,478...52,476,627
Ensembl chr13:52,455,429...52,476,628
JBrowse link
G CKAP2L cytoskeleton associated protein 2 like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CKAP2L mRNA CTD PMID:25510870 NCBI chr 2:112,736,349...112,764,609
Ensembl chr 2:112,736,349...112,764,664
JBrowse link
G CKAP4 cytoskeleton associated protein 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CKAP4 mRNA CTD PMID:25510870 NCBI chr12:106,237,881...106,248,020
Ensembl chr12:106,237,881...106,304,279
JBrowse link
G CKLF chemokine like factor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CKLF mRNA CTD PMID:25510870 NCBI chr16:66,552,563...66,566,287
Ensembl chr16:66,552,563...66,566,251
JBrowse link
G CKMT1B creatine kinase, mitochondrial 1B increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CKMT1 protein CTD PMID:21673325 NCBI chr15:43,592,857...43,599,406
Ensembl chr15:43,593,054...43,604,901
Ensembl chr15:43,593,054...43,604,901
JBrowse link
G CKS2 CDC28 protein kinase regulatory subunit 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CKS2 mRNA CTD PMID:25510870 NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
JBrowse link
G CLDN2 claudin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLDN2 mRNA CTD PMID:25510870 NCBI chr  X:106,900,164...106,930,861
Ensembl chr  X:106,900,164...106,930,861
JBrowse link
G CLDN4 claudin 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLDN4 mRNA CTD PMID:25510870 NCBI chr 7:73,830,996...73,832,690
Ensembl chr 7:73,799,542...73,832,690
JBrowse link
G CLEC12B C-type lectin domain family 12 member B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CLEC12B mRNA CTD PMID:25510870 NCBI chr12:10,006,209...10,018,800
Ensembl chr12:10,010,627...10,018,796
JBrowse link
G CLEC5A C-type lectin domain containing 5A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CLEC5A mRNA CTD PMID:25510870 NCBI chr 7:141,927,357...141,946,974
Ensembl chr 7:141,927,357...141,947,007
JBrowse link
G CLEC7A C-type lectin domain containing 7A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CLEC7A mRNA CTD PMID:25510870 NCBI chr12:10,116,777...10,130,304
Ensembl chr12:10,116,777...10,130,258
JBrowse link
G CLHC1 clathrin heavy chain linker domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CLHC1 mRNA CTD PMID:25510870 NCBI chr 2:55,172,547...55,232,563
Ensembl chr 2:55,172,547...55,232,563
JBrowse link
G CLMP CXADR like membrane protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CLMP mRNA CTD PMID:25510870 NCBI chr11:123,069,872...123,195,248
Ensembl chr11:123,069,872...123,195,248
JBrowse link
G CLRN2 clarin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLRN2 mRNA CTD PMID:25510870 NCBI chr 4:17,515,165...17,527,104
Ensembl chr 4:17,515,165...17,527,104
JBrowse link
G CLRN3 clarin 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CLRN3 mRNA CTD PMID:25510870 NCBI chr10:127,877,841...127,892,941
Ensembl chr10:127,877,841...127,892,941
JBrowse link
G CLSPN claspin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CLSPN mRNA CTD PMID:25510870 NCBI chr 1:35,720,213...35,769,978
Ensembl chr 1:35,720,218...35,769,978
JBrowse link
G CLSTN1 calsyntenin 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CLSTN1 mRNA CTD PMID:23829299 NCBI chr 1:9,728,926...9,824,526
Ensembl chr 1:9,728,926...9,823,984
JBrowse link
G CLTC clathrin heavy chain increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CLTC protein CTD PMID:21673325 NCBI chr17:59,619,895...59,696,956
Ensembl chr17:59,619,680...59,696,956
JBrowse link
G CMA1 chymase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CMA1 mRNA CTD PMID:25510870 NCBI chr14:24,505,353...24,508,265
Ensembl chr14:24,505,353...24,508,265
JBrowse link
G CMPK2 cytidine/uridine monophosphate kinase 2 multiple interactions
decreases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CMPK2 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CMPK2 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 2:6,840,553...6,866,635
Ensembl chr 2:6,840,570...6,866,635
JBrowse link
G CNGB3 cyclic nucleotide gated channel subunit beta 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CNGB3 mRNA CTD PMID:23829299 NCBI chr 8:86,574,179...86,743,634
Ensembl chr 8:86,553,977...86,743,675
JBrowse link
G CNNM3 cyclin and CBS domain divalent metal cation transport mediator 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CNNM3 mRNA CTD PMID:25510870 NCBI chr 2:96,816,268...96,837,466
Ensembl chr 2:96,816,245...96,835,382
JBrowse link
G CNP 2',3'-cyclic nucleotide 3' phosphodiesterase decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CNP protein CTD PMID:21673325 NCBI chr17:41,966,795...41,977,740
Ensembl chr17:41,966,763...41,977,740
JBrowse link
G CNPY1 canopy FGF signaling regulator 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNPY1 mRNA CTD PMID:25510870 NCBI chr 7:155,501,129...155,546,559
Ensembl chr 7:155,474,206...155,555,450
JBrowse link
G CNTLN centlein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CNTLN mRNA CTD PMID:25510870 NCBI chr 9:17,135,040...17,528,634
Ensembl chr 9:17,134,982...17,503,923
JBrowse link
G CNTN2 contactin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNTN2 mRNA CTD PMID:25510870 NCBI chr 1:205,042,949...205,078,289
Ensembl chr 1:205,042,937...205,078,289
JBrowse link
G CNTN4 contactin 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CNTN4 mRNA CTD PMID:25510870 NCBI chr 3:2,098,866...3,057,959
Ensembl chr 3:2,098,813...3,057,959
JBrowse link
G CNTNAP2 contactin associated protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CNTNAP2 mRNA CTD PMID:25510870 NCBI chr 7:146,116,801...148,420,998
Ensembl chr 7:146,116,002...148,420,998
JBrowse link
G CNTRL centriolin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNTRL mRNA CTD PMID:25510870 NCBI chr 9:121,074,955...121,177,610
Ensembl chr 9:121,074,660...121,177,729
JBrowse link
G CNTROB centrobin, centriole duplication and spindle assembly protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNTROB mRNA CTD PMID:25510870 NCBI chr17:7,932,081...7,949,920
Ensembl chr17:7,932,101...7,949,920
JBrowse link
G COA5 cytochrome c oxidase assembly factor 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of COA5 mRNA CTD PMID:25510870 NCBI chr 2:98,599,314...98,608,512
Ensembl chr 2:98,599,314...98,608,515
JBrowse link
G COCH cochlin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of COCH mRNA CTD PMID:25510870 NCBI chr14:30,874,559...30,895,615
Ensembl chr14:30,874,514...30,895,065
JBrowse link
G COG5 component of oligomeric golgi complex 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of COG5 mRNA CTD PMID:25510870 NCBI chr 7:107,201,372...107,563,920
Ensembl chr 7:107,201,372...107,564,261
JBrowse link
G COG7 component of oligomeric golgi complex 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of COG7 mRNA CTD PMID:25510870 NCBI chr16:23,388,493...23,453,189
Ensembl chr16:23,388,493...23,453,189
JBrowse link
G COL11A1 collagen type XI alpha 1 chain multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of COL11A1 mRNA CTD PMID:25510870 NCBI chr 1:102,876,473...103,108,522
Ensembl chr 1:102,876,467...103,108,872
JBrowse link
G COL12A1 collagen type XII alpha 1 chain multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of COL12A1 mRNA CTD PMID:25510870 NCBI chr 6:75,084,326...75,206,053
Ensembl chr 6:75,084,326...75,206,267
JBrowse link
G COL23A1 collagen type XXIII alpha 1 chain decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of COL23A1 mRNA CTD PMID:23829299 NCBI chr 5:178,237,618...178,590,393
Ensembl chr 5:178,237,476...178,590,393
JBrowse link
G COL24A1 collagen type XXIV alpha 1 chain multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of COL24A1 mRNA CTD PMID:25510870 NCBI chr 1:85,729,233...86,156,984
Ensembl chr 1:85,729,233...86,156,943
JBrowse link
G COL4A1 collagen type IV alpha 1 chain decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of COL4A1 mRNA CTD PMID:23829299 NCBI chr13:110,148,963...110,307,157
Ensembl chr13:110,148,963...110,307,202
JBrowse link
G COL4A3 collagen type IV alpha 3 chain decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of COL4A3 mRNA CTD PMID:23829299 NCBI chr 2:227,164,624...227,314,792
Ensembl chr 2:227,164,624...227,314,792
JBrowse link
G COL6A3 collagen type VI alpha 3 chain multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of COL6A3 mRNA CTD PMID:25510870 NCBI chr 2:237,324,018...237,414,164
Ensembl chr 2:237,324,003...237,414,328
JBrowse link
G COMMD1 copper metabolism domain containing 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of COMMD1 mRNA CTD PMID:23829299 NCBI chr 2:61,888,391...62,136,058
Ensembl chr 2:61,888,724...62,147,247
JBrowse link
G COPS9 COP9 signalosome subunit 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of COPS9 mRNA CTD PMID:25510870 NCBI chr 2:240,126,548...240,136,347
Ensembl chr 2:240,126,563...240,136,807
JBrowse link
G COPZ2 COPI coat complex subunit zeta 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of COPZ2 mRNA CTD PMID:25510870 NCBI chr17:48,026,167...48,048,053
Ensembl chr17:48,026,167...48,038,030
JBrowse link
G CORO2A coronin 2A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CORO2A mRNA CTD PMID:25510870 NCBI chr 9:98,120,975...98,192,637
Ensembl chr 9:98,120,975...98,192,637
JBrowse link
G CORT cortistatin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CORT mRNA CTD PMID:25510870 NCBI chr 1:10,450,031...10,451,998
Ensembl chr 1:10,450,031...10,451,998
JBrowse link
G COX4I1 cytochrome c oxidase subunit 4I1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of COX4I1 mRNA CTD PMID:25510870 NCBI chr16:85,799,695...85,807,068
Ensembl chr16:85,798,633...85,807,068
JBrowse link
G COX6B2 cytochrome c oxidase subunit 6B2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of COX6B2 mRNA CTD PMID:25510870 NCBI chr19:55,349,704...55,354,719
Ensembl chr19:55,349,306...55,354,719
JBrowse link
G COX7A1 cytochrome c oxidase subunit 7A1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of COX7A1 mRNA CTD PMID:25510870 NCBI chr19:36,150,922...36,152,447
Ensembl chr19:36,150,922...36,152,449
JBrowse link
G CPA2 carboxypeptidase A2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CPA2 mRNA CTD PMID:25510870 NCBI chr 7:130,266,863...130,289,798
Ensembl chr 7:130,266,863...130,289,798
JBrowse link
G CPE carboxypeptidase E decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CPE mRNA CTD PMID:23829299 NCBI chr 4:165,379,008...165,498,547
Ensembl chr 4:165,361,194...165,498,547
JBrowse link
G CPLX1 complexin 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CPLX1 mRNA CTD PMID:23829299 NCBI chr 4:784,957...826,129
Ensembl chr 4:784,957...826,129
JBrowse link
G CPNE1 copine 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CPNE1 mRNA CTD PMID:25510870 NCBI chr20:35,626,044...35,664,900
Ensembl chr20:35,626,031...35,664,956
JBrowse link
G CPNE9 copine family member 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CPNE9 mRNA CTD PMID:25510870 NCBI chr 3:9,703,833...9,729,908
Ensembl chr 3:9,703,826...9,729,908
JBrowse link
G CPSF4L cleavage and polyadenylation specific factor 4 like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CPSF4L mRNA CTD PMID:25510870 NCBI chr17:73,242,101...73,263,778
Ensembl chr17:73,248,449...73,262,352
JBrowse link
G CPT1C carnitine palmitoyltransferase 1C decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CPT1C mRNA CTD PMID:23829299 NCBI chr19:49,690,662...49,713,731
Ensembl chr19:49,690,898...49,713,731
JBrowse link
G CPTP ceramide-1-phosphate transfer protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CPTP mRNA CTD PMID:25510870 NCBI chr 1:1,324,802...1,328,896
Ensembl chr 1:1,324,756...1,328,896
JBrowse link
G CRB3 crumbs cell polarity complex component 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CRB3 mRNA CTD PMID:25510870 NCBI chr19:6,463,777...6,467,221
Ensembl chr19:6,463,777...6,467,221
JBrowse link
G CREBL2 cAMP responsive element binding protein like 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CREBL2 mRNA CTD PMID:25510870 NCBI chr12:12,611,876...12,645,108
Ensembl chr12:12,611,827...12,645,108
JBrowse link
G CREM cAMP responsive element modulator decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CREM mRNA CTD PMID:23829299 NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
JBrowse link
G CRHR2 corticotropin releasing hormone receptor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CRHR2 mRNA CTD PMID:25510870 NCBI chr 7:30,651,942...30,700,103
Ensembl chr 7:30,651,942...30,700,129
JBrowse link
G CRIPTO cripto, EGF-CFC family member multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CRIPTO mRNA CTD PMID:25510870 NCBI chr 3:46,574,535...46,582,457
Ensembl chr 3:46,574,534...46,582,457
JBrowse link
G CRISP2 cysteine rich secretory protein 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CRISP2 mRNA CTD PMID:23829299 NCBI chr 6:49,676,652...49,714,220
Ensembl chr 6:49,692,358...49,713,590
JBrowse link
G CRLF1 cytokine receptor like factor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CRLF1 mRNA CTD PMID:25510870 NCBI chr19:18,593,237...18,606,799
Ensembl chr19:18,572,220...18,607,741
JBrowse link
G CRTAM cytotoxic and regulatory T cell molecule multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CRTAM mRNA CTD PMID:25510870 NCBI chr11:122,838,500...122,872,643
Ensembl chr11:122,838,500...122,872,643
JBrowse link
G CRYAB crystallin alpha B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CRYAB mRNA CTD PMID:25510870 NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722
JBrowse link
G CRYBB2 crystallin beta B2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CRYBB2 mRNA CTD PMID:25510870 NCBI chr22:25,211,661...25,231,869
Ensembl chr22:25,212,564...25,231,870
JBrowse link
G CRYBG3 crystallin beta-gamma domain containing 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CRYBG3 mRNA CTD PMID:25510870 NCBI chr 3:97,822,011...97,944,984
Ensembl chr 3:97,822,011...97,944,984
JBrowse link
G CSDC2 cold shock domain containing C2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CSDC2 mRNA CTD PMID:25510870 NCBI chr22:41,561,010...41,576,666
Ensembl chr22:41,561,010...41,577,741
JBrowse link
G CSMD3 CUB and Sushi multiple domains 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CSMD3 mRNA CTD PMID:25510870 NCBI chr 8:112,222,928...113,436,939
Ensembl chr 8:112,222,928...113,436,939
JBrowse link
G CSN3 casein kappa multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CSN3 mRNA CTD PMID:25510870 NCBI chr 4:70,238,381...70,251,432
Ensembl chr 4:70,238,382...70,251,474
JBrowse link
G CSNK2A1 casein kinase 2 alpha 1 affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of CSNK2A1 mRNA CTD PMID:21703328 NCBI chr20:472,498...543,790
Ensembl chr20:472,498...543,835
JBrowse link
G CSPP1 centrosome and spindle pole associated protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CSPP1 mRNA CTD PMID:25510870 NCBI chr 8:67,064,368...67,196,614
Ensembl chr 8:67,062,417...67,196,778
JBrowse link
G CSRP1 cysteine and glycine rich protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CSRP1 mRNA CTD PMID:25510870 NCBI chr 1:201,483,530...201,507,123
Ensembl chr 1:201,483,530...201,509,456
JBrowse link
G CST13P cystatin 13, pseudogene multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CST13 mRNA CTD PMID:25510870 NCBI chr20:23,519,146...23,542,018
Ensembl chr20:23,519,146...23,542,018
Ensembl chr20:23,519,146...23,542,018
JBrowse link
G CST3 cystatin C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CST3 mRNA CTD PMID:25510870 NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473
JBrowse link
G CST6 cystatin E/M multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CST6 mRNA CTD PMID:25510870 NCBI chr11:66,012,008...66,013,505
Ensembl chr11:66,012,008...66,013,505
JBrowse link
G CTF2P cardiotrophin 2, pseudogene multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CTF2 mRNA CTD PMID:25510870 NCBI chr16:30,904,248...30,910,308
Ensembl chr16:30,904,348...30,910,208
JBrowse link
G CTNND1 catenin delta 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CTNND1 mRNA CTD PMID:25510870 NCBI chr11:57,761,802...57,819,540
Ensembl chr11:57,753,243...57,819,546
JBrowse link
G CTNS cystinosin, lysosomal cystine transporter increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CTNS mRNA CTD PMID:23829299 NCBI chr17:3,636,459...3,663,103
Ensembl chr17:3,636,459...3,663,103
JBrowse link
G CTRC chymotrypsin C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CTRC mRNA CTD PMID:25510870 NCBI chr 1:15,438,443...15,449,242
Ensembl chr 1:15,438,442...15,449,242
JBrowse link
G CTXN1 cortexin 1 multiple interactions
increases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CTXN1 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CTXN1 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr19:7,924,491...7,926,135
Ensembl chr19:7,924,491...7,926,135
JBrowse link
G CUTALP cutA divalent cation tolerance like, pseudogene multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CUTAL mRNA CTD PMID:25510870 NCBI chr 9:120,843,075...120,854,373
Ensembl chr 9:120,824,828...120,854,385
Ensembl chr 9:120,824,828...120,854,385
JBrowse link
G CXCL12 C-X-C motif chemokine ligand 12 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CXCL12 mRNA CTD PMID:25510870 NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493
JBrowse link
G CYCTP cytochrome c, testis, pseudogene multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CYCT mRNA CTD PMID:25510870 NCBI chr 2:178,092,500...178,104,470
Ensembl chr 2:178,092,503...178,104,470
JBrowse link
G CYP17A1 cytochrome P450 family 17 subfamily A member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CYP17A1 mRNA CTD PMID:25510870 NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 increases activity ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased activity of CYP1A1 protein CTD PMID:15093247 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 decreases response to substance
multiple interactions
ISO CYP1A2 results in decreased susceptibility to 2,2',3',4,4',5-hexachlorobiphenyl
2,2',3',4,4',5-hexachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]; [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] promotes the reaction [AHR protein results in increased expression of CYP1A2 mRNA]; [AHR protein co-treated with CYP1A2 protein] affects the susceptibility to [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with 2,3,3',4,4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180]
CTD PMID:20961953 PMID:21571617 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
JBrowse link
G CYP20A1 cytochrome P450 family 20 subfamily A member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CYP20A1 mRNA CTD PMID:25510870 NCBI chr 2:203,239,018...203,306,026
Ensembl chr 2:203,238,977...203,306,026
JBrowse link
G CYP27B1 cytochrome P450 family 27 subfamily B member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CYP27B1 mRNA CTD PMID:25510870 NCBI chr12:57,762,334...57,767,078
Ensembl chr12:57,762,334...57,768,986
JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CYP2C38 mRNA CTD PMID:25510870 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
JBrowse link
G CYP2R1 cytochrome P450 family 2 subfamily R member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CYP2R1 mRNA CTD PMID:25510870 NCBI chr11:14,877,440...14,892,443
Ensembl chr11:14,877,440...14,892,231
JBrowse link
G CYP3A43 cytochrome P450 family 3 subfamily A member 43 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CYP3A18 mRNA CTD PMID:23829299 NCBI chr 7:99,828,013...99,866,093
Ensembl chr 7:99,828,013...99,866,093
JBrowse link
G CYP46A1 cytochrome P450 family 46 subfamily A member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CYP46A1 mRNA CTD PMID:25510870 NCBI chr14:99,684,298...99,727,301
Ensembl chr14:99,684,298...99,727,301
JBrowse link
G CYSTM1 cysteine rich transmembrane module containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CYSTM1 mRNA CTD PMID:25510870 NCBI chr 5:140,175,188...140,243,789
Ensembl chr 5:140,175,156...140,282,052
JBrowse link
G CYTH4 cytohesin 4 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CYTH4 mRNA CTD PMID:23829299 NCBI chr22:37,282,508...37,315,341
Ensembl chr22:37,282,027...37,315,341
JBrowse link
G DAB1 DAB adaptor protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DAB1 mRNA CTD PMID:25510870 NCBI chr 1:56,994,778...58,546,726
Ensembl chr 1:56,994,778...58,546,734
JBrowse link
G DACH1 dachshund family transcription factor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DACH1 mRNA CTD PMID:25510870 NCBI chr13:71,437,966...71,867,204
Ensembl chr13:71,437,966...71,867,204
JBrowse link
G DACT1 dishevelled binding antagonist of beta catenin 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DACT1 mRNA CTD PMID:25510870 NCBI chr14:58,634,061...58,648,321
Ensembl chr14:58,633,967...58,648,321
JBrowse link
G DACT2 dishevelled binding antagonist of beta catenin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DACT2 mRNA CTD PMID:25510870 NCBI chr 6:168,292,830...168,319,777
Ensembl chr 6:168,292,830...168,319,777
JBrowse link
G DAG1 dystroglycan 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of DAG1 mRNA CTD PMID:23829299 NCBI chr 3:49,468,948...49,535,615
Ensembl chr 3:49,468,713...49,535,618
JBrowse link
G DAO D-amino acid oxidase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DAO mRNA CTD PMID:25510870 NCBI chr12:108,880,092...108,901,043
Ensembl chr12:108,858,932...108,901,043
JBrowse link
G DAPK1 death associated protein kinase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DAPK1 mRNA CTD PMID:25510870 NCBI chr 9:87,497,228...87,708,634
Ensembl chr 9:87,497,228...87,708,634
JBrowse link
G DBF4 DBF4-CDC7 kinase regulatory subunit multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DBF4 mRNA CTD PMID:25510870 NCBI chr 7:87,876,493...87,909,553
Ensembl chr 7:87,876,216...87,909,553
JBrowse link
G DBIL5P diazepam binding inhibitor-like 5, pseudogene multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DBIL5 mRNA CTD PMID:25510870 NCBI chr17:752,333...755,336
Ensembl chr17:752,884...753,133
JBrowse link
G DBN1 drebrin 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DBN1 mRNA CTD PMID:25510870 NCBI chr 5:177,456,610...177,473,634
Ensembl chr 5:177,456,608...177,474,401
JBrowse link
G DCAF17 DDB1 and CUL4 associated factor 17 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DCAF17 mRNA CTD PMID:25510870 NCBI chr 2:171,434,226...171,485,052
Ensembl chr 2:171,434,217...171,485,052
JBrowse link
G DCK deoxycytidine kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DCK mRNA CTD PMID:25510870 NCBI chr 4:70,993,649...71,030,914
Ensembl chr 4:70,992,538...71,030,914
JBrowse link
G DCPS decapping enzyme, scavenger multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DCPS mRNA CTD PMID:25510870 NCBI chr11:126,304,060...126,350,005
Ensembl chr11:126,304,060...126,350,005
JBrowse link
G DCX doublecortin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DCX mRNA CTD PMID:25510870 NCBI chr  X:111,293,779...111,412,192
Ensembl chr  X:111,293,779...111,412,429
JBrowse link
G DDIAS DNA damage induced apoptosis suppressor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DDIAS mRNA CTD PMID:25510870 NCBI chr11:82,901,736...82,934,659
Ensembl chr11:82,899,975...82,958,277
JBrowse link
G DDR2 discoidin domain receptor tyrosine kinase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DDR2 mRNA CTD PMID:25510870 NCBI chr 1:162,630,863...162,787,405
Ensembl chr 1:162,631,373...162,787,405
JBrowse link
G DDT D-dopachrome tautomerase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DDT mRNA CTD PMID:25510870 NCBI chr22:23,971,370...23,980,504
Ensembl chr22:23,970,542...23,980,525
JBrowse link
G DEFB103A defensin beta 103A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DEFB14 mRNA CTD PMID:25510870 NCBI chr 8:7,881,392...7,882,663
Ensembl chr 8:7,881,392...7,882,663
Ensembl chr 8:7,881,392...7,882,663
JBrowse link
G DEFB110 defensin beta 110 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DEFB41 mRNA CTD PMID:25510870 NCBI chr 6:50,009,138...50,021,994
Ensembl chr 6:50,009,138...50,021,994
JBrowse link
G DEK DEK proto-oncogene increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of DEK mRNA CTD PMID:23829299 NCBI chr 6:18,223,860...18,264,530
Ensembl chr 6:18,223,860...18,264,548
JBrowse link
G DEPDC1 DEP domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DEPDC1A mRNA CTD PMID:25510870 NCBI chr 1:68,474,152...68,497,082
Ensembl chr 1:68,474,152...68,497,221
JBrowse link
G DEUP1 deuterosome assembly protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DEUP1 mRNA CTD PMID:25510870 NCBI chr11:93,329,998...93,438,470
Ensembl chr11:93,329,971...93,438,487
JBrowse link
G DGKG diacylglycerol kinase gamma multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DGKG mRNA CTD PMID:25510870 NCBI chr 3:186,147,201...186,362,234
Ensembl chr 3:186,105,668...186,362,234
JBrowse link
G DHX35 DEAH-box helicase 35 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of DHX35 mRNA CTD PMID:23829299 NCBI chr20:38,962,344...39,039,721
Ensembl chr20:38,962,299...39,039,723
JBrowse link
G DHX9 DExH-box helicase 9 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of DHX9 mRNA CTD PMID:23829299 NCBI chr 1:182,839,347...182,887,982
Ensembl chr 1:182,839,347...182,887,982
JBrowse link
G DIP2B disco interacting protein 2 homolog B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIP2B mRNA CTD PMID:25510870 NCBI chr12:50,504,985...50,748,657
Ensembl chr12:50,504,985...50,748,657
JBrowse link
G DIRAS2 DIRAS family GTPase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIRAS2 mRNA CTD PMID:25510870 NCBI chr 9:90,609,832...90,642,824
Ensembl chr 9:90,609,832...90,642,862
JBrowse link
G DIRAS3 DIRAS family GTPase 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DIRAS3 mRNA CTD PMID:23829299 NCBI chr 1:68,045,962...68,050,627
Ensembl chr 1:68,045,886...68,051,717
JBrowse link
G DISC1 DISC1 scaffold protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DISC1 mRNA CTD PMID:25510870 NCBI chr 1:231,626,790...232,041,272
Ensembl chr 1:231,626,790...232,041,272
JBrowse link
G DISP2 dispatched RND transporter family member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DISP2 mRNA CTD PMID:25510870 NCBI chr15:40,358,219...40,378,621
Ensembl chr15:40,358,219...40,378,621
JBrowse link
G DKK4 dickkopf WNT signaling pathway inhibitor 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DKK4 mRNA CTD PMID:25510870 NCBI chr 8:42,374,063...42,391,322
Ensembl chr 8:42,374,063...42,377,229
JBrowse link
G DLEU7 deleted in lymphocytic leukemia 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DLEU7 mRNA CTD PMID:25510870 NCBI chr13:50,711,026...50,843,939
Ensembl chr13:50,519,364...50,843,939
JBrowse link
G DLG2 discs large MAGUK scaffold protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DLG2 mRNA CTD PMID:25510870 NCBI chr11:83,455,012...85,628,373
Ensembl chr11:83,455,012...85,628,335
JBrowse link
G DLG4 discs large MAGUK scaffold protein 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with APP protein modified form] results in decreased expression of DLG4 protein CTD PMID:26480858 NCBI chr17:7,187,187...7,220,050
Ensembl chr17:7,187,187...7,219,836
JBrowse link
G DLGAP3 DLG associated protein 3 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of DLGAP3 mRNA CTD PMID:23829299 NCBI chr 1:34,865,436...34,929,650
Ensembl chr 1:34,865,436...34,929,650
JBrowse link
G DLGAP5 DLG associated protein 5 multiple interactions
decreases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DLGAP5 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DLGAP5 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr14:55,148,135...55,191,585
Ensembl chr14:55,148,112...55,191,608
JBrowse link
G DMD dystrophin multiple interactions
decreases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DMD mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DMD mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr  X:31,119,222...33,339,388
Ensembl chr  X:31,097,677...33,339,609
JBrowse link
G DMRTC1B DMRT like family C1B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DMRTC1B mRNA CTD PMID:25510870 NCBI chr  X:72,776,890...72,848,803
Ensembl chr  X:72,776,890...72,848,803
JBrowse link
G DNAH8 dynein axonemal heavy chain 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DNAH8 mRNA CTD PMID:25510870 NCBI chr 6:38,715,311...39,030,792
Ensembl chr 6:38,715,311...39,030,792
JBrowse link
G DNAJB4 DnaJ heat shock protein family (Hsp40) member B4 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DNAJB4 mRNA CTD PMID:23829299 NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
JBrowse link
G DNAJB8 DnaJ heat shock protein family (Hsp40) member B8 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of DNAJB8 mRNA CTD PMID:23829299 NCBI chr 3:128,462,437...128,466,890
Ensembl chr 3:128,462,437...128,466,968
JBrowse link
G DNAJC27 DnaJ heat shock protein family (Hsp40) member C27 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DNAJC27 mRNA CTD PMID:25510870 NCBI chr 2:24,943,636...24,972,094
Ensembl chr 2:24,943,636...24,972,094
JBrowse link
G DNAJC6 DnaJ heat shock protein family (Hsp40) member C6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DNAJC6 mRNA CTD PMID:25510870 NCBI chr 1:65,264,749...65,415,871
Ensembl chr 1:65,248,219...65,415,871
JBrowse link
G DNAJC8 DnaJ heat shock protein family (Hsp40) member C8 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DNAJC8 mRNA CTD PMID:23829299 NCBI chr 1:28,200,278...28,233,029
Ensembl chr 1:28,199,456...28,233,029
JBrowse link
G DNASE2B deoxyribonuclease 2 beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DNASE2B mRNA CTD PMID:25510870 NCBI chr 1:84,398,484...84,415,018
Ensembl chr 1:84,398,484...84,415,018
JBrowse link
G DNM1 dynamin 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DNM1 protein CTD PMID:21673325 NCBI chr 9:128,203,379...128,255,244
Ensembl chr 9:128,191,655...128,255,248
JBrowse link
G DNM2 dynamin 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DNM2 mRNA CTD PMID:23829299 NCBI chr19:10,718,079...10,831,903
Ensembl chr19:10,718,055...10,833,488
JBrowse link
G DNM3 dynamin 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DNM3 protein CTD PMID:21673325 NCBI chr 1:171,841,498...172,418,466
Ensembl chr 1:171,817,887...172,418,466
JBrowse link
G DNMT3B DNA methyltransferase 3 beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DNMT3B mRNA CTD PMID:25510870 NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
JBrowse link
G DNMT3L DNA methyltransferase 3 like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DNMT3L mRNA CTD PMID:25510870 NCBI chr21:44,246,339...44,261,897
Ensembl chr21:44,246,339...44,262,216
JBrowse link
G DOC2B double C2 domain beta decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DOC2B mRNA CTD PMID:23829299 NCBI chr17:142,789...181,650
Ensembl chr17:142,789...181,650
JBrowse link
G DOCK11 dedicator of cytokinesis 11 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DOCK11 mRNA CTD PMID:25510870 NCBI chr  X:118,495,815...118,686,147
Ensembl chr  X:118,495,815...118,686,163
JBrowse link
G DOCK7 dedicator of cytokinesis 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DOCK7 mRNA CTD PMID:25510870 NCBI chr 1:62,454,726...62,688,386
Ensembl chr 1:62,454,298...62,688,386
JBrowse link
G DOK3 docking protein 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DOK3 mRNA CTD PMID:25510870 NCBI chr 5:177,501,904...177,511,100
Ensembl chr 5:177,501,904...177,511,274
JBrowse link
G DOK5 docking protein 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DOK5 mRNA CTD PMID:23829299 NCBI chr20:54,475,593...54,651,169
Ensembl chr20:54,475,593...54,651,169
JBrowse link
G DOK6 docking protein 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DOK6 mRNA CTD PMID:25510870 NCBI chr18:69,400,888...69,849,087
Ensembl chr18:69,400,888...69,849,087
JBrowse link
G DPF3 double PHD fingers 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DPF3 mRNA CTD PMID:23829299 NCBI chr14:72,609,034...72,894,101
Ensembl chr14:72,609,034...72,894,101
JBrowse link
G DPH5 diphthamide biosynthesis 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DPH5 mRNA CTD PMID:25510870 NCBI chr 1:100,989,623...101,025,784
Ensembl chr 1:100,989,623...101,026,088
JBrowse link
G DPP10 dipeptidyl peptidase like 10 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DPP10 mRNA CTD PMID:25510870 NCBI chr 2:114,442,641...115,845,780
Ensembl chr 2:114,442,299...115,845,780
JBrowse link
G DPYSL3 dihydropyrimidinase like 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DPYSL3 mRNA; 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DPYSL3 protein CTD PMID:21673325 PMID:23829299 NCBI chr 5:147,390,808...147,510,068
Ensembl chr 5:147,390,808...147,510,068
JBrowse link
G DPYSL5 dihydropyrimidinase like 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DPYSL5 protein CTD PMID:21673325 NCBI chr 2:26,847,995...26,950,351
Ensembl chr 2:26,847,747...26,950,351
JBrowse link
G DRAXIN dorsal inhibitory axon guidance protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DRAXIN mRNA CTD PMID:25510870 NCBI chr 1:11,686,635...11,725,857
Ensembl chr 1:11,691,710...11,725,857
JBrowse link
G DRC3 dynein regulatory complex subunit 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DRC3 mRNA CTD PMID:25510870 NCBI chr17:17,972,813...18,016,889
Ensembl chr17:17,972,813...18,016,889
JBrowse link
G DSCAM DS cell adhesion molecule decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DSCAM mRNA CTD PMID:23829299 NCBI chr21:40,010,999...40,847,158
Ensembl chr21:40,010,999...40,847,158
JBrowse link
G DSCAML1 DS cell adhesion molecule like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DSCAML1 mRNA CTD PMID:25510870 NCBI chr11:117,427,772...117,817,514
Ensembl chr11:117,427,772...117,817,525
JBrowse link
G DSCC1 DNA replication and sister chromatid cohesion 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DSCC1 mRNA CTD PMID:25510870 NCBI chr 8:119,833,976...119,855,894
Ensembl chr 8:119,833,976...119,855,894
JBrowse link
G DTNA dystrobrevin alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DTNA mRNA CTD PMID:25510870 NCBI chr18:34,493,312...34,891,844
Ensembl chr18:34,493,291...34,891,844
JBrowse link
G DTNB dystrobrevin beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DTNB mRNA CTD PMID:25510870 NCBI chr 2:25,377,243...25,673,577
Ensembl chr 2:25,377,198...25,673,647
JBrowse link
G DUSP14 dual specificity phosphatase 14 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DUSP14 mRNA CTD PMID:25510870 NCBI chr17:37,488,566...37,513,498
Ensembl chr17:37,489,891...37,513,501
JBrowse link
G DUSP19 dual specificity phosphatase 19 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DUSP19 mRNA CTD PMID:25510870 NCBI chr 2:183,078,747...183,100,008
Ensembl chr 2:183,078,559...183,100,008
JBrowse link
G DVL3 dishevelled segment polarity protein 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DVL3 mRNA CTD PMID:25510870 NCBI chr 3:184,155,377...184,173,614
Ensembl chr 3:184,155,377...184,173,614
JBrowse link
G DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DYRK2 mRNA CTD PMID:25510870 NCBI chr12:67,648,745...67,665,406
Ensembl chr12:67,648,338...67,665,406
JBrowse link
G E2F2 E2F transcription factor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of E2F2 mRNA CTD PMID:25510870 NCBI chr 1:23,505,212...23,531,233
Ensembl chr 1:23,506,438...23,531,233
JBrowse link
G E2F7 E2F transcription factor 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of E2F7 mRNA CTD PMID:25510870 NCBI chr12:77,021,251...77,065,569
Ensembl chr12:77,021,248...77,065,569
JBrowse link
G E2F8 E2F transcription factor 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of E2F8 mRNA CTD PMID:25510870 NCBI chr11:19,224,063...19,241,655
Ensembl chr11:19,224,063...19,241,620
JBrowse link
G EBF1 EBF transcription factor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EBF1 mRNA CTD PMID:25510870 NCBI chr 5:158,695,920...159,099,916
Ensembl chr 5:158,695,920...159,099,916
JBrowse link
G EBF2 EBF transcription factor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EBF2 mRNA CTD PMID:25510870 NCBI chr 8:25,841,725...26,045,413
Ensembl chr 8:25,841,725...26,045,413
JBrowse link
G EBF3 EBF transcription factor 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EBF3 mRNA CTD PMID:25510870 NCBI chr10:129,835,233...129,964,274
Ensembl chr10:129,835,233...129,973,053
JBrowse link
G ECT2 epithelial cell transforming 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ECT2 mRNA CTD PMID:25510870 NCBI chr 3:172,750,726...172,829,265
Ensembl chr 3:172,750,682...172,821,474
JBrowse link
G EEF1A1 eukaryotic translation elongation factor 1 alpha 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of EEF1A1 protein CTD PMID:21673325 NCBI chr 6:73,515,750...73,521,032
Ensembl chr 6:73,489,308...73,525,587
JBrowse link
G EEF2 eukaryotic translation elongation factor 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of EEF2 protein CTD PMID:21673325 NCBI chr19:3,976,056...3,985,463
Ensembl chr19:3,976,056...3,985,463
JBrowse link
G EEF2K eukaryotic elongation factor 2 kinase decreases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of EEF2K mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of EEF2K mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr16:22,206,278...22,288,738
Ensembl chr16:22,206,278...22,288,738
JBrowse link
G EFCAB11 EF-hand calcium binding domain 11 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EFCAB11 mRNA CTD PMID:25510870 NCBI chr14:89,794,669...89,954,777
Ensembl chr14:89,794,669...89,954,777
JBrowse link
G EFNA3 ephrin A3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of EFNA3 mRNA CTD PMID:25510870 NCBI chr 1:155,078,837...155,087,538
Ensembl chr 1:155,078,837...155,087,538
JBrowse link
G EFS embryonal Fyn-associated substrate increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of EFS mRNA CTD PMID:23829299 NCBI chr14:23,356,406...23,365,172
Ensembl chr14:23,356,403...23,365,752
JBrowse link
G EGF epidermal growth factor increases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of EGF mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EGF mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
JBrowse link
G EIF4EBP3 eukaryotic translation initiation factor 4E binding protein 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EIF4EBP3 mRNA CTD PMID:25510870 NCBI chr 5:140,547,662...140,549,576
Ensembl chr 5:140,547,662...140,549,576
JBrowse link
G EIF5 eukaryotic translation initiation factor 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of EIF5 mRNA CTD PMID:23829299 NCBI chr14:103,334,237...103,345,025
Ensembl chr14:103,333,544...103,345,025
JBrowse link
G EIF5B eukaryotic translation initiation factor 5B increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of EIF5B mRNA CTD PMID:23829299 NCBI chr 2:99,337,389...99,401,326
Ensembl chr 2:99,337,389...99,401,326
JBrowse link
G ELAVL2 ELAV like RNA binding protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ELAVL2 mRNA CTD PMID:25510870 NCBI chr 9:23,690,104...23,850,601
Ensembl chr 9:23,690,104...23,826,337
JBrowse link
G ELF4 E74 like ETS transcription factor 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ELF4 mRNA CTD PMID:25510870 NCBI chr  X:130,063,955...130,111,927
Ensembl chr  X:130,063,955...130,110,716
JBrowse link
G ELK4 ETS transcription factor ELK4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ELK4 mRNA CTD PMID:25510870 NCBI chr 1:205,607,943...205,632,011
Ensembl chr 1:205,597,556...205,632,011
JBrowse link
G ELL3 elongation factor for RNA polymerase II 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ELL3 mRNA CTD PMID:25510870 NCBI chr15:43,772,620...43,776,966
Ensembl chr15:43,772,605...43,777,315
JBrowse link
G ELMO3 engulfment and cell motility 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ELMO3 mRNA CTD PMID:25510870 NCBI chr16:67,199,131...67,204,004
Ensembl chr16:67,199,111...67,204,029
JBrowse link
G EME1 essential meiotic structure-specific endonuclease 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of EME1 mRNA CTD PMID:23829299 NCBI chr17:50,373,229...50,381,483
Ensembl chr17:50,373,220...50,381,483
JBrowse link
G EML2 EMAP like 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of EML2 mRNA CTD PMID:23829299 NCBI chr19:45,609,400...45,645,629
Ensembl chr19:45,606,994...45,645,602
JBrowse link
G ENC1 ectodermal-neural cortex 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ENC1 mRNA CTD PMID:25510870 NCBI chr 5:74,627,409...74,640,728
Ensembl chr 5:74,627,406...74,641,424
JBrowse link
G ENO1 enolase 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ENO1 protein CTD PMID:21673325 NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
JBrowse link
G ENO2 enolase 2 multiple interactions
increases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ENO2 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ENO2 protein
CTD PMID:21673325 PMID:25510870 NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
JBrowse link
G ENPP2 ectonucleotide pyrophosphatase/phosphodiesterase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ENPP2 mRNA CTD PMID:25510870 NCBI chr 8:119,557,086...119,673,390
Ensembl chr 8:119,557,086...119,673,453
JBrowse link
G ENTPD4 ectonucleoside triphosphate diphosphohydrolase 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ENTPD4 mRNA CTD PMID:25510870 NCBI chr 8:23,429,162...23,457,647
Ensembl chr 8:23,385,783...23,457,695
JBrowse link
G EOMES eomesodermin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EOMES mRNA CTD PMID:25510870 NCBI chr 3:27,715,953...27,722,713
Ensembl chr 3:27,715,949...27,722,711
JBrowse link
G EP400 E1A binding protein p400 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EP400 mRNA CTD PMID:25510870 NCBI chr12:131,949,942...132,080,460
Ensembl chr12:131,949,942...132,080,460
JBrowse link
G EPB41L1 erythrocyte membrane protein band 4.1 like 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of EPB41L1 mRNA CTD PMID:23829299 NCBI chr20:36,091,414...36,232,799
Ensembl chr20:36,091,504...36,232,799
JBrowse link
G EPB41L5 erythrocyte membrane protein band 4.1 like 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of EPB41L5 mRNA CTD PMID:25510870 NCBI chr 2:120,013,077...120,179,119
Ensembl chr 2:120,013,077...120,179,119
JBrowse link
G EPHA5 EPH receptor A5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of EPHA5 mRNA CTD PMID:25510870 NCBI chr 4:65,319,567...65,670,489
Ensembl chr 4:65,319,563...65,670,495
JBrowse link
G EPPIN epididymal peptidase inhibitor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of EPPIN mRNA CTD PMID:25510870 NCBI chr20:45,540,626...45,547,401
Ensembl chr20:45,540,626...45,547,752
JBrowse link
G EPS8L2 EPS8 signaling adaptor L2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of EPS8L2 mRNA CTD PMID:25510870 NCBI chr11:706,231...727,727
Ensembl chr11:694,438...727,727
JBrowse link
G ERCC6L ERCC excision repair 6 like, spindle assembly checkpoint helicase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ERCC6L mRNA CTD PMID:25510870 NCBI chr  X:72,204,665...72,239,027
Ensembl chr  X:72,204,657...72,239,027
JBrowse link
G ERI1 exoribonuclease 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ERI1 mRNA CTD PMID:25510870 NCBI chr 8:9,002,897...9,100,104
Ensembl chr 8:9,002,147...9,116,746
JBrowse link
G ERI2 ERI1 exoribonuclease family member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ERI2 mRNA CTD PMID:25510870 NCBI chr16:20,780,193...20,806,472
Ensembl chr16:20,780,193...20,900,349
JBrowse link
G ERP27 endoplasmic reticulum protein 27 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ERP27 mRNA CTD PMID:23829299 NCBI chr12:14,914,039...14,938,537
Ensembl chr12:14,914,039...14,938,537
JBrowse link
G ESCO1 establishment of sister chromatid cohesion N-acetyltransferase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ESCO1 mRNA CTD PMID:25510870 NCBI chr18:21,529,284...21,600,704
Ensembl chr18:21,529,284...21,600,884
JBrowse link
G ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ESCO2 mRNA CTD PMID:25510870 NCBI chr 8:27,771,974...27,819,660
Ensembl chr 8:27,771,949...27,812,640
JBrowse link
G ESPL1 extra spindle pole bodies like 1, separase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ESPL1 mRNA CTD PMID:25510870 NCBI chr12:53,268,299...53,293,638
Ensembl chr12:53,268,299...53,293,638
JBrowse link
G ESRRB estrogen related receptor beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ESRRB mRNA CTD PMID:25510870 NCBI chr14:76,310,777...76,501,837
Ensembl chr14:76,310,712...76,501,837
JBrowse link
G ESYT3 extended synaptotagmin 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ESYT3 mRNA CTD PMID:25510870 NCBI chr 3:138,434,616...138,481,686
Ensembl chr 3:138,434,586...138,481,686
JBrowse link
G ETNPPL ethanolamine-phosphate phospho-lyase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ETNPPL mRNA CTD PMID:25510870 NCBI chr 4:108,742,053...108,763,053
Ensembl chr 4:108,742,048...108,763,054
JBrowse link
G ETV1 ETS variant transcription factor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ETV1 mRNA CTD PMID:25510870 NCBI chr 7:13,891,229...13,991,425
Ensembl chr 7:13,891,229...13,991,425
JBrowse link
G ETV2 ETS variant transcription factor 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ETV2 mRNA CTD PMID:23829299 NCBI chr19:35,641,745...35,644,871
Ensembl chr19:35,641,745...35,644,871
JBrowse link
G EXO1 exonuclease 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EXO1 mRNA CTD PMID:25510870 NCBI chr 1:241,847,986...241,889,939
Ensembl chr 1:241,847,967...241,895,148
JBrowse link
G EXOSC2 exosome component 2 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of EXOSC2 mRNA CTD PMID:23829299 NCBI chr 9:130,693,760...130,704,894
Ensembl chr 9:130,693,721...130,707,288
JBrowse link
G EZH2 enhancer of zeste 2 polycomb repressive complex 2 subunit multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EZH2 mRNA CTD PMID:25510870 NCBI chr 7:148,807,383...148,884,291
Ensembl chr 7:148,807,257...148,884,321
JBrowse link
G EZR ezrin decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of EZR protein CTD PMID:21673325 NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,368
JBrowse link
G F11 coagulation factor XI increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of F11 mRNA CTD PMID:23829299 NCBI chr 4:186,266,189...186,289,681
Ensembl chr 4:186,266,189...186,289,681
JBrowse link
G F2 coagulation factor II, thrombin affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of F2 mRNA CTD PMID:21703328 NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
JBrowse link
G F2R coagulation factor II thrombin receptor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of F2R mRNA CTD PMID:25510870 NCBI chr 5:76,716,126...76,735,770
Ensembl chr 5:76,716,126...76,735,770
JBrowse link
G F5 coagulation factor V increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of F5 mRNA CTD PMID:23829299 NCBI chr 1:169,511,951...169,586,481
Ensembl chr 1:169,511,951...169,586,588
JBrowse link
G FABP4 fatty acid binding protein 4 multiple interactions ISO 2,2',3',4,4',5-hexachlorobiphenyl promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 protein] CTD PMID:29704545 NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
JBrowse link
G FABP9 fatty acid binding protein 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FABP9 mRNA CTD PMID:25510870 NCBI chr 8:81,458,253...81,461,579
Ensembl chr 8:81,458,253...81,461,579
JBrowse link
G FADD Fas associated via death domain affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of FADD mRNA CTD PMID:21703328 NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
JBrowse link
G FADS3 fatty acid desaturase 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of FADS3 mRNA CTD PMID:23829299 NCBI chr11:61,873,526...61,892,224
Ensembl chr11:61,873,519...61,892,051
JBrowse link
G FAIM2 Fas apoptotic inhibitory molecule 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FAIM2 mRNA CTD PMID:25510870 NCBI chr12:49,866,896...49,903,900
Ensembl chr12:49,866,896...49,904,217
JBrowse link
G FAM107A family with sequence similarity 107 member A decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of FAM107A mRNA CTD PMID:23829299 NCBI chr 3:58,564,117...58,627,610
Ensembl chr 3:58,564,117...58,627,610
JBrowse link
G FAM111A FAM111 trypsin like peptidase A decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of FAM111A mRNA CTD PMID:23829299 NCBI chr11:59,142,856...59,155,039
Ensembl chr11:59,142,748...59,155,039
JBrowse link
G FAM13C family with sequence similarity 13 member C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FAM13C mRNA CTD PMID:25510870 NCBI chr10:59,246,129...59,363,181
Ensembl chr10:59,246,130...59,363,181
JBrowse link
G FAM217B family with sequence similarity 217 member B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FAM217B mRNA CTD PMID:25510870 NCBI chr20:59,933,779...59,948,680
Ensembl chr20:59,933,764...59,948,680
JBrowse link
G FAM228A family with sequence similarity 228 member A decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of FAM228A mRNA CTD PMID:23829299 NCBI chr 2:24,175,053...24,191,698
Ensembl chr 2:24,175,053...24,200,849
JBrowse link
G FAM234A family with sequence similarity 234 member A increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of FAM234A mRNA CTD PMID:23829299 NCBI chr16:234,821...269,963
Ensembl chr16:234,521...272,183
JBrowse link
G FAM43B family with sequence similarity 43 member B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FAM43B mRNA CTD PMID:25510870 NCBI chr 1:20,552,573...20,555,020
Ensembl chr 1:20,552,573...20,555,020
JBrowse link
G FAM53B family with sequence similarity 53 member B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FAM53B mRNA CTD PMID:25510870 NCBI chr10:124,619,292...124,744,378
Ensembl chr10:124,619,292...124,744,378
JBrowse link
G FAM83F family with sequence similarity 83 member F decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of FAM83F mRNA CTD PMID:23829299 NCBI chr22:39,994,954...40,043,534
Ensembl chr22:39,994,954...40,043,534
JBrowse link
G FANCA FA complementation group A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FANCA mRNA CTD PMID:25510870 NCBI chr16:89,737,549...89,816,647
Ensembl chr16:89,726,683...89,816,977
JBrowse link
G FANCD2 FA complementation group D2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FANCD2 mRNA CTD PMID:25510870 NCBI chr 3:10,026,437...10,101,932
Ensembl chr 3:10,026,370...10,101,932
JBrowse link
G FANCI FA complementation group I multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FANCI mRNA CTD PMID:25510870 NCBI chr15:89,243,979...89,317,259
Ensembl chr15:89,243,945...89,317,261
JBrowse link
G FARSA phenylalanyl-tRNA synthetase subunit alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FARSA mRNA CTD PMID:25510870 NCBI chr19:12,922,479...12,933,711
Ensembl chr19:12,922,479...12,934,037
JBrowse link
G FASTKD2 FAST kinase domains 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FASTKD2 mRNA CTD PMID:25510870 NCBI chr 2:206,765,606...206,796,189
Ensembl chr 2:206,765,357...206,796,189
JBrowse link
G FAT2 FAT atypical cadherin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FAT2 mRNA CTD PMID:25510870 NCBI chr 5:151,504,092...151,594,819
Ensembl chr 5:151,504,092...151,591,331
JBrowse link
G FAT3 FAT atypical cadherin 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FAT3 mRNA CTD PMID:25510870 NCBI chr11:92,224,818...92,896,473
Ensembl chr11:92,224,818...92,896,473
JBrowse link
G FBL fibrillarin increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of FBL mRNA CTD PMID:23829299 NCBI chr19:39,834,458...39,846,379
Ensembl chr19:39,834,458...39,846,379
JBrowse link
G FBLN1 fibulin 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of FBLN1 mRNA CTD PMID:23829299 NCBI chr22:45,502,883...45,601,135
Ensembl chr22:45,502,238...45,601,135
JBrowse link
G FBXO5 F-box protein 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FBXO5 mRNA CTD PMID:25510870 NCBI chr 6:152,970,535...152,983,579
Ensembl chr 6:152,970,519...152,983,579
JBrowse link
G FCGR1A Fc gamma receptor Ia multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FCGR1 mRNA CTD PMID:25510870 NCBI chr 1:149,782,694...149,800,609
Ensembl chr 1:149,782,671...149,791,675
JBrowse link
G FCRL5 Fc receptor like 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FCRL5 mRNA CTD PMID:25510870 NCBI chr 1:157,513,377...157,552,515
Ensembl chr 1:157,513,377...157,552,515
JBrowse link
G FCRLA Fc receptor like A increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of FCRLA mRNA CTD PMID:23829299 NCBI chr 1:161,707,229...161,714,352
Ensembl chr 1:161,706,972...161,714,352
JBrowse link
G FER1L4 fer-1 like family member 4 (pseudogene) multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FER1L4 mRNA CTD PMID:25510870 NCBI chr20:35,558,737...35,607,562
Ensembl chr20:35,558,866...35,607,494
JBrowse link
G FGD1 FYVE, RhoGEF and PH domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FGD1 mRNA CTD PMID:25510870 NCBI chr  X:54,445,454...54,496,234
Ensembl chr  X:54,445,454...54,496,234
JBrowse link
G FGD4 FYVE, RhoGEF and PH domain containing 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FGD4 mRNA CTD PMID:25510870 NCBI chr12:32,399,558...32,646,050
Ensembl chr12:32,399,558...32,646,050
JBrowse link
G FGF1 fibroblast growth factor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FGF1 mRNA CTD PMID:25510870 NCBI chr 5:142,592,178...142,698,070
Ensembl chr 5:142,592,178...142,698,070
JBrowse link
G FGF12 fibroblast growth factor 12 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FGF12 mRNA CTD PMID:25510870 NCBI chr 3:192,139,390...192,727,541
Ensembl chr 3:192,139,390...192,767,764
JBrowse link
G FGF14 fibroblast growth factor 14 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FGF14 mRNA CTD PMID:25510870 NCBI chr13:101,710,804...102,402,443
Ensembl chr13:101,710,804...102,402,457
JBrowse link
G FGF21 fibroblast growth factor 21 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FGF21 mRNA CTD PMID:25510870 NCBI chr19:48,755,524...48,758,330
Ensembl chr19:48,755,524...48,758,333
JBrowse link
G FGF3 fibroblast growth factor 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FGF3 mRNA CTD PMID:25510870 NCBI chr11:69,809,968...69,819,416
Ensembl chr11:69,809,968...69,819,416
JBrowse link
G FGF6 fibroblast growth factor 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FGF6 mRNA CTD PMID:25510870 NCBI chr12:4,434,142...4,445,815
Ensembl chr12:4,428,155...4,445,815
JBrowse link
G FGF7 fibroblast growth factor 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FGF7 mRNA CTD PMID:25510870 NCBI chr15:49,423,242...49,488,775
Ensembl chr15:49,423,237...49,488,775
JBrowse link
G FGFR3 fibroblast growth factor receptor 3 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of FGFR3 mRNA CTD PMID:23829299 NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872
JBrowse link
G FGGY FGGY carbohydrate kinase domain containing multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FGGY mRNA CTD PMID:25510870 NCBI chr 1:59,296,378...59,762,730
Ensembl chr 1:59,296,638...59,810,647
JBrowse link
G FHIP1A FHF complex subunit HOOK interacting protein 1A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FHIP1A mRNA CTD PMID:25510870 NCBI chr 4:151,409,176...151,670,503
Ensembl chr 4:151,409,176...151,670,503
JBrowse link
G FIGNL1 fidgetin like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FIGNL1 mRNA CTD PMID:25510870 NCBI chr 7:50,444,133...50,450,350
Ensembl chr 7:50,444,128...50,450,390
JBrowse link
G FITM1 fat storage inducing transmembrane protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FITM1 mRNA CTD PMID:25510870 NCBI chr14:24,130,659...24,132,847
Ensembl chr14:24,130,659...24,132,849
JBrowse link
G FKBP1A FKBP prolyl isomerase 1A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FKBP1A mRNA CTD PMID:25510870 NCBI chr20:1,368,978...1,393,054
Ensembl chr20:1,368,977...1,393,164
JBrowse link
G FKBP4 FKBP prolyl isomerase 4 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of FKBP4 protein CTD PMID:21673325 NCBI chr12:2,794,970...2,805,423
Ensembl chr12:2,794,970...2,805,423
JBrowse link
G FLNA filamin A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FLNA mRNA CTD PMID:25510870 NCBI chr  X:154,348,531...154,374,634
Ensembl chr  X:154,348,524...154,374,634
JBrowse link
G FLT1 fms related receptor tyrosine kinase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FLT1 mRNA CTD PMID:25510870 NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
JBrowse link
G FN1 fibronectin 1 increases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of FN1 mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FN1 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
JBrowse link
G FN3KRP fructosamine 3 kinase related protein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of FN3KRP mRNA CTD PMID:23829299 NCBI chr17:82,716,706...82,728,013
Ensembl chr17:82,716,706...82,730,328
JBrowse link
G FNBP1 formin binding protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FNBP1 mRNA CTD PMID:25510870 NCBI chr 9:129,887,187...130,053,879
Ensembl chr 9:129,887,187...130,043,189
JBrowse link
G FNBP1L formin binding protein 1 like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FNBP1L mRNA CTD PMID:25510870 NCBI chr 1:93,448,118...93,554,661
Ensembl chr 1:93,448,118...93,554,661
JBrowse link
G FNBP4 formin binding protein 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FNBP4 mRNA CTD PMID:25510870 NCBI chr11:47,716,494...47,767,341
Ensembl chr11:47,716,494...47,767,443
JBrowse link
G FNDC1 fibronectin type III domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FNDC1 mRNA CTD PMID:25510870 NCBI chr 6:159,169,400...159,272,108
Ensembl chr 6:159,169,400...159,272,108
JBrowse link
G FOLR1 folate receptor alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FOLR1 mRNA CTD PMID:25510870 NCBI chr11:72,189,709...72,196,323
Ensembl chr11:72,189,558...72,196,323
JBrowse link
G FOS Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FOS protein CTD PMID:21190954 NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
JBrowse link
G FOXL2 forkhead box L2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FOXL2 mRNA CTD PMID:25510870 NCBI chr 3:138,944,224...138,947,137
Ensembl chr 3:138,944,224...138,947,137
JBrowse link
G FOXM1 forkhead box M1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FOXM1 mRNA CTD PMID:25510870 NCBI chr12:2,857,680...2,877,174
Ensembl chr12:2,857,680...2,877,174
JBrowse link
G FOXP1 forkhead box P1 increases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of FOXP1 mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FOXP1 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 3:70,954,708...71,583,978
Ensembl chr 3:70,954,693...71,583,978
JBrowse link
G FOXP2 forkhead box P2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FOXP2 mRNA CTD PMID:25510870 NCBI chr 7:114,086,327...114,693,765
Ensembl chr 7:114,086,327...114,693,772
JBrowse link
G FRMD4A FERM domain containing 4A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FRMD4A mRNA CTD PMID:25510870 NCBI chr10:13,643,706...14,330,924
Ensembl chr10:13,643,706...14,462,142
JBrowse link
G FRMPD3 FERM and PDZ domain containing 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FRMPD3 mRNA CTD PMID:25510870 NCBI chr  X:107,449,652...107,605,251
Ensembl chr  X:107,449,652...107,605,255
JBrowse link
G FRMPD4 FERM and PDZ domain containing 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FRMPD4 mRNA CTD PMID:25510870 NCBI chr  X:11,822,439...12,724,523
Ensembl chr  X:11,822,423...12,724,523
JBrowse link
G FRY FRY microtubule binding protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FRY mRNA CTD PMID:25510870 NCBI chr13:32,031,774...32,299,125
Ensembl chr13:31,846,713...32,299,125
JBrowse link
G FRYL FRY like transcription coactivator multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FRYL mRNA CTD PMID:25510870 NCBI chr 4:48,497,357...48,780,279
Ensembl chr 4:48,497,357...48,780,322
JBrowse link
G FSCN2 fascin actin-bundling protein 2, retinal decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of FSCN2 mRNA CTD PMID:23829299 NCBI chr17:81,515,062...81,537,130
Ensembl chr17:81,528,377...81,537,130
JBrowse link
G FTSJ1 FtsJ RNA 2'-O-methyltransferase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of FTSJ1 mRNA CTD PMID:25510870 NCBI chr  X:48,476,021...48,486,364
Ensembl chr  X:48,476,021...48,486,364
JBrowse link
G FUOM fucose mutarotase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FUOM mRNA CTD PMID:25510870 NCBI chr10:133,352,773...133,358,019
Ensembl chr10:133,355,158...133,358,025
JBrowse link
G FUT7 fucosyltransferase 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FUT7 mRNA CTD PMID:25510870 NCBI chr 9:137,030,174...137,032,088
Ensembl chr 9:137,030,174...137,032,088
JBrowse link
G FUT8 fucosyltransferase 8 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of FUT8 mRNA CTD PMID:23829299 NCBI chr14:65,356,842...65,744,121
Ensembl chr14:65,410,592...65,744,121
JBrowse link
G FXYD1 FXYD domain containing ion transport regulator 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FXYD1 mRNA CTD PMID:25510870 NCBI chr19:35,137,188...35,143,109
Ensembl chr19:35,138,824...35,143,109
JBrowse link
G G2E3 G2/M-phase specific E3 ubiquitin protein ligase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of G2E3 mRNA CTD PMID:25510870 NCBI chr14:30,559,158...30,620,064
Ensembl chr14:30,559,158...30,620,064
JBrowse link
G GAA alpha glucosidase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GAA mRNA CTD PMID:25510870 NCBI chr17:80,101,581...80,119,881
Ensembl chr17:80,101,533...80,119,881
JBrowse link
G GABBR2 gamma-aminobutyric acid type B receptor subunit 2 multiple interactions ISO [2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GABBR2 mRNA CTD PMID:21277884 NCBI chr 9:98,288,109...98,708,935
Ensembl chr 9:98,288,109...98,708,935
JBrowse link
G GABPA GA binding protein transcription factor subunit alpha increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of GABPA mRNA CTD PMID:23829299 NCBI chr21:25,734,972...25,772,460
Ensembl chr21:25,734,570...25,772,460
JBrowse link
G GABPB1 GA binding protein transcription factor subunit beta 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GABPB1 mRNA CTD PMID:25510870 NCBI chr15:50,275,389...50,355,198
Ensembl chr15:50,275,389...50,355,408
JBrowse link
G GABRP gamma-aminobutyric acid type A receptor subunit pi multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GABRP mRNA CTD PMID:25510870 NCBI chr 5:170,782,720...170,814,047
Ensembl chr 5:170,763,350...170,814,047
JBrowse link
G GADL1 glutamate decarboxylase like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GADL1 mRNA CTD PMID:25510870 NCBI chr 3:30,726,197...30,894,661
Ensembl chr 3:30,726,197...30,894,661
JBrowse link
G GALNS galactosamine (N-acetyl)-6-sulfatase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GALNS mRNA CTD PMID:25510870 NCBI chr16:88,813,734...88,856,947
Ensembl chr16:88,813,734...88,856,970
JBrowse link
G GALNT15 polypeptide N-acetylgalactosaminyltransferase 15 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GALNT15 mRNA CTD PMID:25510870 NCBI chr 3:16,174,680...16,248,224
Ensembl chr 3:16,174,680...16,231,992
JBrowse link
G GALNT17 polypeptide N-acetylgalactosaminyltransferase 17 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GALNT17 mRNA CTD PMID:25510870 NCBI chr 7:71,132,144...71,713,599
Ensembl chr 7:71,132,144...71,713,600
JBrowse link
G GALNTL6 polypeptide N-acetylgalactosaminyltransferase like 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GALNTL6 mRNA CTD PMID:25510870 NCBI chr 4:171,813,404...173,041,559
Ensembl chr 4:171,812,254...173,041,559
JBrowse link
G GALR1 galanin receptor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GALR1 mRNA CTD PMID:25510870 NCBI chr18:77,249,848...77,277,900
Ensembl chr18:77,249,848...77,277,900
JBrowse link
G GAPDH glyceraldehyde-3-phosphate dehydrogenase decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GAPDH protein CTD PMID:21673325 NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374
JBrowse link
G GAPDHS glyceraldehyde-3-phosphate dehydrogenase, spermatogenic multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GAPDHS mRNA CTD PMID:25510870 NCBI chr19:35,533,456...35,545,319
Ensembl chr19:35,533,455...35,545,319
JBrowse link
G GAR1 GAR1 ribonucleoprotein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GAR1 mRNA CTD PMID:25510870 NCBI chr 4:109,815,510...109,824,737
Ensembl chr 4:109,815,510...109,824,740
JBrowse link
G GARNL3 GTPase activating Rap/RanGAP domain like 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GARNL3 mRNA CTD PMID:25510870 NCBI chr 9:127,224,613...127,393,660
Ensembl chr 9:127,224,265...127,393,660
JBrowse link
G GAS7 growth arrest specific 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GAS7 mRNA CTD PMID:25510870 NCBI chr17:9,910,606...10,198,606
Ensembl chr17:9,910,606...10,198,606
JBrowse link
G GATA1 GATA binding protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GATA1 mRNA CTD PMID:25510870 NCBI chr  X:48,786,590...48,794,311
Ensembl chr  X:48,786,540...48,794,311
JBrowse link
G GATA3 GATA binding protein 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GATA3 mRNA CTD PMID:25510870 NCBI chr10:8,045,333...8,075,198
Ensembl chr10:8,045,378...8,075,198
JBrowse link
G GATAD1 GATA zinc finger domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GATAD1 mRNA CTD PMID:25510870 NCBI chr 7:92,447,482...92,495,769
Ensembl chr 7:92,447,482...92,460,075
JBrowse link
G GBP4 guanylate binding protein 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GBP4 mRNA CTD PMID:25510870 NCBI chr 1:89,181,144...89,198,942
Ensembl chr 1:89,181,144...89,198,942
JBrowse link
G GBX1 gastrulation brain homeobox 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GBX1 mRNA CTD PMID:25510870 NCBI chr 7:151,148,009...151,167,694
Ensembl chr 7:151,148,009...151,174,745
JBrowse link
G GCG glucagon decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GCG mRNA CTD PMID:23829299 NCBI chr 2:162,142,882...162,152,247
Ensembl chr 2:162,142,882...162,152,404
JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GCLM mRNA CTD PMID:23829299 NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
JBrowse link
G GDF11 growth differentiation factor 11 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GDF11 mRNA CTD PMID:23829299 NCBI chr12:55,743,122...55,757,264
Ensembl chr12:55,743,122...55,757,264
JBrowse link
G GDF6 growth differentiation factor 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GDF6 mRNA CTD PMID:25510870 NCBI chr 8:96,142,333...96,160,806
Ensembl chr 8:96,142,333...96,160,806
JBrowse link
G GDI1 GDP dissociation inhibitor 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GDI1 protein CTD PMID:21673325 NCBI chr  X:154,437,154...154,443,467
Ensembl chr  X:154,436,913...154,443,467
JBrowse link
G GDI2 GDP dissociation inhibitor 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GDI2 protein CTD PMID:21673325 NCBI chr10:5,765,223...5,813,434
Ensembl chr10:5,765,223...5,842,132
JBrowse link
G GDPD5 glycerophosphodiester phosphodiesterase domain containing 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GDPD5 mRNA CTD PMID:25510870 NCBI chr11:75,434,640...75,525,941
Ensembl chr11:75,434,640...75,525,941
JBrowse link
G GDPGP1 GDP-D-glucose phosphorylase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GDPGP1 mRNA CTD PMID:25510870 NCBI chr15:90,234,209...90,245,811
Ensembl chr15:90,233,808...90,245,811
JBrowse link
G GEMIN6 gem nuclear organelle associated protein 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GEMIN6 mRNA CTD PMID:25510870 NCBI chr 2:38,778,210...38,785,002
Ensembl chr 2:38,751,534...38,785,002
JBrowse link
G GFOD1 Gfo/Idh/MocA-like oxidoreductase domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GFOD1 mRNA CTD PMID:25510870 NCBI chr 6:13,357,830...13,487,600
Ensembl chr 6:13,357,830...13,487,662
JBrowse link
G GFRA2 GDNF family receptor alpha 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GFRA2 mRNA CTD PMID:25510870 NCBI chr 8:21,690,398...21,812,345
Ensembl chr 8:21,690,398...21,812,357
JBrowse link
G GGACT gamma-glutamylamine cyclotransferase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GGACT mRNA CTD PMID:25510870 NCBI chr13:100,530,180...100,588,789
Ensembl chr13:100,530,164...100,589,528
JBrowse link
G GGNBP1 gametogenetin binding protein 1 (pseudogene) multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GGNBP1 mRNA CTD PMID:25510870 NCBI chr 6:33,583,699...33,589,026
Ensembl chr 6:33,540,046...33,589,026
Ensembl chr 6:33,540,046...33,589,026
JBrowse link
G GGT6 gamma-glutamyltransferase 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GGT6 mRNA CTD PMID:25510870 NCBI chr17:4,556,140...4,560,577
Ensembl chr17:4,556,927...4,560,818
JBrowse link
G GH1 growth hormone 1 multiple interactions ISO [2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in decreased expression of GH1 mRNA CTD PMID:19327374 NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
JBrowse link
G GIMAP8 GTPase, IMAP family member 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GIMAP8 mRNA CTD PMID:25510870 NCBI chr 7:150,450,630...150,479,393
Ensembl chr 7:150,450,630...150,479,393
JBrowse link
G GINS1 GINS complex subunit 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GINS1 mRNA CTD PMID:25510870 NCBI chr20:25,407,673...25,448,563
Ensembl chr20:25,391,008...25,452,700
JBrowse link
G GIPC2 GIPC PDZ domain containing family member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GIPC2 mRNA CTD PMID:25510870 NCBI chr 1:78,044,970...78,138,444
Ensembl chr 1:77,979,542...78,138,444
JBrowse link
G GJC2 gap junction protein gamma 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GJC2 mRNA CTD PMID:23829299 NCBI chr 1:228,149,930...228,159,826
Ensembl chr 1:228,149,930...228,159,826
JBrowse link
G GLCE glucuronic acid epimerase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GLCE mRNA CTD PMID:25510870 NCBI chr15:69,160,635...69,272,207
Ensembl chr15:69,160,584...69,272,217
JBrowse link
G GLI2 GLI family zinc finger 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GLI2 mRNA CTD PMID:25510870 NCBI chr 2:120,735,868...120,992,653
Ensembl chr 2:120,735,623...120,992,653
JBrowse link
G GLS glutaminase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GLS mRNA CTD PMID:25510870 NCBI chr 2:190,880,821...190,965,552
Ensembl chr 2:190,880,821...190,965,552
JBrowse link
G GLT1D1 glycosyltransferase 1 domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GLT1D1 mRNA CTD PMID:25510870 NCBI chr12:128,853,478...128,984,968
Ensembl chr12:128,853,427...128,984,968
JBrowse link
G GLTP glycolipid transfer protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GLTP mRNA CTD PMID:25510870 NCBI chr12:109,850,945...109,880,541
Ensembl chr12:109,850,945...109,880,541
JBrowse link
G GLUL glutamate-ammonia ligase increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of GLUL protein CTD PMID:21673325 NCBI chr 1:182,378,098...182,391,790
Ensembl chr 1:182,378,098...182,392,206
JBrowse link
G GMEB1 glucocorticoid modulatory element binding protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GMEB1 mRNA CTD PMID:25510870 NCBI chr 1:28,668,229...28,719,353
Ensembl chr 1:28,668,778...28,719,353
JBrowse link
G GMPPA GDP-mannose pyrophosphorylase A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GMPPA mRNA CTD PMID:25510870 NCBI chr 2:219,498,891...219,506,989
Ensembl chr 2:219,498,865...219,513,898
JBrowse link
G GMPS guanine monophosphate synthase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GMPS mRNA CTD PMID:25510870 NCBI chr 3:155,869,430...155,944,020
Ensembl chr 3:155,870,650...155,944,020
JBrowse link
G GNAL G protein subunit alpha L multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GNAL mRNA CTD PMID:25510870 NCBI chr18:11,689,264...11,885,685
Ensembl chr18:11,689,264...11,885,685
JBrowse link
G GNAS GNAS complex locus decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GNAS mRNA CTD PMID:23829299 NCBI chr20:58,839,748...58,911,192
Ensembl chr20:58,839,718...58,911,192
JBrowse link
G GNB3 G protein subunit beta 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GNB3 mRNA CTD PMID:25510870 NCBI chr12:6,840,925...6,847,393
Ensembl chr12:6,839,954...6,847,393
JBrowse link
G GNB4 G protein subunit beta 4 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GNB4 mRNA CTD PMID:23829299 NCBI chr 3:179,396,088...179,527,798
Ensembl chr 3:179,396,088...179,451,476
JBrowse link
G GNG13 G protein subunit gamma 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GNG13 mRNA CTD PMID:25510870 NCBI chr16:798,041...800,734
Ensembl chr16:798,041...800,734
JBrowse link
G GNG7 G protein subunit gamma 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GNG7 mRNA CTD PMID:25510870 NCBI chr19:2,511,219...2,702,694
Ensembl chr19:2,511,219...2,702,694
JBrowse link
G GNG8 G protein subunit gamma 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GNG8 mRNA CTD PMID:25510870 NCBI chr19:46,633,953...46,639,326
Ensembl chr19:46,633,953...46,636,541
JBrowse link
G GOLGA6L9 golgin A6 family like 9 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GOLGA6L9 mRNA CTD PMID:23829299 NCBI chr15:82,415,923...82,439,153
Ensembl chr15:82,429,816...82,439,153
JBrowse link
G GOT1 glutamic-oxaloacetic transaminase 1 affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of GOT1 mRNA CTD PMID:21703328 NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
JBrowse link
G GPBP1 GC-rich promoter binding protein 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of GPBP1 mRNA CTD PMID:23829299 NCBI chr 5:57,174,059...57,264,679
Ensembl chr 5:57,173,948...57,264,679
JBrowse link
G GPC2 glypican 2 multiple interactions
decreases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GPC2 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GPC2 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 7:100,169,606...100,177,381
Ensembl chr 7:100,169,606...100,177,381
JBrowse link
G GPC5 glypican 5 multiple interactions
decreases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GPC5 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GPC5 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr13:91,398,621...92,867,237
Ensembl chr13:91,398,621...92,873,682
JBrowse link
G GPR137C G protein-coupled receptor 137C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GPR137C mRNA CTD PMID:25510870 NCBI chr14:52,552,836...52,637,713
Ensembl chr14:52,552,836...52,637,713
JBrowse link
G GPR37 G protein-coupled receptor 37 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GPR37 mRNA CTD PMID:25510870 NCBI chr 7:124,743,885...124,765,792
Ensembl chr 7:124,743,885...124,765,792
JBrowse link
G GPR75 G protein-coupled receptor 75 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GPR75 mRNA CTD PMID:25510870 NCBI chr 2:53,852,912...53,859,967
Ensembl chr 2:53,852,912...53,859,967
JBrowse link
G GPR82 G protein-coupled receptor 82 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GPR82 mRNA CTD PMID:25510870 NCBI chr  X:41,724,181...41,730,130
Ensembl chr  X:41,724,181...41,730,130
JBrowse link
G GPR88 G protein-coupled receptor 88 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GPR88 mRNA CTD PMID:25510870 NCBI chr 1:100,538,139...100,542,021
Ensembl chr 1:100,538,139...100,542,021
JBrowse link
G GPRC5B G protein-coupled receptor class C group 5 member B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GPRC5B mRNA CTD PMID:25510870 NCBI chr16:19,856,691...19,885,634
Ensembl chr16:19,856,691...19,886,167
JBrowse link
G GPRC5C G protein-coupled receptor class C group 5 member C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GPRC5C mRNA CTD PMID:25510870 NCBI chr17:74,432,088...74,451,658
Ensembl chr17:74,424,851...74,451,653
JBrowse link
G GPRIN3 GPRIN family member 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GPRIN3 mRNA CTD PMID:25510870 NCBI chr 4:89,236,383...89,307,800
Ensembl chr 4:89,236,383...89,307,937
JBrowse link
G GPX4 glutathione peroxidase 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GPX4 mRNA CTD PMID:25510870 NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
JBrowse link
G GPX6 glutathione peroxidase 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GPX6 mRNA CTD PMID:25510870 NCBI chr 6:28,503,296...28,515,793
Ensembl chr 6:28,503,296...28,528,215
JBrowse link
G GRAMD2A GRAM domain containing 2A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GRAMD2A mRNA CTD PMID:25510870 NCBI chr15:72,159,806...72,197,787
Ensembl chr15:72,159,806...72,197,787
JBrowse link
G GRAP2 GRB2 related adaptor protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GRAP2 mRNA CTD PMID:25510870 NCBI chr22:39,893,820...39,973,721
Ensembl chr22:39,901,084...39,973,721
JBrowse link
G GREB1 growth regulating estrogen receptor binding 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GREB1 mRNA CTD PMID:25510870 NCBI chr 2:11,482,888...11,642,788
Ensembl chr 2:11,482,341...11,642,788
JBrowse link
G GRIN1 glutamate ionotropic receptor NMDA type subunit 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of GRIN1 protein CTD PMID:20297801 NCBI chr 9:137,139,154...137,168,756
Ensembl chr 9:137,138,346...137,168,756
JBrowse link
G GRIN2A glutamate ionotropic receptor NMDA type subunit 2A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GRIN2A mRNA CTD PMID:25510870 NCBI chr16:9,753,404...10,182,908
Ensembl chr16:9,753,404...10,182,928
JBrowse link
G GRIN2B glutamate ionotropic receptor NMDA type subunit 2B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GRIN2B mRNA
[2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GRIN2B mRNA; [2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GRIN2B mRNA
CTD PMID:21190954 PMID:21277884 PMID:25510870 NCBI chr12:13,537,337...13,982,134
Ensembl chr12:13,437,942...13,982,002
JBrowse link
G GRIN2C glutamate ionotropic receptor NMDA type subunit 2C multiple interactions
increases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GRIN2C mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of GRIN2C protein
CTD PMID:20297801 PMID:25510870 NCBI chr17:74,842,023...74,861,532
Ensembl chr17:74,842,023...74,861,504
JBrowse link
G GRK3 G protein-coupled receptor kinase 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GRK3 mRNA CTD PMID:25510870 NCBI chr22:25,564,675...25,729,294
Ensembl chr22:25,564,675...25,729,294
JBrowse link
G GRM5 glutamate metabotropic receptor 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GRM5 mRNA CTD PMID:25510870 NCBI chr11:88,504,642...89,065,982
Ensembl chr11:88,504,576...89,065,982
JBrowse link
G GSN gelsolin decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GSN protein CTD PMID:21673325 NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
JBrowse link
G GSTM2 glutathione S-transferase mu 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of GSTM2 mRNA CTD PMID:23829299 NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
JBrowse link
G GTF2A1 general transcription factor IIA subunit 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GTF2A1 mRNA CTD PMID:25510870 NCBI chr14:81,175,452...81,221,390
Ensembl chr14:81,175,452...81,221,377
JBrowse link
G GTF3C6 general transcription factor IIIC subunit 6 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of GTF3C6 mRNA CTD PMID:23829299 NCBI chr 6:110,958,706...110,967,872
Ensembl chr 6:110,958,706...110,967,890
JBrowse link
G GTSE1 G2 and S-phase expressed 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of GTSE1 mRNA CTD PMID:25510870 NCBI chr22:46,296,870...46,330,810
Ensembl chr22:46,296,870...46,330,810
JBrowse link
G GUCA1A guanylate cyclase activator 1A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GUCA1A mRNA CTD PMID:25510870 NCBI chr 6:42,173,364...42,180,056
Ensembl chr 6:42,173,364...42,181,338
JBrowse link
G H2AC18 H2A clustered histone 18 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of H2AC19 mRNA CTD PMID:25510870 NCBI chr 1:149,842,218...149,842,750
Ensembl chr 1:149,842,218...149,842,750
JBrowse link
G H2AC21 H2A clustered histone 21 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of H2AC21 mRNA CTD PMID:25510870 NCBI chr 1:149,887,469...149,887,965
Ensembl chr 1:149,887,469...149,887,965
JBrowse link
G H3C1 H3 clustered histone 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of H3C1 mRNA CTD PMID:25510870 NCBI chr 6:26,020,451...26,020,958
Ensembl chr 6:26,020,451...26,020,958
JBrowse link
G H4C9 H4 clustered histone 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of H4C9 mRNA CTD PMID:25510870 NCBI chr 6:27,139,282...27,139,678
Ensembl chr 6:27,139,282...27,139,678
JBrowse link
G HAS2 hyaluronan synthase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HAS2 mRNA CTD PMID:25510870 NCBI chr 8:121,612,116...121,641,440
Ensembl chr 8:121,612,116...121,641,440
JBrowse link
G HASPIN histone H3 associated protein kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HASPIN mRNA CTD PMID:25510870 NCBI chr17:3,723,903...3,726,699
Ensembl chr17:3,723,903...3,726,699
JBrowse link
G HBE1 hemoglobin subunit epsilon 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of HBE1 mRNA CTD PMID:23829299 NCBI chr11:5,268,345...5,269,945
Ensembl chr11:5,268,345...5,505,652
JBrowse link
G HBEGF heparin binding EGF like growth factor increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of HBEGF mRNA CTD PMID:23829299 NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603
JBrowse link
G HCFC1 host cell factor C1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HCFC1 mRNA CTD PMID:25510870 NCBI chr  X:153,947,557...153,971,818
Ensembl chr  X:153,947,557...153,971,818
JBrowse link
G HCN3 hyperpolarization activated cyclic nucleotide gated potassium channel 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HCN3 mRNA CTD PMID:25510870 NCBI chr 1:155,277,463...155,289,848
Ensembl chr 1:155,277,463...155,289,848
JBrowse link
G HCRTR1 hypocretin receptor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HCRTR1 mRNA CTD PMID:25510870 NCBI chr 1:31,617,689...31,634,492
Ensembl chr 1:31,617,686...31,632,518
JBrowse link
G HDAC8 histone deacetylase 8 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of HDAC8 mRNA CTD PMID:23829299 NCBI chr  X:72,329,516...72,572,843
Ensembl chr  X:72,329,516...72,573,101
JBrowse link
G HDHD2 haloacid dehalogenase like hydrolase domain containing 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HDHD2 mRNA CTD PMID:25510870 NCBI chr18:47,107,410...47,150,500
Ensembl chr18:47,107,408...47,150,500
JBrowse link
G HDHD3 haloacid dehalogenase like hydrolase domain containing 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HDHD3 mRNA CTD PMID:25510870 NCBI chr 9:113,373,416...113,376,986
Ensembl chr 9:113,373,419...113,376,986
JBrowse link
G HELZ2 helicase with zinc finger 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HELZ2 mRNA CTD PMID:25510870 NCBI chr20:63,558,086...63,574,239
Ensembl chr20:63,558,086...63,574,239
JBrowse link
G HES3 hes family bHLH transcription factor 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HES3 mRNA CTD PMID:25510870 NCBI chr 1:6,244,179...6,245,578
Ensembl chr 1:6,244,179...6,245,578
JBrowse link
G HEXD hexosaminidase D decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of HEXD mRNA CTD PMID:23829299 NCBI chr17:82,418,347...82,442,645
Ensembl chr17:82,418,318...82,442,645
JBrowse link
G HIF1AN hypoxia inducible factor 1 subunit alpha inhibitor decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of HIF1AN mRNA CTD PMID:23829299 NCBI chr10:100,535,943...100,559,998
Ensembl chr10:100,529,072...100,559,998
JBrowse link
G HINT2 histidine triad nucleotide binding protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HINT2 mRNA CTD PMID:25510870 NCBI chr 9:35,812,960...35,815,479
Ensembl chr 9:35,812,960...35,815,354
JBrowse link
G HIRIP3 HIRA interacting protein 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HIRIP3 mRNA CTD PMID:25510870 NCBI chr16:29,992,321...29,996,096
Ensembl chr16:29,992,330...29,996,074
JBrowse link
G HIVEP1 HIVEP zinc finger 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HIVEP1 mRNA CTD PMID:25510870 NCBI chr 6:12,007,693...12,212,048
Ensembl chr 6:12,008,762...12,164,999
JBrowse link
G HJURP Holliday junction recognition protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HJURP mRNA CTD PMID:25510870 NCBI chr 2:233,836,702...233,854,535
Ensembl chr 2:233,833,416...233,854,566
JBrowse link
G HJV hemojuvelin BMP co-receptor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HJV mRNA CTD PMID:25510870 NCBI chr 1:146,017,470...146,021,735
Ensembl chr 1:146,017,468...146,036,746
JBrowse link
G HLA-DMB major histocompatibility complex, class II, DM beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of H2-DMB1 mRNA CTD PMID:25510870 NCBI chr 6:32,934,636...32,941,028
Ensembl chr 6:32,934,629...32,941,028
JBrowse link
G HLA-DOB major histocompatibility complex, class II, DO beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of H2-OB mRNA CTD PMID:25510870 NCBI chr 6:32,812,763...32,817,002
Ensembl chr 6:32,812,763...32,820,466
JBrowse link
G HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of H2-AA mRNA CTD PMID:25510870 NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
JBrowse link
G HLA-DRB1 major histocompatibility complex, class II, DR beta 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of RT1-DB1 mRNA CTD PMID:23829299 NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
JBrowse link
G HMGA1 high mobility group AT-hook 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HMGA1 mRNA CTD PMID:25510870 NCBI chr 6:34,236,873...34,246,231
Ensembl chr 6:34,236,873...34,246,231
JBrowse link
G HMGB2 high mobility group box 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HMGB2 mRNA CTD PMID:25510870 NCBI chr 4:173,331,376...173,334,358
Ensembl chr 4:173,331,376...173,334,432
JBrowse link
G HMGB3 high mobility group box 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HMGB3 mRNA CTD PMID:25510870 NCBI chr  X:150,980,507...150,990,771
Ensembl chr  X:150,980,509...150,990,771
JBrowse link
G HMMR hyaluronan mediated motility receptor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HMMR mRNA CTD PMID:25510870 NCBI chr 5:163,460,632...163,491,941
Ensembl chr 5:163,460,203...163,491,941
JBrowse link
G HNF1A HNF1 homeobox A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HNF1A mRNA CTD PMID:25510870 NCBI chr12:120,978,543...121,002,512
Ensembl chr12:120,978,543...121,002,512
JBrowse link
G HNF4G hepatocyte nuclear factor 4 gamma multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HNF4G mRNA CTD PMID:25510870 NCBI chr 8:75,407,649...75,566,834
Ensembl chr 8:75,407,914...75,566,834
JBrowse link
G HNRNPA1 heterogeneous nuclear ribonucleoprotein A1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of HNRNPA1 mRNA CTD PMID:23829299 NCBI chr12:54,280,726...54,287,087
Ensembl chr12:54,280,193...54,287,088
JBrowse link
G HNRNPA2B1 heterogeneous nuclear ribonucleoprotein A2/B1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of HNRNPA2B1 protein CTD PMID:21673325 NCBI chr 7:26,189,927...26,200,746
Ensembl chr 7:26,171,151...26,201,529
JBrowse link
G HNRNPA3 heterogeneous nuclear ribonucleoprotein A3 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of HNRNPA3 mRNA CTD PMID:23829299 NCBI chr 2:177,212,794...177,223,959
Ensembl chr 2:177,212,694...177,223,959
JBrowse link
G HNRNPDL heterogeneous nuclear ribonucleoprotein D like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HNRNPDL mRNA CTD PMID:25510870 NCBI chr 4:82,422,564...82,430,462
Ensembl chr 4:82,422,565...82,430,462
JBrowse link
G HNRNPM heterogeneous nuclear ribonucleoprotein M increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of HNRNPM mRNA CTD PMID:23829299 NCBI chr19:8,444,975...8,489,114
Ensembl chr19:8,444,767...8,489,114
JBrowse link
G HNRNPU heterogeneous nuclear ribonucleoprotein U increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of HNRNPU mRNA CTD PMID:23829299 NCBI chr 1:244,850,297...244,864,543
Ensembl chr 1:244,840,638...244,864,560
JBrowse link
G HOMER3 homer scaffold protein 3 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of HOMER3 protein CTD PMID:21673325 NCBI chr19:18,929,201...18,941,217
Ensembl chr19:18,929,201...18,941,261
JBrowse link
G HOXA11-AS HOXA11 antisense RNA multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HOXA11OS mRNA CTD PMID:25510870 NCBI chr 7:27,185,408...27,189,293
Ensembl chr 7:27,184,507...27,189,298
JBrowse link
G HOXD1 homeobox D1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HOXD1 mRNA CTD PMID:25510870 NCBI chr 2:176,188,668...176,190,907
Ensembl chr 2:176,188,668...176,190,907
JBrowse link
G HPCAL4 hippocalcin like 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HPCAL4 mRNA CTD PMID:25510870 NCBI chr 1:39,678,648...39,691,433
Ensembl chr 1:39,678,648...39,691,485
JBrowse link
G HRH3 histamine receptor H3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HRH3 mRNA CTD PMID:25510870 NCBI chr20:62,214,960...62,220,278
Ensembl chr20:62,214,960...62,220,278
JBrowse link
G HS3ST1 heparan sulfate-glucosamine 3-sulfotransferase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HS3ST1 mRNA CTD PMID:25510870 NCBI chr 4:11,393,150...11,434,327
Ensembl chr 4:11,393,150...11,429,564
JBrowse link
G HS3ST2 heparan sulfate-glucosamine 3-sulfotransferase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HS3ST2 mRNA CTD PMID:25510870 NCBI chr16:22,814,162...22,916,338
Ensembl chr16:22,814,162...22,916,338
JBrowse link
G HS6ST1 heparan sulfate 6-O-sulfotransferase 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of HS6ST1 mRNA CTD PMID:23829299 NCBI chr 2:128,265,480...128,318,868
Ensembl chr 2:128,236,716...128,318,868
JBrowse link
G HSD11B2 hydroxysteroid 11-beta dehydrogenase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HSD11B2 mRNA CTD PMID:25510870 NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
JBrowse link
G HSP90AA1 heat shock protein 90 alpha family class A member 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of HSP90AA1 protein CTD PMID:21673325 NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
JBrowse link
G HSP90AB1 heat shock protein 90 alpha family class B member 1 affects expression
decreases expression
EXP
ISO
2,2',3',4,4',5-hexachlorobiphenyl affects the expression of HSP90AB1 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of HSP90AB1 protein
CTD PMID:21673325 PMID:21703328 NCBI chr 6:44,246,194...44,253,883
Ensembl chr 6:44,246,166...44,253,888
JBrowse link
G HSP90B1 heat shock protein 90 beta family member 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of HSP90B1 protein CTD PMID:21673325 NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
JBrowse link
G HSPA4 heat shock protein family A (Hsp70) member 4 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of HSPA4 mRNA CTD PMID:23829299 NCBI chr 5:133,052,013...133,106,449
Ensembl chr 5:133,052,013...133,106,449
JBrowse link
G HSPB7 heat shock protein family B (small) member 7 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of HSPB7 mRNA CTD PMID:23829299 NCBI chr 1:16,014,029...16,019,594
Ensembl chr 1:16,014,028...16,019,594
JBrowse link
G HTR1B 5-hydroxytryptamine receptor 1B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HTR1B mRNA CTD PMID:25510870 NCBI chr 6:77,460,924...77,463,491
Ensembl chr 6:77,460,924...77,463,491
JBrowse link
G HTR2A 5-hydroxytryptamine receptor 2A decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of HTR2A mRNA CTD PMID:23829299 NCBI chr13:46,831,546...46,898,082
Ensembl chr13:46,831,546...46,897,076
JBrowse link
G HTR2C 5-hydroxytryptamine receptor 2C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HTR2C mRNA CTD PMID:25510870 NCBI chr  X:114,584,086...114,910,061
Ensembl chr  X:114,584,078...114,910,061
JBrowse link
G HTR4 5-hydroxytryptamine receptor 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of HTR4 mRNA CTD PMID:25510870 NCBI chr 5:148,451,032...148,654,527
Ensembl chr 5:148,446,042...148,677,235
JBrowse link
G HUNK hormonally up-regulated Neu-associated kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HUNK mRNA CTD PMID:25510870 NCBI chr21:31,873,020...32,004,064
Ensembl chr21:31,873,020...32,044,633
JBrowse link
G IAPP islet amyloid polypeptide multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IAPP mRNA CTD PMID:25510870 NCBI chr12:21,354,959...21,379,980
Ensembl chr12:21,354,959...21,379,980
JBrowse link
G ICE2 interactor of little elongation complex ELL subunit 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ICE2 mRNA CTD PMID:25510870 NCBI chr15:60,419,609...60,479,142
Ensembl chr15:60,419,609...60,479,160
JBrowse link
G IFIH1 interferon induced with helicase C domain 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IFIH1 mRNA CTD PMID:25510870 NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684
JBrowse link
G IFNA13 interferon alpha 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IFNA13 mRNA CTD PMID:25510870 NCBI chr 9:21,367,372...21,368,057
Ensembl chr 9:21,367,372...21,368,057
JBrowse link
G IFNA4 interferon alpha 4 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of IFNA4 mRNA CTD PMID:23829299 NCBI chr 9:21,186,618...21,187,587
Ensembl chr 9:21,186,618...21,187,587
JBrowse link
G IFTAP intraflagellar transport associated protein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of IFTAP mRNA CTD PMID:23829299 NCBI chr11:36,594,502...36,659,272
Ensembl chr11:36,594,369...36,675,695
JBrowse link
G IGF1 insulin like growth factor 1 multiple interactions ISO [2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased expression of IGF1 protein; [2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IGF1 mRNA CTD PMID:19327374 PMID:21190954 NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
JBrowse link
G IGFBPL1 insulin like growth factor binding protein like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGFBPL1 mRNA CTD PMID:25510870 NCBI chr 9:38,406,528...38,424,454
Ensembl chr 9:38,406,528...38,424,454
JBrowse link
G IGSF10 immunoglobulin superfamily member 10 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGSF10 mRNA CTD PMID:25510870 NCBI chr 3:151,432,432...151,619,925
Ensembl chr 3:151,425,384...151,461,061
JBrowse link
G IGSF9 immunoglobulin superfamily member 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGSF9 mRNA CTD PMID:25510870 NCBI chr 1:159,927,041...159,945,613
Ensembl chr 1:159,927,039...159,945,613
JBrowse link
G IGSF9B immunoglobulin superfamily member 9B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IGSF9B mRNA CTD PMID:25510870 NCBI chr11:133,896,438...133,956,968
Ensembl chr11:133,896,438...133,956,968
JBrowse link
G IKBKG inhibitor of nuclear factor kappa B kinase regulatory subunit gamma decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of IKBKG mRNA CTD PMID:23829299 NCBI chr  X:154,541,238...154,565,046
Ensembl chr  X:154,541,199...154,565,046
JBrowse link
G IL12A interleukin 12A affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of IL12A mRNA CTD PMID:21703328 NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
JBrowse link
G IL17D interleukin 17D multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IL17D mRNA CTD PMID:25510870 NCBI chr13:20,701,513...20,723,098
Ensembl chr13:20,702,127...20,723,098
JBrowse link
G IL17RB interleukin 17 receptor B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IL17RB mRNA CTD PMID:25510870 NCBI chr 3:53,846,568...53,865,794
Ensembl chr 3:53,846,568...53,865,794
JBrowse link
G IL1RAPL1 interleukin 1 receptor accessory protein like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IL1RAPL1 mRNA CTD PMID:25510870 NCBI chr  X:28,587,446...29,956,718
Ensembl chr  X:28,587,446...29,956,718
JBrowse link
G IL2 interleukin 2 affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of IL2 mRNA CTD PMID:21703328 NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
JBrowse link
G IL23A interleukin 23 subunit alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IL23A mRNA CTD PMID:25510870 NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
JBrowse link
G IL2RA interleukin 2 receptor subunit alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IL2RA mRNA CTD PMID:25510870 NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
JBrowse link
G IL2RB interleukin 2 receptor subunit beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IL2RB mRNA CTD PMID:25510870 NCBI chr22:37,125,838...37,175,118
Ensembl chr22:37,118,666...37,175,118
JBrowse link
G IL4 interleukin 4 decreases expression EXP 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of IL4 protein CTD PMID:11266329 NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
JBrowse link
G IL4R interleukin 4 receptor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IL4RA mRNA CTD PMID:25510870 NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
JBrowse link
G IL7 interleukin 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IL7 mRNA CTD PMID:25510870 NCBI chr 8:78,675,044...78,805,463
Ensembl chr 8:78,675,743...78,805,523
JBrowse link
G ILRUN inflammation and lipid regulator with UBA-like and NBR1-like domains multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ILRUN mRNA CTD PMID:25510870 NCBI chr 6:34,587,288...34,696,767
Ensembl chr 6:34,587,288...34,696,859
JBrowse link
G IMPA1 inositol monophosphatase 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of IMPA1 protein CTD PMID:21673325 NCBI chr 8:81,656,914...81,686,325
Ensembl chr 8:81,656,914...81,686,331
JBrowse link
G INCENP inner centromere protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INCENP mRNA CTD PMID:25510870 NCBI chr11:62,124,011...62,153,169
Ensembl chr11:62,123,998...62,153,169
JBrowse link
G ING5 inhibitor of growth family member 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ING5 mRNA CTD PMID:25510870 NCBI chr 2:241,687,020...241,729,478
Ensembl chr 2:241,687,085...241,729,478
JBrowse link
G INHA inhibin subunit alpha decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of INHA mRNA CTD PMID:23829299 NCBI chr 2:219,572,310...219,575,711
Ensembl chr 2:219,569,162...219,575,711
JBrowse link
G INHBA inhibin subunit beta A increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of INHBA mRNA CTD PMID:23829299 NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834
JBrowse link
G INHBE inhibin subunit beta E multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of INHBE mRNA CTD PMID:25510870 NCBI chr12:57,455,307...57,458,025
Ensembl chr12:57,452,323...57,459,280
JBrowse link
G INO80D INO80 complex subunit D multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INO80D mRNA CTD PMID:25510870 NCBI chr 2:205,993,721...206,086,174
Ensembl chr 2:205,993,721...206,086,303
JBrowse link
G INPP4A inositol polyphosphate-4-phosphatase type I A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of INPP4A mRNA CTD PMID:25510870 NCBI chr 2:98,444,587...98,594,392
Ensembl chr 2:98,444,854...98,594,392
JBrowse link
G INPP5A inositol polyphosphate-5-phosphatase A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of INPP5A mRNA CTD PMID:25510870 NCBI chr10:132,537,787...132,783,480
Ensembl chr10:132,537,787...132,783,480
JBrowse link
G INS-IGF2 INS-IGF2 readthrough multiple interactions ISO 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of BCL2L1 protein]; 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of BIRC5 protein]; 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased cleavage of PARP1 protein]; 2,2',3',4,4',5-hexachlorobiphenyl promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 protein]; 2,2',3',4,4',5-hexachlorobiphenyl promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein] CTD PMID:29704545 NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
JBrowse link
G INSM1 INSM transcriptional repressor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INSM1 mRNA CTD PMID:25510870 NCBI chr20:20,368,104...20,370,949
Ensembl chr20:20,368,104...20,370,949
JBrowse link
G INSM2 INSM transcriptional repressor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INSM2 mRNA CTD PMID:25510870 NCBI chr14:35,534,164...35,537,054
Ensembl chr14:35,534,164...35,537,054
JBrowse link
G INTS11 integrator complex subunit 11 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INTS11 mRNA CTD PMID:25510870 NCBI chr 1:1,311,600...1,324,660
Ensembl chr 1:1,311,585...1,324,687
JBrowse link
G INTS7 integrator complex subunit 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INTS7 mRNA CTD PMID:25510870 NCBI chr 1:211,940,403...212,035,557
Ensembl chr 1:211,940,399...212,035,557
JBrowse link
G INTU inturned planar cell polarity protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INTU mRNA CTD PMID:25510870 NCBI chr 4:127,632,957...127,726,737
Ensembl chr 4:127,623,271...127,726,737
JBrowse link
G IPCEF1 interaction protein for cytohesin exchange factors 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IPCEF1 mRNA CTD PMID:25510870 NCBI chr 6:154,154,496...154,356,803
Ensembl chr 6:154,154,496...154,356,803
JBrowse link
G IQGAP3 IQ motif containing GTPase activating protein 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IQGAP3 mRNA CTD PMID:25510870 NCBI chr 1:156,525,405...156,572,565
Ensembl chr 1:156,525,405...156,572,604
JBrowse link
G IQSEC3 IQ motif and Sec7 domain ArfGEF 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IQSEC3 mRNA CTD PMID:25510870 NCBI chr12:66,767...178,455
Ensembl chr12:66,767...178,455
JBrowse link
G IRAG1 inositol 1,4,5-triphosphate receptor associated 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IRAG1 mRNA CTD PMID:25510870 NCBI chr11:10,573,095...10,693,755
Ensembl chr11:10,573,091...10,693,988
JBrowse link
G IRAK2 interleukin 1 receptor associated kinase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IRAK2 mRNA CTD PMID:25510870 NCBI chr 3:10,164,919...10,243,745
Ensembl chr 3:10,164,919...10,243,745
JBrowse link
G IRF6 interferon regulatory factor 6 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of IRF6 mRNA CTD PMID:23829299 NCBI chr 1:209,785,617...209,806,142
Ensembl chr 1:209,785,617...209,806,175
JBrowse link
G IRS3P insulin receptor substrate 3, pseudogene multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of IRS3 mRNA CTD PMID:25510870 NCBI chr 7:100,570,193...100,571,401
Ensembl chr 7:100,570,131...100,571,136
JBrowse link
G ISCA1 iron-sulfur cluster assembly 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ISCA1 mRNA CTD PMID:25510870 NCBI chr 9:86,264,546...86,282,538
Ensembl chr 9:86,264,546...86,283,102
JBrowse link
G ISM2 isthmin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ISM2 mRNA CTD PMID:25510870 NCBI chr14:77,474,394...77,498,816
Ensembl chr14:77,474,394...77,498,816
JBrowse link
G ITGA4 integrin subunit alpha 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ITGA4 mRNA CTD PMID:25510870 NCBI chr 2:181,457,205...181,538,940
Ensembl chr 2:181,457,202...181,538,940
JBrowse link
G ITGAD integrin subunit alpha D multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ITGAD mRNA CTD PMID:25510870 NCBI chr16:31,393,335...31,426,505
Ensembl chr16:31,393,335...31,426,505
JBrowse link
G ITM2C integral membrane protein 2C decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ITM2C mRNA CTD PMID:23829299 NCBI chr 2:230,864,185...230,879,254
Ensembl chr 2:230,864,639...230,879,248
JBrowse link
G ITPKA inositol-trisphosphate 3-kinase A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ITPKA mRNA CTD PMID:25510870 NCBI chr15:41,493,874...41,503,551
Ensembl chr15:41,493,393...41,503,551
JBrowse link
G ITPR1 inositol 1,4,5-trisphosphate receptor type 1 increases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ITPR1 protein
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ITPR1 mRNA
CTD PMID:21673325 PMID:25510870 NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
JBrowse link
G ITPRID1 ITPR interacting domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ITPRID1 mRNA CTD PMID:25510870 NCBI chr 7:31,514,090...31,658,720
Ensembl chr 7:31,514,090...31,656,504
JBrowse link
G ITSN1 intersectin 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ITSN1 mRNA CTD PMID:25510870 NCBI chr21:33,642,501...33,899,861
Ensembl chr21:33,642,400...33,899,861
JBrowse link
G IWS1 interacts with SUPT6H, CTD assembly factor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IWS1 mRNA CTD PMID:25510870 NCBI chr 2:127,480,812...127,527,336
Ensembl chr 2:127,436,207...127,526,886
JBrowse link
G JPH1 junctophilin 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of JPH1 mRNA CTD PMID:25510870 NCBI chr 8:74,234,700...74,321,540
Ensembl chr 8:74,234,700...74,321,540
JBrowse link
G JPH3 junctophilin 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of JPH3 mRNA CTD PMID:25510870 NCBI chr16:87,601,835...87,698,156
Ensembl chr16:87,601,835...87,698,156
JBrowse link
G KALRN kalirin RhoGEF kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KALRN mRNA CTD PMID:25510870 NCBI chr 3:124,033,369...124,726,325
Ensembl chr 3:124,033,369...124,726,325
JBrowse link
G KANTR KANTR integral membrane protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KANTR mRNA CTD PMID:25510870 NCBI chr  X:53,094,142...53,147,921
Ensembl chr  X:53,094,142...53,170,914
JBrowse link
G KASH5 KASH domain containing 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KASH5 mRNA CTD PMID:23829299 NCBI chr19:49,388,249...49,417,990
Ensembl chr19:49,388,219...49,417,990
JBrowse link
G KAT14 lysine acetyltransferase 14 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KAT14 mRNA CTD PMID:25510870 NCBI chr20:18,137,153...18,188,372
Ensembl chr20:18,137,228...18,188,387
JBrowse link
G KBTBD12 kelch repeat and BTB domain containing 12 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KBTBD12 mRNA CTD PMID:25510870 NCBI chr 3:127,915,232...127,987,677
Ensembl chr 3:127,915,232...127,987,671
JBrowse link
G KCNAB2 potassium voltage-gated channel subfamily A regulatory beta subunit 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCNAB2 mRNA CTD PMID:25510870 NCBI chr 1:5,992,676...6,101,180
Ensembl chr 1:5,990,927...6,101,193
JBrowse link
G KCNC3 potassium voltage-gated channel subfamily C member 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCNC3 mRNA CTD PMID:25510870 NCBI chr19:50,311,937...50,333,536
Ensembl chr19:50,311,937...50,333,515
JBrowse link
G KCND2 potassium voltage-gated channel subfamily D member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCND2 mRNA CTD PMID:25510870 NCBI chr 7:120,272,908...120,750,337
Ensembl chr 7:120,273,175...120,750,337
JBrowse link
G KCND3 potassium voltage-gated channel subfamily D member 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCND3 mRNA CTD PMID:25510870 NCBI chr 1:111,770,662...111,989,668
Ensembl chr 1:111,770,662...111,989,668
JBrowse link
G KCNE2 potassium voltage-gated channel subfamily E regulatory subunit 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCNE2 mRNA CTD PMID:25510870 NCBI chr21:34,364,006...34,371,381
Ensembl chr21:34,364,006...34,371,381
JBrowse link
G KCNG2 potassium voltage-gated channel modifier subfamily G member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCNG2 mRNA CTD PMID:25510870 NCBI chr18:79,797,938...79,900,100
Ensembl chr18:79,797,938...79,900,184
JBrowse link
G KCNG4 potassium voltage-gated channel modifier subfamily G member 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCNG4 mRNA CTD PMID:25510870 NCBI chr16:84,218,657...84,240,012
Ensembl chr16:84,218,657...84,240,012
JBrowse link
G KCNH3 potassium voltage-gated channel subfamily H member 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KCNH3 mRNA CTD PMID:23829299 NCBI chr12:49,539,030...49,558,337
Ensembl chr12:49,539,030...49,558,337
JBrowse link
G KCNIP4 potassium voltage-gated channel interacting protein 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCNIP4 mRNA CTD PMID:25510870 NCBI chr 4:20,728,606...21,948,772
Ensembl chr 4:20,728,606...21,948,772
JBrowse link
G KCNJ13 potassium inwardly rectifying channel subfamily J member 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCNJ13 mRNA CTD PMID:25510870 NCBI chr 2:232,765,802...232,776,565
Ensembl chr 2:232,765,802...232,776,565
JBrowse link
G KCNK12 potassium two pore domain channel subfamily K member 12 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCNK12 mRNA CTD PMID:25510870 NCBI chr 2:47,509,290...47,570,985
Ensembl chr 2:47,509,290...47,570,985
JBrowse link
G KCNMA1 potassium calcium-activated channel subfamily M alpha 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCNMA1 mRNA; [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCNMA1 protein CTD PMID:25510870 NCBI chr10:76,869,602...77,637,808
Ensembl chr10:76,869,601...77,638,369
JBrowse link
G KCNMB2 potassium calcium-activated channel subfamily M regulatory beta subunit 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCNMB2 mRNA CTD PMID:25510870 NCBI chr 3:178,536,436...178,844,429
Ensembl chr 3:178,272,932...178,844,429
JBrowse link
G KCNQ2 potassium voltage-gated channel subfamily Q member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KCNQ2 mRNA CTD PMID:25510870 NCBI chr20:63,400,208...63,472,655
Ensembl chr20:63,400,208...63,472,677
JBrowse link
G KCNQ5 potassium voltage-gated channel subfamily Q member 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KCNQ5 mRNA CTD PMID:25510870 NCBI chr 6:72,622,064...73,198,853
Ensembl chr 6:72,621,792...73,198,853
JBrowse link
G KCTD1 potassium channel tetramerization domain containing 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KCTD1 mRNA CTD PMID:23829299 NCBI chr18:26,454,910...26,657,473
Ensembl chr18:26,454,910...26,657,401
JBrowse link
G KCTD14 potassium channel tetramerization domain containing 14 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCTD14 mRNA CTD PMID:25510870 NCBI chr11:78,015,715...78,046,191
Ensembl chr11:78,015,715...78,046,191
JBrowse link
G KCTD15 potassium channel tetramerization domain containing 15 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KCTD15 mRNA CTD PMID:25510870 NCBI chr19:33,794,040...33,815,761
Ensembl chr19:33,795,933...33,815,763
JBrowse link
G KDM5B lysine demethylase 5B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KDM5B mRNA CTD PMID:25510870 NCBI chr 1:202,724,495...202,808,421
Ensembl chr 1:202,724,495...202,808,487
JBrowse link
G KDM6B lysine demethylase 6B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KDM6B mRNA CTD PMID:25510870 NCBI chr17:7,834,217...7,854,796
Ensembl chr17:7,834,217...7,854,796
JBrowse link
G KDR kinase insert domain receptor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KDR mRNA CTD PMID:25510870 NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
JBrowse link
G KEL Kell metallo-endopeptidase (Kell blood group) multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KEL mRNA CTD PMID:25510870 NCBI chr 7:142,941,114...142,962,363
Ensembl chr 7:142,941,114...142,962,363
JBrowse link
G KHDC4 KH domain containing 4, pre-mRNA splicing factor decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KHDC4 mRNA CTD PMID:23829299 NCBI chr 1:155,913,045...155,934,413
Ensembl chr 1:155,913,045...155,934,413
JBrowse link
G KIAA1958 KIAA1958 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KIAA1958 mRNA CTD PMID:23829299 NCBI chr 9:112,486,827...112,669,397
Ensembl chr 9:112,486,827...112,669,397
JBrowse link
G KIF15 kinesin family member 15 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF15 mRNA CTD PMID:25510870 NCBI chr 3:44,761,794...44,868,687
Ensembl chr 3:44,761,721...44,873,376
JBrowse link
G KIF17 kinesin family member 17 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KIF17 mRNA CTD PMID:25510870 NCBI chr 1:20,661,630...20,718,007
Ensembl chr 1:20,664,014...20,718,017
JBrowse link
G KIF18A kinesin family member 18A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF18A mRNA CTD PMID:25510870 NCBI chr11:28,020,619...28,108,156
Ensembl chr11:28,020,619...28,108,156
JBrowse link
G KIF18B kinesin family member 18B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF18B mRNA CTD PMID:25510870 NCBI chr17:44,924,711...44,947,773
Ensembl chr17:44,924,709...44,947,773
JBrowse link
G KIF1B kinesin family member 1B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF1B mRNA CTD PMID:25510870 NCBI chr 1:10,210,570...10,381,603
Ensembl chr 1:10,210,570...10,381,603
JBrowse link
G KIF20A kinesin family member 20A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF20A mRNA CTD PMID:25510870 NCBI chr 5:138,179,112...138,187,723
Ensembl chr 5:138,178,719...138,187,723
JBrowse link
G KIF20B kinesin family member 20B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF20B mRNA CTD PMID:25510870 NCBI chr10:89,701,590...89,774,934
Ensembl chr10:89,701,590...89,774,939
JBrowse link
G KIF21B kinesin family member 21B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF21B mRNA CTD PMID:25510870 NCBI chr 1:200,969,390...201,023,714
Ensembl chr 1:200,969,390...201,023,714
JBrowse link
G KIF23 kinesin family member 23 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF23 mRNA CTD PMID:25510870 NCBI chr15:69,414,349...69,448,427
Ensembl chr15:69,414,246...69,448,427
JBrowse link
G KIF26B kinesin family member 26B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KIF26B mRNA CTD PMID:25510870 NCBI chr 1:245,154,985...245,709,432
Ensembl chr 1:245,154,985...245,709,432
JBrowse link
G KIF27 kinesin family member 27 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KIF27 mRNA CTD PMID:23829299 NCBI chr 9:83,834,099...83,921,432
Ensembl chr 9:83,834,099...83,921,465
JBrowse link
G KIF2C kinesin family member 2C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF2C mRNA CTD PMID:25510870 NCBI chr 1:44,739,837...44,767,767
Ensembl chr 1:44,739,818...44,767,767
JBrowse link
G KIF4A kinesin family member 4A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF4 mRNA CTD PMID:25510870 NCBI chr  X:70,290,104...70,420,886
Ensembl chr  X:70,290,104...70,420,886
JBrowse link
G KIF5A kinesin family member 5A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIF5A mRNA CTD PMID:25510870 NCBI chr12:57,550,044...57,586,633
Ensembl chr12:57,546,026...57,586,633
JBrowse link
G KIF5B kinesin family member 5B decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KIF5B protein CTD PMID:21673325 NCBI chr10:32,009,015...32,056,425
Ensembl chr10:32,009,015...32,056,425
JBrowse link
G KIFAP3 kinesin associated protein 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KIFAP3 mRNA CTD PMID:23829299 NCBI chr 1:169,921,329...170,085,184
Ensembl chr 1:169,921,326...170,085,208
JBrowse link
G KIFC1 kinesin family member C1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIFC1 mRNA CTD PMID:25510870 NCBI chr 6:33,391,461...33,409,896
Ensembl chr 6:33,391,823...33,409,896
JBrowse link
G KIN Kin17 DNA and RNA binding protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIN mRNA CTD PMID:25510870 NCBI chr10:7,750,962...7,787,993
Ensembl chr10:7,750,962...7,787,993
JBrowse link
G KIRREL1 kirre like nephrin family adhesion molecule 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KIRREL1 mRNA CTD PMID:25510870 NCBI chr 1:157,993,645...158,100,262
Ensembl chr 1:157,993,273...158,100,262
JBrowse link
G KISS1 KiSS-1 metastasis suppressor multiple interactions ISO [2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KISS1 protein
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KISS1 mRNA
CTD PMID:21190954 PMID:25510870 NCBI chr 1:204,190,341...204,196,491
Ensembl chr 1:204,190,341...204,196,491
JBrowse link
G KISS1R KISS1 receptor multiple interactions ISO [2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KISS1R mRNA CTD PMID:21277884 NCBI chr19:917,333...921,005
Ensembl chr19:917,287...921,005
JBrowse link
G KITLG KIT ligand affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of KITLG mRNA CTD PMID:21703328 NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,793...88,580,851
JBrowse link
G KLC3 kinesin light chain 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KLC3 mRNA CTD PMID:23829299 NCBI chr19:45,340,750...45,351,519
Ensembl chr19:45,333,434...45,351,520
JBrowse link
G KLF11 KLF transcription factor 11 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KLF11 mRNA CTD PMID:25510870 NCBI chr 2:10,043,550...10,054,836
Ensembl chr 2:10,042,849...10,054,836
JBrowse link
G KLF12 KLF transcription factor 12 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KLF12 mRNA CTD PMID:25510870 NCBI chr13:73,686,089...74,306,045
Ensembl chr13:73,686,089...74,134,404
JBrowse link
G KLF5 KLF transcription factor 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KLF5 mRNA CTD PMID:23829299 NCBI chr13:73,054,976...73,077,538
Ensembl chr13:73,054,976...73,077,541
JBrowse link
G KLHL42 kelch like family member 42 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KLHL42 mRNA CTD PMID:23829299 NCBI chr12:27,780,233...27,803,040
Ensembl chr12:27,780,048...27,803,040
JBrowse link
G KLK3 kallikrein related peptidase 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KLK1C10 mRNA CTD PMID:23829299 NCBI chr19:50,854,915...50,860,764
Ensembl chr19:50,854,915...50,860,764
JBrowse link
G KNDC1 kinase non-catalytic C-lobe domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KNDC1 mRNA CTD PMID:25510870 NCBI chr10:133,160,219...133,226,412
Ensembl chr10:133,160,219...133,226,412
JBrowse link
G KNSTRN kinetochore localized astrin (SPAG5) binding protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KNSTRN mRNA CTD PMID:25510870 NCBI chr15:40,382,721...40,394,288
Ensembl chr15:40,382,721...40,394,288
JBrowse link
G KNTC1 kinetochore associated 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KNTC1 mRNA CTD PMID:25510870 NCBI chr12:122,527,249...122,626,396
Ensembl chr12:122,527,246...122,626,396
JBrowse link
G KPNA2 karyopherin subunit alpha 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KPNA2 mRNA CTD PMID:25510870 NCBI chr17:68,035,735...68,046,854
Ensembl chr17:68,035,636...68,047,364
JBrowse link
G KRT13 keratin 13 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KRT13 mRNA CTD PMID:23829299 NCBI chr17:41,500,981...41,505,612
Ensembl chr17:41,500,981...41,505,705
JBrowse link
G KRT71 keratin 71 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KRT71 mRNA CTD PMID:25510870 NCBI chr12:52,543,909...52,553,145
Ensembl chr12:52,543,909...52,553,145
JBrowse link
G KRT77 keratin 77 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of KRT77 mRNA CTD PMID:23829299 NCBI chr12:52,689,626...52,703,524
Ensembl chr12:52,689,626...52,703,524
JBrowse link
G KRT78 keratin 78 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KRT78 mRNA CTD PMID:25510870 NCBI chr12:52,837,804...52,848,994
Ensembl chr12:52,837,804...52,849,092
JBrowse link
G KRT85 keratin 85 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KRT85 mRNA CTD PMID:25510870 NCBI chr12:52,360,006...52,367,481
Ensembl chr12:52,360,006...52,367,481
JBrowse link
G KRTAP19-5 keratin associated protein 19-5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KRTAP19-4 mRNA CTD PMID:25510870 NCBI chr21:30,501,657...30,502,141
Ensembl chr21:30,501,657...30,502,141
JBrowse link
G KSR2 kinase suppressor of ras 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KSR2 mRNA CTD PMID:25510870 NCBI chr12:117,453,012...117,968,990
Ensembl chr12:117,453,012...117,968,990
JBrowse link
G L1TD1 LINE1 type transposase domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of L1TD1 mRNA CTD PMID:25510870 NCBI chr 1:62,194,849...62,212,328
Ensembl chr 1:62,194,849...62,212,328
JBrowse link
G L3MBTL4 L3MBTL histone methyl-lysine binding protein 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of L3MBTL4 mRNA CTD PMID:25510870 NCBI chr18:5,954,717...6,415,259
Ensembl chr18:5,954,706...6,415,237
JBrowse link
G LAMA5 laminin subunit alpha 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of LAMA5 mRNA CTD PMID:23829299 NCBI chr20:62,309,065...62,367,312
Ensembl chr20:62,307,955...62,367,312
JBrowse link
G LANCL3 LanC like family member 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LANCL3 mRNA CTD PMID:25510870 NCBI chr  X:37,571,661...37,684,463
Ensembl chr  X:37,571,569...37,684,463
JBrowse link
G LARP7 La ribonucleoprotein 7, transcriptional regulator multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LARP7 mRNA CTD PMID:25510870 NCBI chr 4:112,637,143...112,657,586
Ensembl chr 4:112,637,077...112,657,696
JBrowse link
G LBR lamin B receptor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LBR mRNA CTD PMID:25510870 NCBI chr 1:225,401,502...225,428,821
Ensembl chr 1:225,401,502...225,428,925
JBrowse link
G LCA5 lebercilin LCA5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LCA5 mRNA CTD PMID:25510870 NCBI chr 6:79,484,991...79,538,782
Ensembl chr 6:79,484,991...79,537,458
JBrowse link
G LCN12 lipocalin 12 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LCN12 mRNA CTD PMID:25510870 NCBI chr 9:136,949,197...136,956,538
Ensembl chr 9:136,949,551...136,955,497
JBrowse link
G LDB3 LIM domain binding 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LDB3 mRNA CTD PMID:25510870 NCBI chr10:86,666,788...86,736,072
Ensembl chr10:86,666,785...86,736,072
JBrowse link
G LEF1 lymphoid enhancer binding factor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LEF1 mRNA CTD PMID:25510870 NCBI chr 4:108,047,548...108,168,932
Ensembl chr 4:108,047,545...108,168,956
JBrowse link
G LEPR leptin receptor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA CTD PMID:25510870 NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
JBrowse link
G LGALS1 galectin 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of LGALS1 mRNA CTD PMID:23829299 NCBI chr22:37,675,636...37,679,802
Ensembl chr22:37,675,636...37,679,802
JBrowse link
G LGALS2 galectin 2 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of LGALS2 mRNA CTD PMID:23829299 NCBI chr22:37,570,248...37,580,087
Ensembl chr22:37,570,248...37,582,616
JBrowse link
G LGALS3BP galectin 3 binding protein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of LGALS3BP mRNA CTD PMID:23829299 NCBI chr17:78,971,255...78,979,923
Ensembl chr17:78,971,238...78,979,947
JBrowse link
G LGALS8 galectin 8 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of LGALS8 mRNA CTD PMID:23829299 NCBI chr 1:236,518,214...236,552,981
Ensembl chr 1:236,518,000...236,552,981
JBrowse link
G LGR6 leucine rich repeat containing G protein-coupled receptor 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LGR6 mRNA CTD PMID:25510870 NCBI chr 1:202,193,799...202,319,761
Ensembl chr 1:202,193,799...202,319,781
JBrowse link
G LHX1 LIM homeobox 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LHX1 mRNA CTD PMID:25510870 NCBI chr17:36,936,785...36,944,612
Ensembl chr17:36,936,785...36,944,612
JBrowse link
G LHX2 LIM homeobox 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of LHX2 mRNA CTD PMID:23829299 NCBI chr 9:124,011,768...124,033,301
Ensembl chr 9:124,001,670...124,033,301
JBrowse link
G LIAS lipoic acid synthetase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LIAS mRNA CTD PMID:25510870 NCBI chr 4:39,459,056...39,479,506
Ensembl chr 4:39,459,004...39,485,109
JBrowse link
G LILRA6 leukocyte immunoglobulin like receptor A6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LILRA6 mRNA CTD PMID:25510870 NCBI chr19:54,236,590...54,242,790
Ensembl chr19:54,236,590...54,242,790
JBrowse link
G LIN7A lin-7 homolog A, crumbs cell polarity complex component multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LIN7A mRNA CTD PMID:25510870 NCBI chr12:80,792,520...80,937,934
Ensembl chr12:80,792,520...80,937,934
JBrowse link
G LIN7B lin-7 homolog B, crumbs cell polarity complex component multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LIN7B mRNA CTD PMID:25510870 NCBI chr19:49,114,370...49,118,460
Ensembl chr19:49,114,324...49,118,460
JBrowse link
G LMBRD2 LMBR1 domain containing 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LMBRD2 mRNA CTD PMID:25510870 NCBI chr 5:36,098,407...36,151,887
Ensembl chr 5:36,098,407...36,151,887
JBrowse link
G LMNB1 lamin B1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LMNB1 mRNA CTD PMID:25510870 NCBI chr 5:126,776,623...126,837,020
Ensembl chr 5:126,776,623...126,837,020
JBrowse link
G LMNTD2 lamin tail domain containing 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LMNTD2 mRNA CTD PMID:25510870 NCBI chr11:554,850...560,738
Ensembl chr11:554,850...560,738
JBrowse link
G LOXHD1 lipoxygenase homology PLAT domains 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LOXHD1 mRNA CTD PMID:25510870 NCBI chr18:46,476,961...46,657,220
Ensembl chr18:46,476,972...46,657,220
JBrowse link
G LPAR2 lysophosphatidic acid receptor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LPAR2 mRNA CTD PMID:25510870 NCBI chr19:19,623,655...19,628,220
Ensembl chr19:19,623,655...19,628,930
JBrowse link
G LPL lipoprotein lipase affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of LPL mRNA CTD PMID:21703328 NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
JBrowse link
G LRATD2 LRAT domain containing 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of LRATD2 mRNA CTD PMID:23829299 NCBI chr 8:126,552,443...126,558,478
Ensembl chr 8:126,552,443...126,558,478
JBrowse link
G LRBA LPS responsive beige-like anchor protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] affects the expression of LRBA mRNA CTD PMID:25510870 NCBI chr 4:150,264,435...151,015,727
Ensembl chr 4:150,264,435...151,015,727
JBrowse link
G LRP5 LDL receptor related protein 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of LRP5 mRNA CTD PMID:23829299 NCBI chr11:68,298,412...68,449,275
Ensembl chr11:68,312,591...68,449,275
JBrowse link
G LRRC26 leucine rich repeat containing 26 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LRRC26 mRNA CTD PMID:25510870 NCBI chr 9:137,168,758...137,170,051
Ensembl chr 9:137,168,758...137,170,051
JBrowse link
G LRRC34 leucine rich repeat containing 34 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LRRC34 mRNA CTD PMID:25510870 NCBI chr 3:169,793,003...169,812,904
Ensembl chr 3:169,793,003...169,812,986
JBrowse link
G LRRC55 leucine rich repeat containing 55 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LRRC55 mRNA CTD PMID:25510870 NCBI chr11:57,181,953...57,191,717
Ensembl chr11:57,181,747...57,191,717
JBrowse link
G LRRC72 leucine rich repeat containing 72 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LRRC72 mRNA CTD PMID:25510870 NCBI chr 7:16,526,825...16,581,568
Ensembl chr 7:16,526,825...16,581,568
JBrowse link
G LRRN3 leucine rich repeat neuronal 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LRRN3 mRNA CTD PMID:25510870 NCBI chr 7:111,091,127...111,125,454
Ensembl chr 7:111,091,006...111,125,454
JBrowse link
G LRRTM3 leucine rich repeat transmembrane neuronal 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LRRTM3 mRNA CTD PMID:25510870 NCBI chr10:66,926,036...67,101,551
Ensembl chr10:66,926,036...67,101,551
JBrowse link
G LSS lanosterol synthase decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of LSS mRNA CTD PMID:23829299 NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
JBrowse link
G LTA lymphotoxin alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LTA mRNA CTD PMID:25510870 NCBI chr 6:31,560,610...31,574,324
Ensembl chr 6:31,572,054...31,574,324
JBrowse link
G LTN1 listerin E3 ubiquitin protein ligase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LTN1 mRNA CTD PMID:25510870 NCBI chr21:28,928,144...28,992,877
Ensembl chr21:28,928,144...28,992,956
JBrowse link
G LURAP1 leucine rich adaptor protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LURAP1 mRNA CTD PMID:25510870 NCBI chr 1:46,203,334...46,221,256
Ensembl chr 1:46,203,334...46,221,256
JBrowse link
G LURAP1L leucine rich adaptor protein 1 like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LURAP1L mRNA CTD PMID:25510870 NCBI chr 9:12,775,020...12,823,060
Ensembl chr 9:12,775,020...12,823,060
JBrowse link
G LYNX1 Ly6/neurotoxin 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LYNX1 mRNA CTD PMID:25510870 NCBI chr 8:142,771,197...142,777,872
Ensembl chr 8:142,771,197...142,777,810
JBrowse link
G LYPD1 LY6/PLAUR domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LYPD1 mRNA CTD PMID:25510870 NCBI chr 2:132,643,286...132,671,526
Ensembl chr 2:132,643,286...132,671,579
JBrowse link
G LYZL1 lysozyme like 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of LYZL1 mRNA CTD PMID:23829299 NCBI chr10:29,289,070...29,318,328
Ensembl chr10:29,289,061...29,318,328
JBrowse link
G LYZL4 lysozyme like 4 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of LYZL4 mRNA CTD PMID:23829299 NCBI chr 3:42,360,764...42,410,610
Ensembl chr 3:42,397,083...42,410,610
JBrowse link
G MAB21L1 mab-21 like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MAB21L1 mRNA CTD PMID:25510870 NCBI chr13:35,473,789...35,476,689
Ensembl chr13:35,473,419...35,478,764
JBrowse link
G MAB21L2 mab-21 like 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MAB21L2 mRNA CTD PMID:25510870 NCBI chr 4:150,582,151...150,584,693
Ensembl chr 4:150,582,151...150,584,693
JBrowse link
G MACROD1 mono-ADP ribosylhydrolase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MACROD1 mRNA CTD PMID:25510870 NCBI chr11:63,998,558...64,166,113
Ensembl chr11:63,998,558...64,166,113
JBrowse link
G MACROD2 mono-ADP ribosylhydrolase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MACROD2 mRNA CTD PMID:25510870 NCBI chr20:13,995,516...16,053,197
Ensembl chr20:13,995,369...16,053,197
JBrowse link
G MAD2L1 mitotic arrest deficient 2 like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MAD2L1 mRNA CTD PMID:25510870 NCBI chr 4:120,055,623...120,066,848
Ensembl chr 4:120,055,623...120,066,858
JBrowse link
G MAD2L1BP MAD2L1 binding protein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MAD2L1BP mRNA CTD PMID:23829299 NCBI chr 6:43,629,540...43,640,941
Ensembl chr 6:43,629,540...43,640,941
JBrowse link
G MAG myelin associated glycoprotein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MAG protein CTD PMID:21673325 NCBI chr19:35,292,161...35,313,807
Ensembl chr19:35,292,125...35,313,807
JBrowse link
G MAGEB16 MAGE family member B16 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MAGEB16 mRNA CTD PMID:25510870 NCBI chr  X:35,798,342...35,803,772
Ensembl chr  X:35,798,342...35,803,772
JBrowse link
G MAGI1 membrane associated guanylate kinase, WW and PDZ domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MAGI1 mRNA CTD PMID:25510870 NCBI chr 3:65,353,526...66,038,918
Ensembl chr 3:65,353,525...66,038,918
JBrowse link
G MAGI2 membrane associated guanylate kinase, WW and PDZ domain containing 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MAGI2 mRNA CTD PMID:23829299 NCBI chr 7:78,017,055...79,453,667
Ensembl chr 7:78,017,055...79,453,667
JBrowse link
G MAGIX MAGI family member, X-linked multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MAGIX mRNA CTD PMID:25510870 NCBI chr  X:49,162,665...49,168,774
Ensembl chr  X:49,162,564...49,168,774
JBrowse link
G MAL2 mal, T cell differentiation protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MAL2 mRNA CTD PMID:25510870 NCBI chr 8:119,208,363...119,245,673
Ensembl chr 8:119,165,034...119,245,673
JBrowse link
G MAMSTR MEF2 activating motif and SAP domain containing transcriptional regulator multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MAMSTR mRNA CTD PMID:25510870 NCBI chr19:48,705,718...48,719,725
Ensembl chr19:48,712,725...48,719,725
JBrowse link
G MAN1A1 mannosidase alpha class 1A member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MAN1A mRNA CTD PMID:25510870 NCBI chr 6:119,177,205...119,350,605
Ensembl chr 6:119,177,205...119,349,761
JBrowse link
G MAN2A1 mannosidase alpha class 2A member 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of MAN2A1 mRNA CTD PMID:23829299 NCBI chr 5:109,689,927...109,869,625
Ensembl chr 5:109,689,927...109,869,625
JBrowse link
G MANBAL mannosidase beta like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MANBAL mRNA CTD PMID:25510870 NCBI chr20:37,289,655...37,317,260
Ensembl chr20:37,289,649...37,317,260
JBrowse link
G MAP1B microtubule associated protein 1B increases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of MAP1B protein
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MAP1B mRNA
CTD PMID:21673325 PMID:25510870 NCBI chr 5:72,107,475...72,209,565
Ensembl chr 5:72,107,234...72,209,565
JBrowse link
G MAP3K1 mitogen-activated protein kinase kinase kinase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MAP3K1 mRNA CTD PMID:25510870 NCBI chr 5:56,815,549...56,896,152
Ensembl chr 5:56,815,549...56,896,152
JBrowse link
G MAP3K10 mitogen-activated protein kinase kinase kinase 10 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MAP3K10 mRNA CTD PMID:23829299 NCBI chr19:40,191,426...40,215,575
Ensembl chr19:40,191,426...40,215,575
JBrowse link
G MAP6 microtubule associated protein 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MAP6 mRNA CTD PMID:25510870 NCBI chr11:75,586,918...75,669,038
Ensembl chr11:75,586,918...75,669,038
JBrowse link
G MAP7 microtubule associated protein 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MAP7 mRNA CTD PMID:25510870 NCBI chr 6:136,342,734...136,550,422
Ensembl chr 6:136,342,281...136,550,819
JBrowse link
G MAP7D2 MAP7 domain containing 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MAP7D2 mRNA CTD PMID:25510870 NCBI chr  X:20,006,713...20,116,907
Ensembl chr  X:20,006,713...20,116,907
JBrowse link
G MAP7D3 MAP7 domain containing 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MAP7D3 mRNA CTD PMID:25510870 NCBI chr  X:136,213,220...136,256,482
Ensembl chr  X:136,213,220...136,256,482
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 decreases phosphorylation EXP 2,2',3',4,4',5-hexachlorobiphenyl results in decreased phosphorylation of MAPK1 protein CTD PMID:19751709 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
JBrowse link
G MAPK11 mitogen-activated protein kinase 11 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of MAPK11 mRNA CTD PMID:23829299 NCBI chr22:50,263,713...50,270,380
Ensembl chr22:50,263,713...50,270,767
JBrowse link
G MAPK13 mitogen-activated protein kinase 13 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MAPK13 mRNA CTD PMID:23829299 NCBI chr 6:36,130,513...36,144,521
Ensembl chr 6:36,127,809...36,144,524
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 decreases phosphorylation EXP 2,2',3',4,4',5-hexachlorobiphenyl results in decreased phosphorylation of MAPK3 protein CTD PMID:19751709 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G MAPK9 mitogen-activated protein kinase 9 affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of MAPK9 mRNA CTD PMID:21703328 NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
JBrowse link
G MARCHF5 membrane associated ring-CH-type finger 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MARCHF5 mRNA CTD PMID:25510870 NCBI chr10:92,291,167...92,353,964
Ensembl chr10:92,291,167...92,353,964
JBrowse link
G MARCKS myristoylated alanine rich protein kinase C substrate increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of MARCKS protein CTD PMID:21673325 NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475
JBrowse link
G MAS1 MAS1 proto-oncogene, G protein-coupled receptor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MAS1 mRNA CTD PMID:25510870 NCBI chr 6:159,888,787...159,917,447
Ensembl chr 6:159,890,988...159,917,447
JBrowse link
G MASP2 MBL associated serine protease 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MASP2 mRNA CTD PMID:25510870 NCBI chr 1:11,026,523...11,047,239
Ensembl chr 1:11,022,009...11,047,239
JBrowse link
G MATR3 matrin 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MATR3 protein CTD PMID:21673325 NCBI chr 5:139,274,101...139,331,677
Ensembl chr 5:139,273,752...139,331,671
Ensembl chr 5:139,273,752...139,331,671
JBrowse link
G MAU2 MAU2 sister chromatid cohesion factor decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MAU2 mRNA CTD PMID:23829299 NCBI chr19:19,320,829...19,358,754
Ensembl chr19:19,320,829...19,358,754
JBrowse link
G MBNL3 muscleblind like splicing regulator 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MBNL3 mRNA CTD PMID:25510870 NCBI chr  X:132,369,320...132,490,035
Ensembl chr  X:132,369,320...132,489,968
JBrowse link
G MBOAT4 membrane bound O-acyltransferase domain containing 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MBOAT4 mRNA CTD PMID:25510870 NCBI chr 8:30,131,671...30,144,665
Ensembl chr 8:30,131,671...30,144,665
JBrowse link
G MBP myelin basic protein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MBP protein CTD PMID:21673325 NCBI chr18:76,978,833...77,133,708
Ensembl chr18:76,978,827...77,133,683
JBrowse link
G MBTD1 mbt domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MBTD1 mRNA CTD PMID:25510870 NCBI chr17:51,177,425...51,260,958
Ensembl chr17:51,177,425...51,260,163
JBrowse link
G MCF2L MCF.2 cell line derived transforming sequence like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MCF2L mRNA CTD PMID:25510870 NCBI chr13:112,894,335...113,099,742
Ensembl chr13:112,894,378...113,099,742
JBrowse link
G MCM10 minichromosome maintenance 10 replication initiation factor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM10 mRNA CTD PMID:25510870 NCBI chr10:13,161,558...13,211,110
Ensembl chr10:13,161,558...13,211,110
JBrowse link
G MCM2 minichromosome maintenance complex component 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM2 mRNA CTD PMID:25510870 NCBI chr 3:127,598,411...127,622,436
Ensembl chr 3:127,598,223...127,622,436
JBrowse link
G MCM3 minichromosome maintenance complex component 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM3 mRNA CTD PMID:25510870 NCBI chr 6:52,264,015...52,284,742
Ensembl chr 6:52,264,014...52,284,881
JBrowse link
G MCM4 minichromosome maintenance complex component 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM4 mRNA CTD PMID:25510870 NCBI chr 8:47,960,941...47,978,160
Ensembl chr 8:47,960,185...47,978,160
JBrowse link
G MCM5 minichromosome maintenance complex component 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM5 mRNA CTD PMID:25510870 NCBI chr22:35,400,140...35,455,031
Ensembl chr22:35,400,134...35,425,431
JBrowse link
G MCM6 minichromosome maintenance complex component 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM6 mRNA CTD PMID:25510870 NCBI chr 2:135,839,626...135,876,443
Ensembl chr 2:135,839,626...135,876,443
JBrowse link
G MCOLN1 mucolipin TRP cation channel 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MCOLN1 mRNA CTD PMID:23829299 NCBI chr19:7,522,624...7,534,009
Ensembl chr19:7,522,624...7,534,009
JBrowse link
G MCTP1 multiple C2 and transmembrane domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MCTP1 mRNA CTD PMID:25510870 NCBI chr 5:94,703,690...95,285,094
Ensembl chr 5:94,703,690...95,285,094
JBrowse link
G MCU mitochondrial calcium uniporter multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MCU mRNA CTD PMID:25510870 NCBI chr10:72,692,143...72,887,694
Ensembl chr10:72,692,143...72,887,694
JBrowse link
G MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MDGA1 mRNA CTD PMID:25510870 NCBI chr 6:37,630,679...37,697,883
Ensembl chr 6:37,630,679...37,699,306
JBrowse link
G MDM2 MDM2 proto-oncogene increases phosphorylation EXP 2,2',3',4,4',5-hexachlorobiphenyl results in increased phosphorylation of MDM2 protein CTD PMID:19751709 NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
JBrowse link
G ME3 malic enzyme 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ME3 mRNA CTD PMID:25510870 NCBI chr11:86,434,930...86,672,616
Ensembl chr11:86,441,108...86,672,636
JBrowse link
G MELK maternal embryonic leucine zipper kinase decreases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MELK mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MELK mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 9:36,572,895...36,677,682
Ensembl chr 9:36,572,862...36,677,683
JBrowse link
G MEOX2 mesenchyme homeobox 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MEOX2 mRNA CTD PMID:25510870 NCBI chr 7:15,611,212...15,686,683
Ensembl chr 7:15,611,212...15,686,683
JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of MET mRNA CTD PMID:21703328 NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
JBrowse link
G METRN meteorin, glial cell differentiation regulator multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of METRN mRNA CTD PMID:25510870 NCBI chr16:715,118...719,655
Ensembl chr16:715,118...719,655
JBrowse link
G MEX3A mex-3 RNA binding family member A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MEX3A mRNA CTD PMID:25510870 NCBI chr 1:156,072,013...156,082,465
Ensembl chr 1:156,072,013...156,082,465
JBrowse link
G MEX3B mex-3 RNA binding family member B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MEX3B mRNA CTD PMID:25510870 NCBI chr15:82,041,778...82,046,018
Ensembl chr15:82,041,778...82,046,119
JBrowse link
G MFAP3L microfibril associated protein 3 like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MFAP3L mRNA CTD PMID:25510870 NCBI chr 4:169,986,602...170,027,277
Ensembl chr 4:169,986,597...170,033,031
JBrowse link
G MFAP4 microfibril associated protein 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MFAP4 mRNA CTD PMID:25510870 NCBI chr17:19,383,445...19,387,190
Ensembl chr17:19,383,442...19,387,190
JBrowse link
G MFHAS1 multifunctional ROCO family signaling regulator 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of MFHAS1 mRNA CTD PMID:23829299 NCBI chr 8:8,783,354...8,893,630
Ensembl chr 8:8,783,354...8,893,630
JBrowse link
G MFSD4A major facilitator superfamily domain containing 4A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MFSD4A mRNA CTD PMID:25510870 NCBI chr 1:205,569,014...205,602,918
Ensembl chr 1:205,568,885...205,602,918
JBrowse link
G MGAT4EP MGAT4 family member E, pseudogene multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MGAT4E mRNA CTD PMID:25510870 NCBI chr 1:202,820,257...202,827,225
Ensembl chr 1:202,825,186...202,826,320
Ensembl chr 1:202,825,186...202,826,320
JBrowse link
G MGAT5 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MGAT5 mRNA CTD PMID:25510870 NCBI chr 2:134,119,935...134,454,621
Ensembl chr 2:134,119,983...134,454,621
JBrowse link
G MGLL monoglyceride lipase decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MGLL mRNA CTD PMID:23829299 NCBI chr 3:127,689,066...127,823,185
Ensembl chr 3:127,689,062...128,052,190
JBrowse link
G MGST3 microsomal glutathione S-transferase 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MGST3 mRNA CTD PMID:25510870 NCBI chr 1:165,631,234...165,656,136
Ensembl chr 1:165,631,213...165,661,796
JBrowse link
G MICAL2 microtubule associated monooxygenase, calponin and LIM domain containing 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MICAL2 mRNA CTD PMID:25510870 NCBI chr11:12,110,590...12,362,140
Ensembl chr11:12,094,008...12,359,144
JBrowse link
G MICU2 mitochondrial calcium uptake 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MICU2 mRNA CTD PMID:23829299 NCBI chr13:21,492,691...21,604,170
Ensembl chr13:21,492,691...21,604,181
JBrowse link
G MILR1 mast cell immunoglobulin like receptor 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MILR1 mRNA CTD PMID:23829299 NCBI chr17:64,449,115...64,497,356
Ensembl chr17:64,449,037...64,468,643
JBrowse link
G MINDY4 MINDY lysine 48 deubiquitinase 4 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MINDY4 mRNA CTD PMID:23829299 NCBI chr 7:30,771,417...30,892,387
Ensembl chr 7:30,771,417...30,892,387
JBrowse link
G MIR17HG miR-17-92a-1 cluster host gene multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MIR17HG mRNA CTD PMID:25510870 NCBI chr13:91,347,820...91,354,575
Ensembl chr13:91,347,686...91,397,592
JBrowse link
G MIS18A MIS18 kinetochore protein A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MIS18A mRNA CTD PMID:25510870 NCBI chr21:32,154,682...32,279,049
Ensembl chr21:32,268,228...32,279,049
JBrowse link
G MKI67 marker of proliferation Ki-67 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MKI67 mRNA CTD PMID:25510870 NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
JBrowse link
G MLIP muscular LMNA interacting protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MLIP mRNA CTD PMID:25510870 NCBI chr 6:54,018,970...54,266,280
Ensembl chr 6:53,929,982...54,266,280
JBrowse link
G MLXIP MLX interacting protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MLXIP mRNA CTD PMID:25510870 NCBI chr12:122,078,756...122,147,344
Ensembl chr12:122,078,756...122,147,344
JBrowse link
G MMAB metabolism of cobalamin associated B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MMAB mRNA CTD PMID:25510870 NCBI chr12:109,553,715...109,573,504
Ensembl chr12:109,553,715...109,573,580
JBrowse link
G MMP2 matrix metallopeptidase 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MMP2 mRNA CTD PMID:23829299 NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
JBrowse link
G MMP27 matrix metallopeptidase 27 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MMP27 mRNA CTD PMID:25510870 NCBI chr11:102,691,487...102,705,769
Ensembl chr11:102,691,487...102,705,769
JBrowse link
G MMP28 matrix metallopeptidase 28 multiple interactions
increases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MMP28 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of MMP28 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr17:35,756,249...35,795,641
Ensembl chr17:35,756,249...35,795,707
JBrowse link
G MMRN1 multimerin 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of MMRN1 mRNA CTD PMID:23829299 NCBI chr 4:89,879,511...89,954,614
Ensembl chr 4:89,879,532...89,954,629
JBrowse link
G MOB1A MOB kinase activator 1A increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of MOB1A mRNA CTD PMID:23829299 NCBI chr 2:74,152,528...74,178,879
Ensembl chr 2:74,152,528...74,178,898
JBrowse link
G MOBP myelin associated oligodendrocyte basic protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MOBP mRNA CTD PMID:25510870 NCBI chr 3:39,467,680...39,529,497
Ensembl chr 3:39,467,198...39,529,479
JBrowse link
G MOG myelin oligodendrocyte glycoprotein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MOG protein CTD PMID:21673325 NCBI chr 6:29,657,092...29,672,365
Ensembl chr 6:29,657,002...29,672,372
JBrowse link
G MOGAT1 monoacylglycerol O-acyltransferase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MOGAT1 mRNA CTD PMID:25510870 NCBI chr 2:222,671,658...222,709,930
Ensembl chr 2:222,671,658...222,709,930
JBrowse link
G MPP2 MAGUK p55 scaffold protein 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MPP2 mRNA CTD PMID:23829299 NCBI chr17:43,875,360...43,909,711
Ensembl chr17:43,875,357...43,909,711
JBrowse link
G MPTX1 mucosal pentraxin 1 (pseudogene) multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MPTX1 mRNA CTD PMID:25510870 NCBI chr 1:159,276,507...159,277,182
Ensembl chr 1:159,276,503...159,277,111
JBrowse link
G MRAP2 melanocortin 2 receptor accessory protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MRAP2 mRNA CTD PMID:25510870 NCBI chr 6:84,033,178...84,146,282
Ensembl chr 6:84,033,772...84,090,881
JBrowse link
G MRGPRE MAS related GPR family member E decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MRGPRE mRNA CTD PMID:23829299 NCBI chr11:3,225,030...3,232,417
Ensembl chr11:3,225,030...3,232,417
JBrowse link
G MRGPRX2 MAS related GPR family member X2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MRGPRX2 mRNA CTD PMID:25510870 NCBI chr11:19,054,455...19,060,717
Ensembl chr11:19,054,455...19,060,717
JBrowse link
G MROH7 maestro heat like repeat family member 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MROH7 mRNA CTD PMID:25510870 NCBI chr 1:54,641,786...54,710,266
Ensembl chr 1:54,641,754...54,710,266
JBrowse link
G MRPL34 mitochondrial ribosomal protein L34 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of MRPL34 mRNA CTD PMID:23829299 NCBI chr19:17,292,573...17,306,843
Ensembl chr19:17,292,609...17,306,843
JBrowse link
G MS4A10 membrane spanning 4-domains A10 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MS4A10 mRNA CTD PMID:23829299 NCBI chr11:60,785,333...60,801,305
Ensembl chr11:60,785,333...60,801,305
JBrowse link
G MS4A13 membrane spanning 4-domains A13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MS4A13 mRNA CTD PMID:25510870 NCBI chr11:60,515,392...60,543,424
Ensembl chr11:60,515,392...60,542,721
JBrowse link
G MSH4 mutS homolog 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MSH4 mRNA CTD PMID:25510870 NCBI chr 1:75,796,882...75,913,242
Ensembl chr 1:75,796,882...75,913,242
JBrowse link
G MSH6 mutS homolog 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MSH6 mRNA CTD PMID:25510870 NCBI chr 2:47,783,145...47,810,101
Ensembl chr 2:47,695,530...47,810,063
JBrowse link
G MSR1 macrophage scavenger receptor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MSR1 mRNA CTD PMID:25510870 NCBI chr 8:16,107,881...16,192,651
Ensembl chr 8:16,107,878...16,567,490
JBrowse link
G MSS51 MSS51 mitochondrial translational activator multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MSS51 mRNA CTD PMID:25510870 NCBI chr10:73,423,579...73,433,561
Ensembl chr10:73,423,579...73,433,561
JBrowse link
G MTHFR methylenetetrahydrofolate reductase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MTHFR mRNA CTD PMID:25510870 NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
JBrowse link
G MTM1 myotubularin 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MTM1 mRNA CTD PMID:25510870 NCBI chr  X:150,562,653...150,673,143
Ensembl chr  X:150,568,417...150,673,143
JBrowse link
G MTMR14 myotubularin related protein 14 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MTMR14 mRNA CTD PMID:25510870 NCBI chr 3:9,649,505...9,702,393
Ensembl chr 3:9,649,433...9,702,393
JBrowse link
G MX2 MX dynamin like GTPase 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MX2 mRNA CTD PMID:23829299 NCBI chr21:41,362,027...41,409,393
Ensembl chr21:41,361,999...41,409,393
JBrowse link
G MXD3 MAX dimerization protein 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MXD3 mRNA CTD PMID:25510870 NCBI chr 5:177,305,499...177,312,752
Ensembl chr 5:177,301,461...177,312,757
JBrowse link
G MYBL2 MYB proto-oncogene like 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYBL2 mRNA CTD PMID:25510870 NCBI chr20:43,667,114...43,716,482
Ensembl chr20:43,667,019...43,716,495
JBrowse link
G MYCN MYCN proto-oncogene, bHLH transcription factor multiple interactions
decreases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYCN mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MYCN mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 2:15,940,550...15,947,004
Ensembl chr 2:15,940,550...15,947,007
JBrowse link
G MYH13 myosin heavy chain 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MYH13 mRNA CTD PMID:25510870 NCBI chr17:10,300,865...10,373,006
Ensembl chr17:10,300,865...10,373,130
JBrowse link
G MYL4 myosin light chain 4 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MYL4 mRNA CTD PMID:23829299 NCBI chr17:47,189,433...47,227,650
Ensembl chr17:47,200,446...47,223,679
JBrowse link
G MYL7 myosin light chain 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MYL7 mRNA CTD PMID:25510870 NCBI chr 7:44,138,864...44,141,332
Ensembl chr 7:44,138,864...44,141,332
JBrowse link
G MYLK2 myosin light chain kinase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYLK2 mRNA CTD PMID:25510870 NCBI chr20:31,819,356...31,834,684
Ensembl chr20:31,819,308...31,834,689
JBrowse link
G MYO19 myosin XIX multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYO19 mRNA CTD PMID:25510870 NCBI chr17:36,495,636...36,544,815
Ensembl chr17:36,495,636...36,543,435
JBrowse link
G MYO1B myosin IB decreases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MYO1B mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYO1B mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 2:191,245,404...191,425,386
Ensembl chr 2:191,245,185...191,425,389
JBrowse link
G MYO1H myosin IH multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MYO1H mRNA CTD PMID:25510870 NCBI chr12:109,310,468...109,448,379
Ensembl chr12:109,347,900...109,455,523
JBrowse link
G MYRFL myelin regulatory factor like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MYRFL mRNA CTD PMID:25510870 NCBI chr12:69,825,227...69,959,097
Ensembl chr12:69,825,227...69,959,097
JBrowse link
G MYT1 myelin transcription factor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYT1 mRNA CTD PMID:25510870 NCBI chr20:64,164,452...64,242,253
Ensembl chr20:64,102,394...64,242,253
JBrowse link
G N4BP1 NEDD4 binding protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of N4BP1 mRNA CTD PMID:25510870 NCBI chr16:48,538,726...48,610,180
Ensembl chr16:48,538,726...48,620,148
JBrowse link
G NAB2 NGFI-A binding protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NAB2 mRNA CTD PMID:25510870 NCBI chr12:57,089,114...57,095,476
Ensembl chr12:57,089,043...57,095,476
JBrowse link
G NABP1 nucleic acid binding protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NABP1 mRNA CTD PMID:25510870 NCBI chr 2:191,678,136...191,686,943
Ensembl chr 2:191,678,068...191,741,097
JBrowse link
G NAGS N-acetylglutamate synthase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NAGS mRNA CTD PMID:25510870 NCBI chr17:44,004,622...44,009,068
Ensembl chr17:44,004,622...44,009,068
JBrowse link
G NALCN sodium leak channel, non-selective multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NALCN mRNA CTD PMID:25510870 NCBI chr13:101,053,776...101,417,179
Ensembl chr13:101,053,776...101,416,508
JBrowse link
G NALF2 NALCN channel auxiliary factor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NALF2 mRNA CTD PMID:25510870 NCBI chr  X:69,504,326...69,532,508
Ensembl chr  X:69,504,326...69,532,508
JBrowse link
G NANOS2 nanos C2HC-type zinc finger 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NANOS2 mRNA CTD PMID:25510870 NCBI chr19:45,913,214...45,914,778
Ensembl chr19:45,913,214...45,914,778
JBrowse link
G NAP1L5 nucleosome assembly protein 1 like 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NAP1L5 mRNA CTD PMID:25510870 NCBI chr 4:88,695,913...88,697,829
Ensembl chr 4:88,695,913...88,697,829
JBrowse link
G NAPA NSF attachment protein alpha decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NAPA protein CTD PMID:21673325 NCBI chr19:47,484,530...47,515,063
Ensembl chr19:47,487,637...47,515,091
JBrowse link
G NASP nuclear autoantigenic sperm protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NASP mRNA CTD PMID:25510870 NCBI chr 1:45,584,041...45,618,893
Ensembl chr 1:45,583,846...45,618,904
JBrowse link
G NAT8 N-acetyltransferase 8 (putative) multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NAT8 mRNA CTD PMID:25510870 NCBI chr 2:73,640,723...73,642,422
Ensembl chr 2:73,640,723...73,642,422
JBrowse link
G NAV2 neuron navigator 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NAV2 mRNA CTD PMID:25510870 NCBI chr11:19,345,236...20,121,601
Ensembl chr11:19,350,724...20,121,601
JBrowse link
G NBEA neurobeachin increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of NBEA mRNA CTD PMID:23829299 NCBI chr13:34,942,270...35,672,736
Ensembl chr13:34,942,270...35,673,022
JBrowse link
G NCAM1 neural cell adhesion molecule 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NCAM1 protein CTD PMID:21673325 NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436
JBrowse link
G NCAPD2 non-SMC condensin I complex subunit D2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NCAPD2 mRNA CTD PMID:25510870 NCBI chr12:6,494,102...6,531,955
Ensembl chr12:6,493,356...6,531,955
JBrowse link
G NCAPG non-SMC condensin I complex subunit G multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NCAPG mRNA CTD PMID:25510870 NCBI chr 4:17,810,979...17,844,865
Ensembl chr 4:17,810,979...17,844,865
JBrowse link
G NCAPG2 non-SMC condensin II complex subunit G2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NCAPG2 mRNA CTD PMID:25510870 NCBI chr 7:158,631,169...158,704,804
Ensembl chr 7:158,631,169...158,704,804
JBrowse link
G NCAPH non-SMC condensin I complex subunit H multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NCAPH mRNA CTD PMID:25510870 NCBI chr 2:96,335,766...96,377,091
Ensembl chr 2:96,335,766...96,377,091
JBrowse link
G NDUFA2 NADH:ubiquinone oxidoreductase subunit A2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NDUFA2 mRNA CTD PMID:25510870 NCBI chr 5:140,645,285...140,647,630
Ensembl chr 5:140,638,740...140,647,771
JBrowse link
G NDUFA7 NADH:ubiquinone oxidoreductase subunit A7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NDUFA7 mRNA CTD PMID:25510870 NCBI chr19:8,308,595...8,321,375
Ensembl chr19:8,308,768...8,321,375
JBrowse link
G NDUFC2 NADH:ubiquinone oxidoreductase subunit C2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NDUFC2 mRNA CTD PMID:23829299 NCBI chr11:78,068,297...78,079,862
Ensembl chr11:78,068,297...78,079,862
JBrowse link
G NDUFV3 NADH:ubiquinone oxidoreductase subunit V3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NDUFV3 mRNA CTD PMID:25510870 NCBI chr21:42,893,309...42,913,299
Ensembl chr21:42,879,644...42,913,304
JBrowse link
G NECAB1 N-terminal EF-hand calcium binding protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NECAB1 mRNA CTD PMID:25510870 NCBI chr 8:90,791,775...90,959,393
Ensembl chr 8:90,791,741...90,959,393
JBrowse link
G NECAB2 N-terminal EF-hand calcium binding protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NECAB2 mRNA CTD PMID:25510870 NCBI chr16:83,965,177...84,002,776
Ensembl chr16:83,968,244...84,002,776
JBrowse link
G NECTIN1 nectin cell adhesion molecule 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NECTIN1 mRNA CTD PMID:23829299 NCBI chr11:119,638,098...119,729,200
Ensembl chr11:119,623,408...119,729,200
JBrowse link
G NECTIN4 nectin cell adhesion molecule 4 decreases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NECTIN4 mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NECTIN4 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 1:161,070,998...161,089,558
Ensembl chr 1:161,070,998...161,089,558
JBrowse link
G NEDD4L NEDD4 like E3 ubiquitin protein ligase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NEDD4L mRNA CTD PMID:25510870 NCBI chr18:58,044,226...58,401,540
Ensembl chr18:58,044,226...58,401,540
JBrowse link
G NEFH neurofilament heavy chain decreases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NEFH protein
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NEFH mRNA
CTD PMID:21673325 PMID:25510870 NCBI chr22:29,480,218...29,491,390
Ensembl chr22:29,480,218...29,491,390
JBrowse link
G NEFL neurofilament light chain multiple interactions
decreases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NEFL mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NEFL protein
CTD PMID:21673325 PMID:25510870 NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
JBrowse link
G NEFM neurofilament medium chain decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NEFM protein CTD PMID:21673325 NCBI chr 8:24,913,761...24,919,093
Ensembl chr 8:24,913,758...24,919,098
JBrowse link
G NEIL3 nei like DNA glycosylase 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NEIL3 mRNA CTD PMID:25510870 NCBI chr 4:177,309,874...177,371,268
Ensembl chr 4:177,309,874...177,362,936
JBrowse link
G NEK2 NIMA related kinase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NEK2 mRNA CTD PMID:25510870 NCBI chr 1:211,658,256...211,675,621
Ensembl chr 1:211,658,657...211,675,630
JBrowse link
G NELL2 neural EGFL like 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NELL2 mRNA CTD PMID:25510870 NCBI chr12:44,508,275...44,921,848
Ensembl chr12:44,508,275...44,921,848
JBrowse link
G NEURL1 neuralized E3 ubiquitin protein ligase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NEURL1A mRNA CTD PMID:25510870 NCBI chr10:103,493,705...103,592,546
Ensembl chr10:103,493,705...103,592,546
JBrowse link
G NEUROD4 neuronal differentiation 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NEUROD4 mRNA CTD PMID:25510870 NCBI chr12:55,019,974...55,030,017
Ensembl chr12:55,019,974...55,030,017
JBrowse link
G NFIB nuclear factor I B decreases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NFIB mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NFIB mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 9:14,081,843...14,532,077
Ensembl chr 9:14,081,843...14,398,983
JBrowse link
G NFIX nuclear factor I X affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of NFIX mRNA CTD PMID:21703328 NCBI chr19:12,995,475...13,098,796
Ensembl chr19:12,995,475...13,098,796
JBrowse link
G NFYA nuclear transcription factor Y subunit alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NFYA mRNA CTD PMID:25510870 NCBI chr 6:41,072,974...41,102,403
Ensembl chr 6:41,072,974...41,102,403
JBrowse link
G NFYB nuclear transcription factor Y subunit beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NFYB mRNA CTD PMID:25510870 NCBI chr12:104,117,086...104,138,210
Ensembl chr12:104,117,086...104,138,241
JBrowse link
G NHLH1 nescient helix-loop-helix 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NHLH1 mRNA CTD PMID:25510870 NCBI chr 1:160,367,071...160,372,846
Ensembl chr 1:160,367,071...160,372,846
JBrowse link
G NHLH2 nescient helix-loop-helix 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NHLH2 mRNA CTD PMID:25510870 NCBI chr 1:115,831,344...115,841,126
Ensembl chr 1:115,836,377...115,843,917
JBrowse link
G NIBAN3 niban apoptosis regulator 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NIBAN3 mRNA CTD PMID:25510870 NCBI chr19:17,523,301...17,555,537
Ensembl chr19:17,523,301...17,553,839
JBrowse link
G NKAIN2 sodium/potassium transporting ATPase interacting 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NKAIN2 mRNA CTD PMID:25510870 NCBI chr 6:123,803,865...124,825,640
Ensembl chr 6:123,803,865...124,825,640
JBrowse link
G NKAP NFKB activating protein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NKAP mRNA CTD PMID:23829299 NCBI chr  X:119,920,672...119,943,751
Ensembl chr  X:119,920,672...119,943,751
JBrowse link
G NKD1 NKD inhibitor of WNT signaling pathway 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NKD1 mRNA CTD PMID:25510870 NCBI chr16:50,548,396...50,649,249
Ensembl chr16:50,548,396...50,649,249
JBrowse link
G NLRP2 NLR family pyrin domain containing 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NLRP2 mRNA CTD PMID:25510870 NCBI chr19:54,965,284...55,001,138
Ensembl chr19:54,953,130...55,001,142
JBrowse link
G NLRP5 NLR family pyrin domain containing 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NLRP5 mRNA CTD PMID:25510870 NCBI chr19:55,999,726...56,061,810
Ensembl chr19:55,999,726...56,061,810
JBrowse link
G NLRP9 NLR family pyrin domain containing 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NLRP9B mRNA CTD PMID:25510870 NCBI chr19:55,708,438...55,738,402
Ensembl chr19:55,708,438...55,738,402
JBrowse link
G NME2 NME/NM23 nucleoside diphosphate kinase 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NME2 protein CTD PMID:21673325 NCBI chr17:51,165,536...51,171,744
Ensembl chr17:51,165,435...51,171,744
JBrowse link
G NME4 NME/NM23 nucleoside diphosphate kinase 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NME4 mRNA CTD PMID:25510870 NCBI chr16:396,729...400,754
Ensembl chr16:396,725...410,367
JBrowse link
G NMNAT2 nicotinamide nucleotide adenylyltransferase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NMNAT2 mRNA CTD PMID:25510870 NCBI chr 1:183,248,237...183,418,380
Ensembl chr 1:183,248,237...183,418,380
JBrowse link
G NMS neuromedin S multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NMS mRNA CTD PMID:25510870 NCBI chr 2:100,470,482...100,483,280
Ensembl chr 2:100,470,482...100,483,280
JBrowse link
G NNT nicotinamide nucleotide transhydrogenase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NNT mRNA CTD PMID:25510870 NCBI chr 5:43,602,675...43,707,396
Ensembl chr 5:43,602,692...43,707,405
JBrowse link
G NOCT nocturnin decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NOCT mRNA CTD PMID:23829299 NCBI chr 4:139,015,781...139,045,939
Ensembl chr 4:139,015,781...139,045,939
JBrowse link
G NOL4 nucleolar protein 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NOL4 mRNA CTD PMID:25510870 NCBI chr18:33,851,100...34,224,913
Ensembl chr18:33,851,100...34,224,952
JBrowse link
G NOP58 NOP58 ribonucleoprotein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NOP58 mRNA CTD PMID:25510870 NCBI chr 2:202,265,763...202,303,661
Ensembl chr 2:202,265,736...202,303,661
JBrowse link
G NOTCH2 notch receptor 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NOTCH2 mRNA CTD PMID:23829299 NCBI chr 1:119,911,553...120,069,662
Ensembl chr 1:119,911,553...120,100,779
JBrowse link
G NOVA1 NOVA alternative splicing regulator 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NOVA1 mRNA CTD PMID:25510870 NCBI chr14:26,443,090...26,598,033
Ensembl chr14:26,443,090...26,598,033
JBrowse link
G NPIPA5 nuclear pore complex interacting protein family member A5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DEFB10 mRNA CTD PMID:25510870 NCBI chr16:15,363,624...15,381,646
Ensembl chr16:15,363,628...15,381,047
JBrowse link
G NPTX1 neuronal pentraxin 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NPTX1 mRNA CTD PMID:25510870 NCBI chr17:80,466,834...80,476,607
Ensembl chr17:80,466,834...80,477,843
JBrowse link
G NPY4R neuropeptide Y receptor Y4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NPY4R mRNA; [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NPY4R protein CTD PMID:25510870 NCBI chr10:46,461,099...46,470,668
Ensembl chr10:46,461,099...46,465,958
JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 multiple interactions
increases activity
increases expression
EXP
ISO
2,2',3',4,4',5-hexachlorobiphenyl binds to and results in increased activity of NR1I2 protein
2,2',3',4,4',5-hexachlorobiphenyl results in increased activity of NR1I2 protein
NR1I2 gene mutant form inhibits the reaction [2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CYP2B1 protein]; NR1I2 gene mutant form promotes the reaction [2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CYP2B1 mRNA]
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of NR1I2 mRNA
CTD PMID:20024649 PMID:22664347 PMID:23770461 PMID:24812009 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 multiple interactions
increases expression
increases activity
ISO
EXP
NR1I3 gene mutant form inhibits the reaction [2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CYP2B1 mRNA]; NR1I3 gene mutant form inhibits the reaction [2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CYP2B1 protein]; NR1I3 gene mutant form inhibits the reaction [2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of CYP3A23-3A1 mRNA]
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of NR1I3 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in increased activity of NR1I3 protein
CTD PMID:23770461 PMID:26231822 NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
JBrowse link
G NR3C2 nuclear receptor subfamily 3 group C member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NR3C2 mRNA CTD PMID:25510870 NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
JBrowse link
G NR4A2 nuclear receptor subfamily 4 group A member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NR4A2 mRNA CTD PMID:25510870 NCBI chr 2:156,324,437...156,332,721
Ensembl chr 2:156,324,437...156,342,348
JBrowse link
G NR4A3 nuclear receptor subfamily 4 group A member 3 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of NR4A3 mRNA CTD PMID:23829299 NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891
JBrowse link
G NRG1 neuregulin 1 affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of NRG1 mRNA CTD PMID:21703328 NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666
JBrowse link
G NRG3 neuregulin 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NRG3 mRNA CTD PMID:25510870 NCBI chr10:81,875,194...82,987,179
Ensembl chr10:81,875,194...82,987,179
JBrowse link
G NRK Nik related kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NRK mRNA CTD PMID:25510870 NCBI chr  X:105,821,786...105,958,610
Ensembl chr  X:105,822,539...105,958,610
JBrowse link
G NRSN1 neurensin 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of NRSN1 mRNA CTD PMID:23829299 NCBI chr 6:24,126,215...24,147,530
Ensembl chr 6:24,126,186...24,154,900
JBrowse link
G NRXN3 neurexin 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NRXN3 mRNA CTD PMID:25510870 NCBI chr14:78,170,373...79,868,291
Ensembl chr14:78,170,373...79,868,291
JBrowse link
G NSD2 nuclear receptor binding SET domain protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NSD2 mRNA CTD PMID:25510870 NCBI chr 4:1,871,393...1,982,192
Ensembl chr 4:1,871,393...1,982,207
JBrowse link
G NSF N-ethylmaleimide sensitive factor, vesicle fusing ATPase increases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of NSF mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NSF mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr17:46,590,669...46,757,464
Ensembl chr17:46,590,669...46,757,679
JBrowse link
G NSL1 NSL1 component of MIS12 kinetochore complex multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NSL1 mRNA CTD PMID:25510870 NCBI chr 1:212,726,153...212,791,777
Ensembl chr 1:212,726,153...212,791,782
JBrowse link
G NTM neurotrimin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NTM mRNA CTD PMID:25510870 NCBI chr11:131,370,615...132,336,822
Ensembl chr11:131,370,478...132,336,822
JBrowse link
G NTSR1 neurotensin receptor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NTSR1 mRNA CTD PMID:25510870 NCBI chr20:62,708,836...62,762,771
Ensembl chr20:62,708,836...62,762,771
JBrowse link
G NUDT5 nudix hydrolase 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NUDT5 mRNA CTD PMID:23829299 NCBI chr10:12,165,330...12,195,891
Ensembl chr10:12,165,330...12,195,891
JBrowse link
G NUF2 NUF2 component of NDC80 kinetochore complex multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUF2 mRNA CTD PMID:25510870 NCBI chr 1:163,321,954...163,355,759
Ensembl chr 1:163,266,576...163,355,764
JBrowse link
G NUMB NUMB endocytic adaptor protein increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of NUMB mRNA CTD PMID:23829299 NCBI chr14:73,275,216...73,458,546
Ensembl chr14:73,275,107...73,458,617
JBrowse link
G NUP155 nucleoporin 155 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUP155 mRNA CTD PMID:25510870 NCBI chr 5:37,288,137...37,371,106
Ensembl chr 5:37,288,137...37,371,106
JBrowse link
G NUP205 nucleoporin 205 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUP205 mRNA CTD PMID:25510870 NCBI chr 7:135,557,917...135,648,753
Ensembl chr 7:135,557,917...135,648,757
JBrowse link
G NUP37 nucleoporin 37 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUP37 mRNA CTD PMID:25510870 NCBI chr12:102,073,103...102,120,114
Ensembl chr12:102,073,103...102,120,120
JBrowse link
G NUP93 nucleoporin 93 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NUP93 mRNA CTD PMID:25510870 NCBI chr16:56,730,129...56,850,286
Ensembl chr16:56,730,118...56,850,286
JBrowse link
G NUPR2 nuclear protein 2, transcriptional regulator multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NUPR2 mRNA CTD PMID:25510870 NCBI chr 7:56,114,681...56,116,417
Ensembl chr 7:56,114,681...56,116,417
JBrowse link
G NUSAP1 nucleolar and spindle associated protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUSAP1 mRNA CTD PMID:25510870 NCBI chr15:41,332,881...41,381,046
Ensembl chr15:41,320,794...41,381,050
JBrowse link
G NWD2 NACHT and WD repeat domain containing 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NWD2 mRNA CTD PMID:25510870 NCBI chr 4:37,244,743...37,449,463
Ensembl chr 4:37,244,743...37,449,463
JBrowse link
G NXNL1 nucleoredoxin like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NXNL1 mRNA CTD PMID:25510870 NCBI chr19:17,455,425...17,460,926
Ensembl chr19:17,455,425...17,460,926
JBrowse link
G NXPE3 neurexophilin and PC-esterase domain family member 3 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of NXPE3 mRNA CTD PMID:23829299 NCBI chr 3:101,779,211...101,828,231
Ensembl chr 3:101,779,177...101,843,743
JBrowse link
G NXPH3 neurexophilin 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of NXPH3 mRNA CTD PMID:23829299 NCBI chr17:49,575,871...49,583,827
Ensembl chr17:49,575,871...49,583,827
JBrowse link
G NYAP2 neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NYAP2 mRNA CTD PMID:25510870 NCBI chr 2:225,397,939...225,703,654
Ensembl chr 2:225,399,710...225,729,887
JBrowse link
G OBI1 ORC ubiquitin ligase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OBI1 mRNA CTD PMID:25510870 NCBI chr13:78,614,289...78,659,155
Ensembl chr13:78,614,289...78,659,155
JBrowse link
G ODF2L outer dense fiber of sperm tails 2 like decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ODF2L mRNA CTD PMID:23829299 NCBI chr 1:86,346,837...86,396,323
Ensembl chr 1:86,346,824...86,396,342
JBrowse link
G OGDHL oxoglutarate dehydrogenase L multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OGDHL mRNA CTD PMID:25510870 NCBI chr10:49,734,641...49,762,379
Ensembl chr10:49,734,641...49,762,379
JBrowse link
G OGT O-linked N-acetylglucosamine (GlcNAc) transferase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OGT mRNA CTD PMID:25510870 NCBI chr  X:71,533,104...71,575,892
Ensembl chr  X:71,533,087...71,575,892
JBrowse link
G OIP5 Opa interacting protein 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OIP5 mRNA CTD PMID:25510870 NCBI chr15:41,309,273...41,332,591
Ensembl chr15:41,309,273...41,332,591
JBrowse link
G OLFML3 olfactomedin like 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OLFML3 mRNA CTD PMID:25510870 NCBI chr 1:113,979,474...113,982,253
Ensembl chr 1:113,979,391...114,035,572
JBrowse link
G OLIG3 oligodendrocyte transcription factor 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OLIG3 mRNA CTD PMID:25510870 NCBI chr 6:137,492,199...137,494,394
Ensembl chr 6:137,492,199...137,494,394
JBrowse link
G OMG oligodendrocyte myelin glycoprotein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OMG mRNA CTD PMID:25510870 NCBI chr17:31,294,647...31,297,239
Ensembl chr17:31,272,013...31,297,539
JBrowse link
G OPCML opioid binding protein/cell adhesion molecule like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OPCML mRNA CTD PMID:25510870 NCBI chr11:132,414,981...133,532,501
Ensembl chr11:132,414,977...133,532,501
JBrowse link
G OPRM1 opioid receptor mu 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OPRM1 mRNA CTD PMID:25510870 NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867
JBrowse link
G OR10C1 olfactory receptor family 10 subfamily C member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR10C1 mRNA CTD PMID:25510870 NCBI chr 6:29,439,306...29,440,977
Ensembl chr 6:29,439,306...29,440,977
JBrowse link
G OR10S1 olfactory receptor family 10 subfamily S member 1 multiple interactions
decreases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR10S1 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of OR10S1 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr11:123,976,661...123,977,781
Ensembl chr11:123,976,661...123,977,781
JBrowse link
G OR1F1 olfactory receptor family 1 subfamily F member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OR1F19 mRNA CTD PMID:25510870 NCBI chr16:3,188,204...3,206,556
Ensembl chr16:3,188,204...3,224,779
JBrowse link
G OR1L8 olfactory receptor family 1 subfamily L member 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR1L8 mRNA CTD PMID:25510870 NCBI chr 9:122,546,271...122,583,384
Ensembl chr 9:122,567,117...122,583,384
JBrowse link
G OR2A25 olfactory receptor family 2 subfamily A member 25 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR2A25 mRNA CTD PMID:25510870 NCBI chr 7:144,069,811...144,075,870
Ensembl chr 7:144,069,811...144,075,870
JBrowse link
G OR2AG1 olfactory receptor family 2 subfamily AG member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] affects the expression of OR2AG1 mRNA CTD PMID:25510870 NCBI chr11:6,783,020...6,791,558
Ensembl chr11:6,783,020...6,791,558
JBrowse link
G OR2AG2 olfactory receptor family 2 subfamily AG member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR2AG2B mRNA CTD PMID:25510870 NCBI chr11:6,765,626...6,771,976
Ensembl chr11:6,765,626...6,771,976
JBrowse link
G OR2K2 olfactory receptor family 2 subfamily K member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR2K2 mRNA CTD PMID:25510870 NCBI chr 9:111,327,229...111,330,224
Ensembl chr 9:111,327,229...111,330,224
JBrowse link
G OR2Z1 olfactory receptor family 2 subfamily Z member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR2Z9 mRNA CTD PMID:25510870 NCBI chr19:8,721,634...8,732,160
Ensembl chr19:8,721,634...8,732,160
JBrowse link
G OR3A1 olfactory receptor family 3 subfamily A member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR3A1C mRNA CTD PMID:25510870 NCBI chr17:3,291,017...3,298,360
Ensembl chr17:3,291,017...3,298,360
JBrowse link
G OR4C3 olfactory receptor family 4 subfamily C member 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR4C3 mRNA CTD PMID:25510870 NCBI chr11:48,324,920...48,325,955
Ensembl chr11:48,324,920...48,325,955
JBrowse link
G OR4D2 olfactory receptor family 4 subfamily D member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR4D2 mRNA CTD PMID:25510870 NCBI chr17:58,166,982...58,171,116
Ensembl chr17:58,166,982...58,171,411
JBrowse link
G OR51H1 olfactory receptor family 51 subfamily H member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR51H1 mRNA CTD PMID:25510870 NCBI chr11:4,859,617...4,863,652
Ensembl chr11:4,859,617...4,860,564
Ensembl chr11:4,859,617...4,860,564
JBrowse link
G OR5A1 olfactory receptor family 5 subfamily A member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR5A1 mRNA CTD PMID:25510870 NCBI chr11:59,436,469...59,451,380
Ensembl chr11:59,436,469...59,451,380
JBrowse link
G OR5AC2 olfactory receptor family 5 subfamily AC member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR5AC16 mRNA CTD PMID:25510870 NCBI chr 3:98,087,173...98,088,102
Ensembl chr 3:98,087,173...98,088,102
JBrowse link
G OR5D13 olfactory receptor family 5 subfamily D member 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR5D43 mRNA CTD PMID:25510870 NCBI chr11:55,773,438...55,774,382
Ensembl chr11:55,773,438...55,774,382
JBrowse link
G OR5V1 olfactory receptor family 5 subfamily V member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR5V1B mRNA CTD PMID:25510870 NCBI chr 6:29,353,749...29,368,865
Ensembl chr 6:29,353,749...29,431,967
JBrowse link
G OR6A2 olfactory receptor family 6 subfamily A member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR6A2 mRNA CTD PMID:25510870 NCBI chr11:6,791,736...6,799,689
Ensembl chr11:6,791,736...6,799,689
JBrowse link
G OR6F1 olfactory receptor family 6 subfamily F member 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of OR6F1 mRNA CTD PMID:23829299 NCBI chr 1:247,711,436...247,716,646
Ensembl chr 1:247,711,436...247,716,646
JBrowse link
G OR6Q1 olfactory receptor family 6 subfamily Q member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR6AE1 mRNA CTD PMID:25510870 NCBI chr11:58,030,953...58,031,906
Ensembl chr11:58,030,953...58,031,906
JBrowse link
G OR6Y1 olfactory receptor family 6 subfamily Y member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR6Y1 mRNA CTD PMID:25510870 NCBI chr 1:158,544,550...158,554,405
Ensembl chr 1:158,544,550...158,554,405
JBrowse link
G OR8B12 olfactory receptor family 8 subfamily B member 12 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR8B12 mRNA CTD PMID:25510870 NCBI chr11:124,542,722...124,543,654
Ensembl chr11:124,539,635...124,545,333
JBrowse link
G OR8K5 olfactory receptor family 8 subfamily K member 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR8K18 mRNA CTD PMID:25510870 NCBI chr11:56,159,394...56,160,317
Ensembl chr11:56,159,394...56,160,317
JBrowse link
G OR9H1P olfactory receptor family 9 subfamily H member 1 pseudogene decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of OR9S18 mRNA CTD PMID:23829299 NCBI chr 1:247,770,169...247,779,524
Ensembl chr 1:247,770,169...247,779,524
JBrowse link
G ORM1 orosomucoid 1 affects expression
multiple interactions
EXP
ISO
2,2',3',4,4',5-hexachlorobiphenyl affects the expression of ORM1 mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ORM1 mRNA
CTD PMID:21703328 PMID:25510870 NCBI chr 9:114,323,098...114,326,479
Ensembl chr 9:114,323,098...114,326,479
JBrowse link
G OTOG otogelin decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of OTOG mRNA CTD PMID:23829299 NCBI chr11:17,547,259...17,646,044
Ensembl chr11:17,547,259...17,647,150
JBrowse link
G OTUD4 OTU deubiquitinase 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OTUD4 mRNA CTD PMID:25510870 NCBI chr 4:145,133,650...145,180,589
Ensembl chr 4:145,110,838...145,180,589
JBrowse link
G OTUD7B OTU deubiquitinase 7B increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of OTUD7B mRNA CTD PMID:23829299 NCBI chr 1:149,937,812...150,067,653
Ensembl chr 1:149,937,812...150,010,726
JBrowse link
G OTX1 orthodenticle homeobox 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OTX1 mRNA CTD PMID:25510870 NCBI chr 2:63,049,735...63,057,831
Ensembl chr 2:63,050,057...63,057,836
JBrowse link
G OVGP1 oviductal glycoprotein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OVGP1 mRNA CTD PMID:25510870 NCBI chr 1:111,414,319...111,427,735
Ensembl chr 1:111,414,319...111,427,735
JBrowse link
G OXLD1 oxidoreductase like domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OXLD1 mRNA CTD PMID:25510870 NCBI chr17:81,665,036...81,666,605
Ensembl chr17:81,665,036...81,666,635
JBrowse link
G PABPC3 poly(A) binding protein cytoplasmic 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PABPC6 mRNA CTD PMID:25510870 NCBI chr13:25,096,136...25,099,254
Ensembl chr13:25,096,136...25,099,254
JBrowse link
G PADI4 peptidyl arginine deiminase 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PADI4 mRNA CTD PMID:25510870 NCBI chr 1:17,308,197...17,364,004
Ensembl chr 1:17,308,195...17,364,004
JBrowse link
G PADI6 peptidyl arginine deiminase 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PADI6 mRNA CTD PMID:25510870 NCBI chr 1:17,372,196...17,401,699
Ensembl chr 1:17,372,196...17,401,699
JBrowse link
G PAFAH1B2 platelet activating factor acetylhydrolase 1b catalytic subunit 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PAFAH1B2 protein CTD PMID:21673325 NCBI chr11:117,144,287...117,178,173
Ensembl chr11:117,144,284...117,176,894
JBrowse link
G PAK6 p21 (RAC1) activated kinase 6 affects expression ISO 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of PAK6 mRNA CTD PMID:23829299 NCBI chr15:40,239,063...40,277,487
Ensembl chr15:40,217,428...40,277,487
JBrowse link
G PALB2 partner and localizer of BRCA2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PALB2 mRNA CTD PMID:25510870 NCBI chr16:23,603,165...23,641,310
Ensembl chr16:23,603,160...23,641,321
JBrowse link
G PAM16 presequence translocase associated motor 16 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PAM16 mRNA CTD PMID:23829299 NCBI chr16:4,340,251...4,351,321
Ensembl chr16:4,331,549...4,355,607
JBrowse link
G PAPLN papilin, proteoglycan like sulfated glycoprotein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PAPLN mRNA CTD PMID:25510870 NCBI chr14:73,235,805...73,274,623
Ensembl chr14:73,237,497...73,274,640
JBrowse link
G PAPOLB poly(A) polymerase beta decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PAPOLB mRNA CTD PMID:23829299 NCBI chr 7:4,857,738...4,862,030
Ensembl chr 7:4,857,738...4,862,030
JBrowse link
G PAQR9 progestin and adipoQ receptor family member 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PAQR9 mRNA CTD PMID:25510870 NCBI chr 3:142,949,164...142,964,008
Ensembl chr 3:142,949,164...142,963,674
JBrowse link
G PARM1 prostate androgen-regulated mucin-like protein 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PARM1 mRNA CTD PMID:23829299 NCBI chr 4:74,933,116...75,050,113
Ensembl chr 4:74,933,095...75,050,115
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 multiple interactions ISO 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased cleavage of PARP1 protein] CTD PMID:29704545 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
JBrowse link
G PARP14 poly(ADP-ribose) polymerase family member 14 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PARP14 mRNA CTD PMID:25510870 NCBI chr 3:122,680,839...122,730,840
Ensembl chr 3:122,680,839...122,730,840
JBrowse link
G PARPBP PARP1 binding protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PARPBP mRNA CTD PMID:25510870 NCBI chr12:102,120,183...102,197,520
Ensembl chr12:102,120,183...102,197,520
JBrowse link
G PARVA parvin alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PARVA mRNA CTD PMID:25510870 NCBI chr11:12,376,436...12,535,356
Ensembl chr11:12,377,563...12,535,356
JBrowse link
G PASK PAS domain containing serine/threonine kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PASK mRNA CTD PMID:25510870 NCBI chr 2:241,106,099...241,150,347
Ensembl chr 2:241,106,099...241,150,264
JBrowse link
G PBK PDZ binding kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PBK mRNA CTD PMID:25510870 NCBI chr 8:27,809,624...27,837,817
Ensembl chr 8:27,809,624...27,838,082
JBrowse link
G PBRM1 polybromo 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PBRM1 mRNA CTD PMID:25510870 NCBI chr 3:52,545,367...52,685,913
Ensembl chr 3:52,545,352...52,685,917
JBrowse link
G PBX1 PBX homeobox 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PBX1 mRNA CTD PMID:25510870 NCBI chr 1:164,559,184...164,886,047
Ensembl chr 1:164,555,584...164,899,296
JBrowse link
G PC pyruvate carboxylase decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PC protein CTD PMID:21673325 NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386
JBrowse link
G PCDH11X protocadherin 11 X-linked multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCDH11X mRNA CTD PMID:25510870 NCBI chr  X:91,779,375...92,623,230
Ensembl chr  X:91,779,261...92,623,230
JBrowse link
G PCDH9 protocadherin 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCDH9 mRNA CTD PMID:25510870 NCBI chr13:66,302,834...67,230,336
Ensembl chr13:66,302,834...67,230,445
JBrowse link
G PCDHA9 protocadherin alpha 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PCDHA8 mRNA CTD PMID:25510870 NCBI chr 5:140,847,772...141,012,347
Ensembl chr 5:140,847,772...141,012,347
JBrowse link
G PCDHB16 protocadherin beta 16 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PCDHB16 mRNA; [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PCDHB17 mRNA CTD PMID:25510870 NCBI chr 5:141,182,387...141,186,226
Ensembl chr 5:141,182,387...141,186,226
JBrowse link
G PCDHB18P protocadherin beta 18 pseudogene multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PCDHB21 mRNA CTD PMID:25510870 NCBI chr 5:141,234,333...141,237,529
Ensembl chr 5:141,234,333...141,237,529
Ensembl chr 5:141,234,333...141,237,529
JBrowse link
G PCNP PEST proteolytic signal containing nuclear protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCNP mRNA CTD PMID:25510870 NCBI chr 3:101,574,094...101,594,465
Ensembl chr 3:101,574,180...101,594,465
JBrowse link
G PCP2 Purkinje cell protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCP2 mRNA CTD PMID:25510870 NCBI chr19:7,631,615...7,637,006
Ensembl chr19:7,631,611...7,633,719
JBrowse link
G PCSK1N proprotein convertase subtilisin/kexin type 1 inhibitor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCSK1N mRNA CTD PMID:25510870 NCBI chr  X:48,831,096...48,835,610
Ensembl chr  X:48,831,096...48,835,610
JBrowse link
G PCSK4 proprotein convertase subtilisin/kexin type 4 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PCSK4 mRNA CTD PMID:23829299 NCBI chr19:1,481,428...1,490,876
Ensembl chr19:1,481,428...1,490,752
JBrowse link
G PCSK9 proprotein convertase subtilisin/kexin type 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PCSK9 mRNA CTD PMID:25510870 NCBI chr 1:55,039,548...55,064,852
Ensembl chr 1:55,039,445...55,064,852
JBrowse link
G PCYT1A phosphate cytidylyltransferase 1A, choline decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PCYT1A mRNA CTD PMID:23829299 NCBI chr 3:196,234,368...196,287,726
Ensembl chr 3:196,214,222...196,287,957
JBrowse link
G PDCL3 phosducin like 3 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PDCL3 mRNA CTD PMID:23829299 NCBI chr 2:100,562,993...100,576,739
Ensembl chr 2:100,562,993...100,576,739
JBrowse link
G PDE1C phosphodiesterase 1C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PDE1C mRNA CTD PMID:25510870 NCBI chr 7:31,616,777...32,428,224
Ensembl chr 7:31,751,179...32,428,131
JBrowse link
G PDE4B phosphodiesterase 4B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PDE4B mRNA CTD PMID:25510870 NCBI chr 1:65,792,510...66,374,579
Ensembl chr 1:65,792,514...66,374,579
JBrowse link
G PDE4DIP phosphodiesterase 4D interacting protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PDE4DIP mRNA CTD PMID:25510870 NCBI chr 1:148,808,434...149,033,016
Ensembl chr 1:148,808,140...149,048,286
JBrowse link
G PDE5A phosphodiesterase 5A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PDE5A mRNA CTD PMID:25510870 NCBI chr 4:119,494,403...119,628,804
Ensembl chr 4:119,494,397...119,628,804
JBrowse link
G PDE6H phosphodiesterase 6H multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PDE6H mRNA CTD PMID:25510870 NCBI chr12:14,973,042...14,981,865
Ensembl chr12:14,973,042...14,981,865
JBrowse link
G PDE7A phosphodiesterase 7A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PDE7A mRNA CTD PMID:25510870 NCBI chr 8:65,714,334...65,842,064
Ensembl chr 8:65,714,334...65,842,322
JBrowse link
G PDE7B phosphodiesterase 7B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PDE7B mRNA CTD PMID:25510870 NCBI chr 6:135,851,701...136,195,574
Ensembl chr 6:135,851,701...136,195,574
JBrowse link
G PDGFRA platelet derived growth factor receptor alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PDGFRA mRNA CTD PMID:25510870 NCBI chr 4:54,229,293...54,298,245
Ensembl chr 4:54,229,280...54,298,245
JBrowse link
G PDHA1 pyruvate dehydrogenase E1 subunit alpha 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PDHA1 protein CTD PMID:21673325 NCBI chr  X:19,343,927...19,361,718
Ensembl chr  X:19,343,893...19,361,718
JBrowse link
G PDLIM2 PDZ and LIM domain 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PDLIM2 mRNA CTD PMID:25510870 NCBI chr 8:22,578,741...22,598,026
Ensembl chr 8:22,578,279...22,598,025
JBrowse link
G PDP2 pyruvate dehydrogenase phosphatase catalytic subunit 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PDP2 mRNA CTD PMID:25510870 NCBI chr16:66,880,515...66,891,101
Ensembl chr16:66,878,589...66,895,754
JBrowse link
G PDXK pyridoxal kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PDXK mRNA CTD PMID:25510870 NCBI chr21:43,737,000...43,738,097
Ensembl chr21:43,719,094...43,762,307
JBrowse link
G PDZD9 PDZ domain containing 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PDZD9 mRNA CTD PMID:25510870 NCBI chr16:21,957,540...22,001,116
Ensembl chr16:21,983,865...22,001,116
JBrowse link
G PENK proenkephalin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PENK mRNA CTD PMID:25510870 NCBI chr 8:56,440,957...56,446,641
Ensembl chr 8:56,436,674...56,446,671
JBrowse link
G PEX5L peroxisomal biogenesis factor 5 like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PEX5L mRNA CTD PMID:25510870 NCBI chr 3:179,794,958...180,036,937
Ensembl chr 3:179,794,958...180,037,053
JBrowse link
G PFDN5 prefoldin subunit 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PFDN5 mRNA CTD PMID:25510870 NCBI chr12:53,295,542...53,299,450
Ensembl chr12:53,295,291...53,299,452
JBrowse link
G PFKFB1 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PFKFB1 mRNA CTD PMID:25510870 NCBI chr  X:54,932,961...54,998,789
Ensembl chr  X:54,932,961...54,998,534
JBrowse link
G PFKP phosphofructokinase, platelet multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PFKP mRNA CTD PMID:25510870 NCBI chr10:3,067,548...3,136,805
Ensembl chr10:3,066,333...3,137,718
JBrowse link
G PGC progastricsin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PGC mRNA CTD PMID:25510870 NCBI chr 6:41,736,711...41,747,397
Ensembl chr 6:41,736,711...41,754,109
JBrowse link
G PGM5 phosphoglucomutase 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PGM5 mRNA CTD PMID:23829299 NCBI chr 9:68,356,611...68,531,061
Ensembl chr 9:68,328,308...68,531,061
JBrowse link
G PGR progesterone receptor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PGR mRNA CTD PMID:25510870 NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
JBrowse link
G PHB2 prohibitin 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PHB2 protein CTD PMID:21673325 NCBI chr12:6,965,327...6,970,753
Ensembl chr12:6,965,327...6,970,780
JBrowse link
G PHF20L1 PHD finger protein 20 like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PHF20L1 mRNA CTD PMID:25510870 NCBI chr 8:132,775,388...132,848,807
Ensembl chr 8:132,775,358...132,848,807
JBrowse link
G PHF6 PHD finger protein 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PHF6 mRNA CTD PMID:25510870 NCBI chr  X:134,373,312...134,428,790
Ensembl chr  X:134,373,288...134,428,791
JBrowse link
G PHF7 PHD finger protein 7 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PHF7 mRNA CTD PMID:23829299 NCBI chr 3:52,410,660...52,423,641
Ensembl chr 3:52,410,660...52,423,641
JBrowse link
G PHIP pleckstrin homology domain interacting protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PHIP mRNA CTD PMID:25510870 NCBI chr 6:78,934,419...79,078,254
Ensembl chr 6:78,934,419...79,078,287
JBrowse link
G PHLDB3 pleckstrin homology like domain family B member 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PHLDB3 mRNA CTD PMID:25510870 NCBI chr19:43,475,103...43,504,746
Ensembl chr19:43,474,954...43,504,935
JBrowse link
G PHYHIP phytanoyl-CoA 2-hydroxylase interacting protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PHYHIP mRNA CTD PMID:25510870 NCBI chr 8:22,219,703...22,232,099
Ensembl chr 8:22,219,703...22,232,101
JBrowse link
G PIANP PILR alpha associated neural protein increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PIANP mRNA CTD PMID:23829299 NCBI chr12:6,692,178...6,700,815
Ensembl chr12:6,693,791...6,700,815
JBrowse link
G PIDD1 p53-induced death domain protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PIDD1 mRNA CTD PMID:25510870 NCBI chr11:799,184...809,501
Ensembl chr11:799,179...809,753
JBrowse link
G PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PIK3CG mRNA CTD PMID:25510870 NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
JBrowse link
G PILRB paired immunoglobin like type 2 receptor beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PILRB2 mRNA CTD PMID:25510870 NCBI chr 7:100,358,117...100,367,831
Ensembl chr 7:100,352,176...100,367,831
JBrowse link
G PIMREG PICALM interacting mitotic regulator multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PIMREG mRNA CTD PMID:25510870 NCBI chr17:6,444,455...6,451,469
Ensembl chr17:6,444,441...6,451,469
JBrowse link
G PIP5K1C phosphatidylinositol-4-phosphate 5-kinase type 1 gamma multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PIP5K1C mRNA CTD PMID:25510870 NCBI chr19:3,630,183...3,700,468
Ensembl chr19:3,630,183...3,700,468
JBrowse link
G PITPNM1 phosphatidylinositol transfer protein membrane associated 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PITPNM1 mRNA CTD PMID:25510870 NCBI chr11:67,491,768...67,506,266
Ensembl chr11:67,491,768...67,506,263
JBrowse link
G PJVK pejvakin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PJVK mRNA CTD PMID:25510870 NCBI chr 2:178,451,378...178,462,102
Ensembl chr 2:178,451,346...178,462,102
JBrowse link
G PKIG cAMP-dependent protein kinase inhibitor gamma decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PKIG mRNA CTD PMID:23829299 NCBI chr20:44,531,875...44,619,037
Ensembl chr20:44,531,785...44,624,247
JBrowse link
G PKLR pyruvate kinase L/R decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PKLR mRNA CTD PMID:23829299 NCBI chr 1:155,289,293...155,308,654
Ensembl chr 1:155,289,293...155,301,438
JBrowse link
G PKM pyruvate kinase M1/2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PKM protein CTD PMID:21673325 NCBI chr15:72,199,029...72,231,591
Ensembl chr15:72,199,029...72,231,819
JBrowse link
G PLA2G2E phospholipase A2 group IIE multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLA2G2E mRNA CTD PMID:25510870 NCBI chr 1:19,920,009...19,923,617
Ensembl chr 1:19,920,009...19,923,617
JBrowse link
G PLA2G5 phospholipase A2 group V decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PLA2G5 mRNA CTD PMID:23829299 NCBI chr 1:20,028,408...20,091,911
Ensembl chr 1:20,028,179...20,091,911
JBrowse link
G PLAA phospholipase A2 activating protein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PLAA mRNA CTD PMID:23829299 NCBI chr 9:26,903,372...26,947,242
Ensembl chr 9:26,903,372...26,947,242
JBrowse link
G PLAGL1 PLAG1 like zinc finger 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLAGL1 mRNA CTD PMID:25510870 NCBI chr 6:143,940,300...144,064,599
Ensembl chr 6:143,940,300...144,064,599
JBrowse link
G PLCB4 phospholipase C beta 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLCB4 mRNA CTD PMID:25510870 NCBI chr20:9,068,678...9,480,808
Ensembl chr20:9,067,825...9,504,593
JBrowse link
G PLCD3 phospholipase C delta 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLCD3 mRNA CTD PMID:25510870 NCBI chr17:45,108,959...45,132,515
Ensembl chr17:45,108,959...45,133,354
JBrowse link
G PLCG1 phospholipase C gamma 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLCG1 mRNA CTD PMID:25510870 NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801
JBrowse link
G PLCH2 phospholipase C eta 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLCH2 mRNA CTD PMID:25510870 NCBI chr 1:2,415,943...2,505,532
Ensembl chr 1:2,425,980...2,505,532
JBrowse link
G PLCXD3 phosphatidylinositol specific phospholipase C X domain containing 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLCXD3 mRNA CTD PMID:25510870 NCBI chr 5:41,306,952...41,510,601
Ensembl chr 5:41,306,952...41,510,601
JBrowse link
G PLEKHA1 pleckstrin homology domain containing A1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLEKHA1 mRNA CTD PMID:25510870 NCBI chr10:122,374,708...122,442,600
Ensembl chr10:122,374,696...122,432,354
JBrowse link
G PLEKHA6 pleckstrin homology domain containing A6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLEKHA6 mRNA CTD PMID:25510870 NCBI chr 1:204,218,853...204,378,168
Ensembl chr 1:204,218,853...204,378,214
JBrowse link
G PLEKHB1 pleckstrin homology domain containing B1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLEKHB1 mRNA CTD PMID:25510870 NCBI chr11:73,646,581...73,662,819
Ensembl chr11:73,646,178...73,662,819
JBrowse link
G PLEKHD1 pleckstrin homology and coiled-coil domain containing D1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLEKHD1 mRNA CTD PMID:25510870 NCBI chr14:69,467,744...69,531,551
Ensembl chr14:69,484,692...69,531,551
JBrowse link
G PLEKHG3 pleckstrin homology and RhoGEF domain containing G3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PLEKHG3 mRNA CTD PMID:23829299 NCBI chr14:64,704,424...64,750,249
Ensembl chr14:64,704,102...64,750,249
JBrowse link
G PLEKHG6 pleckstrin homology and RhoGEF domain containing G6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLEKHG6 mRNA CTD PMID:25510870 NCBI chr12:6,310,332...6,328,506
Ensembl chr12:6,310,436...6,328,506
JBrowse link
G PLEKHM2 pleckstrin homology and RUN domain containing M2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PLEKHM2 mRNA CTD PMID:23829299 NCBI chr 1:15,681,506...15,734,769
Ensembl chr 1:15,684,320...15,734,769
JBrowse link
G PLIN1 perilipin 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PLIN1 protein CTD PMID:29704545 NCBI chr15:89,664,367...89,679,367
Ensembl chr15:89,664,367...89,679,427
JBrowse link
G PLK1 polo like kinase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLK1 mRNA CTD PMID:25510870 NCBI chr16:23,678,889...23,690,367
Ensembl chr16:23,677,656...23,690,367
JBrowse link
G PLN phospholamban multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PLN mRNA CTD PMID:25510870 NCBI chr 6:118,548,296...118,561,716
Ensembl chr 6:118,548,296...118,561,716
JBrowse link
G PLP1 proteolipid protein 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PLP1 protein CTD PMID:21673325 NCBI chr  X:103,776,506...103,792,619
Ensembl chr  X:103,773,718...103,792,619
JBrowse link
G PLPBP pyridoxal phosphate binding protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLPBP mRNA CTD PMID:25510870 NCBI chr 8:37,762,546...37,779,768
Ensembl chr 8:37,762,595...37,779,768
JBrowse link
G PLPPR1 phospholipid phosphatase related 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLPPR1 mRNA CTD PMID:25510870 NCBI chr 9:101,028,727...101,325,135
Ensembl chr 9:101,028,727...101,325,135
JBrowse link
G PLPPR3 phospholipid phosphatase related 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLPPR3 mRNA CTD PMID:25510870 NCBI chr19:812,488...823,797
Ensembl chr19:812,488...821,955
JBrowse link
G PLXNA2 plexin A2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLXNA2 mRNA CTD PMID:25510870 NCBI chr 1:208,022,242...208,244,384
Ensembl chr 1:208,022,242...208,244,384
JBrowse link
G PLXNA3 plexin A3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLXNA3 mRNA CTD PMID:25510870 NCBI chr  X:154,458,281...154,477,779
Ensembl chr  X:154,458,281...154,477,779
JBrowse link
G PLXNC1 plexin C1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLXNC1 mRNA CTD PMID:25510870 NCBI chr12:94,148,577...94,307,675
Ensembl chr12:94,148,577...94,307,675
JBrowse link
G PNCK pregnancy up-regulated nonubiquitous CaM kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PNCK mRNA CTD PMID:25510870 NCBI chr  X:153,669,733...153,687,771
Ensembl chr  X:153,669,733...153,689,010
JBrowse link
G PNISR PNN interacting serine and arginine rich protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PNISR mRNA CTD PMID:25510870 NCBI chr 6:99,398,050...99,425,308
Ensembl chr 6:99,397,629...99,425,331
JBrowse link
G PNLIP pancreatic lipase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PNLIP mRNA CTD PMID:25510870 NCBI chr10:116,545,931...116,567,855
Ensembl chr10:116,545,931...116,567,855
JBrowse link
G PNMA2 PNMA family member 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PNMA2 mRNA CTD PMID:23829299 NCBI chr 8:26,504,701...26,513,872
Ensembl chr 8:26,504,701...26,514,092
JBrowse link
G PNPLA5 patatin like phospholipase domain containing 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PNPLA5 mRNA CTD PMID:25510870 NCBI chr22:43,879,678...43,892,013
Ensembl chr22:43,879,678...43,892,013
JBrowse link
G POLA1 DNA polymerase alpha 1, catalytic subunit multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of POLA1 mRNA CTD PMID:25510870 NCBI chr  X:24,693,918...24,996,986
Ensembl chr  X:24,693,873...24,996,986
JBrowse link
G POLA2 DNA polymerase alpha 2, accessory subunit multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of POLA2 mRNA CTD PMID:25510870 NCBI chr11:65,261,962...65,305,985
Ensembl chr11:65,261,913...65,305,959
JBrowse link
G POLE DNA polymerase epsilon, catalytic subunit multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of POLE mRNA CTD PMID:25510870 NCBI chr12:132,623,762...132,687,342
Ensembl chr12:132,623,753...132,687,376
JBrowse link
G POLE2 DNA polymerase epsilon 2, accessory subunit multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of POLE2 mRNA CTD PMID:25510870 NCBI chr14:49,643,555...49,688,214
Ensembl chr14:49,643,555...49,688,422
JBrowse link
G POLQ DNA polymerase theta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of POLQ mRNA CTD PMID:25510870 NCBI chr 3:121,431,431...121,545,988
Ensembl chr 3:121,431,431...121,545,988
JBrowse link
G POLR1A RNA polymerase I subunit A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of POLR1A mRNA CTD PMID:25510870 NCBI chr 2:86,020,216...86,105,886
Ensembl chr 2:86,020,216...86,106,155
JBrowse link
G POM121L2 POM121 transmembrane nucleoporin like 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of POM121L2 mRNA CTD PMID:25510870 NCBI chr 6:27,308,377...27,312,273
Ensembl chr 6:27,285,903...27,312,273
JBrowse link
G POPDC2 popeye domain containing 2 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of POPDC2 mRNA CTD PMID:23829299 NCBI chr 3:119,642,056...119,660,883
Ensembl chr 3:119,636,457...119,665,324
JBrowse link
G POPDC3 popeye domain containing 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of POPDC3 mRNA CTD PMID:25510870 NCBI chr 6:105,157,900...105,180,014
Ensembl chr 6:105,157,900...105,180,014
JBrowse link
G POU3F2 POU class 3 homeobox 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of POU3F2 mRNA CTD PMID:23829299 NCBI chr 6:98,834,574...98,839,458
Ensembl chr 6:98,834,574...98,839,458
JBrowse link
G POU4F1 POU class 4 homeobox 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of POU4F1 mRNA CTD PMID:23829299 NCBI chr13:78,598,362...78,603,552
Ensembl chr13:78,598,362...78,603,552
JBrowse link
G POU5F2 POU domain class 5, transcription factor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of POU5F2 mRNA CTD PMID:25510870 NCBI chr 5:93,733,220...93,741,600
Ensembl chr 5:93,733,220...93,741,600
JBrowse link
G PPARG peroxisome proliferator activated receptor gamma multiple interactions
increases expression
ISO 2,2',3',4,4',5-hexachlorobiphenyl promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PPARG protein
CTD PMID:29704545 NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
JBrowse link
G PPFIA3 PTPRF interacting protein alpha 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PPFIA3 mRNA CTD PMID:25510870 NCBI chr19:49,119,544...49,151,026
Ensembl chr19:49,119,544...49,151,026
JBrowse link
G PPFIA4 PTPRF interacting protein alpha 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PPFIA4 mRNA CTD PMID:25510870 NCBI chr 1:203,026,491...203,078,736
Ensembl chr 1:203,026,491...203,078,740
JBrowse link
G PPM1E protein phosphatase, Mg2+/Mn2+ dependent 1E multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PPM1E mRNA CTD PMID:25510870 NCBI chr17:58,755,854...58,985,179
Ensembl chr17:58,755,854...58,985,179
JBrowse link
G PPM1J protein phosphatase, Mg2+/Mn2+ dependent 1J multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PPM1J mRNA CTD PMID:25510870 NCBI chr 1:112,709,998...112,715,332
Ensembl chr 1:112,709,994...112,715,332
JBrowse link
G PPP1CB protein phosphatase 1 catalytic subunit beta decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PPP1CB mRNA CTD PMID:23829299 NCBI chr 2:28,751,604...28,802,940
Ensembl chr 2:28,751,640...28,802,940
JBrowse link
G PPP1R1B protein phosphatase 1 regulatory inhibitor subunit 1B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PPP1R1B mRNA CTD PMID:25510870 NCBI chr17:39,626,707...39,636,624
Ensembl chr17:39,626,740...39,636,626
JBrowse link
G PPP1R1C protein phosphatase 1 regulatory inhibitor subunit 1C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PPP1R1C mRNA CTD PMID:25510870 NCBI chr 2:181,954,480...182,131,385
Ensembl chr 2:181,954,241...182,131,398
JBrowse link
G PPP1R3A protein phosphatase 1 regulatory subunit 3A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PPP1R3A mRNA CTD PMID:25510870 NCBI chr 7:113,876,777...113,919,009
Ensembl chr 7:113,876,777...114,075,920
JBrowse link
G PPP1R3C protein phosphatase 1 regulatory subunit 3C decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PPP1R3C mRNA CTD PMID:23829299 NCBI chr10:91,628,442...91,633,071
Ensembl chr10:91,628,442...91,633,071
JBrowse link
G PPP2R1B protein phosphatase 2 scaffold subunit Abeta increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PPP2R1B protein CTD PMID:21673325 NCBI chr11:111,688,000...111,766,389
Ensembl chr11:111,726,908...111,766,389
JBrowse link
G PPP2R2B protein phosphatase 2 regulatory subunit Bbeta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PPP2R2B mRNA CTD PMID:25510870 NCBI chr 5:146,580,742...147,081,520
Ensembl chr 5:146,580,742...147,084,784
JBrowse link
G PPTC7 protein phosphatase targeting COQ7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PPTC7 mRNA CTD PMID:25510870 NCBI chr12:110,533,245...110,583,318
Ensembl chr12:110,533,245...110,583,318
JBrowse link
G PRAMEF10 PRAME family member 10 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRAMEL48 mRNA CTD PMID:25510870 NCBI chr 1:12,892,896...12,898,270
Ensembl chr 1:12,892,896...12,898,270
JBrowse link
G PRC1 protein regulator of cytokinesis 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRC1 mRNA CTD PMID:25510870 NCBI chr15:90,966,040...90,994,535
Ensembl chr15:90,966,040...90,995,629
JBrowse link
G PRCP prolylcarboxypeptidase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRCP mRNA CTD PMID:25510870 NCBI chr11:82,822,936...82,901,644
Ensembl chr11:82,822,936...82,970,584
JBrowse link
G PRDM13 PR/SET domain 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRDM13 mRNA CTD PMID:25510870 NCBI chr 6:99,606,833...99,615,562
Ensembl chr 6:99,606,774...99,615,578
JBrowse link
G PRDM8 PR/SET domain 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRDM8 mRNA CTD PMID:25510870 NCBI chr 4:80,185,270...80,204,329
Ensembl chr 4:80,183,879...80,204,329
JBrowse link
G PRDM9 PR/SET domain 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRDM9 mRNA CTD PMID:25510870 NCBI chr 5:23,507,155...23,528,093
Ensembl chr 5:23,443,586...23,528,093
JBrowse link
G PRELP proline and arginine rich end leucine rich repeat protein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PRELP mRNA CTD PMID:23829299 NCBI chr 1:203,475,806...203,491,352
Ensembl chr 1:203,475,806...203,491,352
JBrowse link
G PRIM1 DNA primase subunit 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRIM1 mRNA CTD PMID:25510870 NCBI chr12:56,731,580...56,752,323
Ensembl chr12:56,730,438...56,752,374
JBrowse link
G PRIM2 DNA primase subunit 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] affects the expression of PRIM2 mRNA CTD PMID:25510870 NCBI chr 6:57,221,540...57,646,850
Ensembl chr 6:57,314,805...57,646,850
JBrowse link
G PRKACB protein kinase cAMP-activated catalytic subunit beta affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of PRKACB mRNA CTD PMID:21703328 NCBI chr 1:84,078,079...84,238,498
Ensembl chr 1:84,078,062...84,238,498
JBrowse link
G PRKCE protein kinase C epsilon multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PRKCE mRNA CTD PMID:25510870 NCBI chr 2:45,651,279...46,187,990
Ensembl chr 2:45,651,345...46,187,990
JBrowse link
G PRKCG protein kinase C gamma increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PRKCG protein CTD PMID:21673325 NCBI chr19:53,881,094...53,907,652
Ensembl chr19:53,879,190...53,907,652
JBrowse link
G PRL prolactin increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PRL mRNA CTD PMID:23829299 NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
JBrowse link
G PRM1 protamine 1 multiple interactions
decreases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRM1 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PRM1 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr16:11,280,841...11,281,330
Ensembl chr16:11,280,841...11,281,330
JBrowse link
G PRMT8 protein arginine methyltransferase 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PRMT8 mRNA CTD PMID:25510870 NCBI chr12:3,381,349...3,593,973
Ensembl chr12:3,381,349...3,593,973
JBrowse link
G PROCA1 protein interacting with cyclin A1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PROCA1 mRNA CTD PMID:25510870 NCBI chr17:28,703,197...28,711,888
Ensembl chr17:28,703,197...28,711,888
JBrowse link
G PROKR2 prokineticin receptor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PROKR2 mRNA CTD PMID:25510870 NCBI chr20:5,299,218...5,316,954
Ensembl chr20:5,299,218...5,316,954
JBrowse link
G PRORP protein only RNase P catalytic subunit decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PRORP mRNA CTD PMID:23829299 NCBI chr14:35,121,839...35,277,622
Ensembl chr14:35,121,846...35,277,622
JBrowse link
G PRPF31 pre-mRNA processing factor 31 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRPF31 mRNA CTD PMID:25510870 NCBI chr19:54,115,754...54,131,713
Ensembl chr19:54,115,410...54,131,719
JBrowse link
G PRPF40B pre-mRNA processing factor 40 homolog B decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PRPF40B mRNA CTD PMID:23829299 NCBI chr12:49,622,646...49,644,665
Ensembl chr12:49,568,218...49,644,666
JBrowse link
G PRR11 proline rich 11 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRR11 mRNA CTD PMID:25510870 NCBI chr17:59,155,746...59,206,709
Ensembl chr17:59,155,732...59,206,709
JBrowse link
G PRR32 proline rich 32 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PRR32 mRNA CTD PMID:25510870 NCBI chr  X:126,819,729...126,821,786
Ensembl chr  X:126,819,729...126,821,786
JBrowse link
G PRRG3 proline rich and Gla domain 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRRG3 mRNA CTD PMID:25510870 NCBI chr  X:151,694,607...151,705,924
Ensembl chr  X:151,694,607...151,705,924
JBrowse link
G PRRT2 proline rich transmembrane protein 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PRRT2 mRNA CTD PMID:23829299 NCBI chr16:29,812,193...29,815,881
Ensembl chr16:29,811,382...29,815,892
JBrowse link
G PRSS23 serine protease 23 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PRSS23 mRNA CTD PMID:25510870 NCBI chr11:86,791,071...86,952,910
Ensembl chr11:86,791,059...86,952,910
JBrowse link
G PRSS8 serine protease 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PRSS8 mRNA CTD PMID:25510870 NCBI chr16:31,131,433...31,135,727
Ensembl chr16:31,131,433...31,135,727
JBrowse link
G PRTG protogenin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRTG mRNA CTD PMID:25510870 NCBI chr15:55,611,544...55,743,152
Ensembl chr15:55,611,544...55,743,152
JBrowse link
G PRUNE2 prune homolog 2 with BCH domain multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PRUNE2 mRNA CTD PMID:25510870 NCBI chr 9:76,611,376...76,906,114
Ensembl chr 9:76,611,376...76,906,114
JBrowse link
G PRX periaxin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRX mRNA CTD PMID:25510870 NCBI chr19:40,393,764...40,414,789
Ensembl chr19:40,393,766...40,414,793
JBrowse link
G PSD pleckstrin and Sec7 domain containing multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PSD mRNA CTD PMID:25510870 NCBI chr10:102,402,619...102,419,946
Ensembl chr10:102,402,617...102,421,539
JBrowse link
G PSD3 pleckstrin and Sec7 domain containing 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PSD3 mRNA CTD PMID:25510870 NCBI chr 8:18,527,303...19,084,805
Ensembl chr 8:18,527,303...19,084,730
JBrowse link
G PSRC1 proline and serine rich coiled-coil 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PSRC1 mRNA CTD PMID:25510870 NCBI chr 1:109,279,556...109,283,145
Ensembl chr 1:109,279,556...109,283,186
JBrowse link
G PTBP3 polypyrimidine tract binding protein 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PTBP3 mRNA CTD PMID:25510870 NCBI chr 9:112,217,715...112,379,882
Ensembl chr 9:112,217,716...112,333,664
JBrowse link
G PTCH2 patched 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTCH2 mRNA CTD PMID:25510870 NCBI chr 1:44,819,845...44,843,253
Ensembl chr 1:44,819,844...44,843,253
JBrowse link
G PTGER3 prostaglandin E receptor 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PTGER3 mRNA CTD PMID:25510870 NCBI chr 1:70,852,358...71,047,816
Ensembl chr 1:70,852,353...71,047,816
JBrowse link
G PTGR1 prostaglandin reductase 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PTGR1 mRNA CTD PMID:23829299 NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of PTGS2 mRNA CTD PMID:21703328 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G PTK2B protein tyrosine kinase 2 beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PTK2B mRNA CTD PMID:25510870 NCBI chr 8:27,310,506...27,459,391
Ensembl chr 8:27,311,482...27,459,391
JBrowse link
G PTK7 protein tyrosine kinase 7 (inactive) decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PTK7 mRNA CTD PMID:23829299 NCBI chr 6:43,076,314...43,161,715
Ensembl chr 6:43,076,307...43,161,719
JBrowse link
G PTPA protein phosphatase 2 phosphatase activator decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PTPA mRNA CTD PMID:23829299 NCBI chr 9:129,110,950...129,148,946
Ensembl chr 9:129,110,950...129,148,946
JBrowse link
G PTPN3 protein tyrosine phosphatase non-receptor type 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PTPN3 mRNA CTD PMID:25510870 NCBI chr 9:109,375,694...109,538,420
Ensembl chr 9:109,375,466...109,498,313
JBrowse link
G PTPN4 protein tyrosine phosphatase non-receptor type 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PTPN4 mRNA CTD PMID:25510870 NCBI chr 2:119,759,922...119,984,899
Ensembl chr 2:119,759,922...119,984,899
JBrowse link
G PTPN5 protein tyrosine phosphatase non-receptor type 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PTPN5 mRNA CTD PMID:23829299 NCBI chr11:18,727,928...18,792,721
Ensembl chr11:18,727,928...18,792,721
JBrowse link
G PTPRH protein tyrosine phosphatase receptor type H decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PTPRH mRNA CTD PMID:23829299 NCBI chr19:55,181,247...55,209,501
Ensembl chr19:55,181,247...55,209,506
JBrowse link
G PTPRJ protein tyrosine phosphatase receptor type J multiple interactions
decreases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PTPRJ mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PTPRJ mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr11:47,980,559...48,170,839
Ensembl chr11:47,980,425...48,170,839
JBrowse link
G PTPRN2 protein tyrosine phosphatase receptor type N2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PTPRN2 mRNA CTD PMID:25510870 NCBI chr 7:157,539,056...158,587,823
Ensembl chr 7:157,539,056...158,587,823
JBrowse link
G PTPRS protein tyrosine phosphatase receptor type S multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTPRS mRNA CTD PMID:25510870 NCBI chr19:5,205,508...5,340,812
Ensembl chr19:5,158,495...5,340,812
JBrowse link
G PTPRU protein tyrosine phosphatase receptor type U multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PTPRU mRNA CTD PMID:25510870 NCBI chr 1:29,236,522...29,326,800
Ensembl chr 1:29,236,516...29,326,813
JBrowse link
G PTTG1 PTTG1 regulator of sister chromatid separation, securin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTTG1 mRNA CTD PMID:25510870 NCBI chr 5:160,421,855...160,428,744
Ensembl chr 5:160,421,855...160,428,739
JBrowse link
G PURG purine rich element binding protein G decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PURG mRNA CTD PMID:23829299 NCBI chr 8:30,995,802...31,033,356
Ensembl chr 8:30,995,802...31,033,715
JBrowse link
G PVALB parvalbumin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PVALB mRNA CTD PMID:25510870 NCBI chr22:36,800,703...36,819,499
Ensembl chr22:36,800,684...36,819,479
JBrowse link
G PVR PVR cell adhesion molecule multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PVR mRNA CTD PMID:25510870 NCBI chr19:44,643,910...44,666,162
Ensembl chr19:44,643,798...44,666,162
JBrowse link
G PXYLP1 2-phosphoxylose phosphatase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PXYLP1 mRNA CTD PMID:25510870 NCBI chr 3:141,231,825...141,294,924
Ensembl chr 3:141,228,726...141,367,753
JBrowse link
G PYGB glycogen phosphorylase B decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PYGB protein CTD PMID:21673325 NCBI chr20:25,248,085...25,298,012
Ensembl chr20:25,248,085...25,298,012
JBrowse link
G PYGM glycogen phosphorylase, muscle associated decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PYGM protein CTD PMID:21673325 NCBI chr11:64,746,389...64,760,715
Ensembl chr11:64,746,389...64,759,974
JBrowse link
G QRFP pyroglutamylated RFamide peptide decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of QRFP mRNA CTD PMID:23829299 NCBI chr 9:130,892,707...130,896,812
Ensembl chr 9:130,892,707...130,896,812
JBrowse link
G QRFPR pyroglutamylated RFamide peptide receptor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of QRFPR mRNA CTD PMID:25510870 NCBI chr 4:121,328,642...121,381,018
Ensembl chr 4:121,328,642...121,381,059
JBrowse link
G QSER1 glutamine and serine rich 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of QSER1 mRNA CTD PMID:25510870 NCBI chr11:32,892,811...32,980,270
Ensembl chr11:32,892,811...32,993,316
JBrowse link
G RAB36 RAB36, member RAS oncogene family decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RAB36 mRNA CTD PMID:23829299 NCBI chr22:23,145,324...23,169,280
Ensembl chr22:23,145,366...23,165,663
JBrowse link
G RAB43 RAB43, member RAS oncogene family decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RAB43 mRNA CTD PMID:23829299 NCBI chr 3:129,087,569...129,122,150
Ensembl chr 3:129,087,569...129,122,801
JBrowse link
G RAB4A RAB4A, member RAS oncogene family multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RAB4A mRNA CTD PMID:25510870 NCBI chr 1:229,271,111...229,305,894
Ensembl chr 1:229,271,062...229,305,894
JBrowse link
G RAB5B RAB5B, member RAS oncogene family multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RAB5B mRNA CTD PMID:25510870 NCBI chr12:55,973,949...55,996,683
Ensembl chr12:55,973,913...55,996,683
JBrowse link
G RABEP1 rabaptin, RAB GTPase binding effector protein 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RABEP1 mRNA CTD PMID:23829299 NCBI chr17:5,282,284...5,386,340
Ensembl chr17:5,282,265...5,386,340
JBrowse link
G RACGAP1 Rac GTPase activating protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RACGAP1 mRNA CTD PMID:25510870 NCBI chr12:49,989,162...50,033,440
Ensembl chr12:49,976,923...50,033,136
JBrowse link
G RAD21L1 RAD21 cohesin complex component like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RAD21L mRNA CTD PMID:25510870 NCBI chr20:1,226,044...1,255,876
Ensembl chr20:1,226,044...1,296,421
JBrowse link
G RAD51 RAD51 recombinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RAD51 mRNA CTD PMID:25510870 NCBI chr15:40,694,733...40,732,340
Ensembl chr15:40,694,774...40,732,340
JBrowse link
G RAD51AP1 RAD51 associated protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RAD51AP1 mRNA CTD PMID:25510870 NCBI chr12:4,538,890...4,560,047
Ensembl chr12:4,538,798...4,560,047
JBrowse link
G RAD54B RAD54 homolog B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RAD54B mRNA CTD PMID:25510870 NCBI chr 8:94,371,960...94,475,115
Ensembl chr 8:94,371,960...94,475,115
JBrowse link
G RAG1 recombination activating 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RAG1 mRNA CTD PMID:25510870 NCBI chr11:36,510,353...36,579,762
Ensembl chr11:36,510,372...36,593,156
JBrowse link
G RAI1 retinoic acid induced 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RAI1 mRNA CTD PMID:25510870 NCBI chr17:17,681,458...17,811,453
Ensembl chr17:17,681,458...17,811,453
JBrowse link
G RALGAPA2 Ral GTPase activating protein catalytic subunit alpha 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RALGAPA2 mRNA CTD PMID:25510870 NCBI chr20:20,389,530...20,712,644
Ensembl chr20:20,389,530...20,712,644
JBrowse link
G RALYL RALY RNA binding protein like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RALYL mRNA CTD PMID:25510870 NCBI chr 8:84,182,787...84,921,844
Ensembl chr 8:84,182,787...84,921,844
JBrowse link
G RANBP10 RAN binding protein 10 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RANBP10 mRNA CTD PMID:23829299 NCBI chr16:67,723,070...67,806,560
Ensembl chr16:67,723,070...67,806,560
JBrowse link
G RAP2C RAP2C, member of RAS oncogene family multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RAP2C mRNA CTD PMID:25510870 NCBI chr  X:132,203,025...132,219,447
Ensembl chr  X:132,203,024...132,219,480
JBrowse link
G RAPH1 Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RAPH1 mRNA CTD PMID:25510870 NCBI chr 2:203,433,682...203,535,301
Ensembl chr 2:203,394,345...203,535,335
JBrowse link
G RASGRP1 RAS guanyl releasing protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RASGRP1 mRNA CTD PMID:25510870 NCBI chr15:38,488,103...38,564,814
Ensembl chr15:38,488,103...38,565,575
JBrowse link
G RASGRP4 RAS guanyl releasing protein 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RASGRP4 mRNA CTD PMID:25510870 NCBI chr19:38,409,058...38,426,219
Ensembl chr19:38,409,051...38,426,305
JBrowse link
G RASSF3 Ras association domain family member 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RASSF3 mRNA CTD PMID:25510870 NCBI chr12:64,506,964...64,697,564
Ensembl chr12:64,507,001...64,697,564
JBrowse link
G RASSF4 Ras association domain family member 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RASSF4 mRNA CTD PMID:25510870 NCBI chr10:44,959,802...44,995,891
Ensembl chr10:44,959,407...44,995,891
JBrowse link
G RBL1 RB transcriptional corepressor like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RBL1 mRNA CTD PMID:25510870 NCBI chr20:36,996,349...37,095,997
Ensembl chr20:36,996,349...37,095,997
JBrowse link
G RBM33 RNA binding motif protein 33 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RBM33 mRNA CTD PMID:25510870 NCBI chr 7:155,644,661...155,781,480
Ensembl chr 7:155,644,451...155,781,485
JBrowse link
G RBM41 RNA binding motif protein 41 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RBM41 mRNA CTD PMID:25510870 NCBI chr  X:107,052,102...107,118,822
Ensembl chr  X:107,052,095...107,118,823
JBrowse link
G RBM43 RNA binding motif protein 43 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RBM43 mRNA CTD PMID:23829299 NCBI chr 2:151,247,940...151,261,863
Ensembl chr 2:151,247,940...151,261,863
JBrowse link
G RBM4B RNA binding motif protein 4B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RBM4B mRNA CTD PMID:25510870 NCBI chr11:66,664,998...66,677,887
Ensembl chr11:66,664,998...66,677,887
JBrowse link
G RBMS1 RNA binding motif single stranded interacting protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RBMS1 mRNA CTD PMID:25510870 NCBI chr 2:160,272,151...160,493,807
Ensembl chr 2:160,272,151...160,493,807
JBrowse link
G RBMX RNA binding motif protein X-linked multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RBMX mRNA CTD PMID:25510870 NCBI chr  X:136,869,192...136,880,725
Ensembl chr  X:136,848,004...136,880,764
JBrowse link
G RBP7 retinol binding protein 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RBP7 mRNA CTD PMID:25510870 NCBI chr 1:9,997,228...10,016,021
Ensembl chr 1:9,997,206...10,016,021
JBrowse link
G RCCD1 RCC1 domain containing 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RCCD1 mRNA CTD PMID:23829299 NCBI chr15:90,954,884...90,963,125
Ensembl chr15:90,954,881...90,963,125
JBrowse link
G RCOR2 REST corepressor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RCOR2 mRNA CTD PMID:25510870 NCBI chr11:63,911,230...63,927,762
Ensembl chr11:63,911,230...63,917,164
JBrowse link
G RCOR3 REST corepressor 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RCOR3 mRNA CTD PMID:25510870 NCBI chr 1:211,259,366...211,316,385
Ensembl chr 1:211,258,377...211,316,385
JBrowse link
G REC8 REC8 meiotic recombination protein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of REC8 mRNA CTD PMID:23829299 NCBI chr14:24,172,080...24,180,923
Ensembl chr14:24,171,853...24,180,257
JBrowse link
G RECQL4 RecQ like helicase 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RECQL4 mRNA CTD PMID:25510870 NCBI chr 8:144,511,288...144,517,833
Ensembl chr 8:144,511,288...144,517,845
JBrowse link
G REG1A regenerating family member 1 alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of REG1 mRNA CTD PMID:25510870 NCBI chr 2:79,120,488...79,123,409
Ensembl chr 2:79,120,362...79,123,409
JBrowse link
G RELB RELB proto-oncogene, NF-kB subunit multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RELB mRNA CTD PMID:25510870 NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,461...45,038,192
JBrowse link
G RELL2 RELT like 2 decreases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RELL2 mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RELL2 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 5:141,636,997...141,641,064
Ensembl chr 5:141,636,950...141,641,064
JBrowse link
G RERE arginine-glutamic acid dipeptide repeats multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RERE mRNA CTD PMID:25510870 NCBI chr 1:8,352,404...8,817,640
Ensembl chr 1:8,352,397...8,848,921
JBrowse link
G RET ret proto-oncogene multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RET mRNA CTD PMID:25510870 NCBI chr10:43,077,069...43,130,351
Ensembl chr10:43,077,064...43,130,351
JBrowse link
G RETNLB resistin like beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RETNLB mRNA CTD PMID:25510870 NCBI chr 3:108,755,638...108,757,410
Ensembl chr 3:108,743,424...108,757,410
JBrowse link
G RFC1 replication factor C subunit 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of RFC1 mRNA CTD PMID:23829299 NCBI chr 4:39,287,456...39,366,362
Ensembl chr 4:39,287,456...39,366,375
JBrowse link
G RFC3 replication factor C subunit 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RFC3 mRNA CTD PMID:25510870 NCBI chr13:33,818,149...33,977,377
Ensembl chr13:33,818,069...33,966,558
JBrowse link
G RFFL ring finger and FYVE like domain containing E3 ubiquitin protein ligase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RFFL mRNA CTD PMID:25510870 NCBI chr17:35,005,990...35,089,226
Ensembl chr17:35,005,990...35,089,319
JBrowse link
G RFLNA refilin A decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RFLNA mRNA CTD PMID:23829299 NCBI chr12:123,973,215...124,316,024
Ensembl chr12:123,973,241...124,316,024
JBrowse link
G RFWD3 ring finger and WD repeat domain 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RFWD3 mRNA CTD PMID:25510870 NCBI chr16:74,621,399...74,666,877
Ensembl chr16:74,621,399...74,666,877
JBrowse link
G RFX5 regulatory factor X5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RFX5 mRNA CTD PMID:25510870 NCBI chr 1:151,340,640...151,347,252
Ensembl chr 1:151,340,640...151,347,326
JBrowse link
G RGMA repulsive guidance molecule BMP co-receptor a decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RGMA mRNA CTD PMID:23829299 NCBI chr15:93,035,271...93,089,211
Ensembl chr15:93,035,271...93,089,211
JBrowse link
G RGS13 regulator of G protein signaling 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RGS13 mRNA CTD PMID:25510870 NCBI chr 1:192,636,147...192,660,311
Ensembl chr 1:192,636,138...192,660,311
JBrowse link
G RGS5 regulator of G protein signaling 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RGS5 mRNA CTD PMID:23829299 NCBI chr 1:163,142,299...163,321,735
Ensembl chr 1:163,111,121...163,321,791
JBrowse link
G RGS7BP regulator of G protein signaling 7 binding protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RGS7BP mRNA CTD PMID:25510870 NCBI chr 5:64,506,015...64,612,319
Ensembl chr 5:64,506,015...64,612,319
JBrowse link
G RGS8 regulator of G protein signaling 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RGS8 mRNA CTD PMID:25510870 NCBI chr 1:182,641,818...182,752,376
Ensembl chr 1:182,641,816...182,684,587
JBrowse link
G RGS9 regulator of G protein signaling 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RGS9 mRNA CTD PMID:25510870 NCBI chr17:65,137,370...65,227,703
Ensembl chr17:65,100,812...65,227,703
JBrowse link
G RHOA ras homolog family member A decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RHOA mRNA CTD PMID:23829299 NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
JBrowse link
G RHPN2 rhophilin Rho GTPase binding protein 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RHPN2 mRNA CTD PMID:23829299 NCBI chr19:32,978,592...33,064,888
Ensembl chr19:32,978,592...33,064,888
JBrowse link
G RIMS1 regulating synaptic membrane exocytosis 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RIMS1 mRNA CTD PMID:25510870 NCBI chr 6:71,886,550...72,403,145
Ensembl chr 6:71,886,550...72,403,150
JBrowse link
G RIPK1 receptor interacting serine/threonine kinase 1 multiple interactions ISO 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [TNF protein results in increased degradation of RIPK1 protein] CTD PMID:29704545 NCBI chr 6:3,063,967...3,115,187
Ensembl chr 6:3,063,824...3,115,187
JBrowse link
G RIPK4 receptor interacting serine/threonine kinase 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RIPK4 mRNA CTD PMID:25510870 NCBI chr21:41,739,373...41,767,052
Ensembl chr21:41,739,369...41,767,089
JBrowse link
G RIT2 Ras like without CAAX 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RIT2 mRNA CTD PMID:25510870 NCBI chr18:42,743,227...43,115,685
Ensembl chr18:42,743,227...43,115,691
JBrowse link
G RMDN3 regulator of microtubule dynamics 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RMDN3 mRNA CTD PMID:23829299 NCBI chr15:40,735,887...40,755,254
Ensembl chr15:40,735,884...40,755,851
JBrowse link
G RMRP RNA component of mitochondrial RNA processing endoribonuclease multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RMRP mRNA CTD PMID:25510870 NCBI chr 9:35,657,750...35,658,019
Ensembl chr 9:35,657,754...35,658,017
JBrowse link
G RNF112 ring finger protein 112 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RNF112 mRNA CTD PMID:25510870 NCBI chr17:19,411,232...19,417,276
Ensembl chr17:19,411,125...19,417,276
JBrowse link
G RNF141 ring finger protein 141 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RNF141 mRNA CTD PMID:25510870 NCBI chr11:10,511,673...10,541,187
Ensembl chr11:10,511,673...10,541,230
JBrowse link
G RNF151 ring finger protein 151 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of RNF151 mRNA CTD PMID:23829299 NCBI chr16:1,966,856...1,968,949
Ensembl chr16:1,966,823...1,968,975
JBrowse link
G RNF187 ring finger protein 187 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RNF187 mRNA CTD PMID:23829299 NCBI chr 1:228,487,382...228,496,188
Ensembl chr 1:228,487,382...228,499,899
JBrowse link
G RNF43 ring finger protein 43 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RNF43 mRNA CTD PMID:25510870 NCBI chr17:58,352,500...58,417,534
Ensembl chr17:58,353,676...58,417,595
JBrowse link
G ROBO2 roundabout guidance receptor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ROBO2 mRNA CTD PMID:25510870 NCBI chr 3:75,906,675...77,649,964
Ensembl chr 3:75,906,695...77,649,964
JBrowse link
G ROBO4 roundabout guidance receptor 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ROBO4 mRNA CTD PMID:25510870 NCBI chr11:124,883,691...124,897,865
Ensembl chr11:124,883,691...124,898,500
JBrowse link
G RORA RAR related orphan receptor A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RORA mRNA CTD PMID:25510870 NCBI chr15:60,488,284...61,229,302
Ensembl chr15:60,488,284...61,229,302
JBrowse link
G RP1L1 RP1 like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RP1L1 mRNA CTD PMID:25510870 NCBI chr 8:10,606,349...10,655,143
Ensembl chr 8:10,606,349...10,712,187
JBrowse link
G RPGRIP1 RPGR interacting protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RPGRIP1 mRNA CTD PMID:25510870 NCBI chr14:21,280,083...21,351,301
Ensembl chr14:21,280,083...21,351,301
JBrowse link
G RPL37A ribosomal protein L37a multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPL37A mRNA CTD PMID:25510870 NCBI chr 2:216,498,844...216,504,086
Ensembl chr 2:216,498,825...216,579,180
JBrowse link
G RPL41 ribosomal protein L41 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPL41 mRNA CTD PMID:25510870 NCBI chr12:56,116,633...56,117,967
Ensembl chr12:56,116,590...56,117,967
JBrowse link
G RPLP1 ribosomal protein lateral stalk subunit P1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPLP1 mRNA CTD PMID:25510870 NCBI chr15:69,452,818...69,456,205
Ensembl chr15:69,452,814...69,456,205
JBrowse link
G RPP38 ribonuclease P/MRP subunit p38 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RPP38 mRNA CTD PMID:23829299 NCBI chr10:15,097,355...15,104,257
Ensembl chr10:15,097,180...15,139,818
JBrowse link
G RPRD1B regulation of nuclear pre-mRNA domain containing 1B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPRD1B mRNA CTD PMID:25510870 NCBI chr20:38,033,746...38,092,364
Ensembl chr20:38,033,725...38,127,780
JBrowse link
G RPS16 ribosomal protein S16 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPS16 mRNA CTD PMID:25510870 NCBI chr19:39,433,137...39,435,949
Ensembl chr19:39,433,137...39,435,949
JBrowse link
G RPS6KA3 ribosomal protein S6 kinase A3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RPS6KA3 mRNA CTD PMID:25510870 NCBI chr  X:20,149,911...20,267,097
Ensembl chr  X:20,149,911...20,267,519
JBrowse link
G RPS6KC1 ribosomal protein S6 kinase C1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPS6KC1 mRNA CTD PMID:25510870 NCBI chr 1:213,051,241...213,862,735
Ensembl chr 1:213,051,233...213,274,774
JBrowse link
G RRM1 ribonucleotide reductase catalytic subunit M1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RRM1 mRNA CTD PMID:25510870 NCBI chr11:4,094,685...4,138,932
Ensembl chr11:4,094,707...4,138,932
JBrowse link
G RRM2 ribonucleotide reductase regulatory subunit M2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RRM2 mRNA CTD PMID:25510870 NCBI chr 2:10,122,568...10,211,010
Ensembl chr 2:10,120,698...10,211,725
JBrowse link
G RSAD1 radical S-adenosyl methionine domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RSAD1 mRNA CTD PMID:25510870 NCBI chr17:50,478,860...50,485,974
Ensembl chr17:50,478,860...50,485,974
JBrowse link
G RSPH9 radial spoke head component 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RSPH9 mRNA CTD PMID:25510870 NCBI chr 6:43,645,036...43,672,600
Ensembl chr 6:43,645,036...43,672,600
JBrowse link
G RSRC2 arginine and serine rich coiled-coil 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RSRC2 mRNA CTD PMID:25510870 NCBI chr12:122,503,454...122,526,936
Ensembl chr12:122,503,454...122,527,000
JBrowse link
G RTN1 reticulon 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of RTN1 protein CTD PMID:21673325 NCBI chr14:59,595,976...59,870,776
Ensembl chr14:59,595,976...59,870,776
JBrowse link
G RTN4IP1 reticulon 4 interacting protein 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RTN4IP1 mRNA CTD PMID:23829299 NCBI chr 6:106,570,771...106,630,491
Ensembl chr 6:106,570,771...106,629,498
JBrowse link
G RTP2 receptor transporter protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RTP2 mRNA CTD PMID:25510870 NCBI chr 3:187,698,259...187,715,691
Ensembl chr 3:187,698,259...187,702,557
JBrowse link
G RUFY2 RUN and FYVE domain containing 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RUFY2 mRNA CTD PMID:25510870 NCBI chr10:68,341,112...68,407,277
Ensembl chr10:68,341,107...68,407,294
JBrowse link
G RUFY4 RUN and FYVE domain containing 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RUFY4 mRNA CTD PMID:25510870 NCBI chr 2:218,034,934...218,090,652
Ensembl chr 2:218,034,960...218,090,584
JBrowse link
G RUNX1T1 RUNX1 partner transcriptional co-repressor 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of RUNX1T1 mRNA CTD PMID:23829299 NCBI chr 8:91,954,967...92,103,385
Ensembl chr 8:91,954,972...92,103,385
JBrowse link
G RUNX2 RUNX family transcription factor 2 increases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of RUNX2 mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RUNX2 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
JBrowse link
G S100A11 S100 calcium binding protein A11 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100A11 mRNA CTD PMID:25510870 NCBI chr 1:152,032,506...152,037,004
Ensembl chr 1:152,032,506...152,047,907
JBrowse link
G S100B S100 calcium binding protein B decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of S100B protein CTD PMID:21673325 NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
JBrowse link
G S100PBP S100P binding protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of S100PBP mRNA CTD PMID:25510870 NCBI chr 1:32,816,562...32,858,879
Ensembl chr 1:32,816,767...32,858,875
JBrowse link
G SAA2 serum amyloid A2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SAA2 mRNA CTD PMID:25510870 NCBI chr11:18,238,236...18,248,668
Ensembl chr11:18,239,223...18,248,668
JBrowse link
G SACS sacsin molecular chaperone multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SACS mRNA CTD PMID:25510870 NCBI chr13:23,328,830...23,433,702
Ensembl chr13:23,288,689...23,433,763
JBrowse link
G SAG S-antigen visual arrestin decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SAG mRNA CTD PMID:23829299 NCBI chr 2:233,307,816...233,347,055
Ensembl chr 2:233,307,816...233,347,055
JBrowse link
G SALL2 spalt like transcription factor 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SALL2 mRNA CTD PMID:23829299 NCBI chr14:21,521,080...21,537,121
Ensembl chr14:21,521,080...21,537,216
JBrowse link
G SATB2 SATB homeobox 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SATB2 mRNA CTD PMID:25510870 NCBI chr 2:199,269,500...199,471,266
Ensembl chr 2:199,269,505...199,471,266
JBrowse link
G SBSPON somatomedin B and thrombospondin type 1 domain containing multiple interactions
increases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SBSPON mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SBSPON mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 8:73,064,543...73,093,172
Ensembl chr 8:73,064,543...73,124,088
JBrowse link
G SCAF4 SR-related CTD associated factor 4 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SCAF4 mRNA CTD PMID:23829299 NCBI chr21:31,671,000...31,732,118
Ensembl chr21:31,671,000...31,732,118
JBrowse link
G SCARF1 scavenger receptor class F member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SCARF1 mRNA CTD PMID:25510870 NCBI chr17:1,633,858...1,645,732
Ensembl chr17:1,633,858...1,645,744
JBrowse link
G SCD5 stearoyl-CoA desaturase 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SCD3 mRNA CTD PMID:25510870 NCBI chr 4:82,629,539...82,798,796
Ensembl chr 4:82,629,539...82,798,796
JBrowse link
G SCGB3A2 secretoglobin family 3A member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SCGB3A2 mRNA CTD PMID:25510870 NCBI chr 5:147,878,711...147,882,191
Ensembl chr 5:147,870,682...147,882,191
JBrowse link
G SCML2 Scm polycomb group protein like 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SCML2 mRNA CTD PMID:25510870 NCBI chr  X:18,239,313...18,355,118
Ensembl chr  X:18,239,313...18,354,688
JBrowse link
G SCN1A sodium voltage-gated channel alpha subunit 1 multiple interactions
increases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SCN1A mRNA; [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SCN1A protein
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SCN1A mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 2:165,984,641...166,149,161
Ensembl chr 2:165,984,641...166,182,806
JBrowse link
G SCN2A sodium voltage-gated channel alpha subunit 2 increases expression
multiple interactions
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SCN2A mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SCN2A mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 2:165,239,414...165,392,304
Ensembl chr 2:165,194,993...165,392,310
JBrowse link
G SCN4B sodium voltage-gated channel beta subunit 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SCN4B mRNA CTD PMID:25510870 NCBI chr11:118,133,377...118,152,823
Ensembl chr11:118,133,377...118,152,888
JBrowse link
G SCNN1A sodium channel epithelial 1 subunit alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SCNN1A mRNA CTD PMID:25510870 NCBI chr12:6,346,847...6,377,359
Ensembl chr12:6,346,843...6,377,730
JBrowse link
G SCP2D1 SCP2 sterol binding domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SCP2D1 mRNA CTD PMID:25510870 NCBI chr20:18,813,783...18,814,378
Ensembl chr20:18,813,783...18,814,378
JBrowse link
G SCRT2 scratch family transcriptional repressor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SCRT2 mRNA CTD PMID:25510870 NCBI chr20:661,596...675,802
Ensembl chr20:661,596...675,802
JBrowse link
G SCX scleraxis bHLH transcription factor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SCX mRNA CTD PMID:25510870 NCBI chr 8:144,266,453...144,268,481
Ensembl chr 8:144,266,453...144,268,481
JBrowse link
G SDE2 SDE2 telomere maintenance homolog decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SDE2 mRNA CTD PMID:23829299 NCBI chr 1:225,982,702...225,999,343
Ensembl chr 1:225,982,702...225,999,343
JBrowse link
G SDHA succinate dehydrogenase complex flavoprotein subunit A increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SDHA protein CTD PMID:21673325 NCBI chr 5:218,320...268,746
Ensembl chr 5:218,303...257,082
JBrowse link
G SEBOX SEBOX homeobox multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SEBOX mRNA CTD PMID:25510870 NCBI chr17:28,363,506...28,365,199
Ensembl chr17:28,363,506...28,365,199
JBrowse link
G SEC14L5 SEC14 like lipid binding 5 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SEC14L5 mRNA CTD PMID:23829299 NCBI chr16:4,958,330...5,019,157
Ensembl chr16:4,958,330...5,019,157
JBrowse link
G SEC16B SEC16 homolog B, endoplasmic reticulum export factor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SEC16B mRNA CTD PMID:25510870 NCBI chr 1:177,928,788...177,984,284
Ensembl chr 1:177,923,956...177,984,303
JBrowse link
G SELP selectin P multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SELP mRNA CTD PMID:25510870 NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
JBrowse link
G SEMA3A semaphorin 3A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SEMA3A mRNA CTD PMID:25510870 NCBI chr 7:83,955,777...84,492,725
Ensembl chr 7:83,955,777...84,492,724
JBrowse link
G SEMA6A semaphorin 6A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SEMA6A mRNA CTD PMID:25510870 NCBI chr 5:116,443,555...116,574,823
Ensembl chr 5:116,443,555...116,574,823
JBrowse link
G SENP1 SUMO specific peptidase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SENP1 mRNA CTD PMID:25510870 NCBI chr12:48,042,897...48,106,079
Ensembl chr12:48,039,784...48,106,079
JBrowse link
G SERINC2 serine incorporator 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SERINC2 mRNA CTD PMID:25510870 NCBI chr 1:31,409,777...31,434,678
Ensembl chr 1:31,409,565...31,434,680
JBrowse link
G SERPINA7 serpin family A member 7 decreases expression EXP 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SERPINA7 protein CTD PMID:19750101 NCBI chr  X:106,032,435...106,038,727
Ensembl chr  X:106,032,435...106,038,727
JBrowse link
G SERPING1 serpin family G member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SERPING1 mRNA CTD PMID:25510870 NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171
JBrowse link
G SERTAD3 SERTA domain containing 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SERTAD3 mRNA CTD PMID:23829299 NCBI chr19:40,440,844...40,444,335
Ensembl chr19:40,440,844...40,444,335
JBrowse link
G SETBP1 SET binding protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SETBP1 mRNA CTD PMID:25510870 NCBI chr18:44,680,073...45,068,510
Ensembl chr18:44,680,173...45,068,510
JBrowse link
G SFRP1 secreted frizzled related protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SFRP1 mRNA CTD PMID:25510870 NCBI chr 8:41,261,962...41,309,473
Ensembl chr 8:41,261,962...41,309,473
JBrowse link
G SFRP4 secreted frizzled related protein 4 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SFRP4 mRNA CTD PMID:23829299 NCBI chr 7:37,905,932...37,916,817
Ensembl chr 7:37,905,932...38,025,695
JBrowse link
G SFXN2 sideroflexin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SFXN2 mRNA CTD PMID:25510870 NCBI chr10:102,714,636...102,743,492
Ensembl chr10:102,714,538...102,743,492
JBrowse link
G SGK2 serum/glucocorticoid regulated kinase 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SGK2 mRNA CTD PMID:23829299 NCBI chr20:43,559,027...43,585,627
Ensembl chr20:43,558,968...43,588,237
JBrowse link
G SGMS1 sphingomyelin synthase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SGMS1 mRNA CTD PMID:25510870 NCBI chr10:50,305,600...50,625,184
Ensembl chr10:50,305,586...50,625,163
JBrowse link
G SGO1 shugoshin 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SGO1 mRNA CTD PMID:25510870 NCBI chr 3:20,160,593...20,186,886
Ensembl chr 3:20,160,593...20,186,206
JBrowse link
G SGSM2 small G protein signaling modulator 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SGSM2 mRNA CTD PMID:25510870 NCBI chr17:2,337,501...2,381,054
Ensembl chr17:2,337,498...2,381,058
JBrowse link
G SGSM3 small G protein signaling modulator 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SGSM3 mRNA CTD PMID:25510870 NCBI chr22:40,370,594...40,410,289
Ensembl chr22:40,370,591...40,410,289
JBrowse link
G SH2D2A SH2 domain containing 2A increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SH2D2A mRNA CTD PMID:23829299 NCBI chr 1:156,806,243...156,816,848
Ensembl chr 1:156,806,243...156,816,848
JBrowse link
G SH3GL2 SH3 domain containing GRB2 like 2, endophilin A1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SH3GL2 protein CTD PMID:21673325 NCBI chr 9:17,579,066...17,797,124
Ensembl chr 9:17,579,066...17,797,124
JBrowse link
G SH3RF2 SH3 domain containing ring finger 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SH3RF2 mRNA CTD PMID:23829299 NCBI chr 5:145,936,578...146,081,773
Ensembl chr 5:145,936,578...146,081,791
JBrowse link
G SH3RF3 SH3 domain containing ring finger 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SH3RF3 mRNA CTD PMID:25510870 NCBI chr 2:109,129,205...109,504,634
Ensembl chr 2:109,129,205...109,504,634
JBrowse link
G SH3TC2 SH3 domain and tetratricopeptide repeats 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SH3TC2 mRNA CTD PMID:23829299 NCBI chr 5:148,982,150...149,063,062
Ensembl chr 5:148,923,639...149,063,163
JBrowse link
G SHANK1 SH3 and multiple ankyrin repeat domains 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SHANK1 mRNA CTD PMID:25510870 NCBI chr19:50,659,255...50,719,802
Ensembl chr19:50,659,255...50,719,802
JBrowse link
G SHANK2 SH3 and multiple ankyrin repeat domains 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SHANK2 mRNA CTD PMID:25510870 NCBI chr11:70,467,854...71,253,228
Ensembl chr11:70,467,854...71,252,577
JBrowse link
G SHCBP1 SHC binding and spindle associated 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SHCBP1 mRNA CTD PMID:25510870 NCBI chr16:46,578,591...46,621,379
Ensembl chr16:46,578,591...46,621,379
JBrowse link
G SHE Src homology 2 domain containing E multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SHE mRNA CTD PMID:25510870 NCBI chr 1:154,469,637...154,502,412
Ensembl chr 1:154,469,772...154,502,412
JBrowse link
G SHISAL2B shisa like 2B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SHISAL2B mRNA CTD PMID:25510870 NCBI chr 5:64,690,503...64,718,190
Ensembl chr 5:64,690,442...64,718,190
JBrowse link
G SIRPB1 signal regulatory protein beta 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SIRPB1A mRNA CTD PMID:25510870 NCBI chr20:1,561,385...1,620,009
Ensembl chr20:1,561,385...1,620,061
JBrowse link
G SIRPG signal regulatory protein gamma multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SIRPB1B mRNA CTD PMID:25510870 NCBI chr20:1,629,152...1,686,455
Ensembl chr20:1,629,152...1,657,779
JBrowse link
G SKA1 spindle and kinetochore associated complex subunit 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SKA1 mRNA CTD PMID:25510870 NCBI chr18:50,375,046...50,394,168
Ensembl chr18:50,375,040...50,394,168
JBrowse link
G SKA3 spindle and kinetochore associated complex subunit 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SKA3 mRNA CTD PMID:25510870 NCBI chr13:21,153,595...21,176,552
Ensembl chr13:21,153,595...21,176,552
JBrowse link
G SLC12A5 solute carrier family 12 member 5 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SLC12A5 protein CTD PMID:21673325 NCBI chr20:46,021,686...46,060,150
Ensembl chr20:46,021,690...46,060,150
JBrowse link
G SLC12A8 solute carrier family 12 member 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC12A8 mRNA CTD PMID:25510870 NCBI chr 3:125,082,644...125,212,748
Ensembl chr 3:125,082,636...125,212,864
JBrowse link
G SLC16A11 solute carrier family 16 member 11 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SLC16A11 mRNA CTD PMID:23829299 NCBI chr17:7,041,621...7,044,092
Ensembl chr17:7,041,621...7,044,092
JBrowse link
G SLC16A6 solute carrier family 16 member 6 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SLC16A6 mRNA CTD PMID:23829299 NCBI chr17:68,267,026...68,291,479
Ensembl chr17:68,267,026...68,291,267
JBrowse link
G SLC16A7 solute carrier family 16 member 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC16A7 mRNA CTD PMID:25510870 NCBI chr12:59,596,029...59,789,841
Ensembl chr12:59,596,029...59,789,855
JBrowse link
G SLC16A8 solute carrier family 16 member 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC16A8 mRNA CTD PMID:25510870 NCBI chr22:38,078,137...38,084,184
Ensembl chr22:38,078,134...38,084,184
JBrowse link
G SLC17A6 solute carrier family 17 member 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC17A6 mRNA CTD PMID:25510870 NCBI chr11:22,338,381...22,379,503
Ensembl chr11:22,338,381...22,379,503
JBrowse link
G SLC17A7 solute carrier family 17 member 7 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SLC17A7 mRNA CTD PMID:23829299 NCBI chr19:49,429,401...49,441,527
Ensembl chr19:49,429,401...49,442,360
JBrowse link
G SLC18A2 solute carrier family 18 member A2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC18A2 mRNA CTD PMID:25510870 NCBI chr10:117,241,114...117,279,430
Ensembl chr10:117,241,093...117,279,430
JBrowse link
G SLC1A3 solute carrier family 1 member 3 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SLC1A3 protein CTD PMID:21673325 NCBI chr 5:36,606,606...36,688,334
Ensembl chr 5:36,596,588...36,688,334
JBrowse link
G SLC1A5 solute carrier family 1 member 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC1A5 mRNA CTD PMID:25510870 NCBI chr19:46,774,883...46,788,594
Ensembl chr19:46,774,883...46,788,594
JBrowse link
G SLC1A6 solute carrier family 1 member 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC1A6 mRNA CTD PMID:25510870 NCBI chr19:14,950,033...15,010,643
Ensembl chr19:14,950,033...15,022,990
JBrowse link
G SLC22A6 solute carrier family 22 member 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC22A6 mRNA CTD PMID:25510870 NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
JBrowse link
G SLC22A8 solute carrier family 22 member 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC22A8 mRNA CTD PMID:25510870 NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
JBrowse link
G SLC25A20 solute carrier family 25 member 20 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SLC25A20 mRNA CTD PMID:23829299 NCBI chr 3:48,856,926...48,898,882
Ensembl chr 3:48,856,926...48,898,904
JBrowse link
G SLC25A27 solute carrier family 25 member 27 multiple interactions
increases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC25A27 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SLC25A27 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr 6:46,652,975...46,678,190
Ensembl chr 6:46,652,915...46,678,190
JBrowse link
G SLC26A11 solute carrier family 26 member 11 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SLC26A11 mRNA CTD PMID:23829299 NCBI chr17:80,220,427...80,253,500
Ensembl chr17:80,219,699...80,253,500
JBrowse link
G SLC27A3 solute carrier family 27 member 3 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SLC27A3 mRNA CTD PMID:23829299 NCBI chr 1:153,775,407...153,780,157
Ensembl chr 1:153,774,354...153,780,157
JBrowse link
G SLC27A4 solute carrier family 27 member 4 affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of SLC27A4 mRNA CTD PMID:21703328 NCBI chr 9:128,340,527...128,361,470
Ensembl chr 9:128,340,527...128,361,470
JBrowse link
G SLC29A1 solute carrier family 29 member 1 (Augustine blood group) multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC29A1 mRNA CTD PMID:25510870 NCBI chr 6:44,219,615...44,234,142
Ensembl chr 6:44,219,553...44,234,142
JBrowse link
G SLC30A2 solute carrier family 30 member 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SLC30A2 mRNA CTD PMID:23829299 NCBI chr 1:26,037,252...26,046,118
Ensembl chr 1:26,037,252...26,046,118
JBrowse link
G SLC32A1 solute carrier family 32 member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC32A1 mRNA CTD PMID:25510870 NCBI chr20:38,724,486...38,729,372
Ensembl chr20:38,724,486...38,729,372
JBrowse link
G SLC35F3 solute carrier family 35 member F3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC35F3 mRNA CTD PMID:25510870 NCBI chr 1:233,904,676...234,324,511
Ensembl chr 1:233,904,676...234,324,511
JBrowse link
G SLC38A10 solute carrier family 38 member 10 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC38A10 mRNA CTD PMID:25510870 NCBI chr17:81,244,811...81,295,307
Ensembl chr17:81,244,811...81,295,547
JBrowse link
G SLC38A9 solute carrier family 38 member 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC38A9 mRNA CTD PMID:25510870 NCBI chr 5:55,625,845...55,712,335
Ensembl chr 5:55,625,845...55,773,194
JBrowse link
G SLC39A10 solute carrier family 39 member 10 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC39A10 mRNA CTD PMID:25510870 NCBI chr 2:195,613,029...195,737,700
Ensembl chr 2:195,575,977...195,737,702
JBrowse link
G SLC39A14 solute carrier family 39 member 14 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SLC39A14 mRNA CTD PMID:23829299 NCBI chr 8:22,367,278...22,434,129
Ensembl chr 8:22,367,278...22,434,129
JBrowse link
G SLC46A2 solute carrier family 46 member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC46A2 mRNA CTD PMID:25510870 NCBI chr 9:112,878,920...112,890,876
Ensembl chr 9:112,878,920...112,890,876
JBrowse link
G SLC4A10 solute carrier family 4 member 10 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC4A10 mRNA CTD PMID:25510870 NCBI chr 2:161,624,416...161,985,270
Ensembl chr 2:161,424,332...161,985,282
JBrowse link
G SLC4A5 solute carrier family 4 member 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC4A5 mRNA CTD PMID:25510870 NCBI chr 2:74,216,242...74,343,416
Ensembl chr 2:74,216,242...74,343,416
JBrowse link
G SLC51B SLC51 subunit beta multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC51B mRNA CTD PMID:25510870 NCBI chr15:65,045,387...65,053,397
Ensembl chr15:65,045,387...65,053,397
JBrowse link
G SLC5A1 solute carrier family 5 member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC5A1 mRNA CTD PMID:25510870 NCBI chr22:32,043,261...32,113,029
Ensembl chr22:32,043,261...32,113,029
JBrowse link
G SLC5A11 solute carrier family 5 member 11 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SLC5A11 mRNA CTD PMID:23829299 NCBI chr16:24,845,963...24,911,626
Ensembl chr16:24,845,841...24,911,628
JBrowse link
G SLC5A2 solute carrier family 5 member 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SLC5A2 mRNA CTD PMID:23829299 NCBI chr16:31,483,123...31,490,769
Ensembl chr16:31,483,002...31,490,860
JBrowse link
G SLC5A5 solute carrier family 5 member 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC5A5 mRNA CTD PMID:25510870 NCBI chr19:17,871,945...17,895,174
Ensembl chr19:17,871,945...17,895,174
JBrowse link
G SLC6A17 solute carrier family 6 member 17 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SLC6A17 mRNA CTD PMID:23829299 NCBI chr 1:110,150,494...110,202,202
Ensembl chr 1:110,150,494...110,202,202
JBrowse link
G SLC6A2 solute carrier family 6 member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC6A2 mRNA CTD PMID:25510870 NCBI chr16:55,655,988...55,706,192
Ensembl chr16:55,655,988...55,707,645
JBrowse link
G SLC6A8 solute carrier family 6 member 8 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SLC6A8 mRNA CTD PMID:23829299 NCBI chr  X:153,687,926...153,696,593
Ensembl chr  X:153,687,926...153,696,588
JBrowse link
G SLC7A1 solute carrier family 7 member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SLC7A1 mRNA CTD PMID:25510870 NCBI chr13:29,509,414...29,595,688
Ensembl chr13:29,509,414...29,595,688
JBrowse link
G SLC7A5 solute carrier family 7 member 5 multiple interactions ISO [2,5,2',5'-tetrachlorobiphenyl co-treated with 2,2',3,5',6-pentachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3,3',4',6-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of SLC7A5 mRNA
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC7A5 mRNA
CTD PMID:25510870 PMID:29142165 NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507
JBrowse link
G SLC7A6 solute carrier family 7 member 6 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SLC7A6 mRNA CTD PMID:23829299 NCBI chr16:68,264,526...68,301,819
Ensembl chr16:68,264,516...68,301,823
JBrowse link
G SLC8A1 solute carrier family 8 member A1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC8A1 mRNA CTD PMID:25510870 NCBI chr 2:40,097,270...40,512,435
Ensembl chr 2:40,097,270...40,611,053
JBrowse link
G SLC8B1 solute carrier family 8 member B1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC8B1 mRNA CTD PMID:25510870 NCBI chr12:113,298,771...113,335,109
Ensembl chr12:113,298,759...113,359,493
JBrowse link
G SLC9A7 solute carrier family 9 member A7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC9A7 mRNA CTD PMID:25510870 NCBI chr  X:46,599,251...46,759,118
Ensembl chr  X:46,599,251...46,759,118
JBrowse link
G SLCO1A2 solute carrier organic anion transporter family member 1A2 multiple interactions ISO [2,5,2',5'-tetrachlorobiphenyl co-treated with 2,2',3,5',6-pentachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3,3',4',6-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of SLCO1A2 mRNA CTD PMID:29142165 NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,594
JBrowse link
G SLCO2B1 solute carrier organic anion transporter family member 2B1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SLCO2B1 mRNA CTD PMID:23829299 NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549
JBrowse link
G SLCO4A1 solute carrier organic anion transporter family member 4A1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLCO4A1 mRNA CTD PMID:25510870 NCBI chr20:62,642,503...62,690,740
Ensembl chr20:62,642,503...62,685,785
JBrowse link
G SLITRK4 SLIT and NTRK like family member 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLITRK4 mRNA CTD PMID:25510870 NCBI chr  X:143,622,790...143,636,101
Ensembl chr  X:143,622,790...143,636,101
JBrowse link
G SMARCB1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of SMARCB1 mRNA CTD PMID:21703328 NCBI chr22:23,786,966...23,838,009
Ensembl chr22:23,786,931...23,838,009
JBrowse link
G SMARCD1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMARCD1 mRNA CTD PMID:25510870 NCBI chr12:50,085,342...50,100,707
Ensembl chr12:50,085,200...50,100,707
JBrowse link
G SMC2 structural maintenance of chromosomes 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMC2 mRNA CTD PMID:25510870 NCBI chr 9:104,088,263...104,141,419
Ensembl chr 9:104,094,260...104,141,419
JBrowse link
G SMC4 structural maintenance of chromosomes 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMC4 mRNA CTD PMID:25510870 NCBI chr 3:160,399,650...160,434,953
Ensembl chr 3:160,399,274...160,434,954
JBrowse link
G SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMCHD1 mRNA CTD PMID:25510870 NCBI chr18:2,655,726...2,805,017
Ensembl chr18:2,655,726...2,805,017
JBrowse link
G SMIM1 small integral membrane protein 1 (Vel blood group) multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMIM1 mRNA CTD PMID:25510870 NCBI chr 1:3,772,749...3,775,956
Ensembl chr 1:3,772,749...3,775,982
JBrowse link
G SMIM15 small integral membrane protein 15 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMIM15 mRNA CTD PMID:25510870 NCBI chr 5:61,157,704...61,162,468
Ensembl chr 5:61,157,704...61,162,468
JBrowse link
G SMIM20 small integral membrane protein 20 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMIM20 mRNA CTD PMID:25510870 NCBI chr 4:25,914,220...25,929,812
Ensembl chr 4:25,861,830...25,929,813
JBrowse link
G SMPD3 sphingomyelin phosphodiesterase 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMPD3 mRNA CTD PMID:25510870 NCBI chr16:68,358,327...68,448,508
Ensembl chr16:68,358,327...68,448,508
JBrowse link
G SMPX small muscle protein X-linked multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMPX mRNA CTD PMID:25510870 NCBI chr  X:21,705,978...21,758,116
Ensembl chr  X:21,705,978...21,758,116
JBrowse link
G SMYD1 SET and MYND domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMYD1 mRNA CTD PMID:25510870 NCBI chr 2:88,067,825...88,113,384
Ensembl chr 2:88,067,825...88,113,384
JBrowse link
G SNAP25 synaptosome associated protein 25 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SNAP25 protein CTD PMID:21673325 NCBI chr20:10,218,830...10,307,418
Ensembl chr20:10,172,395...10,308,258
JBrowse link
G SNAPIN SNAP associated protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SNAPIN mRNA CTD PMID:25510870 NCBI chr 1:153,658,654...153,661,852
Ensembl chr 1:153,658,703...153,661,852
JBrowse link
G SNCA synuclein alpha decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SNCA mRNA CTD PMID:23829299 NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
JBrowse link
G SNHG9 small nucleolar RNA host gene 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SNHG9 mRNA CTD PMID:25510870 NCBI chr16:1,964,996...1,965,504
Ensembl chr16:1,964,895...1,965,509
JBrowse link
G SNRK SNF related kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SNRK mRNA CTD PMID:25510870 NCBI chr 3:43,286,540...43,351,143
Ensembl chr 3:43,286,512...43,424,764
JBrowse link
G SNRNP35 small nuclear ribonucleoprotein U11/U12 subunit 35 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SNRNP35 mRNA CTD PMID:25510870 NCBI chr12:123,458,139...123,473,154
Ensembl chr12:123,458,088...123,473,154
JBrowse link
G SNRPF small nuclear ribonucleoprotein polypeptide F increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SNRPF mRNA CTD PMID:23829299 NCBI chr12:95,858,952...95,866,140
Ensembl chr12:95,858,952...95,903,828
JBrowse link
G SNTG1 syntrophin gamma 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SNTG1 mRNA CTD PMID:25510870 NCBI chr 8:49,909,796...50,796,692
Ensembl chr 8:49,909,789...50,796,692
JBrowse link
G SNX29 sorting nexin 29 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SNX29 mRNA CTD PMID:25510870 NCBI chr16:11,976,734...12,574,287
Ensembl chr16:11,976,734...12,574,287
JBrowse link
G SNX32 sorting nexin 32 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SNX32 mRNA CTD PMID:23829299 NCBI chr11:65,833,963...65,853,701
Ensembl chr11:65,833,834...65,856,896
JBrowse link
G SNX33 sorting nexin 33 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SNX33 mRNA CTD PMID:23829299 NCBI chr15:75,647,912...75,662,301
Ensembl chr15:75,647,912...75,662,301
JBrowse link
G SOCS2 suppressor of cytokine signaling 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SOCS2 mRNA CTD PMID:25510870 NCBI chr12:93,569,969...93,626,236
Ensembl chr12:93,569,814...93,583,487
JBrowse link
G SOD1 superoxide dismutase 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SOD1 protein CTD PMID:21673325 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
JBrowse link
G SORCS1 sortilin related VPS10 domain containing receptor 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SORCS1 mRNA CTD PMID:23829299 NCBI chr10:106,573,663...107,181,138
Ensembl chr10:106,573,663...107,164,706
JBrowse link
G SOSTDC1 sclerostin domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SOSTDC1 mRNA CTD PMID:25510870 NCBI chr 7:16,461,481...16,465,738
Ensembl chr 7:16,461,481...16,530,580
JBrowse link
G SOWAHA sosondowah ankyrin repeat domain family member A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SOWAHA mRNA CTD PMID:25510870 NCBI chr 5:132,813,302...132,816,786
Ensembl chr 5:132,813,302...132,816,786
JBrowse link
G SOX11 SRY-box transcription factor 11 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SOX11 mRNA CTD PMID:25510870 NCBI chr 2:5,692,384...5,701,385
Ensembl chr 2:5,692,384...5,701,385
JBrowse link
G SOX12 SRY-box transcription factor 12 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SOX12 mRNA CTD PMID:23829299 NCBI chr20:325,552...330,224
Ensembl chr20:325,552...330,224
JBrowse link
G SOX14 SRY-box transcription factor 14 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SOX14 mRNA CTD PMID:25510870 NCBI chr 3:137,764,315...137,766,334
Ensembl chr 3:137,764,315...137,766,334
JBrowse link
G SOX6 SRY-box transcription factor 6 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SOX6 mRNA CTD PMID:23829299 NCBI chr11:15,966,449...16,738,477
Ensembl chr11:15,966,449...16,739,591
JBrowse link
G SP110 SP110 nuclear body protein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SP110 mRNA CTD PMID:23829299 NCBI chr 2:230,165,186...230,225,636
Ensembl chr 2:230,165,186...230,225,729
JBrowse link
G SPACA5 sperm acrosome associated 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPACA5 mRNA CTD PMID:25510870 NCBI chr  X:48,004,336...48,009,733
Ensembl chr  X:48,004,336...48,009,733
JBrowse link
G SPATA13 spermatogenesis associated 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPATA13 mRNA CTD PMID:25510870 NCBI chr13:23,979,802...24,307,069
Ensembl chr13:23,979,805...24,307,074
Ensembl chr13:23,979,805...24,307,074
JBrowse link
G SPATA19 spermatogenesis associated 19 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPATA19 mRNA CTD PMID:25510870 NCBI chr11:133,835,930...133,845,513
Ensembl chr11:133,840,631...133,845,538
JBrowse link
G SPATA20 spermatogenesis associated 20 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPATA20 mRNA CTD PMID:25510870 NCBI chr17:50,547,174...50,555,852
Ensembl chr17:50,543,058...50,555,852
JBrowse link
G SPATA45 spermatogenesis associated 45 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPATA45 mRNA CTD PMID:25510870 NCBI chr 1:212,830,141...212,847,649
Ensembl chr 1:212,830,141...212,847,649
JBrowse link
G SPATC1 spermatogenesis and centriole associated 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPATC1 mRNA CTD PMID:25510870 NCBI chr 8:144,010,977...144,047,114
Ensembl chr 8:144,012,280...144,047,114
JBrowse link
G SPC24 SPC24 component of NDC80 kinetochore complex multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPC24 mRNA CTD PMID:25510870 NCBI chr19:11,145,493...11,155,782
Ensembl chr19:11,131,520...11,155,807
JBrowse link
G SPC25 SPC25 component of NDC80 kinetochore complex multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPC25 mRNA CTD PMID:25510870 NCBI chr 2:168,861,521...168,890,430
Ensembl chr 2:168,834,132...168,913,371
JBrowse link
G SPCS2 signal peptidase complex subunit 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPCS2 mRNA CTD PMID:25510870 NCBI chr11:74,949,266...74,979,033
Ensembl chr11:74,949,261...74,979,033
JBrowse link
G SPDL1 spindle apparatus coiled-coil protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPDL1 mRNA CTD PMID:25510870 NCBI chr 5:169,583,773...169,604,778
Ensembl chr 5:169,583,636...169,604,778
JBrowse link
G SPIN1 spindlin 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPIN1 mRNA CTD PMID:25510870 NCBI chr 9:88,388,444...88,478,694
Ensembl chr 9:88,388,430...88,478,694
JBrowse link
G SPINT1 serine peptidase inhibitor, Kunitz type 1 multiple interactions
decreases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPINT1 mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SPINT1 mRNA
CTD PMID:23829299 PMID:25510870 NCBI chr15:40,844,048...40,858,207
Ensembl chr15:40,844,018...40,858,207
JBrowse link
G SPINT3 serine peptidase inhibitor, Kunitz type 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPINT3 mRNA CTD PMID:25510870 NCBI chr20:45,512,461...45,515,622
Ensembl chr20:45,512,461...45,515,622
JBrowse link
G SPINT4 serine peptidase inhibitor, Kunitz type 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPINT4 mRNA CTD PMID:25510870 NCBI chr20:45,722,347...45,725,830
Ensembl chr20:45,722,347...45,725,830
JBrowse link
G SPOCK1 SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPOCK1 mRNA CTD PMID:25510870 NCBI chr 5:136,975,298...137,499,326
Ensembl chr 5:136,975,298...137,598,379
JBrowse link
G SPOCK3 SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPOCK3 mRNA CTD PMID:25510870 NCBI chr 4:166,733,384...167,234,945
Ensembl chr 4:166,733,384...167,234,796
JBrowse link
G SPON1 spondin 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPON1 mRNA CTD PMID:25510870 NCBI chr11:13,962,723...14,268,133
Ensembl chr11:13,962,723...14,268,133
JBrowse link
G SPOP speckle type BTB/POZ protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPOP mRNA CTD PMID:25510870 NCBI chr17:49,598,884...49,678,163
Ensembl chr17:49,598,884...49,678,163
JBrowse link
G SPRR2F small proline rich protein 2F multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPRR2F mRNA CTD PMID:25510870 NCBI chr 1:153,112,121...153,119,468
Ensembl chr 1:153,112,121...153,113,516
JBrowse link
G SPRY4 sprouty RTK signaling antagonist 4 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SPRY4 mRNA CTD PMID:23829299 NCBI chr 5:142,310,430...142,325,021
Ensembl chr 5:142,310,427...142,326,455
JBrowse link
G SPTA1 spectrin alpha, erythrocytic 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPTA1 mRNA CTD PMID:25510870 NCBI chr 1:158,610,704...158,686,715
Ensembl chr 1:158,610,704...158,686,715
JBrowse link
G SPTAN1 spectrin alpha, non-erythrocytic 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SPTAN1 protein CTD PMID:21673325 NCBI chr 9:128,552,587...128,633,662
Ensembl chr 9:128,552,558...128,633,662
JBrowse link
G SPTBN2 spectrin beta, non-erythrocytic 2 increases expression
decreases expression
ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SPTBN2 protein
2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SPTBN2 mRNA
CTD PMID:21673325 PMID:23829299 NCBI chr11:66,682,497...66,744,682
Ensembl chr11:66,682,496...66,744,670
JBrowse link
G SPTLC3 serine palmitoyltransferase long chain base subunit 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPTLC3 mRNA CTD PMID:25510870 NCBI chr20:13,008,972...13,169,103
Ensembl chr20:13,008,972...13,169,103
JBrowse link
G SQSTM1 sequestosome 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SQSTM1 mRNA CTD PMID:23829299 NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
JBrowse link
G SRD5A1 steroid 5 alpha-reductase 1 multiple interactions ISO [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] affects the expression of SRD5A1 protein CTD PMID:19464308 NCBI chr 5:6,633,440...6,674,386
Ensembl chr 5:6,633,290...6,676,539
JBrowse link
G SRD5A2 steroid 5 alpha-reductase 2 multiple interactions ISO [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] affects the expression of SRD5A2 protein CTD PMID:19464308 NCBI chr 2:31,522,480...31,663,009
Ensembl chr 2:31,522,480...31,580,938
JBrowse link
G SRGAP2 SLIT-ROBO Rho GTPase activating protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SRGAP2 mRNA CTD PMID:25510870 NCBI chr 1:206,203,541...206,464,436
Ensembl chr 1:206,203,346...206,464,436
JBrowse link
G SRRM4 serine/arginine repetitive matrix 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SRRM4 mRNA CTD PMID:25510870 NCBI chr12:118,981,541...119,163,051
Ensembl chr12:118,981,541...119,163,051
JBrowse link
G SRSF6 serine and arginine rich splicing factor 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SRSF6 mRNA CTD PMID:25510870 NCBI chr20:43,457,896...43,464,243
Ensembl chr20:43,457,893...43,466,046
JBrowse link
G SS18L1 SS18L1 subunit of BAF chromatin remodeling complex decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SS18L1 mRNA CTD PMID:23829299 NCBI chr20:62,143,769...62,182,514
Ensembl chr20:62,143,769...62,182,514
JBrowse link
G SSMEM1 serine rich single-pass membrane protein 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SSMEM1 mRNA CTD PMID:23829299 NCBI chr 7:130,205,410...130,216,844
Ensembl chr 7:130,206,344...130,216,844
JBrowse link
G SST somatostatin multiple interactions ISO [2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased expression of SST mRNA CTD PMID:19327374 NCBI chr 3:187,668,912...187,670,394
Ensembl chr 3:187,668,912...187,670,394
JBrowse link
G SSTR3 somatostatin receptor 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SSTR3 mRNA CTD PMID:25510870 NCBI chr22:37,204,237...37,220,548
Ensembl chr22:37,204,237...37,212,477
JBrowse link
G ST6GAL1 ST6 beta-galactoside alpha-2,6-sialyltransferase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ST6GAL1 mRNA CTD PMID:25510870 NCBI chr 3:186,930,526...187,078,553
Ensembl chr 3:186,930,325...187,078,553
JBrowse link
G ST6GALNAC6 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST6GALNAC6 mRNA CTD PMID:25510870 NCBI chr 9:127,885,321...127,906,616
Ensembl chr 9:127,885,321...127,905,408
JBrowse link
G ST8SIA2 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ST8SIA2 mRNA CTD PMID:25510870 NCBI chr15:92,393,881...92,468,728
Ensembl chr15:92,393,881...92,468,728
JBrowse link
G ST8SIA5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST8SIA5 mRNA CTD PMID:25510870 NCBI chr18:46,667,821...46,757,053
Ensembl chr18:46,667,821...46,759,257
JBrowse link
G STAB2 stabilin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STAB2 mRNA CTD PMID:25510870 NCBI chr12:103,587,273...103,766,719
Ensembl chr12:103,587,273...103,766,719
JBrowse link
G STARD8 StAR related lipid transfer domain containing 8 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of STARD8 mRNA CTD PMID:23829299 NCBI chr  X:68,647,666...68,725,836
Ensembl chr  X:68,647,666...68,725,842
JBrowse link
G STAU2 staufen double-stranded RNA binding protein 2 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of STAU2 mRNA CTD PMID:23829299 NCBI chr 8:73,420,369...73,747,480
Ensembl chr 8:73,420,369...73,747,708
JBrowse link
G STIL STIL centriolar assembly protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STIL mRNA CTD PMID:25510870 NCBI chr 1:47,250,139...47,314,896
Ensembl chr 1:47,250,139...47,314,892
JBrowse link
G STK35 serine/threonine kinase 35 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of STK35 mRNA CTD PMID:25510870 NCBI chr20:2,101,827...2,148,555
Ensembl chr20:2,101,827...2,177,038
JBrowse link
G STK38 serine/threonine kinase 38 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STK38 mRNA CTD PMID:25510870 NCBI chr 6:36,493,892...36,547,479
Ensembl chr 6:36,493,892...36,547,479
JBrowse link
G STK39 serine/threonine kinase 39 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of STK39 mRNA CTD PMID:23829299 NCBI chr 2:167,954,022...168,247,595
Ensembl chr 2:167,954,020...168,247,595
JBrowse link
G STRIP2 striatin interacting protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of STRIP2 mRNA CTD PMID:25510870 NCBI chr 7:129,434,432...129,488,399
Ensembl chr 7:129,434,432...129,488,399
JBrowse link
G STX1B syntaxin 1B multiple interactions
increases expression
ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of STX1B mRNA
2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of STX1B protein
CTD PMID:21673325 PMID:25510870 NCBI chr16:30,989,256...31,010,638
Ensembl chr16:30,989,256...31,010,638
JBrowse link
G STXBP5L syntaxin binding protein 5L multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of STXBP5L mRNA CTD PMID:25510870 NCBI chr 3:120,908,205...121,424,761
Ensembl chr 3:120,908,072...121,424,761
JBrowse link
G SUDS3 SDS3 homolog, SIN3A corepressor complex component decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SUDS3 mRNA CTD PMID:23829299 NCBI chr12:118,376,555...118,418,033
Ensembl chr12:118,376,555...118,418,033
JBrowse link
G SUGP1 SURP and G-patch domain containing 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SUGP1 mRNA CTD PMID:23829299 NCBI chr19:19,276,033...19,320,509
Ensembl chr19:19,276,018...19,320,509
JBrowse link
G SULT1C2 sulfotransferase family 1C member 2 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SULT1C2 mRNA CTD PMID:23829299 NCBI chr 2:108,288,895...108,309,915
Ensembl chr 2:108,288,639...108,309,915
JBrowse link
G SULT2B1 sulfotransferase family 2B member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SULT2B1 mRNA CTD PMID:25510870 NCBI chr19:48,552,172...48,599,427
Ensembl chr19:48,552,172...48,599,425
JBrowse link
G SUPT20H SPT20 homolog, SAGA complex component multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SUPT20 mRNA CTD PMID:25510870 NCBI chr13:37,009,312...37,059,688
Ensembl chr13:37,009,312...37,059,713
JBrowse link
G SUPT6H SPT6 homolog, histone chaperone and transcription elongation factor increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SUPT6H mRNA CTD PMID:23829299 NCBI chr17:28,662,205...28,702,679
Ensembl chr17:28,662,198...28,702,679
JBrowse link
G SURF6 surfeit 6 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SURF6 mRNA CTD PMID:23829299 NCBI chr 9:133,328,776...133,336,188
Ensembl chr 9:133,328,776...133,336,188
JBrowse link
G SUSD4 sushi domain containing 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SUSD4 mRNA CTD PMID:25510870 NCBI chr 1:223,220,831...223,365,235
Ensembl chr 1:223,220,819...223,364,233
JBrowse link
G SV2A synaptic vesicle glycoprotein 2A decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SV2A protein CTD PMID:21673325 NCBI chr 1:149,903,318...149,917,844
Ensembl chr 1:149,903,318...149,917,844
JBrowse link
G SV2C synaptic vesicle glycoprotein 2C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SV2C mRNA CTD PMID:25510870 NCBI chr 5:75,847,464...76,353,939
Ensembl chr 5:76,083,383...76,353,939
JBrowse link
G SWI5 SWI5 homologous recombination repair protein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SWI5 mRNA CTD PMID:23829299 NCBI chr 9:128,275,356...128,288,989
Ensembl chr 9:128,275,379...128,316,123
JBrowse link
G SYNE2 spectrin repeat containing nuclear envelope protein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SYNE2 mRNA CTD PMID:25510870 NCBI chr14:63,761,596...64,226,449
Ensembl chr14:63,761,899...64,226,433
JBrowse link
G SYP synaptophysin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with APP protein modified form] results in decreased expression of SYP protein CTD PMID:26480858 NCBI chr  X:49,187,815...49,200,193
Ensembl chr  X:49,187,815...49,200,218
JBrowse link
G SYT10 synaptotagmin 10 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SYT10 mRNA CTD PMID:25510870 NCBI chr12:33,374,238...33,439,819
Ensembl chr12:33,374,238...33,439,819
JBrowse link
G SYT2 synaptotagmin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SYT2 mRNA CTD PMID:25510870 NCBI chr 1:202,590,596...202,710,454
Ensembl chr 1:202,590,596...202,710,454
JBrowse link
G SYTL2 synaptotagmin like 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SYTL2 mRNA CTD PMID:23829299 NCBI chr11:85,694,229...85,854,870
Ensembl chr11:85,694,224...85,811,159
JBrowse link
G SYTL5 synaptotagmin like 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SYTL5 mRNA CTD PMID:25510870 NCBI chr  X:37,888,915...38,128,820
Ensembl chr  X:38,006,553...38,128,819
JBrowse link
G TAC1 tachykinin precursor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TAC1 mRNA CTD PMID:25510870 NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
JBrowse link
G TACC3 transforming acidic coiled-coil containing protein 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TACC3 mRNA CTD PMID:25510870 NCBI chr 4:1,721,521...1,745,171
Ensembl chr 4:1,712,858...1,745,171
JBrowse link
G TACSTD2 tumor associated calcium signal transducer 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TACSTD2 mRNA CTD PMID:25510870 NCBI chr 1:58,575,433...58,577,252
Ensembl chr 1:58,575,433...58,577,252
JBrowse link
G TAMALIN trafficking regulator and scaffold protein tamalin decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TAMALIN mRNA CTD PMID:23829299 NCBI chr12:52,006,946...52,015,889
Ensembl chr12:52,006,946...52,015,889
JBrowse link
G TANC1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TANC1 mRNA CTD PMID:25510870 NCBI chr 2:158,968,640...159,232,659
Ensembl chr 2:158,968,640...159,232,659
JBrowse link
G TAP2 transporter 2, ATP binding cassette subfamily B member decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TAP2 mRNA CTD PMID:23829299 NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739
JBrowse link
G TAS1R3 taste 1 receptor member 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TAS1R3 mRNA CTD PMID:25510870 NCBI chr 1:1,331,280...1,335,314
Ensembl chr 1:1,331,280...1,335,314
JBrowse link
G TAS2R1 taste 2 receptor member 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TAS2R119 mRNA CTD PMID:25510870 NCBI chr 5:9,627,347...9,903,876
Ensembl chr 5:9,627,347...9,712,378
JBrowse link
G TATDN1 TatD DNase domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TATDN1 mRNA CTD PMID:25510870 NCBI chr 8:124,488,494...124,539,088
Ensembl chr 8:124,488,485...124,539,458
JBrowse link
G TBATA thymus, brain and testes associated multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TBATA mRNA CTD PMID:25510870 NCBI chr10:70,771,238...70,785,377
Ensembl chr10:70,771,238...70,785,401
JBrowse link
G TBC1D10A TBC1 domain family member 10A decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TBC1D10A mRNA CTD PMID:23829299 NCBI chr22:30,291,990...30,326,941
Ensembl chr22:30,291,990...30,326,947
JBrowse link
G TBC1D20 TBC1 domain family member 20 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TBC1D20 mRNA CTD PMID:25510870 NCBI chr20:435,480...462,533
Ensembl chr20:423,596...462,566
JBrowse link
G TBC1D21 TBC1 domain family member 21 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TBC1D21 mRNA CTD PMID:25510870 NCBI chr15:73,873,564...73,910,024
Ensembl chr15:73,873,564...73,889,214
JBrowse link
G TBC1D32 TBC1 domain family member 32 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TBC1D32 mRNA CTD PMID:25510870 NCBI chr 6:121,079,494...121,334,729
Ensembl chr 6:121,079,494...121,334,745
JBrowse link
G TBC1D4 TBC1 domain family member 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TBC1D4 mRNA CTD PMID:25510870 NCBI chr13:75,283,503...75,482,169
Ensembl chr13:75,283,503...75,482,169
JBrowse link
G TBCK TBC1 domain containing kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TBCK mRNA CTD PMID:25510870 NCBI chr 4:106,041,599...106,316,683
Ensembl chr 4:106,041,599...106,316,683
JBrowse link
G TBR1 T-box brain transcription factor 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TBR1 mRNA CTD PMID:23829299 NCBI chr 2:161,416,297...161,425,870
Ensembl chr 2:161,416,297...161,425,870
JBrowse link
G TCERG1L transcription elongation regulator 1 like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TCERG1L mRNA CTD PMID:25510870 NCBI chr10:131,092,391...131,311,721
Ensembl chr10:131,092,391...131,311,721
JBrowse link
G TCHP trichoplein keratin filament binding multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TCHP mRNA CTD PMID:25510870 NCBI chr12:109,880,667...109,918,069
Ensembl chr12:109,900,264...109,983,841
JBrowse link
G TDRD6 tudor domain containing 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TDRD6 mRNA CTD PMID:25510870 NCBI chr 6:46,680,268...46,704,319
Ensembl chr 6:46,687,875...46,704,319
JBrowse link
G TDRKH tudor and KH domain containing increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of TDRKH mRNA CTD PMID:23829299 NCBI chr 1:151,766,486...151,790,534
Ensembl chr 1:151,770,107...151,791,416
JBrowse link
G TEAD2 TEA domain transcription factor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TEAD2 mRNA CTD PMID:25510870 NCBI chr19:49,340,595...49,362,416
Ensembl chr19:49,340,595...49,362,457
JBrowse link
G TEAD3 TEA domain transcription factor 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TEAD3 mRNA CTD PMID:23829299 NCBI chr 6:35,473,597...35,497,079
Ensembl chr 6:35,473,597...35,497,079
JBrowse link
G TEKT2 tektin 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TEKT2 mRNA CTD PMID:23829299 NCBI chr 1:36,084,094...36,088,275
Ensembl chr 1:36,084,094...36,088,275
JBrowse link
G TESC tescalcin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TESC mRNA CTD PMID:25510870 NCBI chr12:117,038,923...117,099,416
Ensembl chr12:117,038,923...117,099,479
JBrowse link
G TESMIN testis expressed metallothionein like protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TESMIN mRNA CTD PMID:25510870 NCBI chr11:68,704,796...68,751,520
Ensembl chr11:68,707,440...68,751,520
JBrowse link
G TEX2 testis expressed 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TEX2 mRNA CTD PMID:25510870 NCBI chr17:64,147,227...64,263,260
Ensembl chr17:64,147,227...64,263,260
JBrowse link
G TEX22 testis expressed 22 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TEX22 mRNA CTD PMID:25510870 NCBI chr14:105,398,538...105,413,859
Ensembl chr14:105,398,538...105,450,106
JBrowse link
G TEX30 testis expressed 30 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TEX30 mRNA CTD PMID:25510870 NCBI chr13:102,765,888...102,773,786
Ensembl chr13:102,765,888...102,773,811
JBrowse link
G TFAP2C transcription factor AP-2 gamma multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TFAP2C mRNA CTD PMID:25510870 NCBI chr20:56,629,306...56,639,283
Ensembl chr20:56,629,306...56,639,283
JBrowse link
G TFAP4 transcription factor AP-4 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TFAP4 mRNA CTD PMID:23829299 NCBI chr16:4,257,186...4,273,023
Ensembl chr16:4,257,186...4,273,075
JBrowse link
G TFEC transcription factor EC multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TFEC mRNA CTD PMID:25510870 NCBI chr 7:115,935,152...116,159,896
Ensembl chr 7:115,935,148...116,159,896
JBrowse link
G TFF3 trefoil factor 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TFF3 mRNA CTD PMID:25510870 NCBI chr21:42,311,667...42,315,409
Ensembl chr21:42,311,667...42,315,409
JBrowse link
G TFR2 transferrin receptor 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TFR2 mRNA CTD PMID:23829299 NCBI chr 7:100,620,420...100,641,552
Ensembl chr 7:100,620,416...100,642,779
JBrowse link
G TG thyroglobulin multiple interactions EXP [Industrial Waste results in increased abundance of 2,2',3',4,4',5-hexachlorobiphenyl] which results in decreased expression of TG protein CTD PMID:31454572 NCBI chr 8:132,866,958...133,134,899
Ensembl chr 8:132,866,958...133,134,903
JBrowse link
G TGFA transforming growth factor alpha multiple interactions ISO [2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TGFA mRNA CTD PMID:21277884 NCBI chr 2:70,447,284...70,553,826
Ensembl chr 2:70,447,284...70,554,193
JBrowse link
G TGFB1 transforming growth factor beta 1 multiple interactions ISO [2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TGFB1 mRNA CTD PMID:21190954 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
JBrowse link
G TGFBRAP1 transforming growth factor beta receptor associated protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TGFBRAP1 mRNA CTD PMID:25510870 NCBI chr 2:105,249,404...105,329,735
Ensembl chr 2:105,264,391...105,329,735
JBrowse link
G TGM6 transglutaminase 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TGM6 mRNA CTD PMID:25510870 NCBI chr20:2,380,901...2,432,753
Ensembl chr20:2,380,901...2,432,753
JBrowse link
G THEM6 thioesterase superfamily member 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of THEM6 mRNA CTD PMID:25510870 NCBI chr 8:142,727,223...142,736,927
Ensembl chr 8:142,727,223...142,736,927
JBrowse link
G THNSL2 threonine synthase like 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of THNSL2 mRNA CTD PMID:25510870 NCBI chr 2:88,170,346...88,186,627
Ensembl chr 2:88,170,295...88,186,636
JBrowse link
G THPO thrombopoietin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of THPO mRNA CTD PMID:25510870 NCBI chr 3:184,371,935...184,379,688
Ensembl chr 3:184,371,935...184,381,968
JBrowse link
G THRA thyroid hormone receptor alpha multiple interactions EXP [Industrial Waste results in increased abundance of 2,2',3',4,4',5-hexachlorobiphenyl] which results in decreased expression of THRA mRNA CTD PMID:31454572 NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867
JBrowse link
G THY1 Thy-1 cell surface antigen multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of THY1 mRNA CTD PMID:25510870 NCBI chr11:119,415,476...119,424,985
Ensembl chr11:119,415,476...119,424,985
JBrowse link
G TIA1 TIA1 cytotoxic granule associated RNA binding protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TIA1 mRNA CTD PMID:25510870 NCBI chr 2:70,209,444...70,248,793
Ensembl chr 2:70,209,444...70,248,660
JBrowse link
G TICRR TOPBP1 interacting checkpoint and replication regulator multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TICRR mRNA CTD PMID:25510870 NCBI chr15:89,575,469...89,628,023
Ensembl chr15:89,575,469...89,631,056
JBrowse link
G TIE1 tyrosine kinase with immunoglobulin like and EGF like domains 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TIE1 mRNA CTD PMID:25510870 NCBI chr 1:43,300,982...43,323,108
Ensembl chr 1:43,300,982...43,323,108
JBrowse link
G TIMELESS timeless circadian regulator multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TIMELESS mRNA CTD PMID:25510870 NCBI chr12:56,416,363...56,449,426
Ensembl chr12:56,416,363...56,449,426
JBrowse link
G TIMM10B translocase of inner mitochondrial membrane 10B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TIMM10B mRNA CTD PMID:25510870 NCBI chr11:6,481,501...6,484,681
Ensembl chr11:6,481,501...6,484,681
JBrowse link
G TIMM8B translocase of inner mitochondrial membrane 8 homolog B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TIMM8B mRNA CTD PMID:25510870 NCBI chr11:112,084,800...112,086,756
Ensembl chr11:112,084,800...112,086,798
JBrowse link
G TIMMDC1 translocase of inner mitochondrial membrane domain containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TIMMDC1 mRNA CTD PMID:25510870 NCBI chr 3:119,498,547...119,525,090
Ensembl chr 3:119,498,547...119,525,090
JBrowse link
G TIMP4 TIMP metallopeptidase inhibitor 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TIMP4 mRNA CTD PMID:25510870 NCBI chr 3:12,153,068...12,158,912
Ensembl chr 3:12,153,068...12,158,912
JBrowse link
G TJP3 tight junction protein 3 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TJP3 mRNA CTD PMID:23829299 NCBI chr19:3,708,384...3,750,813
Ensembl chr19:3,708,362...3,750,813
JBrowse link
G TK1 thymidine kinase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TK1 mRNA CTD PMID:25510870 NCBI chr17:78,174,079...78,187,204
Ensembl chr17:78,174,091...78,187,233
JBrowse link
G TKT transketolase decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TKT protein CTD PMID:21673325 NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052
JBrowse link
G TLL1 tolloid like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TLL1 mRNA CTD PMID:25510870 NCBI chr 4:165,873,237...166,104,457
Ensembl chr 4:165,873,237...166,104,457
JBrowse link
G TLN2 talin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TLN2 mRNA CTD PMID:25510870 NCBI chr15:62,390,550...62,844,631
Ensembl chr15:62,390,526...62,844,631
JBrowse link
G TM4SF20 transmembrane 4 L six family member 20 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TM4SF20 mRNA CTD PMID:25510870 NCBI chr 2:227,362,038...227,381,647
Ensembl chr 2:227,362,038...227,381,995
JBrowse link
G TM6SF2 transmembrane 6 superfamily member 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TM6SF2 mRNA CTD PMID:25510870 NCBI chr19:19,264,366...19,273,301
Ensembl chr19:19,264,364...19,273,391
JBrowse link
G TMED5 transmembrane p24 trafficking protein 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TMED5 mRNA CTD PMID:25510870 NCBI chr 1:93,149,742...93,180,413
Ensembl chr 1:93,149,742...93,180,516
JBrowse link
G TMED9 transmembrane p24 trafficking protein 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TMED9 mRNA CTD PMID:25510870 NCBI chr 5:177,592,203...177,597,242
Ensembl chr 5:177,592,203...177,597,242
JBrowse link
G TMEM130 transmembrane protein 130 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TMEM130 mRNA CTD PMID:25510870 NCBI chr 7:98,846,490...98,870,014
Ensembl chr 7:98,846,488...98,870,771
JBrowse link
G TMEM132E transmembrane protein 132E multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TMEM132E mRNA CTD PMID:25510870 NCBI chr17:34,579,582...34,639,318
Ensembl chr17:34,579,487...34,639,318
JBrowse link
G TMEM160 transmembrane protein 160 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TMEM160 mRNA CTD PMID:25510870 NCBI chr19:47,045,909...47,048,624
Ensembl chr19:47,045,909...47,048,624
JBrowse link
G TMEM163 transmembrane protein 163 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TMEM163 mRNA CTD PMID:25510870 NCBI chr 2:134,455,759...134,719,000
Ensembl chr 2:134,455,759...134,719,000
JBrowse link
G TMEM171 transmembrane protein 171 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TMEM171 mRNA CTD PMID:25510870 NCBI chr 5:73,120,575...73,131,809
Ensembl chr 5:73,120,569...73,131,809
JBrowse link
G TMEM179 transmembrane protein 179 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TMEM179 mRNA CTD PMID:25510870 NCBI chr14:104,590,864...104,604,772
Ensembl chr14:104,474,678...104,605,647
JBrowse link
G TMEM181 transmembrane protein 181 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TMEM181A mRNA CTD PMID:25510870 NCBI chr 6:158,536,640...158,635,429
Ensembl chr 6:158,536,436...158,635,433
JBrowse link
G TMEM229B transmembrane protein 229B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TMEM229B mRNA CTD PMID:25510870 NCBI chr14:67,470,269...67,533,850
Ensembl chr14:67,447,084...67,533,739
JBrowse link
G TMEM252 transmembrane protein 252 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TMEM252 mRNA CTD PMID:25510870 NCBI chr 9:68,536,580...68,540,883
Ensembl chr 9:68,536,580...68,540,883
JBrowse link
G TMEM255A transmembrane protein 255A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TMEM255A mRNA CTD PMID:25510870 NCBI chr  X:120,251,433...120,311,461
Ensembl chr  X:120,258,650...120,311,556
JBrowse link
G TMEM273 transmembrane protein 273 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TMEM273 mRNA CTD PMID:23829299 NCBI chr10:49,154,736...49,188,391
Ensembl chr10:49,154,725...49,188,585
JBrowse link
G TMEM38A transmembrane protein 38A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TMEM38A mRNA CTD PMID:25510870 NCBI chr19:16,661,139...16,690,023
Ensembl chr19:16,661,139...16,690,023
JBrowse link
G TMEM45B transmembrane protein 45B increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of TMEM45B mRNA CTD PMID:23829299 NCBI chr11:129,815,848...129,860,003
Ensembl chr11:129,815,848...129,860,003
JBrowse link
G TMPRSS11A transmembrane serine protease 11A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TMPRSS11A mRNA CTD PMID:25510870 NCBI chr 4:67,909,395...67,963,493
Ensembl chr 4:67,909,395...67,964,140
JBrowse link
G TMPRSS13 transmembrane serine protease 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TMPRSS13 mRNA CTD PMID:25510870 NCBI chr11:117,900,641...117,929,402
Ensembl chr11:117,900,641...117,929,459
JBrowse link
G TMPRSS2 transmembrane serine protease 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TMPRSS2 mRNA CTD PMID:25510870 NCBI chr21:41,529,791...41,531,118
Ensembl chr21:41,464,300...41,531,116
JBrowse link
G TMTC3 transmembrane O-mannosyltransferase targeting cadherins 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TMTC3 mRNA CTD PMID:25510870 NCBI chr12:88,142,307...88,199,887
Ensembl chr12:88,142,296...88,199,887
JBrowse link
G TNF tumor necrosis factor multiple interactions ISO 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [TNF protein results in decreased expression of BCL2L1 protein]; 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [TNF protein results in decreased expression of BIRC5 protein]; 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [TNF protein results in increased cleavage of CASP3 protein]; 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [TNF protein results in increased degradation of RIPK1 protein] CTD PMID:29704545 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TNFRSF8 TNF receptor superfamily member 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TNFRSF8 mRNA CTD PMID:25510870 NCBI chr 1:12,063,303...12,144,207
Ensembl chr 1:12,063,303...12,144,207
JBrowse link
G TNFRSF9 TNF receptor superfamily member 9 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TNFRSF9 mRNA CTD PMID:25510870 NCBI chr 1:7,915,871...7,940,839
Ensembl chr 1:7,915,871...7,943,165
JBrowse link
G TNFSF12 TNF superfamily member 12 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TNFSF12 mRNA CTD PMID:25510870 NCBI chr17:7,549,058...7,557,881
Ensembl chr17:7,548,508...7,557,890
JBrowse link
G TNIP3 TNFAIP3 interacting protein 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TNIP3 mRNA CTD PMID:25510870 NCBI chr 4:121,131,408...121,227,483
Ensembl chr 4:121,131,408...121,227,466
JBrowse link
G TNPO1 transportin 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TNPO1 mRNA CTD PMID:23829299 NCBI chr 5:72,816,661...72,914,388
Ensembl chr 5:72,816,312...72,916,733
JBrowse link
G TNPO2 transportin 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TNPO2 mRNA CTD PMID:23829299 NCBI chr19:12,699,201...12,723,932
Ensembl chr19:12,699,201...12,724,011
JBrowse link
G TNRC18 trinucleotide repeat containing 18 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TNRC18 mRNA CTD PMID:25510870 NCBI chr 7:5,306,811...5,423,834
Ensembl chr 7:5,306,790...5,425,414
JBrowse link
G TNS3 tensin 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TNS3 mRNA CTD PMID:25510870 NCBI chr 7:47,275,154...47,582,586
Ensembl chr 7:47,275,154...47,582,558
JBrowse link
G TOLLIP toll interacting protein decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TOLLIP mRNA CTD PMID:23829299 NCBI chr11:1,274,371...1,309,632
Ensembl chr11:1,274,371...1,309,654
JBrowse link
G TOMM7 translocase of outer mitochondrial membrane 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TOMM7 mRNA CTD PMID:25510870 NCBI chr 7:22,812,974...22,822,849
Ensembl chr 7:22,812,628...22,822,849
JBrowse link
G TOP2A DNA topoisomerase II alpha multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TOP2A mRNA CTD PMID:25510870 NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896
JBrowse link
G TOPAZ1 testis and ovary specific TOPAZ 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TOPAZ1 mRNA CTD PMID:25510870 NCBI chr 3:44,241,886...44,336,689
Ensembl chr 3:44,241,886...44,332,098
JBrowse link
G TOPBP1 DNA topoisomerase II binding protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TOPBP1 mRNA CTD PMID:25510870 NCBI chr 3:133,600,238...133,661,941
Ensembl chr 3:133,598,175...133,662,380
JBrowse link
G TOR3A torsin family 3 member A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TOR3A mRNA CTD PMID:25510870 NCBI chr 1:179,082,070...179,095,996
Ensembl chr 1:179,082,070...179,098,023
JBrowse link
G TOX3 TOX high mobility group box family member 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TOX3 mRNA CTD PMID:25510870 NCBI chr16:52,436,416...52,547,802
Ensembl chr16:52,436,417...52,547,802
JBrowse link
G TP53 tumor protein p53 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TRP53 mRNA; [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TRP53 protein CTD PMID:25510870 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
JBrowse link
G TP53I11 tumor protein p53 inducible protein 11 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TRP53I11 mRNA CTD PMID:25510870 NCBI chr11:44,932,348...44,951,306
Ensembl chr11:44,885,903...44,951,306
JBrowse link
G TPGS1 tubulin polyglutamylase complex subunit 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TPGS1 mRNA CTD PMID:25510870 NCBI chr19:507,497...519,654
Ensembl chr19:507,497...519,654
JBrowse link
G TPM1 tropomyosin 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TPM1 mRNA CTD PMID:23829299 NCBI chr15:63,042,747...63,071,915
Ensembl chr15:63,042,620...63,071,915
JBrowse link
G TPM3 tropomyosin 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TPM3 mRNA CTD PMID:25510870 NCBI chr 1:154,155,308...154,192,100
Ensembl chr 1:154,155,308...154,194,648
JBrowse link
G TPM4 tropomyosin 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TPM4 mRNA CTD PMID:25510870 NCBI chr19:16,067,538...16,103,002
Ensembl chr19:16,067,021...16,103,002
JBrowse link
G TPX2 TPX2 microtubule nucleation factor multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TPX2 mRNA CTD PMID:25510870 NCBI chr20:31,739,290...31,801,800
Ensembl chr20:31,739,271...31,801,805
JBrowse link
G TRAIP TRAF interacting protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TRAIP mRNA CTD PMID:25510870 NCBI chr 3:49,828,601...49,856,564
Ensembl chr 3:49,828,601...49,856,574
JBrowse link
G TRANK1 tetratricopeptide repeat and ankyrin repeat containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TRANK1 mRNA CTD PMID:25510870 NCBI chr 3:36,826,819...36,945,744
Ensembl chr 3:36,826,819...36,945,057
JBrowse link
G TRDN triadin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TRDN mRNA CTD PMID:25510870 NCBI chr 6:123,216,339...123,636,950
Ensembl chr 6:123,216,339...123,637,189
JBrowse link
G TRIM54 tripartite motif containing 54 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TRIM54 mRNA CTD PMID:23829299 NCBI chr 2:27,282,429...27,307,435
Ensembl chr 2:27,282,429...27,307,439
JBrowse link
G TRIM59 tripartite motif containing 59 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TRIM59 mRNA CTD PMID:25510870 NCBI chr 3:160,435,503...160,449,786
Ensembl chr 3:160,432,445...160,485,773
JBrowse link
G TRIOBP TRIO and F-actin binding protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TRIOBP mRNA CTD PMID:25510870 NCBI chr22:37,697,048...37,776,556
Ensembl chr22:37,697,048...37,776,556
JBrowse link
G TRIP13 thyroid hormone receptor interactor 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TRIP13 mRNA CTD PMID:25510870 NCBI chr 5:892,884...919,348
Ensembl chr 5:892,884...919,357
JBrowse link
G TRMT10A tRNA methyltransferase 10A decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TRMT10A mRNA CTD PMID:23829299 NCBI chr 4:99,546,711...99,564,039
Ensembl chr 4:99,546,709...99,564,039
JBrowse link
G TROAP trophinin associated protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TROAP mRNA CTD PMID:25510870 NCBI chr12:49,323,255...49,331,731
Ensembl chr12:49,323,236...49,331,731
JBrowse link
G TRPC7 transient receptor potential cation channel subfamily C member 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TRPC7 mRNA CTD PMID:25510870 NCBI chr 5:136,212,745...136,365,545
Ensembl chr 5:136,212,745...136,365,545
JBrowse link
G TRPT1 tRNA phosphotransferase 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TRPT1 mRNA CTD PMID:23829299 NCBI chr11:64,223,799...64,226,257
Ensembl chr11:64,223,799...64,226,254
JBrowse link
G TSC22D2 TSC22 domain family member 2 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of TSC22D2 mRNA CTD PMID:23829299 NCBI chr 3:150,408,298...150,466,422
Ensembl chr 3:150,408,298...150,466,422
JBrowse link
G TSGA13 testis specific 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TSGA13 mRNA CTD PMID:25510870 NCBI chr 7:130,668,643...130,687,432
Ensembl chr 7:130,668,643...130,687,432
JBrowse link
G TSHB thyroid stimulating hormone subunit beta multiple interactions EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of and affects the secretion of TSHB protein CTD PMID:19750101 NCBI chr 1:115,029,826...115,034,309
Ensembl chr 1:115,029,826...115,034,302
JBrowse link
G TSHZ2 teashirt zinc finger homeobox 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TSHZ2 mRNA CTD PMID:25510870 NCBI chr20:52,972,358...53,495,330
Ensembl chr20:52,972,358...53,495,330
JBrowse link
G TSPAN18 tetraspanin 18 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TSPAN18 mRNA CTD PMID:25510870 NCBI chr11:44,726,310...44,932,423
Ensembl chr11:44,726,465...44,932,423
JBrowse link
G TSPAN2 tetraspanin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TSPAN2 mRNA CTD PMID:25510870 NCBI chr 1:115,048,011...115,089,503
Ensembl chr 1:115,048,011...115,089,503
JBrowse link
G TSPEAR thrombospondin type laminin G domain and EAR repeats multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TSPEAR mRNA CTD PMID:25510870 NCBI chr21:44,497,893...44,711,572
Ensembl chr21:44,497,893...44,711,572
JBrowse link
G TTC28 tetratricopeptide repeat domain 28 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TTC28 mRNA CTD PMID:25510870 NCBI chr22:27,978,014...28,679,840
Ensembl chr22:27,978,014...28,679,840
JBrowse link
G TTC3 tetratricopeptide repeat domain 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TTC3 mRNA CTD PMID:25510870 NCBI chr21:37,073,254...37,203,118
Ensembl chr21:37,073,226...37,203,112
JBrowse link
G TTC36 tetratricopeptide repeat domain 36 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TTC36 mRNA CTD PMID:25510870 NCBI chr11:118,527,474...118,530,993
Ensembl chr11:118,527,472...118,531,197
JBrowse link
G TTC39A tetratricopeptide repeat domain 39A multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TTC39A mRNA CTD PMID:25510870 NCBI chr 1:51,287,258...51,345,116
Ensembl chr 1:51,287,258...51,345,116
JBrowse link
G TTF2 transcription termination factor 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TTF2 mRNA CTD PMID:25510870 NCBI chr 1:117,060,326...117,107,453
Ensembl chr 1:117,060,326...117,107,453
JBrowse link
G TTK TTK protein kinase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TTK mRNA CTD PMID:25510870 NCBI chr 6:80,004,649...80,042,527
Ensembl chr 6:80,003,887...80,042,527
JBrowse link
G TTLL13 tubulin tyrosine ligase like 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TTLL13 mRNA CTD PMID:25510870 NCBI chr15:90,249,556...90,265,477
Ensembl chr15:90,249,530...90,265,482
JBrowse link
G TTLL5 tubulin tyrosine ligase like 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TTLL5 mRNA CTD PMID:25510870 NCBI chr14:75,661,246...75,955,079
Ensembl chr14:75,633,625...75,955,079
JBrowse link
G TTLL7 tubulin tyrosine ligase like 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TTLL7 mRNA CTD PMID:25510870 NCBI chr 1:83,865,024...83,999,132
Ensembl chr 1:83,865,024...83,999,150
JBrowse link
G TTPA alpha tocopherol transfer protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TTPA mRNA CTD PMID:25510870 NCBI chr 8:63,058,409...63,086,053
Ensembl chr 8:63,048,553...63,086,053
JBrowse link
G TTR transthyretin multiple interactions
affects binding
ISO
EXP
[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TTR mRNA
2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [Thyroxine binds to TTR protein]
2,2',3',4,4',5-hexachlorobiphenyl binds to TTR protein
CTD PMID:21357386 PMID:25510870 NCBI chr18:31,591,877...31,598,821
Ensembl chr18:31,557,009...31,598,833
JBrowse link
G TUBA1B tubulin alpha 1b decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TUBA1B protein CTD PMID:21673325 NCBI chr12:49,127,782...49,131,395
Ensembl chr12:49,127,782...49,131,397
JBrowse link
G TUBA3C tubulin alpha 3c multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TUBA3A mRNA CTD PMID:25510870 NCBI chr13:19,173,772...19,181,824
Ensembl chr13:19,173,772...19,181,824
JBrowse link
G TUBA4A tubulin alpha 4a decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TUBA4A protein CTD PMID:21673325 NCBI chr 2:219,249,710...219,254,740
Ensembl chr 2:219,249,710...219,277,902
JBrowse link
G TUBA8 tubulin alpha 8 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TUBA8 mRNA CTD PMID:25510870 NCBI chr22:18,110,809...18,131,732
Ensembl chr22:18,110,100...18,146,683
JBrowse link
G TUBG2 tubulin gamma 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TUBG2 mRNA CTD PMID:25510870 NCBI chr17:42,659,284...42,667,006
Ensembl chr17:42,659,284...42,667,006
JBrowse link
G TUG1 taurine up-regulated 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TUG1 mRNA CTD PMID:25510870 NCBI chr22:30,969,265...30,979,395
Ensembl chr22:30,969,245...30,979,395
JBrowse link
G TXNRD2 thioredoxin reductase 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TXNRD2 mRNA CTD PMID:23829299 NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820
JBrowse link
G UAP1L1 UDP-N-acetylglucosamine pyrophosphorylase 1 like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UAP1L1 mRNA CTD PMID:25510870 NCBI chr 9:137,077,517...137,084,538
Ensembl chr 9:137,077,517...137,084,539
JBrowse link
G UBAP1L ubiquitin associated protein 1 like decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of UBAP1L mRNA CTD PMID:23829299 NCBI chr15:65,092,760...65,115,200
Ensembl chr15:65,092,760...65,115,200
JBrowse link
G UBASH3B ubiquitin associated and SH3 domain containing B increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of UBASH3B mRNA CTD PMID:23829299 NCBI chr11:122,655,722...122,814,473
Ensembl chr11:122,655,722...122,814,473
JBrowse link
G UBE2C ubiquitin conjugating enzyme E2 C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UBE2C mRNA CTD PMID:25510870 NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957
JBrowse link
G UBE2E1 ubiquitin conjugating enzyme E2 E1 affects expression EXP 2,2',3',4,4',5-hexachlorobiphenyl affects the expression of UBE2E1 mRNA CTD PMID:21703328 NCBI chr 3:23,805,955...23,891,640
Ensembl chr 3:23,805,955...23,891,640
JBrowse link
G UBE2L6 ubiquitin conjugating enzyme E2 L6 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of UBE2L6 mRNA CTD PMID:23829299 NCBI chr11:57,551,662...57,567,935
Ensembl chr11:57,551,656...57,568,284
JBrowse link
G UBE2T ubiquitin conjugating enzyme E2 T multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UBE2T mRNA CTD PMID:25510870 NCBI chr 1:202,331,657...202,341,936
Ensembl chr 1:202,331,544...202,341,984
JBrowse link
G UBE2W ubiquitin conjugating enzyme E2 W multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UBE2W mRNA CTD PMID:25510870 NCBI chr 8:73,780,096...73,878,862
Ensembl chr 8:73,780,097...73,878,910
JBrowse link
G UBN2 ubinuclein 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UBN2 mRNA CTD PMID:25510870 NCBI chr 7:139,231,237...139,330,428
Ensembl chr 7:139,230,356...139,308,236
JBrowse link
G UCMA upper zone of growth plate and cartilage matrix associated increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of UCMA mRNA CTD PMID:23829299 NCBI chr10:13,221,766...13,234,374
Ensembl chr10:13,221,766...13,234,374
JBrowse link
G UHMK1 U2AF homology motif kinase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UHMK1 mRNA CTD PMID:25510870 NCBI chr 1:162,497,174...162,529,631
Ensembl chr 1:162,497,251...162,529,631
JBrowse link
G UHRF1 ubiquitin like with PHD and ring finger domains 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UHRF1 mRNA CTD PMID:25510870 NCBI chr19:4,903,080...4,962,154
Ensembl chr19:4,903,080...4,962,154
JBrowse link
G UIMC1 ubiquitin interaction motif containing 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UIMC1 mRNA CTD PMID:25510870 NCBI chr 5:176,905,005...177,022,602
Ensembl chr 5:176,905,005...177,022,633
JBrowse link
G ULBP1 UL16 binding protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ULBP1 mRNA CTD PMID:25510870 NCBI chr 6:149,963,943...149,973,715
Ensembl chr 6:149,963,943...149,973,715
JBrowse link
G UNC45B unc-45 myosin chaperone B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UNC45B mRNA CTD PMID:25510870 NCBI chr17:35,147,817...35,189,345
Ensembl chr17:35,147,817...35,189,345
JBrowse link
G UNC80 unc-80 homolog, NALCN channel complex subunit multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UNC80 mRNA CTD PMID:25510870 NCBI chr 2:209,771,832...209,999,296
Ensembl chr 2:209,771,569...209,999,300
JBrowse link
G UPF2 UPF2 regulator of nonsense mediated mRNA decay decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of UPF2 mRNA CTD PMID:23829299 NCBI chr10:11,920,022...12,043,170
Ensembl chr10:11,920,022...12,043,170
JBrowse link
G UQCR10 ubiquinol-cytochrome c reductase, complex III subunit X multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UQCR10 mRNA CTD PMID:25510870 NCBI chr22:29,767,369...29,770,413
Ensembl chr22:29,767,369...29,770,413
JBrowse link
G UQCR11 ubiquinol-cytochrome c reductase, complex III subunit XI multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UQCR11 mRNA CTD PMID:25510870 NCBI chr19:1,597,169...1,605,462
Ensembl chr19:1,597,169...1,605,473
JBrowse link
G UQCRC1 ubiquinol-cytochrome c reductase core protein 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of UQCRC1 protein CTD PMID:21673325 NCBI chr 3:48,599,002...48,609,646
Ensembl chr 3:48,599,002...48,610,976
JBrowse link
G UQCRH ubiquinol-cytochrome c reductase hinge protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UQCRH mRNA CTD PMID:25510870 NCBI chr 1:46,303,698...46,316,776
Ensembl chr 1:46,303,698...46,316,776
JBrowse link
G URAD ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of URAD mRNA CTD PMID:25510870 NCBI chr13:27,977,717...27,988,693
Ensembl chr13:27,977,717...27,988,693
JBrowse link
G URB1 URB1 ribosome biogenesis homolog multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of URB1 mRNA CTD PMID:25510870 NCBI chr21:32,311,018...32,393,012
Ensembl chr21:32,311,018...32,393,012
JBrowse link
G URB2 URB2 ribosome biogenesis homolog multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of URB2 mRNA CTD PMID:25510870 NCBI chr 1:229,626,247...229,660,200
Ensembl chr 1:229,626,247...229,660,200
JBrowse link
G USH1C USH1 protein network component harmonin multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of USH1C mRNA CTD PMID:25510870 NCBI chr11:17,493,900...17,544,416
Ensembl chr11:17,493,895...17,544,416
JBrowse link
G USH1G USH1 protein network component sans decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of USH1G mRNA CTD PMID:23829299 NCBI chr17:74,916,083...74,923,255
Ensembl chr17:74,916,083...74,923,256
JBrowse link
G USP17L5 ubiquitin specific peptidase 17 like family member 5 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of USP17LA mRNA CTD PMID:25510870 NCBI chr 4:9,339,403...9,340,995
Ensembl chr 4:9,339,403...9,340,995
JBrowse link
G USP31 ubiquitin specific peptidase 31 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of USP31 mRNA CTD PMID:25510870 NCBI chr16:23,061,406...23,149,452
Ensembl chr16:23,061,406...23,149,452
JBrowse link
G USP33 ubiquitin specific peptidase 33 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of USP33 mRNA CTD PMID:23829299 NCBI chr 1:77,695,987...77,759,852
Ensembl chr 1:77,695,987...77,759,852
JBrowse link
G USP43 ubiquitin specific peptidase 43 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of USP43 mRNA CTD PMID:25510870 NCBI chr17:9,645,260...9,729,687
Ensembl chr17:9,644,698...9,729,687
JBrowse link
G USP44 ubiquitin specific peptidase 44 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of USP44 mRNA CTD PMID:25510870 NCBI chr12:95,516,560...95,551,681
Ensembl chr12:95,516,560...95,551,476
JBrowse link
G USP49 ubiquitin specific peptidase 49 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of USP49 mRNA CTD PMID:25510870 NCBI chr 6:41,789,896...41,895,375
Ensembl chr 6:41,789,896...41,895,375
JBrowse link
G UTS2 urotensin 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UTS2 mRNA CTD PMID:25510870 NCBI chr 1:7,847,612...7,913,249
Ensembl chr 1:7,843,083...7,853,512
JBrowse link
G UTS2B urotensin 2B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UTS2B mRNA CTD PMID:25510870 NCBI chr 3:191,267,168...191,346,182
Ensembl chr 3:191,267,168...191,330,526
JBrowse link
G UXS1 UDP-glucuronate decarboxylase 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UXS1 mRNA CTD PMID:25510870 NCBI chr 2:106,093,311...106,194,301
Ensembl chr 2:106,093,308...106,194,301
JBrowse link
G VAMP1 vesicle associated membrane protein 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VAMP1 mRNA CTD PMID:25510870 NCBI chr12:6,462,237...6,470,677
Ensembl chr12:6,462,237...6,470,677
JBrowse link
G VAMP2 vesicle associated membrane protein 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of VAMP2 mRNA CTD PMID:23829299 NCBI chr17:8,159,147...8,162,948
Ensembl chr17:8,159,149...8,163,546
JBrowse link
G VDAC1 voltage dependent anion channel 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of VDAC1 protein CTD PMID:21673325 NCBI chr 5:133,971,871...134,114,540
Ensembl chr 5:133,971,871...134,004,975
JBrowse link
G VEGFD vascular endothelial growth factor D multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of VEGFD mRNA CTD PMID:25510870 NCBI chr  X:15,345,596...15,384,413
Ensembl chr  X:15,345,596...15,384,413
JBrowse link
G VIPR1 vasoactive intestinal peptide receptor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of VIPR1 mRNA CTD PMID:25510870 NCBI chr 3:42,489,299...42,537,568
Ensembl chr 3:42,489,299...42,537,573
JBrowse link
G VMO1 vitelline membrane outer layer 1 homolog decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of VMO1 mRNA CTD PMID:23829299 NCBI chr17:4,785,285...4,786,364
Ensembl chr17:4,785,285...4,786,433
JBrowse link
G VMP1 vacuole membrane protein 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of VMP1 mRNA CTD PMID:23829299 NCBI chr17:59,707,654...59,842,255
Ensembl chr17:59,707,192...59,842,255
JBrowse link
G VPS4A vacuolar protein sorting 4 homolog A decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of VPS4A mRNA CTD PMID:23829299 NCBI chr16:69,311,350...69,326,939
Ensembl chr16:69,311,336...69,326,939
JBrowse link
G VSIG10 V-set and immunoglobulin domain containing 10 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of VSIG10 mRNA CTD PMID:25510870 NCBI chr12:118,063,593...118,104,011
Ensembl chr12:118,063,593...118,136,026
JBrowse link
G VSTM2L V-set and transmembrane domain containing 2 like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VSTM2L mRNA CTD PMID:25510870 NCBI chr20:37,903,127...37,945,350
Ensembl chr20:37,903,111...37,945,350
JBrowse link
G VTCN1 V-set domain containing T cell activation inhibitor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VTCN1 mRNA CTD PMID:25510870 NCBI chr 1:117,143,587...117,210,927
Ensembl chr 1:117,143,587...117,210,960
JBrowse link
G VWA5B2 von Willebrand factor A domain containing 5B2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of VWA5B2 mRNA CTD PMID:23829299 NCBI chr 3:184,229,585...184,242,329
Ensembl chr 3:184,229,585...184,242,329
JBrowse link
G VWA7 von Willebrand factor A domain containing 7 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of VWA7 mRNA CTD PMID:23829299 NCBI chr 6:31,765,590...31,777,328
Ensembl chr 6:31,765,590...31,777,328
JBrowse link
G VWC2L von Willebrand factor C domain containing 2 like multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VWC2L mRNA CTD PMID:25510870 NCBI chr 2:214,411,054...214,578,976
Ensembl chr 2:214,411,054...214,578,976
JBrowse link
G VWCE von Willebrand factor C and EGF domains decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of VWCE mRNA CTD PMID:23829299 NCBI chr11:61,258,286...61,295,316
Ensembl chr11:61,258,286...61,295,316
JBrowse link
G WASF3 WASP family member 3 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WASF3 mRNA CTD PMID:25510870 NCBI chr13:26,539,139...26,688,948
Ensembl chr13:26,557,683...26,688,948
JBrowse link
G WDR35 WD repeat domain 35 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of WDR35 mRNA CTD PMID:23829299 NCBI chr 2:19,910,263...19,990,105
Ensembl chr 2:19,910,263...19,990,105
JBrowse link
G WDR41 WD repeat domain 41 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WDR41 mRNA CTD PMID:25510870 NCBI chr 5:77,430,933...77,620,577
Ensembl chr 5:77,425,970...77,620,611
JBrowse link
G WDR45B WD repeat domain 45B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of WDR45B mRNA CTD PMID:25510870 NCBI chr17:82,614,562...82,648,444
Ensembl chr17:82,614,562...82,648,553
JBrowse link
G WDR72 WD repeat domain 72 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WDR72 mRNA CTD PMID:25510870 NCBI chr15:53,513,741...53,762,878
Ensembl chr15:53,513,741...53,762,878
JBrowse link
G WFDC2 WAP four-disulfide core domain 2 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WFDC2 mRNA CTD PMID:25510870 NCBI chr20:45,469,753...45,481,532
Ensembl chr20:45,469,753...45,481,532
JBrowse link
G WFDC5 WAP four-disulfide core domain 5 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of WFDC5 mRNA CTD PMID:23829299 NCBI chr20:45,109,463...45,116,319
Ensembl chr20:45,109,452...45,115,174
JBrowse link
G WIPI2 WD repeat domain, phosphoinositide interacting 2 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of WIPI2 mRNA CTD PMID:23829299 NCBI chr 7:5,190,233...5,233,855
Ensembl chr 7:5,190,196...5,233,840
JBrowse link
G WNT2B Wnt family member 2B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WNT2B mRNA CTD PMID:25510870 NCBI chr 1:112,466,541...112,530,165
Ensembl chr 1:112,466,541...112,530,165
JBrowse link
G WNT8B Wnt family member 8B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WNT8B mRNA CTD PMID:25510870 NCBI chr10:100,463,009...100,483,744
Ensembl chr10:100,463,009...100,483,744
JBrowse link
G WRAP53 WD repeat containing antisense to TP53 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of WRAP53 mRNA CTD PMID:23829299 NCBI chr17:7,686,071...7,703,502
Ensembl chr17:7,686,071...7,703,502
JBrowse link
G WWOX WW domain containing oxidoreductase multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of WWOX mRNA CTD PMID:25510870 NCBI chr16:78,099,654...79,212,667
Ensembl chr16:78,099,400...79,212,667
JBrowse link
G XCR1 X-C motif chemokine receptor 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of XCR1 mRNA CTD PMID:25510870 NCBI chr 3:46,017,007...46,085,844
Ensembl chr 3:46,016,990...46,085,825
JBrowse link
G XIAP X-linked inhibitor of apoptosis increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of XIAP protein CTD PMID:29704545 NCBI chr  X:123,859,708...123,913,972
Ensembl chr  X:123,859,712...123,913,972
JBrowse link
G XK X-linked Kx blood group antigen, Kell and VPS13A binding protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of XK mRNA CTD PMID:25510870 NCBI chr  X:37,685,791...37,732,130
Ensembl chr  X:37,685,791...37,732,130
JBrowse link
G XKR7 XK related 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of XKR7 mRNA CTD PMID:25510870 NCBI chr20:31,968,151...32,003,387
Ensembl chr20:31,968,151...32,003,387
JBrowse link
G XPO7 exportin 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of XPO7 mRNA CTD PMID:25510870 NCBI chr 8:21,919,662...22,006,585
Ensembl chr 8:21,919,662...22,006,585
JBrowse link
G XPR1 xenotropic and polytropic retrovirus receptor 1 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of XPR1 mRNA CTD PMID:23829299 NCBI chr 1:180,632,022...180,890,279
Ensembl chr 1:180,632,022...180,890,279
JBrowse link
G YPEL1 yippee like 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of YPEL1 mRNA CTD PMID:25510870 NCBI chr22:21,697,536...21,735,794
Ensembl chr22:21,697,536...21,735,794
JBrowse link
G YPEL5 yippee like 5 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of YPEL5 mRNA CTD PMID:23829299 NCBI chr 2:30,147,007...30,160,533
Ensembl chr 2:30,146,941...30,160,533
JBrowse link
G YWHAB tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of YWHAB protein CTD PMID:21673325 NCBI chr20:44,885,705...44,908,532
Ensembl chr20:44,885,702...44,908,532
JBrowse link
G YWHAG tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of YWHAG protein CTD PMID:21673325 NCBI chr 7:76,326,799...76,358,991
Ensembl chr 7:76,326,799...76,358,991
JBrowse link
G YWHAH tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of YWHAH protein CTD PMID:21673325 NCBI chr22:31,944,535...31,957,603
Ensembl chr22:31,944,522...31,957,603
JBrowse link
G YWHAQ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of YWHAQ protein CTD PMID:21673325 NCBI chr 2:9,583,967...9,630,997
Ensembl chr 2:9,583,967...9,630,997
JBrowse link
G YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of YWHAZ protein CTD PMID:21673325 NCBI chr 8:100,916,523...100,953,382
Ensembl chr 8:100,916,523...100,953,388
JBrowse link
G ZBTB10 zinc finger and BTB domain containing 10 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZBTB10 mRNA CTD PMID:25510870 NCBI chr 8:80,485,593...80,526,265
Ensembl chr 8:80,485,619...80,526,265
JBrowse link
G ZBTB20 zinc finger and BTB domain containing 20 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZBTB20 mRNA CTD PMID:25510870 NCBI chr 3:114,314,500...115,147,288
Ensembl chr 3:114,314,500...115,147,292
JBrowse link
G ZBTB39 zinc finger and BTB domain containing 39 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZBTB39 mRNA CTD PMID:25510870 NCBI chr12:56,998,836...57,006,546
Ensembl chr12:56,998,836...57,006,546
JBrowse link
G ZBTB49 zinc finger and BTB domain containing 49 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZBTB49 mRNA CTD PMID:25510870 NCBI chr 4:4,290,251...4,321,783
Ensembl chr 4:4,290,251...4,321,786
JBrowse link
G ZBTB7B zinc finger and BTB domain containing 7B multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZBTB7B mRNA CTD PMID:25510870 NCBI chr 1:155,001,750...155,018,523
Ensembl chr 1:155,002,630...155,018,523
JBrowse link
G ZC3HAV1 zinc finger CCCH-type containing, antiviral 1 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ZC3HAV1 mRNA CTD PMID:23829299 NCBI chr 7:139,043,515...139,109,720
Ensembl chr 7:139,043,515...139,132,122
JBrowse link
G ZCCHC13 zinc finger CCHC-type containing 13 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZCCHC13 mRNA CTD PMID:25510870 NCBI chr  X:74,304,180...74,305,034
Ensembl chr  X:74,304,180...74,305,034
JBrowse link
G ZEB1 zinc finger E-box binding homeobox 1 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZEB1 mRNA CTD PMID:25510870 NCBI chr10:31,318,417...31,529,804
Ensembl chr10:31,318,495...31,529,814
JBrowse link
G ZEB2 zinc finger E-box binding homeobox 2 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ZEB2 mRNA CTD PMID:23829299 NCBI chr 2:144,384,081...144,520,119
Ensembl chr 2:144,364,364...144,521,057
JBrowse link
G ZFHX4 zinc finger homeobox 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFHX4 mRNA CTD PMID:25510870 NCBI chr 8:76,681,247...76,867,281
Ensembl chr 8:76,681,239...76,867,281
JBrowse link
G ZFP42 ZFP42 zinc finger protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZFP42 mRNA CTD PMID:25510870 NCBI chr 4:187,995,771...188,005,246
Ensembl chr 4:187,995,771...188,005,046
JBrowse link
G ZFP57 ZFP57 zinc finger protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP57 mRNA CTD PMID:25510870 NCBI chr 6:29,672,392...29,681,152
Ensembl chr 6:29,672,483...29,681,155
JBrowse link
G ZIC4 Zic family member 4 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZIC4 mRNA CTD PMID:25510870 NCBI chr 3:147,386,046...147,406,543
Ensembl chr 3:147,386,046...147,406,809
JBrowse link
G ZMYND15 zinc finger MYND-type containing 15 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZMYND15 mRNA CTD PMID:25510870 NCBI chr17:4,739,833...4,746,119
Ensembl chr17:4,739,833...4,746,119
JBrowse link
G ZMYND19 zinc finger MYND-type containing 19 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ZMYND19 mRNA CTD PMID:23829299 NCBI chr 9:137,582,081...137,590,512
Ensembl chr 9:137,582,081...137,590,512
JBrowse link
G ZNF157 zinc finger protein 157 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP157 mRNA CTD PMID:25510870 NCBI chr  X:47,370,578...47,414,498
Ensembl chr  X:47,370,578...47,414,498
JBrowse link
G ZNF182 zinc finger protein 182 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP182 mRNA CTD PMID:25510870 NCBI chr  X:47,974,851...48,003,989
Ensembl chr  X:47,974,851...48,003,989
JBrowse link
G ZNF184 zinc finger protein 184 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP184 mRNA CTD PMID:25510870 NCBI chr 6:27,404,006...27,473,105
Ensembl chr 6:27,450,743...27,473,118
JBrowse link
G ZNF22 zinc finger protein 22 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP422 mRNA CTD PMID:25510870 NCBI chr10:45,000,923...45,005,326
Ensembl chr10:45,000,923...45,005,326
JBrowse link
G ZNF250 zinc finger protein 250 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP647 mRNA CTD PMID:25510870 NCBI chr 8:144,876,955...144,902,177
Ensembl chr 8:144,876,497...144,902,168
JBrowse link
G ZNF277 zinc finger protein 277 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ZNF277 mRNA CTD PMID:23829299 NCBI chr 7:112,206,695...112,343,934
Ensembl chr 7:112,206,695...112,343,934
JBrowse link
G ZNF282 zinc finger protein 282 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZFP282 mRNA CTD PMID:25510870 NCBI chr 7:149,195,546...149,226,243
Ensembl chr 7:149,195,546...149,226,238
JBrowse link
G ZNF366 zinc finger protein 366 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP366 mRNA CTD PMID:25510870 NCBI chr 5:72,439,903...72,507,410
Ensembl chr 5:72,439,903...72,507,410
JBrowse link
G ZNF367 zinc finger protein 367 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZFP367 mRNA CTD PMID:25510870 NCBI chr 9:96,385,941...96,418,370
Ensembl chr 9:96,385,941...96,418,370
JBrowse link
G ZNF385C zinc finger protein 385C multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZFP385C mRNA CTD PMID:25510870 NCBI chr17:42,025,576...42,098,473
Ensembl chr17:42,025,576...42,098,479
JBrowse link
G ZNF397 zinc finger protein 397 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP397 mRNA CTD PMID:25510870 NCBI chr18:35,241,034...35,259,227
Ensembl chr18:35,241,030...35,267,133
JBrowse link
G ZNF467 zinc finger protein 467 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZFP467 mRNA CTD PMID:25510870 NCBI chr 7:149,764,182...149,776,530
Ensembl chr 7:149,764,182...149,773,588
JBrowse link
G ZNF473 zinc finger protein 473 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP473 mRNA CTD PMID:25510870 NCBI chr19:50,026,005...50,048,776
Ensembl chr19:50,025,714...50,053,414
JBrowse link
G ZNF496 zinc finger protein 496 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZKSCAN17 mRNA CTD PMID:25510870 NCBI chr 1:247,297,415...247,331,867
Ensembl chr 1:247,297,412...247,331,867
JBrowse link
G ZNF521 zinc finger protein 521 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ZNF521 mRNA CTD PMID:23829299 NCBI chr18:25,061,924...25,352,166
Ensembl chr18:25,061,924...25,352,190
JBrowse link
G ZNF526 zinc finger protein 526 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP526 mRNA CTD PMID:25510870 NCBI chr19:42,220,312...42,228,201
Ensembl chr19:42,220,292...42,228,201
JBrowse link
G ZNF606 zinc finger protein 606 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP606 mRNA CTD PMID:25510870 NCBI chr19:57,977,053...58,003,346
Ensembl chr19:57,977,076...58,003,349
JBrowse link
G ZNF618 zinc finger protein 618 decreases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ZNF618 mRNA CTD PMID:23829299 NCBI chr 9:113,876,309...114,056,593
Ensembl chr 9:113,876,282...114,056,593
JBrowse link
G ZNF646 zinc finger protein 646 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP646 mRNA CTD PMID:25510870 NCBI chr16:31,072,687...31,084,196
Ensembl chr16:31,074,422...31,084,196
JBrowse link
G ZNF7 zinc finger protein 7 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP7 mRNA CTD PMID:25510870 NCBI chr 8:144,827,560...144,847,508
Ensembl chr 8:144,827,518...144,847,509
JBrowse link
G ZNF76 zinc finger protein 76 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP523 mRNA CTD PMID:25510870 NCBI chr 6:35,259,533...35,295,985
Ensembl chr 6:35,258,909...35,295,985
JBrowse link
G ZNF773 zinc finger protein 773 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP772 mRNA CTD PMID:25510870 NCBI chr19:57,499,938...57,518,437
Ensembl chr19:57,499,915...57,518,404
JBrowse link
G ZNF785 zinc finger protein 785 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZFP459 mRNA CTD PMID:25510870 NCBI chr16:30,578,361...30,585,697
Ensembl chr16:30,573,740...30,585,769
JBrowse link
G ZNF846 zinc finger protein 846 increases expression ISO 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ZNF846 mRNA CTD PMID:23829299 NCBI chr19:9,748,619...9,786,160
Ensembl chr19:9,751,993...9,793,180
JBrowse link
G ZNHIT6 zinc finger HIT-type containing 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZNHIT6 mRNA CTD PMID:25510870 NCBI chr 1:85,649,417...85,708,433
Ensembl chr 1:85,649,417...85,708,433
JBrowse link
G ZSCAN30 zinc finger and SCAN domain containing 30 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZSCAN30 mRNA CTD PMID:25510870 NCBI chr18:35,251,062...35,290,229
Ensembl chr18:35,251,058...35,290,245
JBrowse link
G ZSWIM6 zinc finger SWIM-type containing 6 multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZSWIM6 mRNA CTD PMID:25510870 NCBI chr 5:61,332,258...61,546,172
Ensembl chr 5:61,332,258...61,546,172
JBrowse link
G ZWILCH zwilch kinetochore protein multiple interactions ISO [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZWILCH mRNA CTD PMID:25510870 NCBI chr15:66,505,326...66,550,130
Ensembl chr15:66,504,959...66,550,130
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 26040
    role 25956
      chemical role 24245
        environmental contaminant 20868
          persistent organic pollutant 17375
            polychlorobiphenyl 6073
              PCB138 1913
Path 2
Term Annotations click to browse term
  CHEBI ontology 26040
    subatomic particle 26015
      composite particle 26015
        hadron 26015
          baryon 26015
            nucleon 26015
              atomic nucleus 26015
                atom 26015
                  main group element atom 25840
                    main group molecular entity 25840
                      s-block molecular entity 25160
                        hydrogen molecular entity 24758
                          hydrides 22970
                            organic hydride 21930
                              organic fundamental parent 21930
                                hydrocarbon 21357
                                  halohydrocarbon 16103
                                    haloarene 6452
                                      chloroarene 6075
                                        chlorobiphenyl 6075
                                          polychlorobiphenyl 6073
                                            PCB138 1913
paths to the root